pmcid,label,caption,graphic,disease,modality
PMC1638294,Figure 1,,envhper00309-0150-a,Empty,Empty
PMC1638294,Figure 2,,envhper00309-0151-a,Empty,Empty
PMC2808613,Fig. 1,"Computed tomographic (CT) scan of thorax demonstrates a homogeneous mass expanding the right seventh rib and invading into the adjacent lung, and also a right sided pleural effusion.",jkms-20-316-g001,NotMatch,NotMatch
PMC2808613,Fig. 2,Preoperative angiography shows hypervascularization of the tumor from the right 7th and 8th intercostal arteries.,jkms-20-316-g002,NotMatch,NotMatch
PMC2808613,Fig. 3,"Microscopic evaluation of the tumor reveals a solid mesencymal mass composed of indistinct fusiform to rounded cells arranged around slit-like and branching thin-walled vessels (Hematoxylin-Eosin, ×120).",jkms-20-316-g003,NotMatch,NotMatch
PMC2409972,Figure 1,"Overall survival following surgery, according to tumour size (⩽5 vs >5 cm). The numbers in parentheses indicate the number of patients still at risk at selected time points.",91-6601920f1,NotMatch,NotMatch
PMC1459159,Figure 1,Chest X-ray showing an abnormal shadow associated with ipsilateral pleural effusion.,1477-7819-4-23-1,NotMatch,NotMatch
PMC1459159,Figure 2,Preoperative computed tomographic scan demonstrated a tumor mass located in the mediastinum next to descending aorta and associated with pleural effusion.,1477-7819-4-23-2,NotMatch,NotMatch
PMC1459159,Figure 3,"Round and spindle cells surrounded by thin-walled, endothelium-lined vascular channels, giving a ""staghorn"" appearance to the vessels as typically seen in hemangiopericytoma (Hematoxylin and eosin stain ×400).",1477-7819-4-23-3,Match,NotMatch
PMC1459159,Figure 4,Tumor cells clearly positive for a-SMA (anti-smooth-muscle-actin) protein (×400).,1477-7819-4-23-4,NotMatch,NotMatch
PMC1352359,Figure 1,"Resected specimen measured 18 × 12 × 6 cm and cut surface showed multiple lobulated, solid, well circumscribed nodules of variable sizes 1 cm to 7 cm in diameter with areas of hemorrhage and cystic degeneration.",1477-7819-3-77-1,NotMatch,NotMatch
PMC1352359,Figure 2,"(a) shows dilated, sinuous vascular channels surrounded by oval to spindle tumor cells, having scanty cytoplasm and hyperchromatic nuclei, mitotic figures occasional present (Hematoxylin & Eosin ×200); (b) Reticulin stain (×200) shows intricate reticulum laid down around tumor cells and dilated vascular channels; (c) & (d) shows fibrous capsule of the tumor along with areas of necrosis (Hematoxylin & Eosin ×50).",1477-7819-3-77-2,NotMatch,NotMatch
PMC1852394,Figure 1,"Enhanced computed tomography exhibited a well-defined heterogeneous tumor with contrast enhancement in the left lower quadrant of the abdomen, and demonstrated that the left gastroepiploic artery (arrow) was feeding the tumor.",11605_2007_99_Fig1_HTML,NotMatch,NotMatch
PMC1852394,Figure 2,A solitary tumor arose in the greater omentum and was connected with the greater omentum by a vascular pedicle.,11605_2007_99_Fig2_HTML,NotMatch,NotMatch
PMC1852394,Figure 3,"The resected tumor measured 55 × 45 × 40 mm, weighed 68.5 g, and was solid and encapsulated without central necrosis or hemorrhage.",11605_2007_99_Fig3_HTML,NotMatch,NotMatch
PMC1693778,Figure 1,"A 57-year-old man with hepatic metastases of retroperitoneal hemangiopericytoma. (a) Contrast-enhanced CT reveals a mass in the left lobe. (b) T1-weighted MR image at baseline shows a mass in the left lobe. (c) Gd-BOPTA-enhanced axial T1-weighted MR image in the dynamic phase shows homogeneous enhancement of the left lobe liver lesion with multiple signal flow voids representing large tumour vessels. (d) The corresponding image of Gd-BOPTA in the delayed phase shows the wash-out of contrast agent from the metastasis with delineation. (e) T2-weighted MR image before ferumoxides. (f) Ferumoxides-enhanced axial spin-echo T2-weighted MR image reveals lesion to have homogeneously increased signal. Prominent signal voids correspond to enlarged vessels. (g) Angiography shows three tumour lesions (arrows) and demonstrates increase in the size and number of feeding arteries and a profusion of draining veins. (h) Unenhanced US scan of the liver with detection of multiple hypoechoic lesions (arrow indicates the one highlighted in this image). (i) Following BR1 administration, in the same scan of (h), the metastasis is clearly depicted and appears hyperechoic in the arterial phase (arrow). (j) In the portal venous phase, the lesion shows a central hypoechoic area with peripheral hyperechoic ring (arrow). (k) In the delayed phase, the lesion appears hypoechoic (arrow). ",ci06005601,Match,NotMatch
PMC2071213,Fig. 6-11,,brjcancer00497-0123-a,Empty,Empty
PMC2071213,Fig. 4-5,,brjcancer00497-0122-a,Empty,Empty
PMC2071213,Figs. 18-22,,brjcancer00497-0125-a,Empty,Empty
PMC2071213,Figs. 2-3,,brjcancer00497-0121-a,Empty,Empty
PMC2071213,Figs. 12-17,,brjcancer00497-0124-a,Empty,Empty
PMC1906779,Figure 1,Tumor the greater omentum adjacent to a transverse colon in situ.,1477-7819-5-63-1,NotMatch,NotMatch
PMC1906779,Figure 2,Tumor of the jejunum mesentery (arrow) in situ.,1477-7819-5-63-2,NotMatch,NotMatch
PMC1906779,Figure 3,Retroperitoneal space tumor with the infiltrated part of the diaphragm and the segment VII of the liver – postoperative specimen.,1477-7819-5-63-3,NotMatch,NotMatch
PMC1906779,Figure 4,Site of organ removal.,1477-7819-5-63-4,NotMatch,NotMatch
PMC2627159,Fig. 1,"The normal anatomy of the lacrimal gland and fossa.A. A transverse T2-weighted MR image at the level of the lacrimal gland shows almond-shaped lacrimal glands at the superior lateral aspect of both eyeglobes (arrows).B. A coronal T2-weighted MR image at the level of the lacrimal gland and aponeurosis of the levator palpebrae muscle shows continuous extension of the aponeurosis into the lacrimal gland, which divides the gland into anterior palpebral and deeper orbital lobes (arrowheads).C. A coronal enhanced T1-weighted MR image shows well-enhanced lacrimal glands (arrows).",kjr-8-336-g001,NotMatch,NotMatch
PMC2627159,Fig. 2,"A pleomorphic adenoma in a 44-year-old man.A. A well-circumscribed, spherical tumor is seen in the left lacrimal fossa with heterogeneous intermediate signal intensity on a T2-weighted image (arrow).B. On a gadolinium enhanced T1-weighted image, strong enhancement is noted in the mass (arrow).",kjr-8-336-g002,NotMatch,NotMatch
PMC2627159,Fig. 3,"A pleomorphic adenoma in a 63-year-old woman.A. A well-circumscribed mass is seen in the right lacrimal fossa with heterogenous high signal intensity on T2-weighted images (arrowheads).B. On a gadolinium enhanced T1-weighted image, the tumor shows strong enhancement with poorly enhanced areas (arrowheads), representing cystic changes.",kjr-8-336-g003,NotMatch,NotMatch
PMC2627159,Fig. 4,An adenoid cystic carcinoma in a 55-year-old man.A. Contrast enhanced CT scan shows a well-enhancing soft tissue mass (arrow) in the left lacrimal fossa with destruction of the lateral orbital wall.B. A gadolinium enhanced T1-weighted image shows intracranial extension into the middle cranial fossa with dural enhancement (arrowheads).,kjr-8-336-g004,NotMatch,NotMatch
PMC2627159,Fig. 5,A myoepithelial carcinoma in a 32-year-old man.A contrast enhanced CT scan shows a well-enhancing tumor (arrow) in the right lacrimal fossa with bony destruction of zygomatic and sphenoid bone.,kjr-8-336-g005,NotMatch,NotMatch
PMC2627159,Fig. 6,A malignant lymphoma in a 41-year-old woman.A gadolinium enhanced T1-weighted coronal image shows an elongated soft tissue mass (arrow) along the superior lateral aspect of the left eye globe. This lesion shows homogeneous and strong enhancement. Another enhancing nodule is noted at the inferior medial aspect of the left eye globe.,kjr-8-336-g006,NotMatch,NotMatch
PMC2627159,Fig. 7,Lymphoid hyperplasia in a 43-year-old man.A contrast enhanced coronal CT scan shows a homogeneously-enhancing elongated mass involving the right lacrimal gland (arrow).,kjr-8-336-g007,NotMatch,NotMatch
PMC2627159,Fig. 8,Chronic dacryoadenitis in a 39-year-old woman.A gadolinium-enhanced T1-weighted coronal image shows diffuse and elongated enlargement of both lacrimal glands with contrast enhancement (arrows).,kjr-8-336-g008,NotMatch,NotMatch
PMC2627159,Fig. 9,An inflammatory pseudotumor in a 54-year-old woman.A contrast-enhanced CT scan shows an ill-defined enhancing mass in the superior lateral aspect of left eye globe (arrow). Subcutaneous infiltrations (arrowheads) are accompanied in the lateral outside of the left orbit.,kjr-8-336-g009,NotMatch,NotMatch
PMC2627159,Fig. 10,A dermoid cyst in a 49-year-old woman.A coronal CT scan shows a fat-containing mass with nodular calcification in the superior lateral aspect of right orbit (arrow).,kjr-8-336-g010,NotMatch,NotMatch
PMC2627159,Fig. 11,"An epidermoid cyst in a 35-year-old man.A. A contrast enhanced axial CT scan shows a fat-containing mass with bony scalloping at the lateral orbital wall (arrowheads).B. On a T1-weighted axial image, this mass shows heterogeneous intermediate to high signal intensity (arrowheads).C. On a contrast-enhanced, fat-suppressed T1-weighted image, no enhancement is noted in the mass (arrowheads).",kjr-8-336-g011,NotMatch,NotMatch
PMC2627159,Fig. 12,A hemangiopericytoma in a 65-year-old man.A contrast-enhanced axial CT scan shows a strongly enhancing mass with a lobulated contour in the superior lateral aspect of the right orbit (arrow).,kjr-8-336-g012,Match,NotMatch
PMC2627159,Fig. 13,A lipoma in a 64-year-old man.An axial CT scan shows a fat-containing mass at the superior lateral aspect of the left orbit (arrow).,kjr-8-336-g013,NotMatch,NotMatch
PMC2627159,Fig. 14,A granulocytic sarcoma from chronic myeloid leukemia in a 40-year-old man. A gadolinium-enhanced T1-weighted axial image shows bilaterally-enlongated masses with strong enhancement in the superior lateral aspect of both orbits. Soft tissue infiltrations are noted around the right orbit mass.,kjr-8-336-g014,NotMatch,NotMatch
PMC2627159,Fig. 15,"Xanthogranuloma in a 62-year-old woman.A contrast enhanced axial CT scan shows poorly enhancing, soft tissue density infiltrations at the anterior lateral aspect of the right orbit (arrowheads).",kjr-8-336-g015,NotMatch,NotMatch
PMC2627159,Fig. 16,Plexiform neurofibromatosis in a 66-year-old man.The T1-weighted axial image shows multiple lobulating masses involving the left lacrimal fossa and the subcutaneous layer of the left temporal region (arrowheads).,kjr-8-336-g016,NotMatch,NotMatch
PMC2627159,Fig. 17,Squamous cell carcinoma of the conjunctiva in an upper eyelid of a 61-year-old man.A gadolinium enhanced T1-weighted axial image shows a well-enhanced lobulated mass in the superior lateral aspect of the left eye globe (arrow). The thickened skin is not separable from the mass.,kjr-8-336-g017,NotMatch,NotMatch
PMC2075367,Figure 1,"BCAS3 expression in human ES cells.Human ES cell cultures stained with (A) anti-BCAS3 antibody or (E) isotype control antibody and co-immunostained with (B, F) SSEA4. (C, G) show nuclei stained with DAPI. (D, H) are merged images of all three respective panels on their left. Arrows indicate nuclei of some feeder layer fibroblasts. (I) Flow cytometry analysis of human ES cells expressing Rudhira. Graphs show counts for Isotype control (shaded) and Rudhira positive (unshaded) cells. Scale bar: 50 µm.",pone.0001202.g001,NotMatch,NotMatch
PMC2075367,Figure 2,"Expression of BCAS3 in embryoid bodies at day 8 of differentiation.Human EBs at day 8 of differentiation immunostained for (A, E, I) BCAS3 (green), (M) isotype control (green), (B) Vimentin (red) and (F, J, N) VEGFRII (red). (C, G, K, O) show nuclei stained with DAPI. (D, H, L, P) are merged images of respective panels to their left. Arrowheads indicate groups of cells expressing BCAS3. Arrows indicate (E–H) blood islands or (I–L) nascent vessels. Scale bar: 50 µm.",pone.0001202.g002,NotMatch,NotMatch
PMC2075367,Figure 3,"Expression of BCAS3 in embryoid bodies at day 10 of differentiation.Human EBs at day 10 of differentiation immunostained for (A, E) BCAS3 (green), (B) VEGFRII (red) and (F) PECAM (red). (C, G) show nuclei stained with DAPI. (D, H) are merged images of respective panels to their left. Scale bar: 50 µm.",pone.0001202.g003,NotMatch,NotMatch
PMC2075367,Figure 4,"Expression of BCAS3 in embryoid bodies at day 14 of differentiation.Human EBs at day 14 of differentiation immunostained for (A, E, I, M) BCAS3 (green), (Q) isotype control (green), (B) PECAM (red) and (F, J, N, R) ICAM2 (red). (C, G, K, O, S) show nuclei stained with DAPI. (D, H, L, P, T) are merged images of respective panels to their left. Boxed area in (E–H) imaged at higher magnification shown in (I–L) respectively. Scale bar: (A, M, Q) 50 µm (E, I) 100 µm.",pone.0001202.g004,NotMatch,NotMatch
PMC2075367,Figure 5,"BCAS3 RNA expression in human brain and glioma cell lines.PCR analysis of cDNA from normal brain (A) and glioma cell lines (B) using BCAS3- specific primers. M: marker, WB: whole brain, CB: cerebellum, CC: Cerebral cortex, HC: hippocampus. U87MG, U373MG, LN18, LN229: glioma cell lines.",pone.0001202.g005,NotMatch,NotMatch
PMC2075367,Figure 6,"BCAS3 is not expressed in normal human frontal cerebral cortex (from two individuals).Panels to the extreme left in A and B show immunostaining on frozen sections of brain samples with anti-BCAS3 antibody, panels in the middle are DIC (differential interference contrast) images of the same sections and panels on the extreme right show adjacent sections stained with hematoxylin-eosin. Scale bar: 50 µm.",pone.0001202.g006,NotMatch,NotMatch
PMC2075367,Figure 7,BCAS3 expression in human brain lesions.(A–H) Cryosections immunostained for BCAS3 (green). Fluorescent image with DAPI (blue) marking the nucleus or DIC image of the same field is shown as indicated. Panels to the far right show adjacent sections stained with hematoxylin-eosin. BCAS3 positive tumor cells are indicated by arrows and vessel cells by arrowheads. (I) Graph showing percent BCAS3-expressing cells in normal brain and tumor samples. Sample numbers indicated on X axis are described in Table 1.,pone.0001202.g007,NotMatch,NotMatch
PMC2075367,Figure 8,BCAS3 is expressed in glial cells in glioblastoma multiforme.Human glioblastoma sections immunostained for (A) BCAS3 (green) and (B) anti-GFAP (red). DAPI (blue) marks the nucleus. Arrows indicate glial tumor cells expressing BCAS3 (A) or GFAP (B).,pone.0001202.g008,NotMatch,NotMatch
PMC2661536,Figure 1,"CT images from the described case demonstrating metastatic hemangiopericytoma involving the pancreas. During the parenchymal phase (A) the mass appears well defined and heterogeneously enhancing. Multiple, prominent feeding vessels surround the mass. Subsequent venous phase imaging (B) further defines the mass which is clearly delineated from the pancreatic parenchyma and has central areas of low attenuation consistent with necrosis. The adjacent duodenum is compressed by resultant mass effect. Curved axial reformatting in the venous phase (C) and curved coronal reformatting in the parenchymal phase (D) better define the position of the mass relative to the pancreatic head. The mass again appears well defined and associated mass effect leads to pancreatic ductal dilatation and compression of the second portion of the duodenum. Numerous dilated, feeding vessels are seen as foci of high attenuation throughout the mass on the parenchymal phase image (D).",ci09000301,Match,NotMatch
PMC2661536,Figure 2,"Maximum intensity projection reformat of the patient's large pancreatic mass. This reformatted image clearly demonstrates the multiple, large feeding vessels which supply the mass in the head of the pancreas. Due to the plane of imaging, the pancreatic body and tail are not seen.",ci09000302,NotMatch,NotMatch
PMC2702908,Figure 1,Postoperative image of resected specimen,SJG-14-88-g001,NotMatch,NotMatch
PMC2702908,Figure 2,Histopathology image,SJG-14-88-g002,NotMatch,NotMatch
PMC2739687,Figure 1,"CECT sections through the pelvis. Large heterogeneously enhancing abdominopelvic mass with a few areas of necrosis, proven on cytology to be hemangiopericytoma.",ci09000701,Match,NotMatch
PMC2739687,Figure 2,Peritoneal implants in the omentum and small bowel mesentery (arrowheads). Note the right hydronephrosis.,ci09000702,NotMatch,NotMatch
PMC2739687,Figure 3,Post-chemotherapy repeat contrast-enhanced computed tomography shows significant resolution of the peritoneal implants.,ci09000703,NotMatch,NotMatch
PMC2590878,Figure 1,CT scan revealed a well-defined soft tissue mass measuring about 5 cm in diameter arising from the superficial lobe of the left parotid gland.,ci08003001,NotMatch,NotMatch
PMC2590878,Figure 2,"(a) Markedly pleomorphic spindle cells forming vascular spaces, some of them slit-like and gaping, and with an antler-like appearance. A rare focus of necrosis was also seen. (b) Abnormal mitosis was noticed, the mitotic content being approximately 13 per 10 high-power fields.",ci08003002,NotMatch,NotMatch
PMC2590878,Figure 3,(a) CT demonstrated a pulmonary mass in the right lower lobe and (b) hepatic metastasis. (c) CT scan of the pelvis showed enhancing masses in the gluteus maximus muscle confirming metastatic spread.,ci08003003,NotMatch,NotMatch
PMC2823763,Figure 1,(A) Computed tomography scan showing a large mass in the sacrococcygeal space. (B) Magnetic resonance imaging scan showing heterogeneous high intensity in the outer layer and extremely high intensity in the central layer in T2-weighted image.,1752-1947-4-8-1,NotMatch,NotMatch
PMC2823763,Figure 2,"(A) This is a macroscopic image of the 80 × 75 × 65 mm-sized tumor in the sacrococcygeal space. (B) This image shows the excised tumor with a capsule, with its cut surface mostly grayish white and partially reddish.",1752-1947-4-8-2,NotMatch,NotMatch
PMC2823763,Figure 3,(A) Hematoxylin and eosin staining revealing spindle-shaped cells surrounding the endothelial-lined vascular spaces. (B) Immunohistochemistry demonstrating CD34 positive tumor cells. (C) Immunohistochemistry demonstrating Bcl-2 negative tumor cells.,1752-1947-4-8-3,NotMatch,NotMatch
PMC2918851,Fig. 1,"a Initial biopsy of HPC composed of elongated spindle- to carrot-shaped cells with pleomorphic nuclei and eosinophilic cytoplasm. Dilated vascular channels lined by flattened endothelium are evident. A mitotic figure is noted centrally (HE, ×10). b HPC is characterized by large dilated ‘staghorn’ vascular channels (HE, ×10).",cro0003-0093-f01,NotMatch,Match
PMC2918851,Fig. 2,Contrast-enhancing right temporal lobe mass. a Recurrent mass before third partial resection and craniotomy. Pathology was consistent with HPC. b After third craniotomy and partial resection. c After 1 year of monotherapy with dasatinib (axial T1 with gadolinium enhancement MRI images).,cro0003-0093-f02,NotMatch,NotMatch
PMC2954839,Figure 1,The patient before surgery. A 74-year-old female patient presented with a large right-sided neck mass. The skin over the tumor was intact and normal.,1746-160X-6-23-1,NotMatch,NotMatch
PMC2954839,Figure 2,"Computer Tomography scan. A computer tomography scan showed a large submucosal mass in the neck, 8-9 cm in greatest diameter, extending to the muscular sites.",1746-160X-6-23-2,NotMatch,NotMatch
PMC2954839,Figure 3,Surgical resection. The spindle-shaped incision during surgical resection of the tumor.,1746-160X-6-23-3,NotMatch,NotMatch
PMC2954839,Figure 4,"Histopathological examination. Histopathological examination of the surgical specimen revealed the presence of solitary fibrous tumor, cellular variant, with haemangiopericytoma-like features (Haematoxilin and Eosin, magnification × 100).",1746-160X-6-23-4,NotMatch,Match
PMC2954839,Figure 5,"Histopathological examination. Monomorphic tumor cells arranged around thin-walled vessels (Hematoxilin and Eosin, magnification × 200).",1746-160X-6-23-5,NotMatch,NotMatch
PMC2954839,Figure 6,Histopathological examination. Masson trichrone stain × 100 - scanty fibrosis.,1746-160X-6-23-6,NotMatch,Match
PMC2954839,Figure 7,Histopathological examination. CD34 immunohistochemical stain: strong positinity of tumor cells.,1746-160X-6-23-7,NotMatch,NotMatch
PMC2954839,Figure 8,After surgery. The patient after surgery.,1746-160X-6-23-8,NotMatch,NotMatch
PMC2994457,Figure 1,A. Preoperative axial CT scan of C3. Note the destructive process involving the vertebral body. B. Preoperative coronal CT scan of C3.,rt-2009-2-e43-g001,NotMatch,NotMatch
PMC2994457,Figure 2,Preoperative T2-weighted axial MR image of C3. The hyperintense lesion is noted anterior to the spinal canal within the vertebral body of C3 adjacent to the left vertebral artery.,rt-2009-2-e43-g002,NotMatch,NotMatch
PMC2994457,Figure 3,"Postoperative sagittal CT of the cervical spine. A corpectomy of the vertebral body has been performed with the placement of a titanium mesh cage, PMMA, and an anterior cervical plate.",rt-2009-2-e43-g003,NotMatch,NotMatch
PMC2994457,Figure 4,"Postoperative T2-weighted sagittal MR image of the cervical spine. A corpectomy of the vertebral body has been performed, and the C3 vertebral body is distorted by the placement of a titanium mesh cage, PMMA, and an anterior cervical plate.",rt-2009-2-e43-g004,NotMatch,NotMatch
PMC3096911,Figure 1,Abdominal computed tomography scans showing active bleeding in the splenic cystic lesion associated with signs of a recent massive hemorrhage and hemoperitoneum.,1865-1380-4-13-1,NotMatch,NotMatch
PMC3118387,Figure 1,"CyberKnife contour for Patient 14, a forty-seven year old male who was treated for a 56.7 cm3 in the posterior fossa. A single fraction at marginal dose of 21 Gy and maximum dose of 27.6 Gy was used. The isodose line was 76% and the conformity index was1.19. At 15 months follow-up, the tumor was stable.",1756-8722-4-26-1,NotMatch,NotMatch
PMC2883783,Figure 1,"Axial T2-weighted (A), contrast-enhanced T1-weighted and CT image in bone window through the posterior fossa. (A) A lobulated mass is seen showing a heterogeneous hyperintense signal on T2-weighted images with flow voids within (arrow). (B) Intense enhancement on postcontrast T1-weighted image with an associated dural tail (arrow). (C) CT scan revealed thinning and scalloping of the underlying bone (arrow).",ci10001701,NotMatch,NotMatch
PMC2883783,Figure 2,Histopathologic features of a hemangiopericytoma. (A) Tumor from the back showing spindly cells exhibiting stag horn vasculature. Inset highlighting stag horn shaped vessels. Immunohistochemical results: (B) CD34 positivity in patchy areas of the tumor; (C) MIC2 positivity in tumor cells; (D) tumor cells displaying BCL2 positivity; (E) focal areas showing positive EMA expression.,ci10001702,Match,NotMatch
PMC2883783,Figure 3,"Fusion PET/CT images show metastatic osseous lesions (arrows) with associated soft tissue masses in the right posterior chest wall (A), right hemipelvis (B) and the left hemimandible (C).",ci10001703,NotMatch,NotMatch
PMC3170345,Figure 1,"(A) Intra-vaginal ultrasonography of a pelvic mass. Intra-vaginal ultrasonography showed a 6.0 × 7.6 × 6.0 cm solid mass (M) between the uterus and the rectum. Dynamic contrast-enhanced computed tomography (CT) of the pelvis was used. (B) A non-enhanced CT scan showed the mass between the uterus and the rectum with nearly homogeneous density with a CT number of 20 Hounsfield units (HU). (C) Arterial phase, (D) venous phase, and (E) delayed phase contrast-enhanced CT showed that CT numbers of regions of interest within the mass (oval) gradually enhanced from 53 to 60 to 70 HU, respectively. A marked contrast-enhanced structure (red arrow) corresponding to tortuous vessels was shown with CT values of 140.0 HU in the arterial phase (C) and 111.6 HU in the venous phase (D). (F) Sagittal multi-planar reformation showed the mass (arrow) anteriorly growing and deforming the uterus (*).",1752-1947-5-352-1,NotMatch,NotMatch
PMC3170345,Figure 2,"Histopathological images. (A) Collagen denaturation can be seen in a partial mesenchyme. Branch-like blood vessels are visible (hematoxylin and eosin [H-E] stain, original magnification ×100). (B) Spindle and oval tumor cells and stromal sinusoid can be observed (H-E stain, original magnification ×200). (C) In CD34 immunohistochemical stains, tumor cells reacted positive for CD34. (D) In Bcl-2 immunohistochemical stains, tumor cells reacted strongly positive for Bcl-2.",1752-1947-5-352-2,NotMatch,Match
PMC3166817,Fig. 1,Abdomen and pelvis minor echotomography showing a well-demarcated tumorous formation.,crg0002-0494-f01,NotMatch,NotMatch
PMC3166817,Fig. 2,Hemangiopericytoma (Gomori staining).,crg0002-0494-f02,Match,NotMatch
PMC3263171,Figure 1,"(a) Clinical photograph of the patient showing right proptosis with a downward displacement of the right eyeball. (b) CT coronal view, showing a well-defined heterogenous mass in the extraconal superior orbit. (c) CT axial view, showing a moderately enhancing well-circumscribed mass in the superior orbit. (d) Gross photograph of the tumor following excision. Note the pinkish color, areas of hemorrhages, and the thin overlying capsule",OJO-4-147-g001,NotMatch,NotMatch
PMC3263171,Figure 2,"(a) Microphotograph of the tumor showing interlacing bundles of spindle cells interspersed with slit-like vascular channels and fibrocollagenous tissue (H and E, ×100). (b) Immunohistochemistry microphotograph showing diffuse and strong positivity with CD 34 (×100). (c) BCL-2 positivity. (d) CD 99 positivity. (e) Vimentin positivity. (f) SMA negativity",OJO-4-147-g002,NotMatch,Match
PMC3349527,Figure 1,CT scan showing left parapharyngeal soft tissue mass protruding into oro and nasopharynx.,1758-3284-4-10-1,NotMatch,NotMatch
PMC3349527,Figure 2,MRI showing 5 × 6 × 3.3 cm enhancing left parapharyngeal mass compressing the upper internal jugular vein.,1758-3284-4-10-2,NotMatch,NotMatch
PMC3349527,Figure 3,Vascular neoplasm with sheets of pericytes in between thin wall blood vessels consistent with hemangiopericytoma.,1758-3284-4-10-3,Match,NotMatch
PMC3297510,Figure 1,MRI findings (axial section and coronal section): The tumor (arrow) in the right temple showed low signal intensity on T1 weighted image (left) and enhanced by the contrast medium. (right).,1746-160X-8-3-1,NotMatch,NotMatch
PMC3297510,Figure 2,"Result of PET study (left side:Choline-PET, right side: FDG-PET). Choline-PET (left side) showed the recurrent tumor in the tip of the right temporal lobe (arrow) but FDG-PET (right side)could not detect the tumor. SUV max 4.",1746-160X-8-3-2,NotMatch,Match
PMC3297510,Figure 3,Angiography findings: Lateral and Frontal view of right external carotid artery angiography showed demonstrated the lesion strongly.,1746-160X-8-3-3,NotMatch,NotMatch
PMC3297510,Figure 4,Operative findings. The tumor was completely resected together with a part of dura from the right temple (right). The skull base was reconstructed by galeal flap and the dead space was plugged with abdominal fat tissue (left).,1746-160X-8-3-4,NotMatch,NotMatch
PMC3297510,Figure 5,"Pathologic finding: a: This tumor was composed of round or spindle-shaped cells, including dilated staghorn-shaped vessels (H-E × 200). b: Immunohistochemical staining of Vimentin showed positive expression in cancer cells. c: Expressions of CD34(+) in cancer cells were positive on immunostaning.",1746-160X-8-3-5,NotMatch,NotMatch
PMC9444536,Figure 1,Tumoral mass in the right-side tongue border.,gr1,NotMatch,NotMatch
PMC3488519,Figure 1,"Histological features of this case. A and B: The tumor was surrounded by a thick fibrous capsule and well-demarcated from the surrounding renal parenchyma. C: It was characterized by an alternation of cellular and paucicellular areas. D: The paucicellular areas were mainly composed of fibrous stroma containing reticular vascular channels, hemosiderin pigment, and rare stromal cells. E: The cellular areas were composed of stromal cells surrounded by a rich capillary network. F and G: The cytoplasm of stromal cells is weakly eosinophilic, and locally contains lipid droplets (arrow) but no hyaline globules. And the stromal cells also showed ovalnuclei, delicate chromatin, and inconspicuous nucleoli. H: Occasionally, pleomorphic, or bizarre tumor cell nuclei was seen.",1746-1596-7-49-1,NotMatch,NotMatch
PMC3488519,Figure 2,"Immunohistochemical staining. A: Positive staining for NSE. B: Positive staining for S100 protein. C: Positive staining for vimentin. D: Positive staining for α-inhibin. E: Negative staining for epithelial membrane antigen (EMA). F: Negative staining for AE1/AE3. G: Negative staining for CD10. H: Negative staining for HMB-45. I and J: CD34 and CD31 underlined the rich and delicate vascular channels, whereas the tumor cells were negative.",1746-1596-7-49-2,NotMatch,NotMatch
PMC3130475,Figure 1,(a and b) Abdominal CT showing well marginated soft tissue mass arising in the upper pole of right kidney,UA-3-110-g001,NotMatch,NotMatch
PMC3130475,Figure 2,"Grossly, yellow-brown tan mass in the upper pole in welldefined cystic space",UA-3-110-g002,NotMatch,NotMatch
PMC3130475,Figure 3,"The tumor shows solid sheets of plump spindle cells with high N:C ratio, pleomorphism and frequent mitoses. The inset shows the clear cell change in tumor cells (H and E, ×40)",UA-3-110-g003,NotMatch,NotMatch
PMC3130475,Figure 4,"Tumor showing hemangiopericytoma-like vascular pattern (H and E, ×40)",UA-3-110-g004,Match,NotMatch
PMC3130475,Figure 5,Immunohistochemical study of tumor cells showing (a) diffuse positivity for BCl-2; (b) focal positivity for EMA; (c) strong positivity for CD99; and (d) negativity for CD34,UA-3-110-g005,NotMatch,NotMatch
PMC3358955,Figure 1,"The initial enhanced T1-weighted MR image. (a-c) Show an extra-axial mass lesion in the left frontal lobe. (d, e) Postoperative MR images revealing the remnant tumor beside the SSS. (f) Histopathological findings showed the diagnosis of HPC. (g-l) Additional gamma-knife irradiation was performed. Two-years after the operation, the remnant tumor showed a rapidly regrowth (g-i), and the patients underwent a second surgical intervention (j-l). An immunohistochemical analysis using CD34 was positive (m) and a histological examination revealed an anaplastic HPC with increasing mitotic cells (n)",AJNS-7-29-g001,NotMatch,NotMatch
PMC3358955,Figure 2,"Synospsis of the recurrence of the tumor. (a-f) The tumor recurred, with a tumor doubling time of 1-week. (g-i) The tumor recurrence necessitated a third operation. (j) A histological examination revealed further increased mitotic cells and an enlarged the necrotic component. (k) An immunohistological examination revealed CD34 positivity. (l) The MIB-1 index was almost 100%",AJNS-7-29-g002,NotMatch,NotMatch
PMC3364100,Fig. 1,Coronal T1-weighted contrast-enhanced MR images. a Image obtained 4 months prior to admission shows an avidly enhancing extra-axial left cerebellar mass. b Image obtained shortly after admission shows dramatic growth of the left cerebellar mass. c Same study as in b; this image shows an additional small nodular extra-axial mass of similar contrast enhancement to the primary lesion (arrow).,cro-0005-0159-g01,NotMatch,NotMatch
PMC3423717,FIGURE 1.,"The axial (A) noncontrast multidetector computed tomography (MDCT) image shows a large isodense mass occupying the right ischiorectal fossa and extending in the femoral anatomic compartment posteriorly to the pectineus muscle (solid arrow in A). Note invasion and destruction of ischiopubic ramus (open arrow in A). The axial (B) fat suppressed T2-w MR image demonstrates a heterogeneous, with predominantly high signal intensity mass (arrow in B). The coronal (C) T1-w and the coronal (D) short tau inversion recovery (STIR) images demonstrate a large bicompartmental mass (with pelvic and femoral component) that shows an “hour-glass” configuration (arrows in C, D).",rado-45-01-22f1,NotMatch,NotMatch
PMC3423717,FIGURE 2.,"The axial (A) and coronal (B) contrast enhanced fat suppressed T1-w MR images show intense enhancement of the lesion (arrows). The diffusion weighted imaging (DWI) (C) and the corresponding apparent diffusion coefficient (ADC) map (D) demonstrate signs of increased restriction in diffusion, a finding in keeping with the high cellular nature of the tumour. Area in dashed line corresponds to the biopsy selected site.",rado-45-01-22f2,NotMatch,NotMatch
PMC3423717,FIGURE 3.,"(A) CT guided biopsy of the lesion with an 18G true cut needle. (B) Power view (H&E stain, X100) of the biopsy, showing a mesenchymal tumour with a hemangiopericytoma-like pattern, composed of spindle cells arranged in short bundles and the characteristic vascular pattern with a partial “staghorn” configuration. (C) High power view of the spindle cell areas (H&A, X400). The spindle cells show no atypia, mitosis or necrosis.",rado-45-01-22f3,Match,Match
PMC3423717,FIGURE 4.,"Assessment of the tumour response 6 months (upper series) and 12 months (lower series), following radiotherapy. Fat suppressed post gadolinium T1-w MR images in the axial (A, E) and coronal plane (B, F), diffusion weighted imaging (DWI) in the coronal (C) and axial (G) plane and the corresponding apparent diffusion coefficient (ADC) maps (D, H). Note consecutive toumoral necrosis (no enhancement), which is more pronounced in the femoral compartment of the mass (open arrows). The increased signal in the femoral part of the lesion (C, G) as well as in the ADC map (D, H), represents tumour liquefaction and thus an evidence of positive response to radiotherapy. For comparison purposes the chosen DWI performed 6 and 12 months following treatment, are of the same b values.",rado-45-01-22f4,NotMatch,NotMatch
PMC5999857,1,"胸部增强CT示右下叶直径约6 cm的球形占位，边界光滑无分叶，呈不均匀增强。此层面CT上尚可见左舌叶小结节影。Contrast-enhanced chest CT scan shows a spherical mass 6cm in diameter in right lower lobe. It has a smooth margin without lobulation, and is irregularly enhanced. A small nodule is also seen in left lingular lobe.",zgfazz-15-9-558-1,NotMatch,NotMatch
PMC5999857,2,"纤维支气管镜下见右中间段支气管内新生物，表面红色，血供丰富，阻塞管腔。Fibrobronchoscopy reveals a blood-red neoplasm in right intermediate bronchus, which has rich blood supply and blocks the lumen.",zgfazz-15-9-558-2,NotMatch,NotMatch
PMC5999857,3,"病理检查见梭形细胞聚集，较多核分裂相，符合梭形细胞瘤（HE, ×100）。Pathological exam: spindle cells are seen aggregated, and have many mitoses, conforming to spindle cell tumor (HE, ×100).",zgfazz-15-9-558-3,NotMatch,Match
PMC3437420,Fig. 1,Endoscopic finding showed a smooth pinkish hard mass filling the left nasal cavity.,ceo-5-173-g001,NotMatch,NotMatch
PMC3437420,Fig. 2,Preoperative contrast-enhanced coronal (A) and axial (B) computed tomography scan revealed a expansile hypervascular tumor in the left nasal cavity and post ethmoid sinus that demonstrated a scattered calcification and expansive bony destruction.,ceo-5-173-g002,NotMatch,NotMatch
PMC3437420,Fig. 3,"(A) Histologic findings of the tumor. Microscopically, this tumor is composed of mainly spindle cells, abundunt blood vessels and metaplastic bony tissues. Spindle cells are interspersed between blood vessels. (B) In immunohistochemical studies, endothelial cells of blood vessels have immunoreactivity for CD34.",ceo-5-173-g003,NotMatch,NotMatch
PMC3457717,Figure 1,MRI scan demonstrates the recurred tumor mostly involved right posterior fossa.,CRIM2012-628756.001,NotMatch,NotMatch
PMC3457717,Figure 2,Histology and immunohistochemistry of meningeal hemangiopericytoma. (a) H&E 20x A hypercellular tumor with staghorn blood vessels. (b) Immunostaining of CD99 is diffuse and strong positive. (c) Immunostaining of CD 34 reveals variable positive.,CRIM2012-628756.002,Match,Match
PMC3454375,Figure 1,"Histopathology of hemangiopericytoma, solitary fibrous tumor and meningiomas (H&E).Representative cases of selected hemangiopericytoma (A), solitary fibrous tumor (B), and, atypical (C), anaplastic (D), meningothelial (E), angiomatous (F), and fibrous (G) meningioma. Solitary fibrous tumors (A) and hemangiopericytomas (B) are occasionally difficult to distinguish from high-grade meningiomas (C, D).",pone.0046053.g001,Match,Match
PMC3454375,Figure 2,"The expression of Slug, Twist, and E-cadherin in meningeal tumors.Consecutive sections of meningothelial meningioma (A–C), atypical meningioma (D–F), solitary fibrous tumor (G–I), and hemangiopericytoma (J–L). Neoplastic cells in meningothelial and atypical meningiomas are negative in immunostaining for Slug (A, D) and Twist (B, E), but are positive for E-cadherin antibody (C, F). The intensity of E-cadherin staining decreases in cases of atypical meningioma (F). In contrast, neoplastic cells in solitary fibrous tumors and hemangiopericytomas are immunopositive for Slug (G, J) and Twist (H, K), but not E-cadherin (I, L). Solitary fibrous tumors demonstrate weaker positivity to Slug (G) and stronger positivity to Twist (H) than those in hemangiopericytomas (J, K). Cytoplasmic expression of N-cadherin is more extensive in angiomatous meningiomas (M). Immunoexpression to N-cadherin is seen around bundles of collagen fibers (arrow head) in fibrous meningiomas (N).",pone.0046053.g002,Match,NotMatch
PMC3605564,Fig. 1,Preoperative photograph shows a mass near the right nasolabial fold.,aps-40-162-g001,NotMatch,NotMatch
PMC3605564,Fig. 2,T1-weighted magnetic resonance imagining findings show a solid mass enhanced in the premaxillary area (2.4×3.4×3.5 cm3).,aps-40-162-g002,NotMatch,NotMatch
PMC3605564,Fig. 3,Photograph of an extracted specimen after complete excision.,aps-40-162-g003,NotMatch,NotMatch
PMC3605564,Fig. 4,"Tumor composed of ectatic, staghorn-shaped vessels and closely packed tumor cells, showing short spindle to round cells with a small amount of pale cytoplasm (H&E, ×200).",aps-40-162-g004,NotMatch,Match
PMC3605564,Fig. 5,The tumor cells are positive for CD34 based on the immunostain (×100).,aps-40-162-g005,NotMatch,Match
PMC3613625,Figure 1,Tc 99m MDP whole body scintigraphy in dual intensity showing scintigraphic picture of metabolic bone disease,IJNM-26-188-g001,NotMatch,NotMatch
PMC3613625,Figure 2,Tc 99m RBC blood pool whole body scintigraphy in anterior projection (dual intensity),IJNM-26-188-g002,NotMatch,NotMatch
PMC3613625,Figure 3,Anterior static Tc 99m RBC blood pool scintigraphy—high resolution static image of the right tibial shaft showing focal abnormal RBC accumulation at the site of tumor,IJNM-26-188-g003,NotMatch,NotMatch
PMC3613625,Figure 4,MRI of both lower limbs showed two elongated tumors corresponding to the site of abnormal RBC accumulation in the right tibial shaft,IJNM-26-188-g004,NotMatch,NotMatch
PMC3613625,Figure 5,"Histopathology of the right tibial tumor—phosphaturic mesenchymal tumor showing round to oval, spindle-shaped cells in a vascular background having a Hemangio pericytoma-like pattern. Presence of myxoid matrix around vascular channels and multi-nucleated giant cells",IJNM-26-188-g005,NotMatch,NotMatch
PMC3611923,Figure 1,"(a) T1-weighted axial image. (b) T2-weighted axial image of the brain, showing an extra-axial lobulated mass arising from left cavernous sinus compressing the overlying brain, lateral ventricle, and the left cerebral peduncle. (c) T1-weighted contrast-enhanced sagittal image. (d) T1-weighted contrast-enhanced axial image. (e) T1-weighted contrast-enhanced coronal image of the brain, showing intense heterogeneous enhancement within the mass with multiple flow-voids. (f) On fluid attenuation inversion recovery (FLAIR), the mass was isointense with the gray matter",JPN-7-237-g001,NotMatch,NotMatch
PMC3611923,Figure 2,"(a) Photomicrograph (H and E, ×100) showing sheet of plump spindloid cells and dilated gaping stag horn vasculature with anaplastic cells. (b) Photomicrograph (H and E, ×100) showing cellular necrosis",JPN-7-237-g002,NotMatch,Match
PMC3637255,Figure 1,CT scans of primary solitary fibrous tumor of the pleura (1A-B) and the loco-regional relapse in mediastinal pleural (1C-D) after 12 years.,2045-3329-3-4-1,NotMatch,NotMatch
PMC3637255,Figure 2,OS curves for patients with local recurrence only (2A) and for those with metastatic ± local recurrence (2B).,2045-3329-3-4-2,NotMatch,NotMatch
PMC3637255,Figure 3,Histopathological pattern of primary typical solitary fibrous tumor (3A) with low expression of Ki-67 (3B) and the malignant counterpart at relapse (3C) with high expression of Ki-67 (3D).,2045-3329-3-4-3,NotMatch,NotMatch
PMC3640234,Figure 1,"Comparative clinical photograph of the patient. At the time of presentation (a), after preoperative radiotherapy (b), after surgery (c), and after postoperative radiotherapy (d)",SNI-4-55-g001,NotMatch,NotMatch
PMC3640234,Figure 2,"Computed tomography scan of head and neck sagittal (a), axial (c), and coronal (d) view showing moderately enhancing soft tissue lesion in the nape of neck, extending from skull base to thyroid gland level. Bone window (b) shows erosion of the posterior arch of atlas and occipital bone",SNI-4-55-g002,NotMatch,NotMatch
PMC3640234,Figure 3,"Photomicroscopy of the excised tumor showing vascular neoplasm consisted of sheets and groups of spindle and oval shaped cells (pericytes) in between thin wall blood vessels in some areas with stag horn pattern (a-low power, b-high power view)",SNI-4-55-g003,NotMatch,NotMatch
PMC3640234,Figure 4,Immunohistochemistry demonstrating CD34 (a) and Vimentin (b) positive tumor cells,SNI-4-55-g004,NotMatch,NotMatch
PMC3640234,Figure 5,"Computed tomography scan done at 2 month, sagittal (a) and axial (b) view demonstrating near total decompression of the craniovertebral junction with minimal residual tumor",SNI-4-55-g005,NotMatch,NotMatch
PMC3643657,Figure 1,The disease was diagnosed as well-differentiated HPC. HPC are characterized histologically by spindle-shaped tumor cells (slender arrow) separated by numerous capillaries (bold arrow).,cbm-09-02-141-f1,NotMatch,NotMatch
PMC3643657,Figure 2,The tumor in the left kidney. A: after operation and before chemotherapy (March 2009); B: after 2 cycles of chemotherapy (May 2009); C: after 4 cycles of chemotherapy (July 2009).,cbm-09-02-141-f2,NotMatch,NotMatch
PMC3643657,Figure 3,"The metastatic tumor of the liver was stable after chemotherapy. The left and right pictures were taken before and after chemotherapy, respectively.",cbm-09-02-141-f3,NotMatch,NotMatch
PMC3647128,Fig. 1,"(A) An orbital computed tomography scan shows a 1.1 cm-sized, well-demarcated nodule with an eccentric nodular enhancement and an internal low attenuation area in the left lacrimal gland. (B) The solitary fibrous tumor specimen from the lacrimal gland is a well-circumscribed, whitish tan, firm, and fibrotic nodule with a hemorrhagic lesion.",kjpathol-47-158-g001,NotMatch,NotMatch
PMC3647128,Fig. 2,"(A, B) Microscopic examination of the lacrimal gland lesion shows proliferation of relatively uniform spindle cells that are either patternless or have a focally storiform pattern. (C) Focal vascular dilatation with collagenized stroma, dense collagen nodules, and perivascular hyalinization is also observed. (D) A small number of floret-type giant cells are scattered at the periphery, but no angiectoid spaces lined with giant cells are found.",kjpathol-47-158-g002,NotMatch,NotMatch
PMC3647128,Fig. 3,"Immunohistochemical staining shows that the spindle cell cytoplasms are strongly and diffuse positive for CD34 (A) and CD99 (C), and the giant cell cytoplasms are focally positive for CD34 (B) and CD99 (D).",kjpathol-47-158-g003,NotMatch,NotMatch
PMC3707070,Figure 1,"Intraoral images at the first visit. (a) Photograph of the pedunculate hemangiopericytoma in the soft palate, taken during the initial examination. (b) Gadolinium-enhanced T1-weighted MRI image showing the irregularly-shaped, protruding mass, measuring 45 mm×20 mm, in the left soft palate of the patient. (c) Contrast CT scan image showing the internally heterogeneous composition and irregular borders of the tumor. CT, computed tomography; MRI, magnetic resonance imaging.",ijos201325f1,Match,NotMatch
PMC3707070,Figure 2,"Histological findings. (a) Lower magnification shows the dense, cellular rich tumor cells arranged around the numerous thin-walled vessels (HE stain, original magnification ×100). (b) Within tumor nests, thin-walled branching vessels, stag-horn configuration are observed (arrowed, HE stain, original magnification ×400). (c) Immunohistochemical staining shows tumor cells with focally weak positivity for CD34 (original magnification ×400). (d) Immunohistochemical staining shows tumor cells with diffused strong positivity for CD99 (original magnification ×400). HE, hematoxylin and eosin.",ijos201325f2,NotMatch,Match
PMC3479786,Fig. 1,A T2-weighted magnetic resonance imaging shows a heterogeneous tumor involving the lower peritoneal cavity.,kjpathol-46-187-g001,NotMatch,NotMatch
PMC3479786,Fig. 2,"Gross and microscopic findings. (A) Gross specimen showing a well-circumscribed tumor with a hemorrhage in the mesentery. (B) Alternating dense and scanty spindle cells with a herringbone-like pattern. (C) Hemangiopericytomatous vascular arrangement and hyalinized stroma. The immunohistochemical findings for (D) transducin-like enhancer of split 1. (E) CD99, (F) bcl-2, and (G) epithelial membrane antigen. (H) Negative expression of CD117 in the tumor cells.",kjpathol-46-187-g002,Match,NotMatch
PMC3479786,Fig. 3,"Analysis of the t(X;18) translocation using the reverse transcriptase-polymerase chain reaction (RT-PCR) is performed to confirm the diagnosis of synovial sarcoma. The RT-PCR reveals a SYT-SSX2 fusion transcript (151 bp) (left, DNA ladder; 1, the current case; 2-4, positive control [2, 4, monophasic synovial sarcoma; 3, biphasic synovial sarcoma]).",kjpathol-46-187-g003,NotMatch,NotMatch
PMC3717006,Figure 1,"Preoperative T2-weighted axial (A) and contrast enhanced sagittal (B) MRI revealed a mass of the L1 vertebral body, originating from the right vertebral arch, extending extra- and intraspinally with a prominent mass effect to the spinal cord. Super selective catheter angiography of the bilateral spinal arteries Th11 to L2 revealed a major tumour blush from feeders originating from the right-sided TH12 spinal artery (C).",1477-7819-11-152-1,NotMatch,NotMatch
PMC3717006,Figure 2,Planning CT scan (A) with contrast enhancement revealed a hyper vascular tumour formation at the right L1 level. Percutaneous injection of Onyx™ was performed (B) and intratumoural distribution was controlled by repeated CT scans (C).,1477-7819-11-152-2,NotMatch,NotMatch
PMC3717006,Figure 3,"Postoperative T2-weighted, contrast-enhanced MRI confirmed complete tumour removal in axial (A) and sagittal (B) planes.",1477-7819-11-152-3,NotMatch,NotMatch
PMC3717006,Figure 4,Six-month follow-up contrast-enhanced MRI confirmed complete tumour removal in axial (A) and sagittal (B) planes.,1477-7819-11-152-4,NotMatch,NotMatch
PMC3813809,Figure 1,"CT plain scan showing an oval, heterogeneous, well-defined mass in the left parotid gland.",OL-06-05-1380-g00,NotMatch,NotMatch
PMC3813809,Figure 2,"(A) Low-power histological appearance showing a well demarcated lesion. Hematoxylin and eosin (HE), original magnification, ×40. (B) A patternless architecture of short spindle cells surrounding the thin-walled branching vessels intermingled with mature adipocytes (HE; original magnification, ×40). (C) Non-lipomatous tumor cells with a weakly eosinophilic cytoplasm and spindle-shaped nuclei with finely granular chromatin (HE; original magnification, ×200).",OL-06-05-1380-g01,NotMatch,NotMatch
PMC3813809,Figure 3,"Immunohistochemical stains showing the positivity of tumor cells for (A) CD34, (B) Bcl-2, (C) CD99 (immunoperoxidase stains, original magnification, ×600) and (D) vimentin (immunoperoxidase stains, original magnification, ×100).",OL-06-05-1380-g02,NotMatch,Match
PMC3659647,Figure 1,"Endoscopic view of the operational field before surgery (a). After embolization, shrinking is clearly seen (b). Nasal septum (S), concha inferior (CI), concha media (CM), sphenoid sinus (SS), and tumor (*).",CRIM.OTOLARYNGOLOGY2013-796713.001,NotMatch,NotMatch
PMC3659647,Figure 2,"Radiologic findings of sinonasal hemangiopericytoma. CT scan (a), MRI scan (b), and MRI angiography (c). A circumscribed, submucosal, heterogeneous soft-tissue mass measuring 5 × 2.4 × 4.5 cm involving the right dorsal nasal cavity, the right ethmoid, and sphenoid sinus as well as the nasopharynx. A strong enhancement was seen after intravenous contrast administration (*tumor).",CRIM.OTOLARYNGOLOGY2013-796713.002,Match,NotMatch
PMC3659647,Figure 3,Sinonasal hemangiopericytoma after embolisation with Onyx. Right maxillary artery embolised with Onyx (→).,CRIM.OTOLARYNGOLOGY2013-796713.003,Match,NotMatch
PMC3659647,Figure 4,"Endoscopically controlled resection. Operation started as a common functional endoscopic sinus surgery including clearing out the ethmoid cells and identifying the frontal sinus and the maxillary sinus. Upon resection of the dorsal part of the septum, a pedicled tumor insertion at the rhinobasis and the lateral nasal wall was found. The tumor's feeder vessels were exhibited. The vessels originating from the arteria sphenopalatine were specifically identified and clipped ((a), (b); →). The tumor was completely resected using four hands technique ((c), (d)). Maxillary sinus (SM), sphenoid sinus (SS), and tumor (*).",CRIM.OTOLARYNGOLOGY2013-796713.004,NotMatch,NotMatch
PMC3659647,Figure 5,"Endoscopic view of the operation field 3 months after surgery (a). No sign of recurrence. Twelve months after surgery (b), there is no sign of irritation. Concha inferior (CI), concha media (CM), and sphenoid sinus (SS).",CRIM.OTOLARYNGOLOGY2013-796713.005,NotMatch,NotMatch
PMC3659647,Figure 6,MRI (a) and MRI angiography (b) 12 months after surgery. The right nasal cavity appears to be free without any signs of tumor recurrence or residual.,CRIM.OTOLARYNGOLOGY2013-796713.006,NotMatch,NotMatch
PMC3818628,Figure 1,"Computed tomography (CT) axial view, showing a small lobulated lesion in the superior orbit (a), which shows an irregular, moderate but progressive enhancement on contrast CT (b), Microphotograph of the tumor showing bundles of spindle cells with vascular channels and interspersed collagen (H and E, ×100) (c), Immunohistochemistry showing a CD99 positivity (d)",JRMS-18-529-g001,NotMatch,Match
PMC3818628,Figure 2,"Immunohistochemistry microphotographs showing diffuse and strong positivity with BCL-2 (a), Vimentin positivity (b), Reticulin negativity (c), and smooth muscle actin negativity (d)",JRMS-18-529-g002,NotMatch,NotMatch
PMC3836937,Fig. 1,Preoperative sagittal (A) and axial (B) T2-weighted magnetic resonance images reveal a heterogeneous ventral intradural 2.5 cm diameter lesion in the C1-2 region. Sagittal T1-weighted images without enhancement (C) and with enhancement (D) reveal a well enhanced tumor with iso-signal intensity. The preoperative diagnosis was meningioma or schwannoma.,jkns-54-253-g001,NotMatch,NotMatch
PMC3836937,Fig. 2,"Intraoperative microscopic finding. A paramedian incision of the dura mater reveal spinal accessory nerves and an oval, flesh-red tumor (asterisk) at the ventral side. The tumor had adhered to the ventral dura. The border between the tumor and the spinal cord is well defined.",jkns-54-253-g002,NotMatch,NotMatch
PMC3836937,Fig. 3,"An anteroposterior (A) and lateral (B) conventional spinal angiogram demonstrates a hyper vascular tumor (arrow head) with feeding vessels (arrow). After embolization with titanium coil and particles, the tumor blush disappears on the anteroposterior (C) and lateral (D) angiogram.",jkns-54-253-g003,NotMatch,NotMatch
PMC3836937,Fig. 4,(A) Postcontrast sagittal T1-weighted image 6 months after the surgical resection demonstrates no recurred or residual tumor. Axial (B) and sagittal (C) T2-weighted images reveals that the spinal cord shifted anteriorly without the tumor. The cord is slightly diminished in caliber.,jkns-54-253-g004,NotMatch,NotMatch
PMC3836937,Fig. 5,"(A) The tumor was somewhat firm and composed of cystic and nodular lesions. (B) Hematoxylin and eosin staining (original magnification, ×100) shows an irregular array of oval nuclei. The tumor is surrounded by many blood vessels resulting in the ""staghorn"" appearance typical of hemangiopericytoma. Upon immunostaining of the specimen, tumor cells are negative for CD34 (C) and EMA (D). EMA : epithelial membrane antigen.",jkns-54-253-g005,Match,Match
PMC3687770,Figure 1,"Intravascular papillary endothelial hyperplasia (IPEH). (a) Papillary structures within a vascular space, lined by monolayer and nonatypical endothelial cells, characterized this lesion (H&E, objective 20x). (b) Several intravascular fibrin deposits are seen (arrows) (H&E, objective 40x). (c) An exuberant, partly organized, and recanalyzed thrombus is shown (H&E, objective 10x). (d) As in (c) at higher magnification (H&E, objective 20x).",BMRI2013-814635.001,NotMatch,Match
PMC3687770,Figure 2,"Tumors of vascular origin. (a) Cavernous haemangioma composed of vessels varying in size and shape (H&E, objective 20x). (b) Capillary hemangioma composed of small, rather uniform vessels (H&E, objective 20x). (c) Large-vessel hemangioma composed of intercommunicating vascular structures (H&E, objective 20x). (d) Epithelioid angiosarcoma characterized by round cells with vesicular nuclei with prominent nucleoli (H&E, objective 40x). (e) Kaposi-like hemangioendothelioma composed of spindle cells around vascular structures (H&E, objective 40x). (f) A particular staghorn appearance of the haemangiopericytoma (H&E, objective 40x).",BMRI2013-814635.002,NotMatch,Match
PMC3687770,Figure 3,"Rhabdomyosarcoma: (a) suburothelial (cambium layer) proliferation of round cells with scant cytoplasm, vesicular nuclei, and prominent nucleoli (H&E, objective 40x); (b) rhabdomyosarcoma characterized by small round and spindle cells, some of which showing a deeply acidophilic cytoplasm (H&E, objective 20x).",BMRI2013-814635.003,NotMatch,Match
PMC3687770,Figure 4,"Bladder primary lymphoma composed of atypical cells showing vesicular nuclei, prominent nucleoli, and abnormal mitosis (arrows) (H&E, objective 40x). ",BMRI2013-814635.004,NotMatch,Match
PMC3687770,Figure 5,"Carcinosarcoma shows an association of malignant epithelial and mesenchymal components. The latter is composed of large, abnormal cells with numerous mitoses (arrows) (H&E, objective 40x).",BMRI2013-814635.005,NotMatch,Match
PMC3687770,Figure 6,"Hemangioma observed by confocal microscopy: (a) red immunofluorescence shows the overexpression and phosphorylation of the PDGFβ receptor, (b) green immunofluorescence detects the expression of the E5 oncoprotein, and (c) colocalization of the receptor and the oncoprotein documented by yellow immunofluorescence of the merged image.",BMRI2013-814635.006,NotMatch,NotMatch
PMC3687770,Figure 7,"Normal vessel observed by confocal microscopy: (a) red immunofluorescence shows the expression and phosphorylation of the constitutive PDGFβ receptor, (b) green immunofluorescence shows no E5 oncoprotein, and (c) immunofluorescence of the merged image failed to show any colocalization of E5 oncoprotein with PDGFβ receptor.",BMRI2013-814635.007,NotMatch,NotMatch
PMC3867875,Figure 1,The neoplasm in lateral cervical region (maximum length of 6 cm) confirmed by CT scan.,CRIM.OTOLARYNGOLOGY2013-231758.001,NotMatch,NotMatch
PMC3867875,Figure 2,CT scan with lung metastases.,CRIM.OTOLARYNGOLOGY2013-231758.002,NotMatch,NotMatch
PMC3841273,Fig. 1,Bone erosion on the right occipital due to intracranial hemangiopericytomas.,jkns-54-309-g001,Match,NotMatch
PMC3841273,Fig. 2,Intracerebral hemorrhage from hemangiopericytomas on a CT scan.,jkns-54-309-g002,Match,NotMatch
PMC3841273,Fig. 3,Preoperative tumor embolization. A : The digital subtraction angiography (DSA) shows a hypervascular contrast staining mass with an arterial feeder from the MCA and PCA. B : The postembolic DSA shows near total occlusion of the feeding arteries and decreased size of the contrast staining mass.,jkns-54-309-g003,NotMatch,NotMatch
PMC3841273,Fig. 4,"Pathologic features of low grade hemangiopericytomas. A : Hematoxylin and eosin, ×200. B : CD34, ×200. C : Ki-67, ×200.",jkns-54-309-g004,Match,NotMatch
PMC3841273,Fig. 5,"Pathologic features of anaplastic hemangiopericytomas. A and B : Hematoxylin and eosin, ×200. C : CD34, ×200. D : Ki-67, ×200.",jkns-54-309-g005,Match,NotMatch
PMC3841273,Fig. 6,Analysis of the recurrence-free survival in our study.,jkns-54-309-g006,NotMatch,NotMatch
PMC3841273,Fig. 7,Correlation analysis between extent of resection and recurrence-free survival.,jkns-54-309-g007,NotMatch,NotMatch
PMC3841273,Fig. 8,Correlation analysis between adjuvant radiotherapy and recurrence-free survival.,jkns-54-309-g008,NotMatch,NotMatch
PMC3841273,Fig. 9,Analysis of the overall survival in our study.,jkns-54-309-g009,NotMatch,NotMatch
PMC3872659,Figure 1,"Pre-operative T1 magnetic resonance imaging (MRI) with gadolinium sagittal (a) MRI showing an enhancing lesion at the occiput to C4 levels with severe spinal cord compression and a small enhancing lesion seen at the upper thoracic spine (T2-3). H and E staining (b) with dense cellularity and oval shaped nuclei forming fascicles. CD34 staining (c) demonstrating the classic staghorn vascular channel, original magnification ×200. 5-year post-operative sagittal T1 MRI with gadolinium (d) showing no evidence of cervical or thoracic disease",JCVJS-4-32-g001,NotMatch,NotMatch
PMC3862697,Figure 1,Swelling of the right lower eyelid due to the tumor in the anterior inferior orbit.,opth-8-031Fig1,NotMatch,NotMatch
PMC3862697,Figure 2,"Histopathological analysis of an orbital hemangiopericytoma.Notes: (A) Low-power view showing the lobular pattern of highly cellular areas separated by fibrous tissue (hematoxylin and eosin [H&E], 40×). (B) Large, dilated vascular channels within the neoplastic cells (H&E, 100×). (C) A high-power view of the cellular areas (H&E, 400×). (D) The fibrotic areas separating the lobules were mostly acellular (H&E, 400×). (E) Factor VIII-positive immunostaining (100×). (F) Ki-67 immunostaining (200×).",opth-8-031Fig2,Match,Match
PMC3892542,Figure 1,"Post-contrast T1-weighted axial (a), sagittal (b), images showing intense homogeneously enhancing extraaxial mass lesion in high parietal region on left side with perilesional edema. Postoperative follow-up sagittal CT image showing gliotic changes at surgical site (c)",SAJC-2-131b-g001,NotMatch,NotMatch
PMC3892542,Figure 2,Axial postcontrast CT images in arterial phase showing multiple intensely enhancing lesions in the right lobe of liver which were proved to be metastatic lesions from hemangiopericytoma,SAJC-2-131b-g002,Match,NotMatch
PMC3892542,Figure 3,(a) Slit-like vessels with hemangiopericytomatous pattern (×10 H and E stain); (b) Plump spindle-shaped cells (×20 H and E stain); (c) Frequent mitotic figures (arrow) (×40 H and E stain); (d) CD34 positivity in tumor cells and accentuated in endothelial cells; (e) Aspiration smears from liver show similar plump oval to spindle-shaped cells in clusters,SAJC-2-131b-g003,Match,Match
PMC3934780,Fig. 1,a Facial skin xerosis. b Large rhomboidal scales covering most of the body. c Dry skin with rhomboidal scales on the lower extremities. d Plantar hyperkeratosis.,cde-0006-0010-g01,NotMatch,NotMatch
PMC3934780,Fig. 2,"a Hyperorthokeratosis, absence of granular layer and reduced rete-papilla pattern (HE, ×40). b Osseous HP.",cde-0006-0010-g02,NotMatch,NotMatch
PMC4124578,Figure 1.,Pathological results of the biopsy specimens and the final pathology of the surgical specimens.,arh0011400820001,NotMatch,NotMatch
PMC3942593,Figure 1,"T1-weighted sagittal view showing a hypointense lesion in the posterior fossa, with displacement of the brainstem and the cerebellum",SNI-5-13-g001,NotMatch,NotMatch
PMC3942593,Figure 2,"T1-weighted axial view showing mildly enlarged ventricles and a contrast-enhancing lesion in the posterior fossa, exerting mass effect on the brainstem",SNI-5-13-g002,NotMatch,NotMatch
PMC4027105,Fig. 1,Pre-operative axial T1 (A) and T2 (B) magnetic resonance images show a tumor mass in the left cerebellum compressing the 4th ventricle with surrounding edema. Gd-enhanced T1 axial (C) and coronal (D) images reveal a well-enhancing lesion with dural attachment adjacent to the junction of the transverse and sigmoid sinuses.,btrt-1-95-g001,NotMatch,NotMatch
PMC4027105,Fig. 2,"A photomicrograph of the tumor specimen shows vascular space surrounded by proliferating oval to spindle-shaped pericytes (A) (hematoxylin and eosin stain; ×400), prominent vasculature (B) (hematoxylin and eosin stain; ×100) represented by staghorn pattern (arrow) and tumor cells strongly expressing CD-34 (C) (immunohistochemistry; ×200).",btrt-1-95-g002,NotMatch,Match
PMC4027105,Fig. 3,Post-operative axial T1 (A) and coronal T1 (B) magnetic resonance images taken within two weeks of the surgery show the resection cavity with residual tumor tissue adherent to the transverse sinus.,btrt-1-95-g003,NotMatch,NotMatch
PMC4050089,Fig. 1,Preoperative computed tomography. Coronal (left) and axial (right) enhancing computed tomography scans showing a residual tumor with mild heterogeneous enhancement in the right maxillary sinus posterior wall (arrows).,ceo-7-145-g001,NotMatch,NotMatch
PMC4050089,Fig. 2,"Pathologic findings. H&E staining (×180) revealed numerous thin-walled, branching staghorn vessels surrounded by oval to spindle-shaped cells (A). Immunohistochemical staining showed a negative reaction to CD31 (B), a negative reaction to CD34 (C), and a positive reaction to smooth muscle actin (D). (B-D) Immunohistochemistry, ×250.",ceo-7-145-g002,NotMatch,Match
PMC4050089,Fig. 3,Postoperative seven months endoscope finding of right maxillary sinus through inferior meatal antrostomy. There is no evidence of residual or recurrent tumor.,ceo-7-145-g003,NotMatch,NotMatch
PMC4105819,Fig. 1,Contrast-enhanced CT scan of abdomen showed aneurysm of 1.7 × 2 cm arising from short gastric artery (red arrow).,kjr-15-538-g001,NotMatch,NotMatch
PMC4105819,Fig. 2,Superselective splenic arteriography confirmed aneurysmatic nature of lesion (orange square).,kjr-15-538-g002,NotMatch,NotMatch
PMC4105664,Photo 1,Computed tomography of the patient with malignant melanoma (patient 2) before (top) and after (below) the surgery,WIITM-9-22514-g001,NotMatch,NotMatch
PMC4105664,Photo 2,Computed tomography of the patient with SCC (patient 8) before (top) and after (below) the surgery,WIITM-9-22514-g002,NotMatch,NotMatch
PMC4137641,Figure 1,"(a) Swelling and scar on upper 1/3 of lower distal extremity. (b) Tumor. (c and d) Solitary fibrous tumor (SFT) - Spindle cells with collagen (H and E, ×100 and ×400). (e) Vascularity in SFT (H and E, ×400). (f) Microscopic foci of adipose tissue in SFT (H and E, ×400)",IJABMR-4-134-g001,NotMatch,Match
PMC4137641,Figure 2,"(a) Solitary fibrous tumor (SFT) with free surgical margin (H and E, ×400). (b-f) Negative staining of SFT with actin, desmin, epithelial membrane antigen, S100 and strong positivity with CD34 (IHC, ×100)",IJABMR-4-134-g002,NotMatch,Match
PMC4145262,Figure 1,TDM cérébrale en coupe axiale de notre patient objectivant un rehaussement massif de l'hémangiopéricytome après injection du produit de contraste,PAMJ-17-223-g001,NotMatch,NotMatch
PMC4145262,Figure 2,IRM cérébrale en coupe sagittale du patient montrant la localisation occipitale de la tumeur,PAMJ-17-223-g002,NotMatch,NotMatch
PMC4145262,Figure 3,Artériographie cérébrale du patient montrant une tumeur hypervasculaire alimentée par les deux artères carotides,PAMJ-17-223-g003,NotMatch,NotMatch
PMC3921271,Fig. 1,"Map of motor task-induced activation differences in patient with cavernous hemangioma. Voxels showing significant brain activation during left hand motor task shown in yellow. Voxels showing significantly reduced activation for the same task shown in light-blue. Deactivations were observed in prefrontal cortex, posterior cingulated, precuneus, and postcentral gyrus.",jkns-54-453-g001,NotMatch,NotMatch
PMC3921271,Fig. 2,Functional magnetic resonance imagings (fMRI) of the patients with intracranial lesions during motor task revealed additive task-induced deactivated regions. The case number is in the left lower corner of each patient's image. Distinctive deactivated regions are marked with arrowhead.,jkns-54-453-g002,NotMatch,NotMatch
PMC3921271,Fig. 3,"MRI and fMRI in a 56-year-old woman with glioblastoma (case 7). A: T1-weighted MRI with gadolinium demonstrating a large, well enhanced mass with central necrosis in the right middle frontal gyrus, which is compatible with gliobalstoma. B: Axial fMRI series during left hand motor task showing activation (orange) and deactivation (light-blue) regions. Arrowhead denote the distinctive deactivated regions.",jkns-54-453-g003,NotMatch,NotMatch
PMC3921271,Fig. 4,MR imaging studies in a 53-year-old man with hemangiopericytoma (case 4). A: T1-weighted MRI with gadolinium demonstrating well enhanced lobulating mass adhering to sagittal sinus in left frontoparietal lobe. B: Axial fMRI series during right hand motor task showing activation (orange) and deactivation (light-blue) regions. Note that distinctive deactivated region in the right crus cerebri in midbrain (arrowhead).,jkns-54-453-g004,Match,NotMatch
PMC4158640,Figure 1,Plain radiograph of the cervical spine showing destruction of the C3 lamina and erosion of the adjacent C2 and C4 lamina by an osteolytic mass,JCVJS-5-95-g001,NotMatch,NotMatch
PMC4158640,Figure 2,Axial view of computed tomography scan of the cervical spine revealing a hyperdense well-defined soft tissue mass eroding the right half of C3 lamina,JCVJS-5-95-g002,NotMatch,NotMatch
PMC4158640,Figure 3,Postcontrast T1-weighted axial magnetic resonance image showing the well-defined enhancing mass extending into both intra -and extra-spinal compartments. Multiple flow voids are noted,JCVJS-5-95-g003,NotMatch,NotMatch
PMC4158640,Figure 4,"Postcontrast sagittal magnetic resonance image showing the cervical tumor to cause epidural compression, and a hyperintense signal is noted in the cervical cord",JCVJS-5-95-g004,NotMatch,NotMatch
PMC4158640,Figure 5,"Photomicrograph of the tumor showing a hemangiopericytoma consisting of a diffuse sheet-like arrangement of round to oval epitheloid cells with ill-defined cell borders. The cells contain a moderate amount of cytoplasm and small round to oval hyperchromatic nuclei. Scattered dilated branching staghorn like and a thin slit like blood vessels are also seen (H and E, ×400)",JCVJS-5-95-g005,Match,NotMatch
PMC4158640,Figure 6,"Photomicrograph of immunohistochemistry of the tumor showing immunoreactivity for reticulin stain characteristic of hemangiopericytoma (Reticulin, ×400)",JCVJS-5-95-g006,Match,NotMatch
PMC4145366,Figure 1,Richly vascularized structure of the tumor with staghorn-appearing vessels (H&E ×20).,CRIONM2014-470268.001,NotMatch,Match
PMC4145366,Figure 2,"
Round-fusiform shaped, diffuse neoplastic infiltration around the vascular structures with high magnification (H&E ×40).",CRIONM2014-470268.002,NotMatch,Match
PMC4145366,Figure 3,Cellular characteristic of lung parenchyma tumor tissue (H&E ×10).,CRIONM2014-470268.003,NotMatch,Match
PMC4178279,Figure 1.,Geographic distribution of the Rare Cancer Network in 2014.,rt-2014-3-5465-g001,NotMatch,NotMatch
PMC4178279,Figure 2.,"The First International Symposium of the Rare Cancer Network, Nice, France, March 21-22, 2014.",rt-2014-3-5465-g002,NotMatch,NotMatch
PMC4164082,Fig. 1,"a Axial T2-weighted MR image showing a round extra-axial tumor within the CoS. The lesion appears slightly hyperintense compared with the gray matter. Prominent intratumoral flow voids are observed (arrow). b Axial contrast-enhanced T1-weighted image revealing a homogenous strong enhancement of the tumor without a dural tail sign. c Sagittal contrast-enhanced T1-weighted image demonstrating a ‘cap sign’ consisting of the tumor and venous blood (arrow), which indicates that the tumor originated from inside of the CoS.",crn-0006-0207-g01,NotMatch,NotMatch
PMC4164082,Fig. 2,"a Carotid angiogram revealing the occlusion of the CoS by the tumor. b In a left external carotid angiogram, moderate tumor stain feeding from the occipital artery (arrow) and MMA (arrow heads) was observed. Anteroposterior view (c) and lateral view (d) of vertebral angiograms showing an abnormal early filling of the straight sinus (arrow) via an enlarged and tortuous dural branch of the left PCA (arrow heads) without any tumor stain, which we diagnosed as the dAVF. e Cone beam CT vertebral angiogram clearly depicted the route of the AVF and fistulous point. The exact location of the fistulous point (arrow) was observed just ventral to the tumor without tumor stain. f After the endovascular procedure, the lateral view of an angiogram from external carotid arteries revealed good embolization of tumor suppliers.",crn-0006-0207-g02,NotMatch,NotMatch
PMC4164082,Fig. 3,a Postoperative MR image confirming the gross total resection of the tumor. b Lateral view of a carotid angiogram demonstrating restored venous flow at the CoS. c Anteroposterior view of a vertebral angiogram revealing complete regression of the dAVF that was observed preoperatively.,crn-0006-0207-g03,NotMatch,NotMatch
PMC4178277,Figure 1.,"A 27-year-old patient was diagnosed with an atypical hemangiopericytoma and baseline magnetic resonance imaging (MRI) in A). Subtotal resection was performed. The post-operative radiation planning MRI is shown in B), GTV outlined as surgical bed (green), a 0.5 cm expansion on the GTV to create the PTV 60 (sky blue), a 1.5 cm CTV applied to the GTV to give a CTV 54 (red) and a 0.5 cm PTV margin applied to the CTV 54 to give a PTV 54 (blue). This patient was treated with a two phase technique to a total of 60 Gy in 30 fractions and isodose lines shown in C). The patient’s tumor was controlled for 5 years with clean images as shown in D). At 5 years, a recurrent tumor nodule developed at the region of the cavernous sinus edge (yellow arrow) and this is where relative under-dosing occurred to keep the optic chiasm to a point maximum dose of 54 Gy. The patient is now on bevacizumab.",rt-2014-3-5449-g001,Match,NotMatch
PMC4179434,Figure 1,Response to pazopanib therapy in case 1. a. PET-CT at baseline and after 3 months of pazopanib treatment. b. Chest radiograph at baseline and after 4.5 months of pazopanib treatment.,2045-3329-4-13-1,NotMatch,NotMatch
PMC4186565,Figure 1,"Patient 1. (A) Unenhanced magnetic resonance imaging scan reveals a heterogeneous iso-signal intensity mass in the right occipital region with a well-defined border. (B) The lesion has a marginally long T2 signal with certain intratumoral vessels (arrow), and peritumoral brain edema may be observed. (C) Enhanced scan demonstrates that the mass was markedly heterogeneously enhanced. (D) Cystic degeneration, necrosis and flow void are visible.",OL-08-05-2140-g00,NotMatch,NotMatch
PMC4186565,Figure 2,"Patient 2. (A) Unenhanced magnetic resonance imaging scan reveals a mass in the left temporal region with heterogeneous iso-signal intensity in the T1-weighted image, and (B) heterogeneous marginally high signal intensity with numerous irregular intratumoral vessels (arrow) in the T2-weighted image. (C) Enhanced scan reveals that the mass is markedly enhanced. The adjacent bone exerts an obstruction effect due to the invasive growth pattern of the tumor (triangle). (D) Coronal reconstruction indicates that the flowing void effect may be visible (arrow).",OL-08-05-2140-g01,NotMatch,NotMatch
PMC4186565,Figure 3,Patient 3. (A) Unenhanced magnetic resonance imaging scan reveals that the boundary of the tumor is well defined and lobular in shape. (B) Flow void can be observed in the T2-weighted image. (C and D) The lesion is markedly enhanced and the dural tail sign is not detectable.,OL-08-05-2140-g02,NotMatch,NotMatch
PMC4186565,Figure 4,Patient 4. (A) Unenhanced magnetic resonance imaging scan reveals that the lesion is located in the anterior skull base with a well-defined border and lobulated shape. (B) The lesion exhibits a crow-midline growth pattern and intratumoral vessels are visible (arrow). (C) Enhanced scan reveals that the lesion is heterogeneously enhanced. (D) A narrow-based attachment to the skull base may be observed.,OL-08-05-2140-g03,NotMatch,NotMatch
PMC4186565,Figure 5,"Patient 5. (A) Unenhanced magnetic resonance imaging scan reveals that the lesion is located in the infratentorial posterior fossa. (B) Peritumoral brain edema may be observed, and the fourth ventricle exhibits compressive change. (C) The lesion is markedly enhanced following injection of contrast agent. (D) The dural tail sign cannot be found, however, a (E) narrow-based attachment is visible and the intratumoral vessel may be detectable.",OL-08-05-2140-g04,NotMatch,NotMatch
PMC4186565,Figure 6,"Patient 3.Pathological features of intracranial hemangiopericytoma. (A) On microscopic examination, tumor cells exhibit a diffuse growth pattern with abundant slit-shaped vessels in the central area (arrow). (B) The tumor cells are uniform in size with obscured nucleoli. (C) The nuclei of the tumor cells are oval and mitotic figures are occasionally observed (arrow). Immunohistochemical analysis reveals (C) marked positive expression of cluster of differentiation 34, but (D) negative expression of epithelial membrane antigen [stain, (A and B) hematoxylin and eosin, (C) cluster of differentiation 34, (D) epithelian membrane antigen; magnification, A, ×100; B, ×100; C, ×200; D, ×200].",OL-08-05-2140-g05,Match,Match
PMC4214701,Figure 1.,(A) Axial CT scan image of the tumor located at the posterior wall of the trachea. (B) Coronal section showing the polypoid tumor over the trachea.,amjcaserep-15-459-g001,NotMatch,NotMatch
PMC4214701,Figure 2.,(A) Preoperative bronchoscopic image of the tumor almost completely obstructing the trachea. (B) Gross appearance of the excised tumor. (C) Bronchoscopic image performed 7 days postoperatively showing mild granulation tissue over the oblique anastomotic site. The trachea is patent and the axis of the distal anastomotic site is not on the same plane as the proximal segment.,amjcaserep-15-459-g002,NotMatch,NotMatch
PMC4214701,Figure 3.,"(A) Representative low-power magnification of a cut section of the glomus tumor showing a hypervascular tumor composed of branching, dilated, thick-walled, vascular channels and thin-walled, capillary-like vascular spaces (hematoxylin and eosin, 40×). (B) High-power magnification of the tumor showing lobular arrangements of oval- to-spindle-shaped cells, with abundant eosinophilic cytoplasm and centrally-located rounded nuclei (hematoxylin and eosin, 400×). (C) Immuno-staining showing tumor cells strongly reactive to actin.",amjcaserep-15-459-g003,NotMatch,NotMatch
PMC4214701,Figure 4.,"Diagrammatic representation of spiral tracheoplasty after tangential resection of a tracheal tumor. (A) After identifying the tumor, the trachea is separated from the esophagus by about 2 cm to allow for manipulation and exposure of the operative field. (B) This is followed by tangential resection of the tracheal lesion. (C) Both transected tracheal ends are rotated 90 degrees in opposite directions. The proximal end is rotated clockwise and the distal end is rotated counter clockwise. (D) The tracheal ends are then trimmed for irregularities to obtain good apposition. (E) The anastomosis is performed using running sutures.",amjcaserep-15-459-g004,NotMatch,NotMatch
PMC4214483,Figure 1,Computed tomography for the right renal hemangiopericytoma.,OL-08-06-2493-g00,Match,NotMatch
PMC4214483,Figure 2,"Microscopic examination in absence of immunohistochemical staining (stain, hematoxylin and eosin; magnification,10×20).",OL-08-06-2493-g01,NotMatch,NotMatch
PMC4214483,Figure 3,"Immunohistochemical staining was positive for (A) CD34, (B) vimentin and (C) Bcl-2 (magnification, 10×20).",OL-08-06-2493-g02,NotMatch,NotMatch
PMC4219805,Figure 1,"Coupe scannographique axiale montrant un processus lésionnel centré sur l’écaille occipitale, latéralisé à droite, accompagné d'une infiltration méningée",PAMJ-17-150-g001,NotMatch,NotMatch
PMC4219805,Figure 2,A. Coupe histologique montrant une prolifération tumorale faite de cellules aux noyaux arrondis avec une vascularisation branchée de type hémangiopéricytaire (hématoxyline éosine ×200). B. Les cellules expriment de façon diffuse et intense l'antigène CD34 (G ×200),PAMJ-17-150-g002,NotMatch,NotMatch
PMC4219805,Figure 3,Coupe scannographique axiale montrant la persistance du processus après la chirurgie d'exérèse,PAMJ-17-150-g003,NotMatch,NotMatch
PMC4219805,Figure 4,Photographie montrant la position de la patiente au cours de son traitement par radiothérapie,PAMJ-17-150-g004,NotMatch,NotMatch
PMC4219805,Figure 5,Images issues du logiciel de planification de traitement pour radiothérapie. A. Coupe scannographique axiale montrant le volume cible (Contour bleu) couvert par l'isodose 95% (Aire rouge). B. Radiographie reconstruite montrant un des deux champs de traitement. C. Modèle 3D généré montrant la balistique du traitement,PAMJ-17-150-g005,NotMatch,NotMatch
PMC4219805,Figure 6,Photographie montrant la persistance d'une dépression de la voûte crânienne avec une alopécie définitive en regard de la zone irradiée,PAMJ-17-150-g006,NotMatch,NotMatch
PMC4219805,Figure 7,Coupe scannographique axiale montrant la disparition complète du processus tumoral,PAMJ-17-150-g007,NotMatch,NotMatch
PMC4279629,Fig. 1,Gross appearance of the subcutaneous mass. The skin over the neoplasm was alopecic and ulcerated,vrf-5-157-g001,NotMatch,NotMatch
PMC4279629,Fig. 2,"Canine hemangiopericytoma, subcutis. a) Spindle shaped cells are arranged around a central capillary, a characteristic ""fingerprint pattern"" appearance, in the collagenous stroma is seen. H & E. Bar =56 µm; b) As it is expected immunolabelling with S-100 is negative for this canine hemangiopericytoma. Bar =56 µm; c) Neoplastic cells are positive by immunolabelling with vimentin. Bar =56 µm",vrf-5-157-g002,Match,Match
PMC4110937,Fig. 1.," Macroscopic appearance of the tumor. a) The mass was spherical and 8 cm in diameter. b) The cut surface of the mass was firm and milky white. There were some small cysts containing clear, colorless, low-viscosity fluid(arrowhead).",tox-27-131-g001,NotMatch,NotMatch
PMC4110937,Fig. 2., Histological appearance of the tumor. a) The lesion consisted of fibrous and myxoid areas with transitional areas. HE stain. Scale Bar = 1 mm. b) Staghorn-shaped vessels without erythrocytes. HE stain. Scale Bar = 100 μm. c) The fibrous area consisted of a proliferation of short spindle cells in abundant wavy interlaced eosinophilic bundles. HE stain. Scale Bar = 40 μm. d) The myxoid area showed loosely arranged neoplastic cells in the myxoid background. HE stain. Scale Bar = 40 μm. e) Some oval cells showed rhabdoid features such as eccentric nuclei and glassy eosinophilic inclusions in the cytoplasm. HE stain. Scale Bar = 40 μm. f) A few cells contained vacuoles in the cytoplasm. HE stain. Scale Bar = 40 μm. g) Microvessels lined by one to three cells (arrow). HE stain. Scale Bar = 40 μm.,tox-27-131-g002,NotMatch,NotMatch
PMC4110937,Fig. 3.," Special stains for the tumor. a) The bundles in the fibrous area were stained blue. Masson’s trichrome staining. Scale Bar = 40 μm. b) There were no argyrophilic fibers surrounding neoplastic cells, while argyrophilic fibers were observed around a vessel. The reticulin silver impregnation method. Scale Bar = 40 μm.",tox-27-131-g003,NotMatch,NotMatch
PMC4110937,Fig. 4.," Immunohistochemistry for S100 (a), neuron-specific enolase (NSE) (b), glial acidic protein (GFAP) (c), von Willebrand factor (vWF) (d) and alpha-smooth muscle actin (α-SMA) (e). a) Nuclei and cytoplasms of neoplastic cells were positive for S100. Scale Bar = 40 μm. b) Cytoplasms of neoplastic cells were partly positive for NSE. Scale Bar = 40 μm. c) Cytoplasms of neoplastic cells were partly positive for GFAP. Scale Bar = 40 μm. d) Neoplastic cells were negative for vWF, while the vascular epithelia were positive. Scale Bar = 40 μm. e) Neoplastic cells were negative for α-SMA, while the vascular smooth muscle cells were positive. Scale Bar = 40 μm.",tox-27-131-g004,NotMatch,NotMatch
PMC4110937,Fig. 5.," Representative ultrastructural appearance of a neoplastic cell. a) Neoplastic cells had oval-shaped nuclei with slight invagination and elongated cytoplasmic processes. Scale Bar = 2 μm. b) Rudimentary cell junctions were observed between the processes (arrowheads). Scale Bar = 2 μm. Inset: Attachment plaques, tonofilaments and intermediate lines were not observed in the rudimentary cell junctions. c) The cytoplasmic processes coiled around themselves. Scale Bar = 2 μm. Inset: A rudimentary cell junction was also observed between these coiled processes. d) Some cytoplasmic processes formed cytoplasmic spaces. Scale Bar = 2 μm.",tox-27-131-g005,NotMatch,NotMatch
PMC4110937,Fig. 6., Ultrastructural appearance of a rhabdoid-featured cell. a) The neoplastic cell had a characteristic large paranuclear whorl in the cytoplasm. Scale Bar = 2 μm. b) High magnification of Fig. 6a. Aggregates of intermediate filaments were observed in the intracytoplasmic whorl of the rhabdoid-featured cell. Scale Bar = 500 nm.,tox-27-131-g006,NotMatch,NotMatch
PMC4286220,Figure 1,(A): hémangiopericytome malin du pied; (B): radiographie standard montrant l'extension de la tumeur vers le calcanéum,PAMJ-19-19-g001,NotMatch,NotMatch
PMC4336055,Fig. 1,"
A polyp, cut open, showing surface ulceration.",10-1055-s-0033-1354746-i130089cr-1,NotMatch,NotMatch
PMC4336055,Fig. 2,"
Lesion is composed of spindle-to-stellate-shaped cells in an oedematous stroma. There is prominent inflammatory infiltrate composed of lymphocytes and eosinophils (Inset right lower corner).",10-1055-s-0033-1354746-i130089cr-2,NotMatch,NotMatch
PMC4248575,Figure 1,"Preoperative T1-weighted plain (a), gadolinium-enhanced (b), and T2-weighted (c) magnetic resonance imaging showing the infratentorial extra-axial tumor with perifocal edema. Note that the tumor shows strong, homogeneous enhancement.",CRINM2014-230681.001,NotMatch,NotMatch
PMC4248575,Figure 2,Right carotid angiography (CAG) revealing microvascular networks in the tumor. Anterior-posterior (a) and lateral (b) CAG demonstrates the tumor being fed by the ascending pharyngeal artery and occipital artery.,CRINM2014-230681.002,NotMatch,NotMatch
PMC4248575,Figure 3,"Photomicrographs revealing a highly cellular tumor consisting of oval and spindle-shaped cells surrounding slit-like, elongated blood vessels with a “staghorn” appearance ((a): ×200). A rich network of reticulin fibers is present among the tumor cells ((b): ×200).",CRINM2014-230681.003,NotMatch,NotMatch
PMC4248575,Figure 4,"Postoperative T1-weighted plain (a), gadolinium-enhanced (b), and T2-weighted (c) MRI with contrast medium suggesting complete removal of the tumor without recurrence at 9 months postoperatively.",CRINM2014-230681.004,NotMatch,NotMatch
PMC4248575,Figure 5,"Computed tomography (CT) revealing infratentorial tumor with massive hematoma around the tumor, compressing the brainstem (a). Postoperative CT shows complete removal of the tumor and hematoma (b).",CRINM2014-230681.005,NotMatch,NotMatch
PMC4248575,Figure 6,Photomicrographs revealing a highly cellular tumor consisting of spindle cells surrounding elongated blood vessels with a “staghorn” appearance ((a): ×200). A rich network of reticulin fibers is present among the tumor cells ((b): ×200).,CRINM2014-230681.006,NotMatch,NotMatch
PMC4320910,Figure 1,A 28 mm × 34 mm well-circumscribed mass at upper lateral quadrant of the right breast. There was no calcification.,CRIONM2015-210643.001,NotMatch,NotMatch
PMC4320910,Figure 2,"Many round to fusiform tumor cells surrounded the capillaries (Hematoxylin/eosin, ×100).",CRIONM2015-210643.002,NotMatch,Match
PMC4320910,Figure 3,"Immunohistochemistry demonstrating the strong expression of the (a) vascular marker CD34 and (b) vimentin by all tumor cells, ×25.",CRIONM2015-210643.003,NotMatch,NotMatch
PMC4450031,Figure 1,"IRM encéphalique objectivant la présence processus expansif de l'angle ponto-cerebelleux étendu au rocher mesurant 20 mm×30 mm, hyperintense en T1 et T2, se rehaussant de façon hétérogène après l'injection du produit de contraste avec effet de masse sur le V4",PAMJ-20-61-g001,NotMatch,NotMatch
PMC4450031,Figure 2,"L'aspect anatomopathologique de la tumeur après coloration standard, montre un processus tumoral mal limité, d'aspect multinodulaire qui se caractérise par une densité cellulaire élevée, faite de nappes cellulaires peu cohésives. La vascularisation est riche, réalisant un aspect angiomateux. Cette vascularisation est spéciale, caractérisée par un aspect ramifié, souvent en « bois de cerf ». La lumière vasculaire n'est pas toujours visible. L'anisocaryose est modérée. L'activité mitotique est élevée atteignant par places 4 mitoses / champ au fort grandissement",PAMJ-20-61-g002,NotMatch,NotMatch
PMC4486097,Fig. 1,Preoperative photograph of the patient 7 showing swelling over lower back.,gr1,NotMatch,NotMatch
PMC4486097,Fig. 2,MRI abdomen and pelvis of patient 10 showing well defined presacral mass.,gr2,NotMatch,NotMatch
PMC4486097,Fig. 3,Post operative photograph showing the transverse incision used for posterior approach.,gr3,NotMatch,NotMatch
PMC4943821,Figure 1,Tomography showing abdominal tumor,1679-4508-eins-13-2-0269-gf01,NotMatch,NotMatch
PMC4943821,Figure 2,Histological analysis with hematoxylin-eosin,1679-4508-eins-13-2-0269-gf02,NotMatch,NotMatch
PMC4943821,Figure 3,Immunohistochemical with positive CD99 staining,1679-4508-eins-13-2-0269-gf03,NotMatch,NotMatch
PMC4943821,Figure 4,Immunohistochemical with positive BCL-2 staining,1679-4508-eins-13-2-0269-gf04,NotMatch,NotMatch
PMC4943821,Figure 5,Immunohistochemical with positive vimentin staining,1679-4508-eins-13-2-0269-gf05,NotMatch,NotMatch
PMC4943821,Figure 6,Immunohistochemical with positive CD34 staining,1679-4508-eins-13-2-0269-gf06,NotMatch,NotMatch
PMC4943821,Figura 1,Tomografia evidenciando tumoração abdominal,1679-4508-eins-13-2-0269-gf01-pt,NotMatch,NotMatch
PMC4943821,Figura 2,Análise histológica com hematoxilina-eosina,1679-4508-eins-13-2-0269-gf02-pt,NotMatch,NotMatch
PMC4943821,Figura 3,Imuno-histoquímica com marcador CD99 positivo,1679-4508-eins-13-2-0269-gf03-pt,NotMatch,NotMatch
PMC4943821,Figura 4,Imuno-histoquímica com marcador BCL-2 positivo,1679-4508-eins-13-2-0269-gf04-pt,NotMatch,NotMatch
PMC4943821,Figura 5,Imuno-histoquímica com marcador vimentina positivo,1679-4508-eins-13-2-0269-gf05-pt,NotMatch,NotMatch
PMC4943821,Figura 6,Imuno-histoquímica com marcador CD34 positivo,1679-4508-eins-13-2-0269-gf06-pt,NotMatch,NotMatch
PMC4450339,Figure 1,Brain primary tumor.,CRIONM2015-214306.001,NotMatch,NotMatch
PMC4450339,Figure 2,"Liver metastases, segment VI.",CRIONM2015-214306.002,NotMatch,NotMatch
PMC4450339,Figure 3,"Liver metastasis, segment VIII.",CRIONM2015-214306.003,NotMatch,NotMatch
PMC4450339,Figure 4,"H&E stain, 200x.",CRIONM2015-214306.004,NotMatch,Match
PMC4450339,Figure 5,"H&E stain, 400x.",CRIONM2015-214306.005,NotMatch,Match
PMC4450339,Figure 6,"CD34 stain, 40x.",CRIONM2015-214306.006,NotMatch,NotMatch
PMC4450339,Figure 7,Multiple hypervascular hepatic lesions.,CRIONM2015-214306.007,NotMatch,NotMatch
PMC4450339,Figure 8,Disappearance of hepatic lesions after transarterial embolization.,CRIONM2015-214306.008,NotMatch,NotMatch
PMC4473787,Figure 1,Coupe axiale passant par le sinus maxillaire: Comblement du sinus et de la fosse nasale homolatérale avec lyse de la paroi intersinuso-nasal,PAMJ-18-53-g001,NotMatch,NotMatch
PMC4473787,Figure 2,Prolifération de cellules fusiformes,PAMJ-18-53-g002,NotMatch,NotMatch
PMC4473787,Figure 3,Extériorisation de la masse par la fosse nasale,PAMJ-18-53-g003,NotMatch,NotMatch
PMC4451651,Figure 1,Swelling seen in the left anterior maxillary region,JOMFP-19-107b-g001,NotMatch,NotMatch
PMC4451651,Figure 2,Intraoral view showing left buccal and palatal swelling,JOMFP-19-107b-g002,NotMatch,NotMatch
PMC4451651,Figure 3,Orthopantomogram showing a poorly circumscribed lesion showing radiolucency with 23 missing,JOMFP-19-107b-g003,NotMatch,NotMatch
PMC4451651,Figure 4,"Photomicrograph showing staghorn pattern and blood vessels are lined by flat endothelial cells (H&E stain, x100). H&E: hematoxylin and eosin",JOMFP-19-107b-g004,NotMatch,Match
PMC4451651,Figure 5,"Photomicrograph showing typical staghorn pattern of vascular channels, the blood vessels are lined by flat endothelial cells(H& E stain, x400)",JOMFP-19-107b-g005,NotMatch,Match
PMC4451651,Figure 6,"Photomicrograph shows network of capillary vessels with a staghorn pattern, where lumen is lined by flat endothelial cells. The tumor cells present a pale cytoplasm with round or ovoid nuclei(H&E stain, x400)",JOMFP-19-107b-g006,NotMatch,Match
PMC4451651,Figure 7,"Tumor showing positive reactivity with CD34 typically around vasculature (IHC stain, x40)",JOMFP-19-107b-g007,NotMatch,Match
PMC4451651,Figure 8,"Tumor showing positive reactivity with CD 99 staining (IHC stain, x100)",JOMFP-19-107b-g008,NotMatch,Match
PMC4451677,Figure 1,Extraoral photograph showing facial asymmetry with a smooth surfaced swelling on the right lower side of the face,JOMFP-19-92-g001,NotMatch,NotMatch
PMC4451677,Figure 2,MRI - STIR image showing hypointense areas suggestive of fat,JOMFP-19-92-g002,NotMatch,NotMatch
PMC4451677,Figure 3,"Hemangiopericytoma-like areas (black arrow) admixed with areas of mature adipocytes (red arrow) (H&E stain, x40)",JOMFP-19-92-g003,Match,Match
PMC4451677,Figure 4,"Typical staghorn pattern with proliferating lesional cells (H&E stain, x200)",JOMFP-19-92-g004,NotMatch,Match
PMC4451677,Figure 5,"Reticulin stain showed distinctive reticulin pattern and each pericyte is surrounded by reticulin fibers (Reticulin stain, x100)",JOMFP-19-92-g005,NotMatch,Match
PMC4451677,Figure 6,"Immunohistochemistry revealing CD99 negativity (IHC stain, x100)",JOMFP-19-92-g006,NotMatch,Match
PMC4451677,Figure 7,"Immunohistochemistry revealing Bcl-2 negativity (IHC stain, x100)",JOMFP-19-92-g007,NotMatch,Match
PMC4451677,Figure 8,"Immunohistochemistry revealing S-100 negativity with positivity in fat containing cells (IHC stain, x100)",JOMFP-19-92-g008,NotMatch,Match
PMC4451677,Figure 9,"Immunohistochemistry revealing Pan cytokeratin negativity (IHC stain, x100)",JOMFP-19-92-g009,NotMatch,Match
PMC4451677,Figure 10,"Immunohistochemistry revealing Desmin negativity (IHC stain, x100)",JOMFP-19-92-g010,NotMatch,Match
PMC4451677,Figure 11,"Immunohistochemistry revealing CD34 negativity in lesional cells, positivity in endothelial cells of vessels (IHC stain, x100)",JOMFP-19-92-g011,NotMatch,Match
PMC4451677,Figure 12,"Immunohistochemistry revealing Smooth muscle actin negativity in lesional cells and positivity in vessel walls (arrow), (IHC stain, x100)",JOMFP-19-92-g012,NotMatch,Match
PMC4495700,Fig. 1,PET/CT findings upon admission. (a) Tumor recurrence of the right occipital lobe. (b) Hyper-metabolic foci at the lower right lung and the vertebrae. (c) Hyper- metabolic foci at the vertebrae and ribs,13000_2015_318_Fig1_HTML,NotMatch,NotMatch
PMC4495700,Fig. 2,"Photomicrographs of the tumor of left-side back of the neck and the third lumbar vertebra. (a) The patternless architecture with intervening irregular hyalinzed collagen bundles (H&E, ×100). (b) Hypercellularity or hypocellularity and perivascular hyalinization can be seen (H&E, ×100). (c) Coagulative necrosis and hemangiopericytoma-like pattern were shown (H&E, ×100). (d) Cellular atypia and atypical mitosis were shown (H&E, ×400). (e) Tumor cells were diffusely positive for CD99 (immunostain, ×200). (f) Tumor cells were focal positive for CD34 (immunostain, ×400). (g) Tumor cells were focal positive for BCL-2 (immunostain, ×400). (h) Most tumor cells showed Ki-67 labeling index of 40 % (immunostain, ×200)",13000_2015_318_Fig2_HTML,Match,Match
PMC4522440,Fig. 1,"Preoperative magnetic resonance imaging (MRI) scans of case 1. (A) and (B) show T2-weighted sagittal and axial MR images demonstrating intramedullary mass lesion and surrounding syrinx cavity at C2 level, expanding to the spinal cord. (C) and (D) show post contrast T1-weighted sagittal and axial MR images with prominently enhancing mass lesion in the spinal cord.",asj-9-522-g001,NotMatch,NotMatch
PMC4522440,Fig. 2,"(A, B) Intraoperative picture following dural opening is shown. (B) Black arrows indicate intermingled capillaries located over the spinal cord. The arrow head indicates the prominent feeder artery supplying the tumor from below. The circumferential dots show the approximate location of the tumor.",asj-9-522-g002,NotMatch,NotMatch
PMC4522440,Fig. 3,"(A) Vascular tumor adherent to spinal dura mater (H&E, ×40). (B) Positive CD34 staining in endothelium of thick-walled vessels and stromal cells (CD34, ×200).",asj-9-522-g003,NotMatch,Match
PMC4522440,Fig. 4,Preoperative and postoperative magnetic resonance imaging scans are shown for the case number 2. (A) and (B) show preoperative post contrast T1-weighted sagittal and axial images with highly enhancing mass lesion and syrinx cavity expanding superiorly and inferiorly in thoracic spinal cord. (C) and (D) show postoperative post contrast images indicating no residual tumor. (E) and (F) show postoperative T2-weighted images demonstrating spinal cord thinning and decrease in the syrinx cavity.,asj-9-522-g004,NotMatch,NotMatch
PMC4522440,Fig. 5,"(A) Stag-horn vascular structures and neoplastic stromal cells around the slit shaped vascular structures (H&E, ×100) are shown. (B) Repellent infiltration to glial tissue can be discriminated with GFAP (glial fibrillary acidic protein, ×40).",asj-9-522-g005,NotMatch,Match
PMC4551704,Fig. 1,"Preoperative CT showing the size, vascularization, and location of the tumor",12957_2015_675_Fig1_HTML,NotMatch,NotMatch
PMC4551704,Fig. 2,Preoperative and postembolization CT showing partial devascularization,12957_2015_675_Fig2_HTML,NotMatch,NotMatch
PMC4551704,Fig. 3,Digital subtraction angiography showing the vascularization of the tumor in the pelvis (arrows indicate the vasculature),12957_2015_675_Fig3_HTML,NotMatch,NotMatch
PMC4551704,Fig. 4,Digital subtraction angiography after the embolization (arrows indicate the coils),12957_2015_675_Fig4_HTML,NotMatch,NotMatch
PMC4551704,Fig. 5,Specimen ex-situ,12957_2015_675_Fig5_HTML,NotMatch,NotMatch
PMC4551704,Fig. 6,"Preoperative CT before the second operation, showing the hepatic mass in segment 7 in the axial plane",12957_2015_675_Fig6_HTML,NotMatch,NotMatch
PMC4551704,Fig. 7,"Preoperative CT before the second operation, showing the hepatic mass in segment 7 in the coronar plane",12957_2015_675_Fig7_HTML,NotMatch,NotMatch
PMC4601948,Fig. 1,Computed tomographic scan showing large metastasis in the falciform ligament. The arrow indicates the metastasis.,gr1,NotMatch,NotMatch
PMC4601948,Fig. 2,Computed tomographic scan showing metastases in the (A) right retrorenal retroperitoneum and (B) hepatic flexure attachments of the right colon. The arrow indicates the retrorenal metastasis.,gr2,NotMatch,NotMatch
PMC4601948,Fig. 3,Laparoscopic resection using ultrasonic dissection. (A) Tumor is visible in tissue. (B) Tumor after it was dissected free.,gr3,NotMatch,NotMatch
PMC4601948,Fig. 4,Computed tomographic scans (A and B) show metastases to small-bowel mesentery.,gr4,NotMatch,NotMatch
PMC4584003,Fig. 1,Representative images of Oct4 staining in normal and vascular tumor tissues. Immunopositivity for Oct4 protein is represented by brown staining. Positive control (left panel) = human testicle; negative control (right panel) = human testicle with no added primary antibody. 400× total magnification for each image,12907_2015_18_Fig1_HTML,NotMatch,NotMatch
PMC4584003,Fig. 2,Representative images of Nanog staining in normal and vascular tumor tissues. Immunopositivity for Nanog protein is represented by brown staining. Positive control (left panel) = human testicle; negative control (right panel) = human testicle with no added primary antibody. 400× total magnification for each image,12907_2015_18_Fig2_HTML,NotMatch,NotMatch
PMC4584003,Fig. 3,Representative images of Myc staining in normal and vascular tumor tissues. Immunopositivity for Myc protein is represented by brown staining. Positive control (left panel) = human colon cancer; negative control (right panel) = human colon cancer with no added primary antibody. 400× total magnification for each image,12907_2015_18_Fig3_HTML,NotMatch,NotMatch
PMC4584003,Fig. 4,Representative images of Sox2 staining in normal and vascular tumor tissues. Immunopositivity for Sox2 protein is represented by brown staining. Positive control (left panel) = rat brain; negative control (right panel) = rat brain with no added primary antibody. 400× total magnification for each image,12907_2015_18_Fig4_HTML,NotMatch,NotMatch
PMC4584003,Fig. 5,Representastive images of Klf4 staining in normal and vascular tumor tissues. Immunopositivity for Klf4 protein is represented by brown staining. Positive control (left panel) = human intestine; negative control (right panel) = human intestine with no added primary antibody. 400× total magnification for each image,12907_2015_18_Fig5_HTML,NotMatch,NotMatch
PMC4584003,Fig. 6,"Antigenicity for embryonic stem cell reprogramming factors in normal tissue and vascular tumors. Box and whisker plots depicting the IHC scores for Oct4, Nanog, Myc, Sox2, and Klf4 in normal vasculature, benign, borderline or malignant vascular tumors, or across a panel of various sarcomas. The Mann-Whitney rank sum test was used to determine statistical significance. Significance was determined if the two-sided P value of the test was < 0.05. Asterisks indicate level of significance relative to normal vasculature (* p < 0.05, ** p < 0.05, *** p < 0.005, **** p < 0.0005)",12907_2015_18_Fig6_HTML,NotMatch,NotMatch
PMC4630351,Fig. 1,A : Preoperative magnetic resonance (MR) images show a temporal fossa meningeal hemangiopericytoma in Case No. 15. B : Immediate postoperative MR images show that the tumor was completely resected. C : MR images taken 81 months later show tumor recurrence. The patient underwent tumor embolization prior to removal. D : Immediate postoperative MR images show complete resection of the tumor.,jkns-58-211-g001,Match,NotMatch
PMC4630351,Fig. 2,Kaplan-Meier analysis of recurrence-free survival rates in patients who were and were not treated with adjuvant radiotherapy after complete resection in the first surgery. There was no significant difference between these groups (p=0.3).,jkns-58-211-g002,NotMatch,NotMatch
PMC4630351,Fig. 3,The Ki-67 index differed significantly between patients who did and did not develop recurrence (p=0.001).,jkns-58-211-g003,NotMatch,NotMatch
PMC4630351,Fig. 4,"Analysis of the recurrence-free survival in our study. The 5- and 10-year recurrence-free survival rates were 83% and 52%, respectively.",jkns-58-211-g004,NotMatch,NotMatch
PMC4550184,Figure 1,"Images of a 72-year-old patient who had a 6-year history of resection of a right occiput HPC.Notes: A tumor (arrow) was found on axial T1WI (A) on the same side (right) as the previous tumor that had been resected 6 years ago; it was diagnosed as recurrent HPC. Multiple nodules (arrows) were distributed bilaterally in the lung and identified by CT (B). Histopathological analysis of a section (C) of one of the nodules through needle biopsy confirmed the nature of the HPC metastasis.Abbreviations: HPC, hemangiopericytoma; CT, computed tomography; T1W1, T1-weighted image.",ott-8-2169Fig1,Match,NotMatch
PMC4550184,Figure 2,"Images of a typical type 1 HPC tumor.Notes: Unenhanced sagittal T1W (A), axial T1W (B), axial T2W (C), and DW (D) MRI images show that the tumor is located in the right temporal lobe outside the brain parenchyma, and has an oval shape and a well-defined margin, but no bone erosion. The solid partitions demonstrate isointense, cystic areas and signal-void vessels (arrows) in the lesion; mild edema (indicated by the arrowhead) can be observed around it. Enhanced sagittal (E) and axial (F) T1W MRI images showing intense enhancement in the solid areas of the tumor, without the “dural tail” sign.Abbreviations: HPC, hemangiopericytoma; MRI, magnetic resonance imaging; T1W, T1-weighted; T2W, T2-weighted; DW, diffusion-weighted.",ott-8-2169Fig2,Match,NotMatch
PMC4550184,Figure 3,"Images depicting the typical presentations of a type 2 HPC tumor.Notes: Routine CT (A) and enhanced CT (B) images show that the tumor is located in the parafalx with an oval shape, with slight hyperattenuation and homogenous enhancement, but without cysts or necrosis. An unenhanced MRI scan shows that the tumor is slightly hyperintense on sagittal (C) and axial T1W (D) images; isointense on the T2W (E), T2W-FLAIR (F), and DW (G) images, with a signal-void vessel (arrow in E) and moderate edema around the lesion (arrowhead in E). Enhanced T1W MRI scan (H) shows homogenous and intensive enhancement of the lesion, without the “dural tail” sign. Enhanced MR venography (I) demonstrates compression in the cupular part of the superior sagittal sinus by the tumor, which had moved to the left side (arrow in I), and an enlarged vein adjacent to the tumor, which was displaced to the posterior side (arrowhead in I). The lesion was totally resected, as can be seen in the postoperative CT scan (J) taken 15 days after surgery. About 48 months later, recurrence was noted on the opposite side with intensive enhancement on a follow-up MRI (K); further, needle biopsy confirmed the presence of an HPC tumor (L).Abbreviations: HPC, hemangiopericytoma; CT, computed tomography; MRI, magnetic resonance imaging; T1W, T1-weighted; T2, T2-weighted; T2W-FLAIR, T2-weighted-fliud-attenuated-inversion recovery; DW, diffusion-weighted.",ott-8-2169Fig3,Match,NotMatch
PMC4550184,Figure 4,"Images depicting the typical features of a type 3 HPC tumor.Notes: Sagittal T1W (A), axial (B) T1W, T2W (C), and DW (D) images show that the tumor is infratentorial, located outside the cerebellar hemisphere, with a well-defined margin, a few cystic areas (arrows) and a small signal-void vessel (arrowhead) in the mass. Moderate enhancement can be identified on enhanced MRI (E and F), without the “dural tail” sign. Postoperative pathological analysis confirmed recurrent HPC (G).Abbreviations: HPC, hemangiopericytoma; T1W, T1-weighted; T2W, T2-weighted; DW, diffusion-weighted; MRI, magnetic resonance imaging.",ott-8-2169Fig4,Match,NotMatch
PMC4550184,Figure 5,"Images for a typical case of type 4 HPC tumor.Notes: The tumor is infratentorial and lobular in shape and is isointense; moreover, several signal-void vessels (arrows) can be seen in and around the mass. Solid partitions demonstrate isointensity on sagittal T1W (A), axial T1W (B), and T2W (C) images, and slight hyperintensity (52 HU) as compared to the normal parenchyma (38 HU) on the opposite side as that observed in the CT image (D), with no obvious calcification of the mass. CE-MRI (E and F) showed that the lesion was intensively and homogenously enhanced, without any obvious cystic areas or the “dural tail” sign. The white circles denote areas used to measure CT attenuations. Postoperative pathological analysis confirmed that it was an HPC tumor (G).Abbreviations: HPC, hemangiopericytoma; T1W, T1-weighted; T2W, T2-weighted; CT, computed tomography; CE-MRI, contrast-enhanced magnetic resonance imaging.",ott-8-2169Fig5,Match,NotMatch
PMC4550184,Figure 6,"Images of a 76-year-old woman admitted with a mass in the left temporal lobe that could be palpated and persistent headaches for 2 months.Notes: Axial CT scan (A) shows an oval mass with mild calcification (arrow in A) in the left temporal lobe with erosion to the adjacent temporal bone (arrowheads in A). MIP of the CTA (B, C, and D) show abundant feeding vessels through the mass (arrows in B), including branches from the left temporalis superficialis artery (arrows in C) and branches from the middle cerebral artery (arrow in D).Abbreviations: CT, computed tomography; MIP, maximum intensity projection; CTA, CT angiography.",ott-8-2169Fig6,NotMatch,NotMatch
PMC4611939,Figure 1,"Endothelial lined blood vessels with perivascular hyalinization in the background of a highly cellular and uniform appearing delicate, collagenous connective tissue stroma (H&E stain, x100)",JOMFP-19-260-g001,NotMatch,Match
PMC4611939,Figure 2,"Higher magnification showing arrangement of cells in typical whorling pattern (H&E stain, x400)",JOMFP-19-260-g002,NotMatch,Match
PMC4611939,Figure 3,"Typical staghorn appearance of blood vessels (H&E stain, x100)",JOMFP-19-260-g003,NotMatch,Match
PMC4611939,Figure 4,"Higher magnification these blood vessels showed plump endothelial cell lining (H&E stain, x400)",JOMFP-19-260-g004,NotMatch,Match
PMC4611939,Figure 5,"Heterotopic ossification in the background of plump proliferating fibroblasts. (H&E stain, x200)",JOMFP-19-260-g005,NotMatch,Match
PMC4611939,Figure 6,"Silver reticulin stain showing reticular fibers surrounding the tumor cells outside the vessel wall. (Silver stain, x100)",JOMFP-19-260-g006,NotMatch,Match
PMC4611939,Figure 7,"The endothelial cells showing positivity for CD34 (IHC stain, x100)",JOMFP-19-260-g007,NotMatch,Match
PMC4656898,Fig. 1,"Representative images of intracranial hemangiopericytoma which adjoins adjacent vessels (case number 17 in Table 2). Magnetic resonance images show heterogenously enhancing mass located in the left tentorium. A: Axial image shows an irregular shaped mushroom-like mass. B: In sagittal image, the mass is bulging bilaterally towards the occipital lobe upwards and cerebellum downwards. C and D: Postoperative axial (C) and sagittal (D) images show the tumor removed gross totally.",btrt-3-68-g001,Match,NotMatch
PMC4656898,Fig. 2,Representative images of intracranial hemangiopericytoma which has no major vessels adjoined (case number 14 in Table 2). Magnetic resonance images show dural-based enhancing mass located in the left convexity. A and B: Axial (A) and coronal (B) images show a round-shaped homogenously enhancing mass in the left convexity. C and D: Postoperative axial (C) and sagittal (D) images show the tumor removed grossly totally.,btrt-3-68-g002,Match,NotMatch
PMC4656898,Fig. 3,Analysis of the overall survival in the present study (Kaplan-Meier curve).,btrt-3-68-g003,NotMatch,NotMatch
PMC4656898,Fig. 4,Analysis of the recurrence-free survival in the present study (Kaplan-Meier curve).,btrt-3-68-g004,NotMatch,NotMatch
PMC4656898,Fig. 5,"Correlation analysis between the extent of resection and recurrence-free survival (log-rank test). GTR, grossly total resection; PR, partial resection.",btrt-3-68-g005,NotMatch,NotMatch
PMC4656898,Fig. 6,Correlation analysis between Simpson grading of surgical resection and recurrence-free survival (log-rank test).,btrt-3-68-g006,NotMatch,NotMatch
PMC4656898,Fig. 7,Correlation analysis between adjuvant radiotherapy and recurrence-free survival (log-rank test).,btrt-3-68-g007,NotMatch,NotMatch
PMC4719796,Figure 1,Large 12 cm × 10 cm enhancing left renal mass with central necrosis and calcification on initial presentation (black arrow).,gr1,NotMatch,NotMatch
PMC4719796,Figure 2,Eight years post left radical nephrectomy with new 4.3 cm enhancing right renal mass with necrotic foci (black arrow).,gr2,NotMatch,NotMatch
PMC4719796,Figure 3,"Histopathology of the resected metachronous right kidney lesion revealing spindle cell architecture, cytological atypia, and diffuse CD 99 staining on immunohistochemistry consistent with malignant SFT.",gr3,NotMatch,NotMatch
PMC4736393,Figure 1,"Axial, noncontrast CT scan (a) demonstrating a hyperdense, bifrontal, parasagittal lesion with surrounding vasogenic edema. T1 weighted, postcontrast MRI images showing (b) axial, (c) sagittal, and (d) coronal views of the mass.",CRINM2016-5245078.001,NotMatch,NotMatch
PMC4736393,Figure 2,Cerebral angiogram in (a) AP and (b) lateral common carotid injections demonstrating blood supply of the tumor crossing midline from the left distal ACA. The left carotid venous phase (c) shows a dense tumor blush. An oblique right common carotid injection (d) demonstrates no contribution to the tumor.,CRINM2016-5245078.002,NotMatch,NotMatch
PMC4736393,Figure 3,"Photomicrograph of tissue sections showing papillary and clear cell morphology with hypervascularity, but no characteristic staghorn appearance (a). Necrosis, intratumoral hemorrhage, nuclear atypia, and frequent mitotic figures were seen (b) and there was patchy and strong CD34 staining (c), as well as strong and diffuse CD99 staining (d).",CRINM2016-5245078.003,NotMatch,NotMatch
PMC4732263,Figure 1,Axial noncontrast (a) computed tomography images shows a well-defined intraconal mass in the posterior right orbit. Postcontrast image (b) heterogenous enhancement of the lesion causing proptosis and medial displacement of optic nerve,AJNS-11-78a-g001,NotMatch,NotMatch
PMC4732263,Figure 2,Magnetic resonance sagittal images shows a retro-orbital lesion of hypointense signal on T1-weighted (a) with postcontrast T1-weighted image (b) revealing heterogenous enhancement of the lesion,AJNS-11-78a-g002,NotMatch,NotMatch
PMC4732263,Figure 3,"(a) Tumor revealing patternless fibroblastic proliferation and vascular channels with pericytomatous arrangement (H and E, ×100) (b) spindle cells growing in a haphazard manner in a variable cellular stroma described as “patternless pattern” (H and E, ×400)",AJNS-11-78a-g003,NotMatch,Match
PMC4732263,Figure 4,Tumor cells with strong and diffuse positivity to CD34 (a) but negativity for S-100 (b),AJNS-11-78a-g004,NotMatch,NotMatch
PMC4804146,Fig. 1.,"Representative brain magnetic resonance images and histopathology of the primary brain tumor from case 10. (A) Prior to radiation therapy. A large, solid and cystic mass is observed in the right frontoparietal lobe with strong enhancement. There was severe mass effect. Intratumoral vessels were identified. (B) After preoperative radiation therapy. The tumor decreased in the size after radiation therapy. (C) The tumor demonstrates low cellular and edematous areas with staghorn-shaped vasculature. The tumor cells may have been ablated by radiotherapy. (D) Aberrant STAT6 nuclear positivity is observed in the primary brain tumor.",jptm-2015-10-30f1,NotMatch,NotMatch
PMC4804146,Fig. 2.,"Computed tomography (CT) and pathology of a metastatic solitary fibrous tumor from case 10. (A) Liver CT scan showing a large, 12-cm soft tissue mass in the right lobe with prominent feeding vessels. (B) The cut surface of a hepatic tumor specimen showing a well-circumscribed, yellowish-tan-colored, solid tumor with multifocal necrosis, and hemorrhage with dilated vessels. (C) Microscopic examination of the liver mass reveals small, discohesive tumor cells with oval nuclei and fine chromatin. Staghorn-shaped hyalinized vessels and osteoclast-like multinucleated giant cells are identified. (D) Tumor cells are focally positive for CD34 on immunohistochemical staining. (E) Aberrant STAT6 nuclear positivity is observed in the metastatic tumor cells in the liver. (F) Ultrastructurally, the tumor is composed of sheets of oval to elongate cells around small capillaries. The tumor cells have nuclei with an oval or indented appearance, and fine, granular chromatin. Skein-like nuclei are also present. The individual tumor cells are surrounded by a thick, electron-dense, amorphous, external laminar material (arrowheads; uranyl acetate and lead citrate, × 5,000).",jptm-2015-10-30f2,NotMatch,NotMatch
PMC4804146,Fig. 3.,"Kaplan-Meier survival curves of patients with solitary fibrous tumors according to the presence or absence of systemic metastases. (A) Paradoxically, the patients with systemic metastases had better prognosis than did those without metastasis. Metastases usually arose approximately 10 years after the initial tumor development. Therefore, only longer survivors developed systemic metastases. (B) Younger patients lived longer and had better survival. The age cut-off to demonstrate a meaningful survival difference is 45 years. (C) Patients with an initial tumor size > 5 cm have poorer survival than did those with smaller tumors. (D) The age of tumor onset is significantly younger in patients with systemic metastases than it is in patients without metastases. The median ages of onset in patients with and without systemic metastases are 37.1 years and 52.5 years, respectively.",jptm-2015-10-30f3,NotMatch,NotMatch
PMC4825158,Figure 1.,"Metastatic HPC in the liver (case 1). (A) The tumor comprises spindle cells of moderate cellularity with the presence of staghorn vessels (H&E stain). (B) The tumor cells display moderate pleomorphism, oval nuclei and a moderate amount of cytoplasm (H&E stain). HPC, hemangiopericytoma.",cmh-22-1-188f1,Match,Match
PMC4746834,Figure 1,"(A) 45/M with polyarthritis for 7 years, progressive weakness of all 4 limbs and wasting of muscles for 5 years. Preoperative biochemical parameters: Serum calcium – 8.2 mg/dL, serum phosphorus – 1.1 mg/dL, serum Vitamin D3 – 14 ng/mL, serum parathyroid hormone – 171 pg/mL, serum alkaline phosphatase – 679 U/L, serum creatinine – 0.6 mg/dL. 99mTechnetium-methylene diphosphonate bone scintigraphy showing a diffuse increase in tracer concentration in axial and appendicular skeleton with microfractures in ribs (arrows) and faint visualization of kidneys suggestive of the metabolic bone disease. (B) Contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography-computed tomography images. (a) Maximum intensity projection image showing physiological tracer distribution and increased fluorodeoxyglucose uptake in the right nasal region. (b) Transaxial and (d) coronal fused contrast enhanced positron emission tomography-computed tomography and corresponding contrast-enhanced computed tomography images showing increased fluorodeoxyglucose uptake (maximum standardized uptake value 5.2) in a soft tissue mass in right nasal cavity with whorl like enhancement on contrast. (c) Low power and (e) high power view photomicrographs showing spindle cell neoplasm with pericytomatous features – possibly sinonasal – type hemangiopericytoma. Postoperative serum calcium – 8.8 mg/dL, serum phosphorus – 3.7 mg/dL",IJNM-31-14-g002,Match,NotMatch
PMC4746834,Figure 2,"(A) 40/M with pain in bilateral hips for 2 years and difficulty in walking with insufficiency fracture in the neck of right femur with nonunion. Preoperative biochemical parameters: Serum calcium – 9.4 mg/dL, serum phosphorus – 1.6 mg/dL, serum Vitamin D3 – 10 ng/mL, serum parathyroid hormone – 43 pg/mL, serum fibroblast growth factor-23 – 3360 RU/mL, serum creatinine – 0.8 mg/dL. 99mTechnetium-methylene diphosphonate bone scintigraphy suggestive of the metabolic bone disease. (B) 18F-fluorodeoxyglucose positron emission contrast-enhanced computed tomography images (a) maximum intensity projection image showing focal fluorodeoxyglucose uptake in region of left lingual tonsil (maximum standardized uptake value 4.4) and in region of greater trochanter of right femur (maximum standardized uptake value 5.4) (b) Transaxial fused contrast enhanced positron emission tomography-computed tomography images showing dual time point imaging which shows increase in maximum standardized uptake value from 4.4 to 5.7 in left lingual tonsil, with no corresponding computed tomography abnormality. (c) Coronal and transaxial contrast-enhanced computed tomography and corresponding fused positron emission contrast-enhanced computed tomography images of a right hand showing focus of fluorodeoxyglucose uptake in soft tissue in the distal forearm between radius and ulna. Histopathological examination of tonsillectomy specimen - reactive lymphoid follicles. (C) 68Gallium-DOTANOC contrast enhanced positron emission tomography-computed tomography images showing a). physiological tracer distribution and focus of abnormal increase in tracer in region of greater trochanter of right femur, (b) Fused contrast enhanced positron emission tomography-computed tomography and (c) corresponding contrast-enhanced computed tomography axial, sagittal and coronal images showing focal increase in tracer uptake in greater trochanter of right femur adjacent to bone chips. The patient underwent bilateral total hip replacement. (d and e) Histopathological examination showed atypical spindle cell lesion. Postoperative serum calcium – 10 mg/dL, serum phosphorus – 2 mg/dL",IJNM-31-14-g003,NotMatch,NotMatch
PMC4746834,Figure 3,"52/M with difficulty in walking since 7 months and proximal myopathy since 7 years. Preoperative biochemical parameters: Serum calcium - 7.5 mg/dL, serum phosphorus – 0.7 mg/dL serum parathyroid hormone – 277.4 pg/ml, serum creatinine – 1.3 mg/dL, serum alkaline phosphatase – 1093 U/L. Fluorodeoxyglucose contrast enhanced positron emission tomography-computed tomography images (a) maximum intensity projection image showing brown fat uptake and focus of increased fluorodeoxyglucose uptake in the region of greater trochanter of left femur (arrow). (b) Transaxial and (c) coronal contrast-enhanced computed tomography and corresponding fused contrast enhanced positron emission tomography-computed tomography showing fluorodeoxyglucose uptake in focal sclerotic lesion in the greater trochanter of left femur (maximum standardized uptake value 6.9). Postoperative serum calcium – 9.4 mg/dL, serum phosphorus 2.8 m/dL",IJNM-31-14-g004,NotMatch,NotMatch
PMC4802986,Figure 1,"Preoperative imaging of the glomangiopericytoma. Axial T1 magnetic resonance imaging with gadolinium (a), T1 without gadolinium (b), flair (c), T2 (d), sagittal (e), and coronal (f) T1 with gadolinium depicting the tumor in the left cavernous sinus simulating an intracavernous meningioma. Axial (g) and coronal (h) computed tomography angiography demonstrating low vascular flow to the tumor in the left cavernous sinus",SNI-7-142-g001,NotMatch,NotMatch
PMC4802986,Figure 2,"Microscopic and immunohistochemical examination of the resected specimen (a and b). Low and high power microscopic examination with H and E stain demonstrating connective vascular arrangements in a kind of honeycomb structure, with a relatively thin walls consisting of endothelial cells and fibroblast-like cells in the stroma. Immunohistochemical examination of the specimen showed diffuse and strong positivity to CD34 in the endothelium alone (c) and muscle-specific actin in the stroma (d)",SNI-7-142-g002,NotMatch,NotMatch
PMC4802986,Figure 3,"Immediate postoperative imaging after endoscopic tumor debulking. Axial (a and b), sagittal (c), and coronal (d) T1 magnetic resonance imaging with gadolinium depicting residual tumor in the left cavernous sinus with expected postoperative changes",SNI-7-142-g003,NotMatch,NotMatch
PMC4802986,Figure 4,Postoperative imaging 5 months after tumor debulking. Axial (a) and sagittal (b) T1 magnetic resonance imaging with gadolinium and coronal T2 (c and d) showing stable tumor with no interval growth/progression,SNI-7-142-g004,NotMatch,NotMatch
PMC4819095,Figure 1,"(a) Microscopic description: the tumor is cellular and composed of many variable ectatic and compressed thin walled branching vessels, giving staghorn configuration. The surrounding tumor cells are spindled to round with scant pale to eosinophilic cytoplasm, bland vesicular nuclei, and low mitotic activity. (b) Immunohistochemically, the tumor cells stain positive for CD34. The combined morphology and immunoprofile are consistent with hemangiopericytoma.",CRIOG2016-2075157.001,Match,NotMatch
PMC4842903,Fig. 1,Case 1. Preoperative T1-weighted post contrast coronal magnetic resonance imaging showing an extra-axial mass with significant mass effect and edema on the adjacent brain parenchyma (A). Anteroposterior view of left external carotid artery arteriogram demonstrating filling of the tumor through branches of the left superficial temporal artery and the left middle meningeal artery draining into a venous fistula and also supplying the tumor through multiple collaterals (B). Anteroposterior skull film demonstrating Onyx cast (C).,jcen-18-12-g001,NotMatch,NotMatch
PMC4842903,Fig. 2,"Case 2. Preoperative T1-weighted post contrast coronal magnetic resonance imaging demonstrates an extra-axial, falcine lesion over the frontoparietal vertex with mass effect and an associated inferolateral peritumoral cyst (A). Anteroposterior view of a distal left external carotid artery arteriogram illustrates the classic ""spoke wheel"" filling of the falcine meningioma supplied by distal branch of the middle meningeal artery (C). Lateral view of post-embolization angiogram of left external carotid artery shows occlusion of the distal middle meningeal artery.",jcen-18-12-g002,NotMatch,NotMatch
PMC4842903,Fig. 3,"Case 3. Preoperative T1-weighted post contrast sagittal magnetic resonance imaging shows an extra-axial enhancing mass centered in the falx cerebri (A). This lesion extended bilaterally with invasion of the anterior and mid superior sagittal sinus. Anteroposterior view of left external carotid artery arteriogram showing multiple arterial feeders to the tumor, mainly from the left middle meningeal artery (B). Anteroposterior view of post-embolization left common carotid artery arteriogram (C).",jcen-18-12-g003,NotMatch,NotMatch
PMC4842903,Fig. 4,"Case 4. Preoperative T1-weighted post contrast axial magnetic resonance imaging shows a right frontal extra-axial mass with intraosseous extension and adjacent dural thickening (A). Lateral view of right external carotid artery angiogram shows a hypervascular tumor blush, supplied by the middle meningeal artery and accessory middle meningeal artery (B). Anteroposterior, unsubtracted view of post-embolization of right external carotid artery angiogram demonstrates Onyx casting within the distal middle meningeal artery, with markedly diminished supply to the tumor but little flow from the accessory middle meningeal artery (C).",jcen-18-12-g004,NotMatch,NotMatch
PMC4842903,Fig. 5,"Case 5. Preoperative T1-weighted post contrast coronal magnetic resonance imaging shows a right temporal occipital extra-axial mass, with midline shift and mass effect noted on the right lateral ventricle and extensive edema (A). Anteroposterior view of right external carotid artery angiogram shows arterial supply to the tumor from branches of right occipital artery and the middle meningeal artery (B). Lateral view of post-embolization of right common carotid artery angiogram demonstrates little residual supply to the tumor (C).",jcen-18-12-g005,NotMatch,NotMatch
PMC4855784,Fig. 1,Abdominal CT-scan showing a hypervascularized solid centrally inhomogeneous tumor measuring 5.7 × 8.3 × 6.8 cm in the left lower quadrant with an emphasized vascular supply originating from the left gastoepiploic vessels.,gr1,NotMatch,NotMatch
PMC4855784,Fig. 2,"Inraoperative image showing the tumor within the greater omentum, mainly supplied by the left gastroepiploic vessels.",gr2,NotMatch,NotMatch
PMC4855784,Fig. 3,"Microscopic examination demonstrating numerous partly hyalinised branching vessels (stag-horn appearance) in the high population of spindle-shaped tumor cells. H&E, × 100.",gr3,NotMatch,Match
PMC4887940,Figure 1.,Magnetic resonance images. The ﬁrst tumor exhibited isointensity to brain parenchyma on (A) T1-weighted sagittal and (B) T2-weighted axial scans. The second tumor was located next to the first lesion and consisted of solid and cystic regions; the cystic region of the mass revealed (C) hypointensity on T1-weighted images and (D) hyperintensity on T2-weighted images. The solid region of the mass exhibited (C) isointensity to the adjacent brain tissue on T1-weighted images and (D) iso- or hyperintensity on T2-weighted images.,ol-11-06-3655-g00,NotMatch,NotMatch
PMC4887940,Figure 2.,"An MRI scan of each lesion and intraoperative image of the meningioma. (A) T1-weighted sagittal MRI exhibiting strongly-enhanced, solid regions of the two tumors following gadolinium administration. (B) Intradural exploration showing the cystic region of the second tumor containing yellow liquid. MRI, magnetic resonance imaging.",ol-11-06-3655-g01,NotMatch,NotMatch
PMC4887940,Figure 3.,"(A) Histological examination determined that the solitary fibrous tumor was composed of proliferating spindle cells (staining, hematoxylin and eosin). Immunohistochemistry demonstrated that the tumor tissue was (B) positive for B-cell lymphoma 2 (magnification, ×100) and (C) negative for epithelial membrane antigen (magnification, ×100).",ol-11-06-3655-g02,NotMatch,Match
PMC4887940,Figure 4.,"(A) Histological examination revealed evidence of multifocal epithelial cell differentiation and an intraepithelial microcavity containing eosinophil pseudopsammoma bodies. Immunohistochemistry demonstrated that the tumor tissue was positive for (B) epithelial membrane antigen (magnification, ×200) and (C) carcinoembryonic antigen (magnification, ×100).",ol-11-06-3655-g03,NotMatch,Match
PMC4899079,Fig. 1,Ultrasound images showing a pelvic mass measuring 60 × 40 mm.,gr1,NotMatch,NotMatch
PMC4899079,Fig. 2,"Laparoscopic findings. a) A well-circumscribed, pedunculated, vascular tumor (arrow) arising from the great omentum (asterisk). b) Detail of vascular pedicle (arrow).",gr2,NotMatch,NotMatch
PMC4899079,Fig. 3,Image showing surgical specimen: tumor and great omentum.,gr3,NotMatch,NotMatch
PMC4868819,Fig. 1,"Post-Gadolinium magnetic resonance imaging of the brain in axial (A), coronal (B), and sagittal (C) views showing a lobulated right cerebellopontine angle tumor with a tentorial attachment base.",btrt-4-8-g001,NotMatch,NotMatch
PMC4868819,Fig. 2,Post-operative axial CT views showing no tumor remnants.,btrt-4-8-g002,NotMatch,NotMatch
PMC4868819,Fig. 3,"Photomicrographs of the tumor specimens showing. A: Diffuse sheets of relatively uniform population of cells interspersed by staghorn vascular channels (H&E, original magnification, ×10). B: Round to oval cells with finely dispersed nuclear chromatin and moderate cytoplasm and no signs of anaplasia (H&E, original magnification, ×20). H&E, hematoxylin and eosin.",btrt-4-8-g003,NotMatch,Match
PMC4868819,Fig. 4,"Immunohistochemical staining showing diffuse positivity with CD34 (original magnification, ×100).",btrt-4-8-g004,NotMatch,Match
PMC4868819,Fig. 5,MRI of the brain after 10 years showing local recurrence.,btrt-4-8-g005,NotMatch,NotMatch
PMC5007728,Fig. 1,Single bone metastasis from meningeal SFT (patient 1 in Table 1): CT scan (venous phase after contrast medium) shows a solid lesion characterized by homogeneous contrast enhancement at the level of the seventh left rib,13569_2016_55_Fig1_HTML,NotMatch,NotMatch
PMC5007728,Fig. 2,"Histopathological pattern of primary meningeal malignant SFT (patient 3 Table 1). Tumour shows patternless growth of a uniform, bland, hypercellular, STAT6 positive, spindle cell proliferation around characteristic thin walled branched vessel. STAT6 200×
",13569_2016_55_Fig2_HTML,NotMatch,NotMatch
PMC5007728,Fig. 3,"Histopathological pattern of hipbone metastasis from primary meningeal malignant SFT (patient 3 Table 1). Similarly to primary lesion, tumour growths with patternless architecture, around thin walled vessel, with a more loose stroma, retaining immunoreactivity for STAT6. STAT6 200×
",13569_2016_55_Fig3_HTML,NotMatch,NotMatch
PMC4954860,Fig. 1,Two views show lipoma (arrows) as a slightly echogenic lesion in the supraperitoneal fat,JoU-2016-0016-g001,NotMatch,NotMatch
PMC4954860,Fig. 2,"Three lipomas (L) in the small bowel mesentery, which in computed tomography showed density ranging from –57 to –74 Hounsfield units",JoU-2016-0016-g002,NotMatch,NotMatch
PMC4954860,Fig. 3,Two views show angiomyolipoma (L) located entirely in the adipose capsule of the right kidney. An arrow points to the site of regrowth in the form of the beak sign,JoU-2016-0016-g003,NotMatch,NotMatch
PMC4954860,Fig. 4,Myelolipoma in the right suprarenal field (arrow) as a visible hyperechoic mass,JoU-2016-0016-g004,NotMatch,NotMatch
PMC4954860,Fig. 5,A heterogeneous mass arising from the retroperitoneal space is a mature teratoma with slight calcifications (arrows),JoU-2016-0016-g005,NotMatch,NotMatch
PMC4954860,Fig. 6,Relapse of liposarcoma in the small bowel mesentery. No lesion compressibility when pressure is applied with the transducer (arrow),JoU-2016-0016-g006,NotMatch,NotMatch
PMC4954860,Fig. 7,Heterogeneous retroperitoneal liposarcoma infiltrates into adjacent tissues (arrows),JoU-2016-0016-g007,NotMatch,NotMatch
PMC4954860,Fig. 8,Mesenteric liposarcoma with pathological vascularity,JoU-2016-0016-g008,NotMatch,NotMatch
PMC4954860,Fig. 9,Mesenteric lymphangioma as a multilocular lesion without flow (arrow),JoU-2016-0016-g009,NotMatch,NotMatch
PMC4954860,Fig. 10,"Retroperitoneal neuroblastoma in a 13-year-old (arrows). A – aorta, V – inferior vena cava",JoU-2016-0016-g010,NotMatch,NotMatch
PMC4954860,Fig. 11,"Desmoid, poorly vascularized tumor (D) in the small bowel mesentery",JoU-2016-0016-g011,NotMatch,NotMatch
PMC4954860,Fig. 12,Rhabdomyosarcoma with rich vascularity in the retroperitoneal space (arrows),JoU-2016-0016-g012,NotMatch,NotMatch
PMC4954860,Fig. 13,Two views present poorly vascularized malignant mesothelioma of the greater omentum (M),JoU-2016-0016-g013,NotMatch,NotMatch
PMC4954860,Fig. 14,Metastasis of malignant melanoma (M) from the interscapular space to the small bowel mesentery,JoU-2016-0016-g014,NotMatch,NotMatch
PMC4954860,Fig. 15,Peritoneal carcinomatosis of ovarian carcinoma. Thickened hypoechoic parietal peritoneum with signs of vascular flow (arrows),JoU-2016-0016-g015,NotMatch,NotMatch
PMC4954860,Fig. 16,Two views show a hyperechoic implant of ovarian carcinoma in the gastrocolonic ligament (arrows),JoU-2016-0016-g016,NotMatch,NotMatch
PMC4954860,Fig. 17,Ovarian carcinoma implants in the pouch of Morison (arrows),JoU-2016-0016-g017,NotMatch,NotMatch
PMC4954860,Fig. 18,“Sandwich” sign in the small bowel mesentery (arrows) created by enlarged lymph nodes surrounding the superior mesenteric vessels – a manifestation of non-Hodgkin lymphoma,JoU-2016-0016-g018,NotMatch,NotMatch
PMC4954860,Fig. 19,Extranodal location of follicular lymphoma in the small bowel mesentery (arrow),JoU-2016-0016-g019,NotMatch,NotMatch
PMC5051306,Figure 1,Clinical photograph showing lesion in the right side of maxilla intraorally,JOMFP-20-532-g001,NotMatch,NotMatch
PMC5051306,Figure 2,"Endothelial lined dilated blood vessels within the background of a highly cellular and uniform appearing delicately collagenous connective tissue stroma (H&E stain, ×40)",JOMFP-20-532-g002,NotMatch,Match
PMC5051306,Figure 3,"Tumor cells arranged in a storiform pattern and in sheets of alternating hypercellular and hypocellular areas (H&E stain, ×40)",JOMFP-20-532-g003,NotMatch,Match
PMC5051306,Figure 4,"Immunohistochemical staining with CD34 shows diffuse positivity (IHC stain, ×100)",JOMFP-20-532-g004,NotMatch,Match
PMC5051306,Figure 5,"Immunohistochemical staining with CD 99 shows tumor cells to be negative for CD99 (IHC stain, ×100)",JOMFP-20-532-g005,NotMatch,Match
PMC5051306,Figure 6,"Immunohistochemical staining with Bcl 2 shows negative staining (IHC stain, ×40)",JOMFP-20-532-g006,NotMatch,NotMatch
PMC5020570,Fig. 1,"A: A small, ulcerated, skin-covered mass (arrow) on the posterosuperior wall partially blocking the entrance of the external auditory canal. B: Contrast-enhanced CT showed a round hyperattenuated mass (arrow) with no clear invasion of adjacent structures. C, D: Four-vessel angiography was used to find and embolize the feeding artery, the posterior auricular artery. C: Round dark mass (arrow) before shutting off. D: Faint mass shadow (arrow) after shutting off.",jao-20-120-g001,NotMatch,NotMatch
PMC5020570,Fig. 2,"Histological and immunohistochemical findings of the solitary fibrous tumor. Well-circumscribed, non-encapsulated spindle-cell tumor located in the dermis (A) (H&E, ×10). The tumor had a patternless architecture of hypo- and hypercellular areas separated by thick, hyalinized collagen with cracking artifact and staghorn vessels (B) (H&E, ×40). Fibroblast-like cells with bland nuclear features, mixed with thick bands of collagen (C) (H&E, ×200). The spindle cells are positive for CD34 (D) (×200), and partially positive for bcl2 (E) (×200) and CD99 (F) (×200).",jao-20-120-g002,NotMatch,Match
PMC5051309,Figure 1,"Photomicrograph showing proliferation of spindle and epithelioid tumor cells admixed with numerous blood vessels (H&E stain, ×100)",JOMFP-20-545a-g001,NotMatch,Match
PMC5051309,Figure 2,Macroscopic appearance of the lesion,JOMFP-20-545a-g002,NotMatch,NotMatch
PMC5051309,Figure 3a,"Photomicrograph showing sheets or clusters of lesional cells alternating with well-differentiated cartilaginous areas (H&E stain, ×100)",JOMFP-20-545a-g003,NotMatch,Match
PMC5051309,Figure 3b,"Photomicrograph showing chondroid area along with ossification (H&E stain, ×100)",JOMFP-20-545a-g004,NotMatch,Match
PMC5051309,Figure 3c,"Photomicrograph showing round to ovoid cells with indistinct cytoplasm around the blood vessels imparting a hemangiopericytoma pattern (H&E stain, ×200)",JOMFP-20-545a-g005,Match,Match
PMC5051309,Figure 4a,"Tumor cells showing varied positivity for S-100 (IHC stain, ×400)",JOMFP-20-545a-g006,NotMatch,NotMatch
PMC5051309,Figure 4b,"Tumor cells showing strong positivity for vimentin (IHC stain, ×40)",JOMFP-20-545a-g007,NotMatch,NotMatch
PMC5051309,Figure 4c,"Tumor cells were negative for CD34 (IHC stain, ×40)",JOMFP-20-545a-g008,NotMatch,NotMatch
PMC5118533,Figure 1,Kaplan-Meier graph is shown with progression-free survival (PFS) and overall survival (OS) for all patients enrolled in the study.,SARCOMA2016-4592768.001,NotMatch,NotMatch
PMC5118533,Figure 2,Pretreatment plasma concentrations of VEGF (a) and PlGF (b) are shown according to sarcoma subtype. Pretreatment VEGF concentrations were highest in the patient with angiosarcoma.,SARCOMA2016-4592768.002,NotMatch,NotMatch
PMC5118533,Figure 3,Plasma concentrations of angiotensin system peptides and angiogenic hormones over time are shown. The data points represent median values for the pretreatment (Time 0) and posttreatment blood draws. The 4-hour and day 22 posttreatment Ang-(1-7) levels were increased over baseline (P < 0.05). Standard error bars are shown.,SARCOMA2016-4592768.003,NotMatch,NotMatch
PMC5177563,Fig. 1,"
Imaging studies demonstrating right temporoparietal mass. (A) CT of the head—axial image demonstrates large-size extracalvarial mass. (B) Axial noncontrast T1-weighted MRI image. (C) Axial noncontrast MRI T2-FLAIR image. (D) Axial postcontrast MRI T1-weighed image.",10-1055-s-0036-1580704-i150266cr-1,NotMatch,NotMatch
PMC5177563,Fig. 2,"
(A and B) Specimen picture shows irregular shape rubber mass with attached hair-bearing skin.",10-1055-s-0036-1580704-i150266cr-2,NotMatch,NotMatch
PMC5177563,Fig. 3,"
Histopathological studies. (A) Low-power photomicrograph showing the abrupt transition between the central, vascular portion of the tumor and the outer rim of myofibroblastic atypical spindle cell proliferation. (B) High-power photomicrograph showing vascular portion of the tumor. (C) High-power photomicrograph showing spindle cell portion of the tumor. (D) High-power photomicrograph showing prominent mitotic activity in the spindle cell portion of the tumor. (E) Low-power photomicrograph showing CD34-positive vascular channels within the spindle cell portion of the tumor. (F) Photomicrograph revealing Ki-67 proliferation index of 40 to 50% in the atypical spindle cell tumor portion.",10-1055-s-0036-1580704-i150266cr-3,NotMatch,NotMatch
PMC5244075,Figure 1,"(a) Noncontrasted computed tomography brain showing a multilobulated and isodense lesion over the occipital lobes bilaterally (black arrow). No tumoral calcification, osteolytic, or hyperosthotic bony change seen. (b) T1-weighted imaging on magnetic resonance imaging shows a well-defined irregular and lobulated mass, which appears heterogeneously isointense. The presence of “cortical buckling” supports the diagnosis of an extraaxial cerebral lesion (black arrow). (c) On T2-WI, a typical “sunburst” pattern is seen diverging radially into the tumor (black arrow). Also seen in this sequence are multiple cerebrospinal fluid clefts (white arrow) and areas of flow voids",JNRP-7-95-g001,NotMatch,NotMatch
PMC5244075,Figure 2,"(a and b) Contrasted magnetic resonance imaging studies shows vivid enhancement of the tumor. Scattered areas lacking enhancement are also seen (white arrow), probably due to necrosis, or hemorrhage within the tumor. Also seen here the “dural tail” sign and a narrow-based tumor (black arrow), at the falx cerebri where the tumor is attached. (c) On fluid attenuation inversion recovery sequence, the mass demonstrates some areas of hyperintensity in the periventricular and perilesional area suggestive of perilesional edema (black arrow)",JNRP-7-95-g002,NotMatch,NotMatch
PMC5244075,Figure 3,"(a) Histological section showing closely packed and moderately pleomorphic cells interlaced with blood vessels exhibiting staghorn pattern (black arrow) (H and E, ×10). (b) The cells have oval to round nuclei, fine chromatin pattern, and prominent nucleoli with moderate cytoplasm and indistinct cytoplasmic border. Occasional intranuclear cytoplasmic inclusion is seen. Mitosis is also seen here (black arrow) (H and E, ×40)",JNRP-7-95-g003,NotMatch,Match
PMC5114184,Fig. 1,"Postcontrast axial T1-weighted magnetic resonance findings of intracranial HPC at preoperation and postoperation. A: Preoperative axial T1-weighted magnetic resonance imaging with gadolinium administration showing an intracranial HPC at the right temporo-occipital region. B: Postoperative axial T1-weighted magnetic resonance imaging with gadolinium administration showing gross total removal of the residual-recurrent intracranial HPC. HPC, hemangiopericytoma.",btrt-4-128-g001,Match,NotMatch
PMC5114184,Fig. 2,Computed tomogram of the spine at the level of L2 reveals invasion of the tumor to vertebral body and anterior epidural space (A and B). T1-weighted image enhanced with gadolinium revealing an isointense lesion in posterior aspect of L2 vertebral body with retropulsion to anterior epidural space (C and D).,btrt-4-128-g002,NotMatch,NotMatch
PMC5114184,Fig. 3,Postoperative lateral & anteroposterior X-ray (A and B) and saggital & axial MRI (C and D). Grossly total removal of tumor at L2 vertebral body and replacement of bone graft. Transpedicular screw fixation from T12 to L4.,btrt-4-128-g003,NotMatch,NotMatch
PMC5114184,Fig. 4,"Tumor histopathology. Right temporooccipital region of intracranial HPC (A and C) and metastatic spinal HPC (B and D) in 13 years later. Photomicrograph demonstrating a hemangiopericytoma with a highly cellular and vascular tumor consisting of compact neoplastic cells (A and B; H&E staining). Ki-67 proliferation index is more increased by about 10% in the metastatic spinal HPC as compared with intracranial HPC (C and D; Ki-67 immunohistochemistry). HPC, hemangiopericytoma.",btrt-4-128-g004,Match,Match
PMC5234272,Figure 1,"Magnetic resonance images from the original patient presentation in 2007. (a) Preoperatively, axial T1-weighted contrast images demonstrated a mass lesion located along the right tentorium, extending toward the temporal lobe and the pons. (b) Postoperative T1-weighted contrast image. A tumor invading into the cavernous sinus (arrow) remained. The extent of resection was judged as “subtotal”",SNI-7-1016-g001,NotMatch,NotMatch
PMC5234272,Figure 2,"Magnetic resonance images from 2013 when the patient was referred back to us with a recurrent intracranial lesion. (a) Axial T1-weighted image of the brain, demonstrating a recurrent mass lesion (arrow). (b, c) Sagittal T1-weighted images demonstrating spinal disseminated lesions (arrowheads). The tumor at T11/12 (arrow) did not cause thoracic myelopathy at that time",SNI-7-1016-g002,NotMatch,NotMatch
PMC5234272,Figure 3,"Preoperative magnetic resonance images of the spinal cord. (a, b) Sagittal T1-weighted images with gadolinium, demonstrating intraspinal disseminated lesions that were increased in size (arrowheads). Note the T11/12 lesion (arrow in B) compressing the spinal cord. (c) Axial T1-weighted contrast image demonstrating the T11/12 tumor now causing a deformity of the spinal cord. (d) Sagittal T2-weighted image demonstrating an abnormal hyperintense area in the dorsal spinal cord where the T11/12 lesion is located (arrow)",SNI-7-1016-g003,NotMatch,NotMatch
PMC5234272,Figure 4,"Intraoperative photographs following left T11 hemilaminectomy. (a) Following the dural opening, a mass lesion was visible underneath the arachnoid membrane (arrow). (b) Subtotal surgical resection was performed. A layer of the tumor was left attached to the dorsal spinal cord (arrow). Note that the left and right sides of the images were the rostral and caudal sides, respectively",SNI-7-1016-g004,NotMatch,NotMatch
PMC5234272,Figure 5,"Histological examination of the tumor cells with hematoxylin and eosin staining, the findings of which were compatible with the diagnosis of hemangiopericytoma. Scale bar = 100 μm",SNI-7-1016-g005,Match,NotMatch
PMC5234272,Figure 6,"Follow-up magnetic resonance images 16 months after resection. (a) Axial T1-weighted image of the brain, demonstrating an intracranial mass lesion (arrow) that was stable in size. Note that it had an altered intensity following the gamma knife treatment. (b, c) Sagittal T1-weighted images demonstrating spinal disseminated lesions (arrowheads) that were stable in size. The resected spinal tumor (arrow) did not recur",SNI-7-1016-g006,NotMatch,NotMatch
PMC5431271,Figure 1.,"A 66-year-old male with AHPC of falx cerebri. (A) Plain scan axial T1WI showed heterogeneous and slightly low signal with an unclear boundary. (B) Plain scan T2WI axial view revealed heterogeneous and slightly high signal, in which multiple hyperintense areas of cystic necrosis could be seen, peritumoral brain edema was obvious. (C) The contrast-enhanced T1WI axial view demonstrated that the tumor was irregular, heterogeneous significant enhancement, and local skull erosion damage. (D) In the AHPC, the tumor cells were densely and irregularly arranged, nuclear atypia and mitotic properties were common (H&E; magnification, ×400). AHPC, anaplastic hemangiopericytoma; H&E, hematoxylin and eosin.",ol-13-05-2945-g00,Match,Match
PMC5431271,Figure 2.,"A 53-year-old male with AHPC of the right temporal lobe. (A) Plain scan T1WI axial view showed heterogeneous low signal with unclear boundary. (B) Plain scan axial T2WI showed a slightly uneven high signal with unclear boundary. (C) The contrast-enhanced T1WI axial view showed that the tumor was lobular in shape with significantly homogeneous enhancement, area of necrosis and cystic without enhancement. AHPC, anaplastic hemangiopericytoma.",ol-13-05-2945-g01,Match,NotMatch
PMC5431271,Figure 3.,"Vimentin cytoplasmic positive staining (immunohistochemical; magnification, ×400).",ol-13-05-2945-g02,NotMatch,NotMatch
PMC5431271,Figure 4.,"CD34 cytoplasmic positive staining (immunohistochemical; magnification, ×400).",ol-13-05-2945-g03,NotMatch,NotMatch
PMC5431271,Figure 5.,"Ki-67 is expressed in the AHPC, nucleus is positive, and positive cells were >15% (immunohistochemical; magnification, ×400). AHPC, anaplastic hemangiopericytoma.",ol-13-05-2945-g04,Match,NotMatch
PMC5450857,Figure 1,"CT scan of the chest showing a lobulated mass with heterogeneous enhancement, compressing the mediastinum, right main bronchus and right pulmonary artery.",BMJ-34-188-g6,NotMatch,NotMatch
PMC5450857,"Figure 2a, 2b",Axial CT and coronal PET-CT slices showing a huge malignant solitary fibrous tumor mass in the lower lobe of right lung.,BMJ-34-188-g7,NotMatch,NotMatch
PMC5450857,Figure 3,Axial CT slice of a solitary fibrous tumor located in anterior mediastinum.,BMJ-34-188-g8,NotMatch,NotMatch
PMC5450857,"Figure 4a, 4b",Axial and coronal PET-CT slices of a solitary fibrous tumor located in mediastinum which slightly compressed trachea.,BMJ-34-188-g9,NotMatch,NotMatch
PMC9422413,Figure 1,Endoscopic visualization of the laryngeal mass via Weerda diverticuloscope with the patient in supine position. The epiglottis appears completely normal above the intralaryngeal tumor mass.,gr1,NotMatch,NotMatch
PMC9422413,Figure 2,Axial computed tomography (CT) at the level of the thyroid (left) and cricoid (right) cartilages with complete lumen obstruction and no evidence cartilage invasion. The patient breathes through a tracheostomy.,gr2,NotMatch,NotMatch
PMC9422413,Figure 3,Histology images of hemangiopericytoma with different stains: (A) hematoxylin–eosin; (B) immunohistochemical stain for Ki-67; (C) immunohistochemical stain for CD34; (D) immunohistochemical stain for CD99.,gr3,Match,NotMatch
PMC5310265,Fig. 1,"Axial (A) and coronal-reformatted (B) contrast-enhanced computed tomography (CT) images demonstrate a large, heterogeneous enhancing mass that appears to arise from the left lateral segment of the liver with associated mass effect on the stomach.",gr1,NotMatch,NotMatch
PMC5310265,Fig. 2,Axial and coronal contrast-enhanced CT images (A and B) demonstrate an enhancing left upper pole renal mass (arrow) measuring up to 3.9 cm. There is also a smaller inferior pole lesion located within the left renal cortex (C).,gr2,NotMatch,NotMatch
PMC5310265,Fig. 3,Axial contrast-enhanced CT image demonstrates a hyperenhancing lesion (arrow) within the pancreatic head in addition to the large lateral segment hepatic mass.,gr3,NotMatch,NotMatch
PMC5310265,Fig. 4,A large liver mass is demonstrated on gross pathology (A) following left hepatic lobectomy. The mass contained areas of necrosis and hemorrhage. Standard hematoxylin and eosin (H&E) stains with magnification observed spindle-shaped cells and a high mitotic index (B). STAT-6 and vimentin immunohistochemical stains were positive. Findings were consistent with solitary fibrous tumor.,gr4,NotMatch,Match
PMC5310265,Fig. 5,Microscopic examination of the hypervascular pancreatic lesion demonstrated similar appearance to the large liver mass with spindle-shaped cells and immunohistochemical staining consistent with solitary fibrous tumor involving the pancreas. The tumor is seen infiltrating normal pancreatic tissue (P).,gr5,NotMatch,NotMatch
PMC5310265,Fig. 6,Split gross pathological specimen (A) following radical nephrectomy demonstrates a tan solid soft tissue lesion within the upper pole of the kidney. The lower pole lesion was identified on gross examination as well (B). Microscopic examination was similar revealing spindle-shaped neoplastic cells consistent with solitary fibrous tumor.,gr6,NotMatch,NotMatch
PMC5310265,Fig. 7,Brain MRI (A-D) performed in this patient more than 10 years before presentation had demonstrated a tumor (arrows) in the left temporal lobe region that was thought to represent a low-grade glial tumor on pathology at the time of resection. Axial FLAIR (A) and coronal T2-weighted (B) images show a peripherally hypointense and internally hyperintense extra-axial lesion near the posteroinferior left temporal lobe with associated mass effect and vasogenic edema. Axial (C) and sagittal (D) postcontrast T1-weighted images demonstrate avid enhancement of this lobulated extra-axial lesion. Secondary pathological review of the previously obtained specimen (E) revealed spindle-shaped cells with moderate pleomorphism that was consistent with solitary fibrous tumor.,gr7,NotMatch,NotMatch
PMC5310265,Fig. 8,"Six months after surgical resection of the large hepatic mass and pancreatic head resection, a routine follow-up CT examination was performed that showed a new enhancing pancreatic tail mass (arrow) (A). The pancreatic tail lesion was resected with spleen-preserving distal pancreatectomy (B), with pathology confirming recurrent metastatic solitary fibrous tumor.",gr8,NotMatch,NotMatch
PMC5471746,Fig. 1,Presence of chorioretinal lesions in the tapetal fundus OD noted on initial presentation. Images represent central view (A) and a view angled to highlight the largest chorioretinal lesion (B). Multifocal pink lesions are noted throughout the tapetal fundus arising from the termination of retinal vessels representing metastatic spread of the hemangiopericytoma. Images obtained with the RetCam Shuttle.,OpenVetJ-7-132-g001,Match,NotMatch
PMC5471746,Fig. 2,(A): Metastatic spindle cell sarcoma. Subgross photograph. Note the carpet of neoplastic cells in the choroid (arrow) and in the ciliary body (*). Hematoxylin and eosin (H&E). (B): Tumor in the choroid. Higher magnification of the neoplastic cells near the arrow in Fig. 2A. Cells infiltrate the tapetum (*) and surround choroidal vessels (arrow). (H&E) (Bar = 100 μm). (C): Tumor in the scleral vessels. Higher magnification of the square in Fig. 2A. Cells surround and infiltrate scleral vessels (arrow). (H&E). (Bar = 100 μm).,OpenVetJ-7-132-g002,NotMatch,Match
PMC5471746,Fig. 3,Immunohistochemical staining of both the original right flank/limb hemangiopericytoma and the left eye metastasis. Both tissues show positive staining for vimentin and alpha-smooth muscle actin (SMA).,OpenVetJ-7-132-g003,Match,NotMatch
PMC5471746,Fig. 4,Image of right tapetal fundus two weeks after initial presentation. The presence of numerous large pink/red colored lesions throughout tapetal fundus present near retinal vessel terminations showing significant progression of chorioretinal lesions. Perilesional retinal elevations are seen around each foci of metastasis and appear as halos of reduced reflectivity. Image obtained with the RetCam Shuttle.,OpenVetJ-7-132-g004,NotMatch,NotMatch
PMC5482024,Figure 1,"18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging shows increased activity in the caput of pancreas with standardized uptake value of 4.2. Primary tumor (black arrow) in the head of pancreas is visualized on coronal maximum intensity projection images (a), axial positron emission tomography (b), computed tomography (c), and fusion (d) images",IJNM-32-230-g001,NotMatch,NotMatch
PMC5482024,Figure 2,"Sixteenth month coronal maximum intensity projection postoperatively (a), coronal whole body fusion (b), and axial thorax fusion (c) 18F-fluorodeoxyglucose positron emission tomography/computed tomography images show mild increased uptake multiple metastatic areas (bilaterally lung, mediastinal lymph node, bone, and iliac lymph node) and local relapse (standardized uptake value: 1.6–4.2). Metastatic pulmonary lesions in the right lung demonstrated with black arrow",IJNM-32-230-g002,NotMatch,NotMatch
PMC5490209,Fig. 1,The catchment area of the canine tumour registry. Left angle: map of Italy and Piedmont; Right angle: map of Piedmont and the catchment area,12917_2017_1126_Fig1_HTML,NotMatch,NotMatch
PMC5490209,Fig. 2,"Population age structure by sex. Age structure of the study population, by sex",12917_2017_1126_Fig2_HTML,NotMatch,NotMatch
PMC5490209,Fig. 3,"Number of cases by tumour site. Number of tumours collected during the study period, by tumour site",12917_2017_1126_Fig3_HTML,NotMatch,NotMatch
PMC5490209,Fig. 4,"Age and sex-specific incidence rates. Age and sex specific incidence rates: cases per 100,000 dog-years at risk",12917_2017_1126_Fig4_HTML,NotMatch,NotMatch
PMC5490209,Fig. 5,"Malignant tumours: site- and sex-specific incidence rates. Site and sex specific incidence rates for malignant tumours: cases per 100,000 dog-years at risk",12917_2017_1126_Fig5_HTML,NotMatch,NotMatch
PMC5495936,Figure 1:,"Pre-op MRI scan. Enhancing intraspinal lesion, most likely extramedullary intradural in location, at the level of T9 causing spinal cord compression associated with extensive cord oedema; (A) T2 sagittal; (B) with contrast, sagittal; (C, D) axial with contrast at T9 level; suggestive of intradural extramedullary (C) extending intramedullary (D).",rjx121f01,NotMatch,NotMatch
PMC5495936,Figure 2:,Post-operative follow-up MRI scan. There is residual focus of dural thickening and enhancement at the level T9 which demonstrated further reduction in prominence (A–C); there is resolution of the cord oedema and no new enhancing lesion is seen in the spinal canal; (A) sagittal with contrast 3 months’ follow-up; (B) 6 months’ follow-up; (C) 11 months’ follow-up; (D + E) axial views with contrast 11 months’ follow-up at T9 level.,rjx121f02,NotMatch,NotMatch
PMC5495936,Figure 3:,"(A) (CD34X40): patchy CD34 immunoreactivity in tumour cells and endothelial cells; (B) (FXIIIAX40): focal FXIIIa positivity in tumour cells; (C) (HEX10): highly vascular spindle cell tumour with numerous slit like and staghorn vascular spaces, featuring hypocellular and cellular areas; (D) (HEX40): closely packed randomly oriented bland spindle cells; and (E) (RETICULINX40): well-developed network of reticulin fibres surrounding individual cells.",rjx121f03,NotMatch,Match
PMC5501453,Fig. 1,"Computed Tomography and macroscopic features of the neoplasm. a Computed tomography showed a large, well defined mass compressing urinary bladder (asterisk marks the prostatic mass; arrow marks the urinary bladder); b Gross appearance of the surgical specimen showing lobulated, well defined and whitish mass with central area of necrosis (arrow)",13000_2017_640_Fig1_HTML,NotMatch,NotMatch
PMC5501453,Fig. 2,Histological features of the neoplasm. (a alternating hypocellular and hypercellular areas; b hypocellular area with a patternless population of ovoid cells with bland nuclear features; c area of necrosis; d hypercellular area with short compact fascicles of spindle cells with moderately atypical nuclei and some evident mitotic figures; e well-demarcated border; f infiltrating behavior in proximity to the right seminal vesicle),13000_2017_640_Fig2_HTML,NotMatch,NotMatch
PMC5501453,Fig. 3,"Immunohistochemical features of the neoplasm. Neoplastic cells are diffusely positive for STAT6, bcl-2, CD99 and CD34; partially positive for PgR and negative for actin A4",13000_2017_640_Fig3_HTML,NotMatch,NotMatch
PMC5525461,Figure 1,"T1-weighted, gadolium-enhanced MR images; a sagittal image shows a homogenously enhanced mass at the ventral foramen magnum, whose size is around 20 mm in diameter (a). On axial image, the tumor seemed to be attached to dura mater around C2. The tumor severely compressed the ventral medulla oblongata. (b and c) The axial, T2-weighted MR image showed no medullary edema (d)",SNI-8-151-g001,NotMatch,NotMatch
PMC5525461,Figure 2,"After opening the dura, the tumor, covered by the arachnoid, was identified. The tumor compressed the medulla (a). It had no severe adhesion to the brain stem or any cranial nerves. When approaching the tumor to detach it from the dura, massive hemorrhaging occurred that was difficult to control (b). After cutting the main feeder from the direction of the dura, the tumor became white and easy to manage. The whole dural attachment of the tumor was detached. Plate c shows the final view, after gross total removal of the tumor was achieved (Simpson Grade 2)",SNI-8-151-g002,NotMatch,NotMatch
PMC5525461,Figure 3,"(a) Hematoxylin-eosin staining showing hypercellular tumor with staghorn appearance (arrow) (original magnification ×10). (b) The arrow showed mitosis. (original magnification ×40). (c) Ki-67 expressed in the HPC, nucleus positive, positive cells were less than 3% (original magnification ×40). (d) The tumor was negative for EMA staining (original magnification ×40)",SNI-8-151-g003,NotMatch,Match
PMC5525461,Figure 4,No residual tumor in the images,SNI-8-151-g004,NotMatch,NotMatch
PMC5588651,Figure 1,Contrast-enhanced computed tomography showing an intensely contrast-enhancing lesion at the left transverse-sigmoid junction causing destruction of the occipital bone,JPN-12-188-g001,NotMatch,NotMatch
PMC5588651,Figure 2,Preoperative axial contrast-enhanced magnetic resonance imaging showing a gadolinium-enhancing extra-axial mass of the left transverse-sigmoid junction,JPN-12-188-g002,NotMatch,NotMatch
PMC5588651,Figure 3,Histological appearance showing spindle cells with diffuse lymphocytes and plasmocytes infiltrate,JPN-12-188-g003,NotMatch,NotMatch
PMC5588651,Figure 4,Spindle cells showing diffuse immunopositivity for smooth muscle actin,JPN-12-188-g004,NotMatch,NotMatch
PMC5588651,Figure 5,Spindle cells showing negative staining for anaplastic lymphoma kinase,JPN-12-188-g005,NotMatch,NotMatch
PMC5604277,Figure 1,"Magnetic resonance imaging (MRI) of intracranial solitary fibrous tumor, (a) axial pre-operative MRI of the first patient, (b) axial pre-operative MRI of the second patient, (c) axial post-operative MRI of the first patient, (d) axial post-operative MRI of the second patient",IJHS-11-69-g001,NotMatch,NotMatch
PMC6232199,Fig. 1,a and b A computed tomography scan showed a small mass in the right nasal cavity that developed from septal wall,12105_2017_870_Fig1_HTML,NotMatch,NotMatch
PMC6232199,Fig. 2,The intraoperative findings. a The tumor was found on the right nasal septal wall mucosa. b An incision was made with margins 5 mm from the tumor. c Resection was achieved using a Colorado Needle Scalpel. d Removing the tumor. e After removing the tumor,12105_2017_870_Fig2_HTML,NotMatch,NotMatch
PMC6232199,Fig. 3,"Histological and immunohistochemical features. The tumor was observed beneath the epithelium and stromal bleeding was noted (a). The tumor histologically showed a uniform proliferation of oval to short-spindle shaped cells with slightly branching vascular structures (b). The tumor cells showed less atypia and mitotic figures were less than 3/10 in high-power-fields (C arrow). Tumor cells were diffusely and strongly positive for β-catenin nuclear staining (d), but negative for STAT6 (e). The MIB-1 labeling index was less than 5% (f). Genetic testing revealed a TCT to TGT substitution at codon33, resulting in an amino acid substitution from serine to cytosine (p.S33C) (g)",12105_2017_870_Fig3_HTML,NotMatch,NotMatch
PMC5613361,Figure 1,(a) Computed tomography (CT) of the abdomen. Green arrow showing the large pelvic mass. (b) Sagittal view-Magnetic Resonance Imaging (MRI). Yellow arrow showing the tumor.,CRIONM2017-4634235.001,NotMatch,NotMatch
PMC5613361,Figure 2,"(a) Macroscopic view of the surgical specimen. (b) Intraoperative view of the pelvis, after tumor resection. Total mesenteric excision plane was entered.",CRIONM2017-4634235.002,NotMatch,NotMatch
PMC5613361,Figure 3,"(a) Microscopic view (H-E ×100) of bland and uniform oval to spindle cells with minimal cytoplasm, small elongated nuclei, and indistinct nucleoli. (b) Immunohistochemical examination with positive staining for CD34.",CRIONM2017-4634235.003,NotMatch,Match
PMC5513090,Fig. 1,"ROCK1 and ROCK2 are overexpressed in vascular tumors. a Box and whisker plots indicating the mean immunohistochemical staining score for ROCK1 in a panel of human tissues obtained from normal endothelium and benign, borderline, and malignant vascular tumors. The number of tumor samples tested (N) for each tissue type is indicated to the right of the plot. For statistical analysis, the Mann-Whitney rank sum test was used. Statistical significance was determined if the two-sided P value of the test was <0.05. b Representative 600× images of immunohistochemical staining for ROCK1 in a panel of human tissues obtained from normal endothelium and benign, borderline, and malignant vascular tumors (a = negative control, b = positive control, c = normal endothelium, d = capillary hemangioma, e = cavernous hemangioma, f = granulomatous hemangioma, g = hemangiopericytoma, h = angiosarcoma). Negative controls lacking the primary antibody and positive controls from the kidney were used to ensure immunopositivity was reliable. Brown staining indicates immunopositivity. c Box and whisker plots indicating the mean immunohistochemical staining score for ROCK2 in a panel of human tissues obtained from normal endothelium and benign, borderline, and malignant vascular tumors. The number of tumor samples tested (N) for each tissue type is indicated to the right of the plot. For statistical analysis, the Mann-Whitney rank sum test was used. Statistical significance was determined if the two-sided P value of the test was <0.05. d Representative 600× images of immunohistochemical staining for ROCK2 in a panel of human tissues obtained from normal endothelium and benign, borderline, and malignant vascular tumors (a = negative control, b = positive control, c = normal endothelium, d = capillary hemangioma, e = cavernous hemangioma, f = granulomatous hemangioma, g = hemangiopericytoma, h = angiosarcoma). Negative controls lacking the primary antibody and positive controls from the kidney were used to ensure immunopositivity was reliable. Brown staining indicates immunopositivity. Please see Additional file 3 for high resolution image",12885_2017_3470_Fig1_HTML,Match,NotMatch
PMC5513090,Fig. 2,"shRNA-mediated knockdown of ROCK1 & 2 in SVR cells. a qPCR quantification of the levels of ROCK1 and 2 mRNA in SVR cells harboring shRNA vectors for scrambled control, ROCK1, or ROCK2. GAPDH mRNA was used as a normalization control for RQ calculations. For statistical analysis, the Student’s t-test was used. Statistical significance was determined if the two-sided P value of the test was <0.05. b Images were collected at 400× total magnification for SVR cells harboring shRNA vectors for scrambled control, ROCK1, or ROCK2 or treated with the pharmacological inhibitor Y-27632 (24 h; 10 μM). Please see Additional file 4 for high resolution image",12885_2017_3470_Fig2_HTML,NotMatch,NotMatch
PMC5513090,Fig. 3,"ROCK1 & 2 knockdowns in a xenograft vascular tumor model. a qPCR quantification of the levels of ROCK1 and ROCK2 mRNA in the SVR xenograft tumors relative to the scrambled control. GAPDH mRNA was used as a normalization control for RQ calculations. For statistical analysis, the Student’s t-test was used. Statistical significance was determined if the two-sided P value of the test was <0.05. b Representative images of mice harboring subcutaneous scrambled control, ROCK1 shRNA, and ROCK2 shRNA vascular xenograft tumors. c Box and whisker plot showing the distribution of tumor weights in scrambled control, ROCK1 shRNA and ROCK2 shRNA vascular xenograft tumors. Asterisks indicate p value <0.0005. (d) Low magnification H&E staining of whole tumor sections showing relative tumor sizes following removal from the host. Please see Additional file 5 for high resolution image",12885_2017_3470_Fig3_HTML,NotMatch,Match
PMC5513090,Fig. 4,ROCK2 knockdown results in reduced proliferation in a xenograft vascular tumor model. a Histogram depicting immunopositivity for Ki67 in scrambled control and ROCK2 knockdown xenograft vascular tumors. Data presented is the mean plus or minus the standard deviation. Asterisks indicate p value <0.005. b Representative images of scrambled control (a) and ROCK2 knockdown (b) angiosarcoma tumors stained via immunohistochemistry for the proliferative marker Ki67 (immunopositivity is brown). Positive control (c) is Ki67 staining of a breast carcinoma and negative control (d) is the xenograft vascular tumor minus primary antibody incubation. Please see Additional file 6 for high resolution image,12885_2017_3470_Fig4_HTML,NotMatch,NotMatch
PMC5513090,Fig. 5,"Omics characterization of ROCK1 and 2 shRNA knockdown SVR cells. a Lysates from SVR tumors harboring shRNA vectors for scrambled control, ROCK1, or ROCK2 were subjected to Full Moon Phospho Explorer Antibody arrays. Two-fold or more protein expression/modification changes between the knockdown and the control tumors are depicted via heatmap analysis. Each lane is the mean of three independent biological replicates. (red = upregulated; green = downregulated) b Western blot analysis detecting the expression of key cell cycle/survival regulators in protein extracts collected from scrambled control and ROCK2 knockdown xenograft vascular tumors. c Lysates from SVR tumors harboring shRNA vectors for scrambled control, ROCK1, or ROCK2 were subjected to 1H NMR analysis metabolomics analysis. Two-fold or more metabolite concentration changes between the knockdown and the control cells are depicted via heatmap analysis. Each column represents the triplicate mean of an individual biological replicate (red = upregulated; green = downregulated). Please see Additional file 7 for high resolution image",12885_2017_3470_Fig5_HTML,NotMatch,NotMatch
PMC5769935,Fig. 1,Sagittal T2-weighted (A) and axial T2-weighted (B) magnetic resonance imaging revealing swelling and edema in the spinal cord. (C) T1-weighted image showing an isointense signal. (D) Postcontrast T1-weighted image with fat suppression showing a homogeneously enhanced lobulated mass. (E) Axial diffusion-weighted imaging (b800) showing an isointense signal (relative to the spinal cord) with definite lesion boundaries. (F) Axial contrast-enhanced computed tomography (CT) images show a homogeneous enhancing mass. (G) Axial positron emission tomography-CT revealing low-grade hypermetabolism (maxSUV: 2.8) in the mass lesion.,kjs-14-4-166f1,NotMatch,NotMatch
PMC5769935,Fig. 2,(A) Hematoxylin and eosin staining (×400) revealing numerous thin-walled vessels surrounded by oval-to spindle-shaped cells. (B) Immunohistochemical analysis revealing positive staining for smooth muscle actin (×200),kjs-14-4-166f2,NotMatch,NotMatch
PMC5737950,Fig. 1,"Terminology evolution of solitary fibrous tumors (SFT) and hemangiopericytomas (HPC). Pleural fibrous tumor (FT) was described in 1870 and later the term solitary was added to differentiate from mesothelioma. HPCs are thought to derive from pericytes, but show significant clinical and morphological overlap with SFT, which are fibroblastic proliferations. They had been considered distinct entities by the WHO Classifications until a shared chromosomal fusion was described, leading to incorporate most HPC as part of the SFT spectrum. Because meningeal HPC show higher rates of metastasis than classic SFT, the CNS edition opted for a composite terminology (HPC/SFT). WHO: World Health Organization; CNS: central nervous system. * Wagner E. Arch Heilk. 1870; 11:497. †Klemperer & Rabin. Arch Pathol. 1931.11:385-412. ‡ Stout & Murray. Ann Surg. 1942 Jul. 116(1):26-33.",gr1,Match,NotMatch
PMC5737950,Fig. 2,"Anatomy of left kidney lesion. Grossly, the tumor was predominantly exophytic with invasion of renal parenchyma and hilum. Residual kidney is highlighted in red. Inset: correlation with coronal CT view. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)",gr2,NotMatch,NotMatch
PMC5737950,Fig. 3,"Histology of SFT, O.M., 40x. Renal lesion consisted of a proliferation of bland spindled to ovoid cells, with hemangiopericytoma-like vasculature (A) in a variably collagenous stroma that produced areas of frank fibrous background (B) and positivity for STAT6 (C). Review of previous meningeal lesion showed similar morphology (D), a single-cell pattern of reticulin histochemistry (E) and diffuse nuclear positivity for STAT6 (F).",gr3,Match,NotMatch
PMC5761185,Fig. 1,"CGMS tracings from individual days, demonstrating (a) maintenance of euglycemia throughout the day. In the setting of pump dysfunction (b), overnight glucagon delivery ceased, precipitating hypoglycemia",40842_2017_53_Fig1_HTML,NotMatch,NotMatch
PMC5761185,Fig. 2,CGMS tracings taken over 1 week after initiation of everolimus. Each color represents an individual day,40842_2017_53_Fig2_HTML,NotMatch,NotMatch
PMC5761185,Fig. 3,CT scan of causative upper right quadrant mass (indicated with dashed line). Scale = 5 cm,40842_2017_53_Fig3_HTML,NotMatch,NotMatch
PMC5768252,Figure 1.,"MRI images: (a) coronal T1-weighted image (TR = 680.0 TE = 20.0), (b) sagittal T1-weighted image (TR = 520.0 TE = 20.0). A heterogeneous mass, almost isointense to muscle, with a central marked hypointense area (white arrow) is shown. (c) Coronal STIR image (TR = 1780.0 and TE = 25.0), (d) axial T2 images (TR = 4340.0 TE = 100.0) conducted at three different levels. A heterogeneous hyperintense lesion with an internal low-signal septation, compatible with intralesional calcification (black arrows) is shown.",10.1177_2050313X17752851-fig1,NotMatch,NotMatch
PMC5768252,Figure 2.,"(a) H&E 20x: the section shows a nodular, pseudoencapsulated lesion composed of papillary formations with hyaline or fibrous bundles and (b and c) H&E 100x, H&E 500x: at high magnification, it is possible to observe some vascular formations, with a labyrinthic structure, lined by plump endothelial cells. The underlying fibrous stroma appears oedematous; necrosis, cellular atypias, or atypical mitotic cannot be detected.",10.1177_2050313X17752851-fig2,NotMatch,Match
PMC5798123,Figure 1:,"Endoscopic view of the right nasal cavity. (A) Before and (B) after rIL-2 administration. After rIL-2 administration, the tumor size was reduced (arrow).",rjx202f01,NotMatch,NotMatch
PMC5798123,Figure 2:,Enhanced CT before rIL-2 administration. A heterogeneous mass lesion with an enhancement effect filled the right nasal cavity.,rjx202f02,NotMatch,NotMatch
PMC5798123,Figure 3:,"(A) After wide surgical excision (B) gross specimen. The tumor with a pedicle on the right nasal septum near the olfactory cleft was extirpated totally, leaving an adequate free margin. (arrow: pedicle of tumor).",rjx202f03,NotMatch,NotMatch
PMC5798123,Figure 4:,Pathological section (H-E staining). A proliferation of spindle-shaped pericytes surrounding the ectatic blood vessels to form a so-called ‘staghorn structure’ was shown.,rjx202f04,NotMatch,NotMatch
PMC5839426,Figure 1,"Transitional meningioma, WHO grade I (A: H&E, x400) showing strong diffuse SSTR2A immunostaining (B: SSTR2A, x400). Rhabdoid meningioma, WHO grade III (C: H&E, x200) showing strong diffuse Claudin - 1 immunostaining (D: Claudin-1, x200) immunostaining of claudin 1 (D: claudin 1x400)",OAMJMS-6-248-g001,NotMatch,Match
PMC5839426,Figure 2,"Hemangiopericytoma (A: H&E, x400) showing negative immunostaining for SSTR2A (B: SSTR2A, x400). Schwannoma (C: H&E, x400) showing negative",OAMJMS-6-248-g002,Match,Match
PMC5798816,Figure 1,"The surgical approach and hemangiopericytoma resection.The surgical approach and resection of the tumor. A: Bicoronal incision has allowed anterior mobilization of a myocutaneous flap, B: The craniotomy has been performed exposing the dura and superior sagittal sinus (SSS), C: The dura has been opened bilaterally and the anterior SSS divided anteriorly to expose the tumor (the insert has the tumor colored in red for clarity), D: The tumor has been completely resected, E: Dural reconstruction utilized a dural synthetic graft (DR) and a pericranial flap was used to seal the frontal sinus (FS) and any anterior cranial fossa (ACF) floor fistulae, F: Three-dimensional (3D) reconstruction of the tumor (red) and skull base.",cureus-0009-00000001875-i01,Match,NotMatch
PMC5798816,Figure 2,"The preoperative magnetic resonance imaging (MRI).The magnetic resonance imaging (MRI) with contrast (A) sagittal (B) axial, and (C) coronal views depict a large contrast-enhancing mass arising from the olfactory groove, D: the MRI T2 weighted image demonstrates corkscrew type flow voids (white arrow), which are consistent with a highly vascular neoplasm.",cureus-0009-00000001875-i02,NotMatch,NotMatch
PMC5898102,Figure 1,(a) T2- and (b) T1-weighted magnetic resonance imaging after gadolinium injection showed a right sphenoid wing solitary fibrous tumor; (c) T1-weighted magnetic resonance imaging after gadolinium injection showed left temporal lobe,AJNS-13-336-g002,NotMatch,NotMatch
PMC5898102,Figure 2,"(a) Solitary fibrous tumor of the hemangiopericytoma type (H and E, ×40); (b) solitary fibrous tumor of the classic type (H and E, ×20); (c) solitary fibrous tumor of the mixed type (H and E, ×10); (d) neoplastic elements extensively CD34 immunoreactivity (×40); (e) neoplastic elements extensively Bcl-2 immunoreactivity (×40)",AJNS-13-336-g003,Match,Match
PMC5906772,Fig. 1,Noncontrast enhanced computed tomography demonstrating original appearance of patient's posterior cervical neck mass.,radcr447-fig-0001,NotMatch,NotMatch
PMC5906772,Fig. 2,Calvarial lesions representing metastatic hemangiopericytoma or solitary fibrous tumors seen on contrast-enhanced T1-weighted brain magnetic resonance imaging.,radcr447-fig-0002,Match,NotMatch
PMC5906772,Fig. 3,"Fluorodeoxyglucose positron emission tomography-computed tomographyimages. (A) MIP (maximum Intensity Projection) whole body FDG image demonstrating hypermetabolic osseous and soft tissue metastases. (B) FDG, (C) hybrid, and (D) computed tomography (CT) images demonstrating a hypermetabolic sclerotic left iliac bone metastasis. (E) FDG, (F) hybrid, and (G) CT images demonstrating an enlarged hypermetabolic right axillary lymph node suspicious for metastases.",radcr447-fig-0003,NotMatch,NotMatch
PMC5906772,Fig. 4,Head computed tomography showing lytic and sclerotic lesions within the calvarium with associated hypermetabolism representing osseous metastases.,radcr447-fig-0004,NotMatch,NotMatch
PMC5919772,Fig. 1,"
Axial postcontrast T1-weigheted image. The mass within the right cerebellar hemisphere shows mainly solid components and smaller cystic areas as well. The solid component enhances fairly homogeneously. The lesion causes mass effect changes in the surrounding parenchyma.
",10-1055-s-0038-1642026-i170026-1,NotMatch,NotMatch
PMC5919772,Fig. 2,"
(
A
–
C
) Axial T1-weighted image, T2-weighted image, and fluid-attenuated inversion recovery showing bilateral subdural hematomas—larger one on the right and a smaller one on the left. The signal characteristics are in keeping with late subacute hematomas. A fluid-fluid level is found on the right.
",10-1055-s-0038-1642026-i170026-2,NotMatch,NotMatch
PMC5919772,Fig. 3,"
Sagittal postcontrast T1-weighted image. The suprasellar and prepontine cisterns are within normal limits. There is no flattening of the pons or medulla. Furthermore, there is no diffuse pachymeningeal enhancement.
",10-1055-s-0038-1642026-i170026-3,NotMatch,NotMatch
PMC5863319,Figure 1,"Phenotype of circulating tumor cells isolated using ScreenCell Cyto kit. In representative images, nuclei are displayed in blue. Pseudocolors were changed for each of the four channels to optimize the visualization of the different signals. (a) Immunofluorescence for CD34, EpCAM, and CD45. Clusters of CD45- cells coexpressing EpCAM and CD34 are displayed. (b) and (c) Immunofluorescence for EpCAM, cytokeratins (CK) 8, 18, and 19, and CD45. Single CD45-/CK- cells expressing EpCAM (b). Cluster of CD45- cells coexpressing EpCAM and CK (c).",ACP2018-9718585.001,NotMatch,NotMatch
PMC5909087,Figure 1,"Axial computed tomography scan (a) and magnetic resonance images (b-d) showing a well-demarcated mass in the tip of the left temporal fossa extending into the orbital apex, and accompanying bony erosions in the medial sphenoid ridge (a). The tumor appears isointense on both T1- (b) and T2-weighted (c) sequences, and intensely enhanced on contrast examinations (a and d). The left optic nerve is considerably compressed by the tumour at the orbital apex (b, arrow)",SNI-9-69-g001,NotMatch,NotMatch
PMC5909087,Figure 2,"(a and b) Intraoperative photos showing drilling of the medial sphenoid ridge overhanging the tumour (a) and exposure of a dura-based, capsulized tumour (a and b asterisk). TD: Temporal dura",SNI-9-69-g002,NotMatch,NotMatch
PMC5909087,Figure 3,"Microscopic appearance of the tumor comprised by spindle-shaped cells, lacking findings of atypia or necrosis (a). Immunohistochemical stains showing positive staining for bcl2 (b), CD34 (c), CD99 (d), and STAT6 (e), with the MIB-1 index of 10% (f). A: Hematoxylin and eosin stain, ×200; b: bcl2; c: CD34; d: CD99; e: STAT6; f: MIB-1, ×100",SNI-9-69-g003,NotMatch,Match
PMC5968740,Figure 1,"Preoperative computed tomography scan. A mass lesion occupies the left maxillary sinus, nasal cavity, and ethmoid sinus with bone destruction. The nasal septum is deviated to the right due to mass effect",TCMJ-30-119-g001,NotMatch,NotMatch
PMC5968740,Figure 2,"Microscopically, the tumor is comprised of closely packed cells, forming short fascicles and focally exhibiting a storiform, or palisaded pattern, interspersed with many “staghorn-like” vascular channels. The tumor cells are uniform and elongated-to-oval shaped with round-to-oval-to-spindle-shaped nuclei. There are mild nuclear pleomorphism and a little mitotic activity, with <4/10 per high-power field. Therefore, this sample represents a low-grade glomangiopericytoma",TCMJ-30-119-g002,NotMatch,NotMatch
PMC5968740,Figure 3,Positive anti-vimentin stain,TCMJ-30-119-g003,NotMatch,NotMatch
PMC5968740,Figure 4,No evidence of residual tumor at 12 months postoperatively,TCMJ-30-119-g004,NotMatch,NotMatch
PMC5950185,Fig. 1,"Preoperative facial photograph. Frontal view of the patient before operation, showing fullness of left inferolateral orbital and periorbital region with slightly upward displacement of the lateral canthus",40662_2018_105_Fig1_HTML,NotMatch,NotMatch
PMC5950185,Fig. 2,"Preoperative imaging. CT scan reveals an isodense intraosseous lesion in the zygomatic bone in axial (a) and coronal sections (b). In orbital MRI, the mass appears heterogenous in T2-weighted images (c) and shows remarkable contrast enhancement after gadolinium injection (d)",40662_2018_105_Fig2_HTML,NotMatch,NotMatch
PMC5950185,Fig. 3,"Pathologic findings. Histopathologically (a and b), the tumor is composed of several slit-like vascular channels with occasional stag-horn appearing structures, surrounded by numerous spindle cells (H&E stain, low and high magnification, respectively). Immunohistochemistry shows positive staining for CD31 and CD34 in endothelial cells of blood vessels (c) and also positive staining for smooth muscle actin (SMA) in spindle cells (d)",40662_2018_105_Fig3_HTML,NotMatch,Match
PMC5950185,Fig. 4,"Postoperative facial photograph. Frontal view of the patient 5 years after the surgery, showing complete resolution of inferolateral orbital fullness",40662_2018_105_Fig4_HTML,NotMatch,NotMatch
PMC5950185,Fig. 5,"Postoperative imaging. Orbital CT scan reveals mild secondary hyperostosis in the previous location of the mass, with reasonable healing and no remnant of the original tumor (a: axial section, b: coronal section)",40662_2018_105_Fig5_HTML,NotMatch,NotMatch
PMC5906773,Fig. 1,Computed tomography scan showing the enhancing mass in the right ischioanal fossa (red arrow).,radcr450-fig-0001,NotMatch,NotMatch
PMC5906773,Fig. 2,Postcontrast T1-weighted magnetic resonance imaging axial image demonstrating intense contrast enhancement (orange arrow) of the right ischioanal fossa mass. The nonenhancing serpentine structures (red arrow) represent intratumoral vascularity.,radcr450-fig-0002,NotMatch,NotMatch
PMC5906773,Fig. 4,T2-weighted magnetic resonance imaging axial image of the pelvis showing a large heterogeneous mass (orange arrow) occupying the right ischioanal fossa and demonstrating areas of hyper- and hypo-signal intensity. Mass effect on the vagina and the rectum noted (red star).,radcr450-fig-0004,NotMatch,NotMatch
PMC5906773,Fig. 3,Noncontrast T1-weighted magnetic resonance imaging axial image of the pelvis demonstrating an isointense mass (orange arrow) in the right ischioanal fossa.,radcr450-fig-0003,NotMatch,NotMatch
PMC5906773,Fig. 5,Pelvic angiogram demonstrating tumor vascularity (black star) in the right hemipelvis.,radcr450-fig-0005,NotMatch,NotMatch
PMC5906773,Fig. 6,Selective catheterization of the right internal pudendal artery with angiogram confirming tumor vascularity (black star).,radcr450-fig-0006,NotMatch,NotMatch
PMC5906773,Fig. 7,Postembolization angiogram demonstrating pruning of the feeding vessels and stasis (black arrows).,radcr450-fig-0007,NotMatch,NotMatch
PMC5906773,Fig. 8,Postembolization angiogram demonstrating pruning of the feeding vessels and stasis (black arrow).,radcr450-fig-0008,NotMatch,NotMatch
PMC5906773,Fig. 9,Gross pathology of en bloc resected mass.,radcr450-fig-0009,NotMatch,NotMatch
PMC5906773,Fig. 10,"Low power view of a cellular area with prominent thin-walled vasculature and zones of dense fibrosis (H&E, ×40)",radcr450-fig-0010,NotMatch,Match
PMC5906773,Fig. 11,"High-power view of a cellular area demonstrating staghorn-like vessels. (H&E, ×200)",radcr450-fig-0011,NotMatch,Match
PMC5906773,Fig. 12,"High-power view demonstrating oval to spindle-shaped nuclei with a dispersed chromatin pattern (H + E, ×600)",radcr450-fig-0012,NotMatch,NotMatch
PMC5906773,Fig. 13,Immunohistochemical stain for STAT6 demonstrating strong nuclear staining.,radcr450-fig-0013,NotMatch,NotMatch
PMC5906773,Fig. 14,Axial contrast-enhanced computed tomography showing a large peritumoral vessel feeding the mass (orange arrow).,radcr450-fig-0014,NotMatch,NotMatch
PMC5906773,Fig. 15,Coronal reformation of the contrast-enhanced computed tomography showing the peritumoral vessel (red arrow).,radcr450-fig-0015,NotMatch,NotMatch
PMC6018277,Figure 1,Extraoral photograph showing diffuse swelling over the right corner of mouth,AMS-8-151-g001,NotMatch,NotMatch
PMC6018277,Figure 2,Intraoral photograph showing a 4 cm × 3.5 cm well-circumscribed growth on broad base stalk,AMS-8-151-g002,NotMatch,NotMatch
PMC6018277,Figure 3,Wide excision of the lesion done with sufficient margins all around,AMS-8-151-g003,NotMatch,NotMatch
PMC6018277,Figure 4,Postexcision specimen,AMS-8-151-g004,NotMatch,NotMatch
PMC6018277,Figure 5,"Microscopic findings indicate diffuse proliferation of oval and spindle-shaped tumor cells with abundant eosinophilic cytoplasm, a multinodular growth pattern, and a “staghorn” configuration",AMS-8-151-g005,NotMatch,NotMatch
PMC5854331,Figure 1,"Plain CT and contrast-enhanced CT (CECT) show a lobulated, heterogeneously enhancing mass with several non-enhancing areas.",jbsr-101-1-1213-g1,NotMatch,NotMatch
PMC5854331,Figure 2,T2FLAIR and DWI show a midline shift but no diffusion restriction.,jbsr-101-1-1213-g2,NotMatch,NotMatch
PMC5854331,Figure 3A and B,Coronal and sagittal T1-weighted images after intravenous administration of gadolinium contrast clearly demonstrate the dural tail sign.,jbsr-101-1-1213-g3,NotMatch,NotMatch
PMC5854331,Figure 4,T1-weighted images before and after intravenous administration of gadolinium contrast show heterogeneous contrast enhancement with less enhancement of the central areas.,jbsr-101-1-1213-g4,NotMatch,NotMatch
PMC5854331,Figure 5,"Hematoxylin-eosin stain with ×200 magnification (A) shows a high concentration of cells. CD 34 stain with ×200 magnification is positive (B). CD 99 stain (×200) (C), and STAT-6 stain (×200) (D) confirm the positive result.",jbsr-101-1-1213-g5,NotMatch,NotMatch
PMC6124774,Fig 1,"Kaplan-Meier analysis of disease free interval according to different clinico-pathological variables.Gross total resection (log-rank test p = 0.0185) (A), WHO grade (log-rank test p = 0.038) (B), tumour phenotype (solitary fibrous tumour versus hemangiopericytoma) (log-rank test p = 0.062) (C), tumour grade according to PHH3-based mitotic count (log-rank test p = 0.094) (D), CD34 expression (log-rank test p = 0.038) (E) and Bcl-2 expression (log-rank test p = 0.010) (F).",pone.0203570.g001,Match,NotMatch
PMC6124774,Fig 2,"Example images showing the different morphological and immunohistochemical features of the case series.Images of the solitary fibrous tumour (A) and the hemangiopericytoma (B) phenotypes. Mitotic figures highlighted by PHH3 immunohistochemistry (C). STAT6 nuclear staining (D), a characteristic finding of SFT/HPC. Diffuse (E) and focal (F) CD34 positivity.",pone.0203570.g002,Match,NotMatch
PMC6211925,Figure 1,"Preoperative computed tomography (CT) scan of the tumor in the frontal bone and orbital roof. (A–C) Preoperative CT of the head showed a 5 × 3.7 × 4 cm sized, well-demarcated osteolytic frontal lesion with mottled ossified density, which also infiltrated the orbital roof. (D) The result of enhanced CT, the lesion was shown to be with sufficient blood supply. (E–I) Enhanced magnetic resonance imaging magnetic resonance imaging revealed a solitary frontal mass, which was hypointense on T1- and T2-weighted images, and enhanced heterogeneously.",medi-97-e12803-g001,NotMatch,NotMatch
PMC6211925,Figure 2,"Pathologic appearance of the tumor. Hematoxylin and eosin (H&E) stained slide demonstrated a bone-forming tumor composed of diffusely trabeculae of woven bone, which was separated by richly vascular fibrous stroma, surrounded by osteoblasts. (A) 200×, (B) 400×.",medi-97-e12803-g002,NotMatch,Match
PMC6279985,Fig. 1,A: On MRI an ovoid mass lesion seen in the right parieto-occipital region measuring 10 × 7 × 4 cm with peritumoral edema. B: The tumor showed intermediate-low signal intensity in the T1-Weighted Image (T1WI). The mass was attached to tentorium and was seen extending into the right transverse sinus.,gr1,NotMatch,NotMatch
PMC6279985,Fig. 2,"A: Photomicrograph depicting a spindle cell tumor with a “PAtternless-pattern with hypercellular and hypocellular areas. (H& E-40 X). B: Tumor cells are spindle shaped and collagen fibres are seen to separate them. Hypercellular areas showed interlacing fascicles of spindle-shaped cells with moderate amount of eosinophilic cytoplasm and oval to elongated nuclei exhibiting variable pleomorphism. (H&E-200X). C: Reticulin fibres are seen to separate the tumor cells (RETICULIN-200X). D: On IHC, CD 99 Is strongly positive in tumor cells. (100×). E: Stat 6 strongly positive in tumor cells (100X).",gr2,NotMatch,Match
PMC6261813,Fig. 1.,"A mass with a diameter of 8 cm in the left flank of a dog. The tumor moved to the dorsal side when laying down (arrow). Bar, 10 cm. Inset: cross section of the formalin fixed sample. Bar,
1 cm.",jvms-80-1728-g001,NotMatch,NotMatch
PMC6261813,Fig. 2.,"Microscopical appearance of the tumor showing monotonous appearance with thin-walled branching staghorn channels (*). The channels lined with endothelial cells (arrowhead) and thin
fibrous bundles (arrow). Bar, 200 µm.",jvms-80-1728-g002,NotMatch,NotMatch
PMC6261813,Fig. 3.,"Microscopical appearance of the tumor displaying placentoid growth pattern. Bar, 100 µm.",jvms-80-1728-g003,NotMatch,NotMatch
PMC6261813,Fig. 4.,"Cytoplasmic expression of vimentin by the neoplastic cells. IHC, Bar, 100 µm. Inset: high magnification. Bar, 20 µm.",jvms-80-1728-g004,NotMatch,NotMatch
PMC6261813,Fig. 5.,"Cytoplasmic expression of CD34 by the neoplastic cells. IHC, Bar, 50 µm. Inset: high magnification. Bar, 20 µm.",jvms-80-1728-g005,NotMatch,NotMatch
PMC6261813,Fig. 6.,"The laminin expressed in the cytoplasm diffusely. IHC, Bar, 100 µm. Inset: high magnification. Bar, 20 µm.",jvms-80-1728-g006,NotMatch,NotMatch
PMC6261813,Fig. 7.,"The S-100 immunoreaction weakly observed in the cytoplasm. IHC, Bar, 100 µm. Inset: high magnification. Bar, 20 µm.",jvms-80-1728-g007,NotMatch,NotMatch
PMC6261813,Fig. 8.,"Endothelial cells of staghorn vessels stained with vWF antibody. IHC, Bar, 50 µm. Inset: high magnification. Bar, 20 µm.",jvms-80-1728-g008,NotMatch,NotMatch
PMC6261813,Fig. 9.,"Endothelial cells of the vessels were stained positively with α-SMA (arrow), but the neoplastic spindle cells were negative. IHC, Bar, 50 µm. Inset: high magnification.
Bar, 20 µm.",jvms-80-1728-g009,NotMatch,NotMatch
PMC6261813,Fig. 10.,"The calponin antibody did not react with the neoplastic spindle cells. IHC, Bar, 100 µm. Inset: high magnification. Bar, 20 µm.",jvms-80-1728-g010,NotMatch,NotMatch
PMC6216087,Fig. 1,Contrast enhanced computed tomography of abdomen showing a large retroperitoneal mass.,gr1,NotMatch,NotMatch
PMC6216087,Fig. 2,Magnetic Resonance Imaging showing an encapsulated and well limited retro peritoneal masse.,gr2,NotMatch,NotMatch
PMC6216087,Fig. 3,Intraoperative view after mass resection (A) and specimen (B).,gr3,NotMatch,NotMatch
PMC6216087,Fig. 4,Microscopic examination showing tumor proliferation with variable cell density highly vascularized. (HE x 50).,gr4,NotMatch,Match
PMC6216087,Fig. 5,IHC for CD34 - tumor cells strongly positive(A) IHC for CD99 - tumor cells strongly positive (B).,gr5,NotMatch,NotMatch
PMC6314754,Figure 1,"Morphological and immunohistochemical findings of the tumor. The tumor displays abundant blood vessels and sheet-like arrangement of uniform spindle cells (A). The tumor has diffuse express of cyclin D1 (B), focal expression of FGF23, STAT-6, and smooth muscle actin (C, D, and E), and 5% of tumor cells are Ki-67 positive (F).",medi-97-e13849-g001,NotMatch,NotMatch
PMC6354750,Figure 1:,"Pre-operative imaging. Axial T1 weighted image post gadolinium enhancement (A), coronal T1 weighted image post gadolinium enhancement (B) showing a large extraaxial well-circumscribed mass lesion in the right frontal–temporal convexity, abutting the skull bone with good enhancement and dural tail sign (black arrow in Fig. 1A). MRA (C) showing a suspicious small aneurysm in bifurcation of the right middle cerebral artery (white arrow). CTA of brain coronal view (D), axial view (E), 3D reconstruction (F) showing a wide-based saccular aneurysm in bifurcation of the right middle cerebral artery abutting the tumor with dome tilting laterally, anteriorly and inferiorly.",rjz013f01,NotMatch,NotMatch
PMC6354750,Figure 2:,"Histology of the specimen. Tumor HE stain 100× (A) showing spindle cells in fascicular and storiform architecture with collagen fibers invested in between tumor cells, and round oval nuclei in haphazard pattern with limited intervening stroma. Tumor HE stain 200× (B) showing staghorn vessel. Tumor STAT6 stain (C) and CD34 stain (D) showing positive staining.",rjz013f02,NotMatch,NotMatch
PMC6354750,Figure 3:,"Post-operative imaging. CTA of brain coronal view (A), axial view (B), 3D reconstruction (C) showing the complete removal of the tumor and the complete surgical clipping of the aneurysm without residual lesions.",rjz013f03,NotMatch,NotMatch
PMC6318085,Figure 1,Chest X-ray showing round mass-like opacity in left suprahilar region,cureus-0010-00000003473-i01,NotMatch,NotMatch
PMC6318085,Figure 2,Heterogeneous mass arising from the pleura adjacent to the superior and medial left pulmonary artery,cureus-0010-00000003473-i02,NotMatch,NotMatch
PMC6318085,Figure 3,Invasion of the left inferior pulmonary vein with extension into the left atrium,cureus-0010-00000003473-i03,NotMatch,NotMatch
PMC6318085,Figure 4,Light microscopy of the biopsied specimen showing spindle and epithelioid cell neoplasm,cureus-0010-00000003473-i04,NotMatch,NotMatch
PMC6513906,Fig. 1,"Tumors classified as solitary fibrous tumor contained uniform ovoid-to-slightly spindled-shaped cell deposited in a collagenized background and arranged around branching and hyalinized blood vessels (a), while hemangiopericytomas were highly cellular tumors composed of predominantly round cells in a sheet-like pattern (b) with less prominent vasculature often showing high mitotic rates (c) and necrosis (d)",401_2018_1952_Fig1_HTML,Match,NotMatch
PMC6513906,Fig. 2,CNS (2016) and Soft Tissue (2013) WHO Classification schemes,401_2018_1952_Fig2_HTML,NotMatch,NotMatch
PMC6513906,Fig. 3,"Kaplan–Meier plots showing the median recurrence-free survival (RFS) and overall survival (OS) from the time of the original diagnosis, 9.6 years and 20.9 years, respectively. Note that there was one death due to disease with unknown date of death and that patient is not included in these plots",401_2018_1952_Fig3_HTML,NotMatch,NotMatch
PMC6513906,Fig. 4,"Univariate analysis shows that both the CNS-G (a) and ST-G (b) are significantly associated with recurrence-free survival (Table 3, p = 0.01, 0.004, respectively) but not overall survival (p = 0.23, p = 0.12, respectively)",401_2018_1952_Fig4_HTML,NotMatch,NotMatch
PMC6513906,Fig. 5,Modified soft-tissue grading scheme showed strong association with recurrence-free survival (p = 0.0006) and remained significant (p = 0.02) when considering only the primary tumors and only recurrent tumors (p = 0.04) (a–c),401_2018_1952_Fig5_HTML,NotMatch,NotMatch
PMC6513906,Fig. 6,"This graph highlights the relationship between the four NAB2–STAT6 fusion groups, and phenotype, mitoses, necrosis, CNS-G, ST-G, and modified ST-G",401_2018_1952_Fig6_HTML,NotMatch,NotMatch
PMC6442711,Figure 1,Scintigraphy showing involvement of the T12 vertebra.,1809-4406-aob-27-02-0108-gf01,NotMatch,NotMatch
PMC6442711,Figure 2,Magnetic resonance imaging (MRI) of the spine in sagittal and axial cuts showing involvement of the T12 vertebra.,1809-4406-aob-27-02-0108-gf02,NotMatch,NotMatch
PMC6442711,Figure 3,Immediate postoperative X-ray showing the en bloc resection and reconstruction.,1809-4406-aob-27-02-0108-gf03,NotMatch,NotMatch
PMC6442711,Figure 4,Chest radiograph showing left lung opacity resulting from the chylothorax profile.,1809-4406-aob-27-02-0108-gf04,NotMatch,NotMatch
PMC6442711,Figure 5,Rod breakage from pseudoarthrosis 14 months after reconstruction.,1809-4406-aob-27-02-0108-gf05,NotMatch,NotMatch
PMC6442711,Figure 6,Magnetic resonance imaging (MRI) showing the lesion in T2.,1809-4406-aob-27-02-0108-gf06,NotMatch,NotMatch
PMC6442711,Figure 7,Radiation treatment plan showing isodose curves sparing the spinal cord. Prescription isodose of 16Gy depicted in red.,1809-4406-aob-27-02-0108-gf07,NotMatch,NotMatch
PMC6442711,Figure 8,One month after radiosurgery of T2; 12 months following vertebrectomy and reconstruction.,1809-4406-aob-27-02-0108-gf08,NotMatch,NotMatch
PMC6442711,Figure 9,Final follow-up computed tomography (CT) of the T12 lesion 45 months following original surgery; 24 months after revision (consolidation of pseudoarthrosis); and 30 months following radiosurgery.,1809-4406-aob-27-02-0108-gf09,NotMatch,NotMatch
PMC6442711,Figure 10,Timeline.,1809-4406-aob-27-02-0108-gf10,NotMatch,NotMatch
PMC6527936,Fig. 1.,T2-weighted magnetic resonance imaging reveals a 5.5 cm multiloculated mass (arrow) with a thick hypointense rim.,jptm-2019-03-20f1,NotMatch,NotMatch
PMC6527936,Fig. 2.,"(A–F) Frozen crush cytology. (A) Cellular smear shows sheets or singly scattered round to oval cells with cellular overlapping. (B) Round- to ovoid-shaped cells have bland nuclear chromatin with a moderate amount of cytoplasm with occasional rhabdoid features. (C) Endothelial cell-lined capillaries crossing the tumor cells. (D) High magnification shows several clusters of oval cells of a pseudoalveolar architecture, coarse chromatin pattern, small inconspicuous nucleoli, and irregular nuclear membranes. Arrow indicates nuclei of endothelial cells. (E) Small round cells (left) and ropy collagenous tails are found. (F) Round to ovoid cells had bland nuclear chromatin with a moderate amount of cytoplasm with occasional rhabdoid features. Inset indicates focal rhabdoid appearance. (G–L) Histological findings. (G, H) Patternless solid growth of spindle to round cells is present with intervening staghorn-like vessels. (I) High magnification shows congested tumor composed of round cells around blood vessels. (J) Pseudoalveolar pattern reveals hypercellularity, pleomorphism, and mitosis (arrow). (K) Congested pseudoalveolar pattern is arranged around blood vessels resembling a pseudorosette-like pattern. Arrow indicates endothelial cells. (L) The tumor cells retain INI-1 immunostainability (left) and nuclear positivity for STAT6 (right).",jptm-2019-03-20f2,NotMatch,NotMatch
PMC6527936,Fig. 3.,"Electron microscopic findings. (A) Round shaped tumor cells have a moderate amount of cytoplasm filled with intermediate filaments, lysosomes with well-formed Golgi apparatus. Note pinocytotic vesicles (black arrow), intermediate junctions (white arrow) and microvillous processes (× 2,500). (B) Basal lamina-like materials (arrows) surround the tumor cells filled with intermediate filaments (×5,000). (C) Well-formed collagen bundles at the extracellular spaces and cytoplasmic intermediate filaments are found (×3,000).",jptm-2019-03-20f3,NotMatch,NotMatch
PMC6504755,Fig. 1,"Radiologic and operative findings. A: Preoperative brain CT shows 8.6-cm-sized solid and cystic mass on right temporal lobe that is associated with hemorrhage and severe mass effect. B: The solid lesion is strongly enhanced after an administration of contrast media. C: Intraoperatively, the mass is an intraparenchymal hemorrhagic lesion with non-dural origin. D: Postoperative 4 months later, MRI shows no enhancing lesion on the right temporal lobe.",btrt-7-53-g001,NotMatch,NotMatch
PMC6504755,Fig. 2,"Pathologic findings of anaplastic solitary fibrous tumor/hemangiopericytoma. Hypocellular and hypercellular areas are divided by hyalinized band with staghorn-like vasculatures (hematoxylin and eosin staining, original magnification ×100) (A). They show high mitotic index with 70/10 high power fields (red arrows: mitoses, hematoxylin and eosin staining, original magnification ×400) (B) and immunopositivity for STAT6 (immunohistochemistry, original magnification ×400) (C).",btrt-7-53-g002,Match,Match
PMC6482201,Fig. 1,"Contrast-enhanced abdominal computed tomography (CT). Plain CT shows a well-defined low-density mass occupying the right lobe (14.0 cm diameter) (a). Contrast-enhanced CT shows heterogeneous enhancement in the peripheral mass during the arterial phase (b). Enhancement is then centripetal and more pronounced during the portal phase (c) and finally progresses to persistent, less heterogeneous enhancement during the delayed phase (d)",40792_2019_625_Fig1_HTML,NotMatch,NotMatch
PMC6482201,Fig. 2,Magnetic resonance imaging (MRI) and [18F]-fluorodeoxyglucose positron emission tomography (FDG-PET). Abdominal MRI shows low intensity on a T1-weighted image (a) and heterogeneously high or iso intensity on a T2-weighted image (b). Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MRI reveals a hypointense mass during the hepatobiliary phase (c). Diffusion-weighted imaging shows higher intensity than for normal liver parenchyma (d) with a high b value of 1000 (e). FDG-PET shows no accumulation of [18F]-FDG (f),40792_2019_625_Fig2_HTML,NotMatch,NotMatch
PMC6482201,Fig. 3,"Macroscopic and microscopic findings of SFT. Macroscopically, the tumor mass was firm and yellowish-white with an intact capsule (13.3 cm maximum diameter) (a). Microscopically, the tumorous tissue showed a proliferation of oval to short spindle-shaped cells arranged in a “pattern-less pattern” (H&E × 400) (b). Immunohistochemically, the tumor cells were negative for CD34 (× 400; c), but positive for STAT6 (nuclei, × 400) (d) and vimentin (× 400) (e). Ki67 labeling index was < 5% (× 400) (f)",40792_2019_625_Fig3_HTML,NotMatch,Match
PMC6482201,Fig. 4,"NAB2–STAT6 fusion gene in the SFT identified by RT-PCR and sequencing. Gel electrophoresis of PCR products reveals the various NAB2–STAT6 fusion genes with heterogeneous exon compositions in the tumor, which were identified using seven primer pairs (a). Direct sequencing shows the junction breakpoint in a stretch of NAB2 intronic sequence between the 3′-end of the NAB2 exon 6 and the 5′-end of the STAT6 exon 16 (b)",40792_2019_625_Fig4_HTML,NotMatch,NotMatch
PMC6441663,Figure 1,"Hepatic epithelioid hemangioendothelioma: Pathological findings. A: Hematoxylin eosin staining, 20× objective; B: CD34 immunostaining, 20× objective; C: CD31 immunostaining, 20× objective, glomerular vessels (arrows); D: CD31 immunostaining, 20× objective.",WJCO-10-110-g001,NotMatch,NotMatch
PMC6441663,Figure 2,"Hepatic angiosarcoma: Pathological findings. A: Hematoxylin eosin staining, 40× objective; B: Hematoxylin eosin staining, 40× objective, vascular spaces lined by malignant endothelial cells; C: Hep par 1 immunostaining - Hematoxylin eosin background staining, 20× objective; hepatocytes Hep par 1 positive, captive in the tumor mass; D: CD 34 immunostaining, 20× objective, liver biopsy; E: CD 34 immunostaining, 40× objective, liver biopsy (enhanced objective); F: CD34 immunostaining, 20× objective; G: CD31 immunostaining, 20× objective; H: CD31 immunostaining, 40× objective",WJCO-10-110-g002,NotMatch,NotMatch
PMC6441663,Figure 3,"Hepatic hemangiopericytoma: Pathological findings. CD34 immunostaining, 20× objective, liver biopsy",WJCO-10-110-g003,Match,NotMatch
PMC6571265,Figure 1,"MRI scanning and pathological analysis of the solitary fibrous tumor in pineal region. (A–C) preoperative MRI. The tumor was a well-circumscribed mass, exhibiting hypo- to iso-intensity on T1 images (A). Axial (B) and sagittal (C) T1-weighted images with contrast showed a strong enhancement of the lesion with tentorium attachment. Postoperative axial (D) and sagittal (E) MRI images indicated gross total resection. (F) the tumor was a mixture of hypercellular and hypocellular areas containing short spindle-shaped cells separated by thin bands of collagen and staghorn-like vessels. (H&E, 100×).",medi-98-e15737-g001,NotMatch,Match
PMC6571265,Figure 2,"MRI scanning and pathological analysis of the in situ recurrent and ectopic metastatic masses. (A–D) preoperative MRI of the recurrent and metastatic masses. Axial (A) and sagittal (B) T1-weighted image with contrast showed a new lesion with strong and homogeneous enhancement in the pineal region. Axial (C) and sagittal (D) T1-weighted image with contrast revealed a new lesion in the left temporal lobe, exhibiting strong and heterogeneous enhancement. Postoperative axial (E) and sagittal (F) MRI images confirmed gross total resection of the temporal lobe mass. (G–J) Immunohistochemical features of the ectopic metastatic tumor. (G) The tumor was composed of short-to-ovale shaped cells with micro-hemorrhage and hypercellularity. (H&E, 100×) Immunohistochemically, tumor cells show weak reactivity for CD34 (H) (100×), strong diffuse reactivity for vimentin (I) (100×), and increased Ki-67 index (J, 40%) (100×) compared to the primary SFT in pineal region (not shown).",medi-98-e15737-g002,NotMatch,Match
PMC6683853,Figure 1.,"The integrated diagnostic workflow used in CNS tumor diagnostics depicted here is based on novel molecular platforms for next-generation sequencing (NGS) and genome-wide DNA methylation profiling besides conventional microscopy. Microscopy for standard histological evaluation includes panels of immunohistochemical staining (IHC) and in some laboratories also FISH analyses. NGS panels with selected genes allow for the detection of mutations, copy number variations (CNVs) and gene fusions. Genome-wide DNA methylation profiling is a novel approach with high potential as a support tool for a more refined and robust classification of CNS tumors. ",mdz164f1,NotMatch,NotMatch
PMC6683853,Figure 2.,"The pathological diagnosis of CNS tumors is a multi-step process starting with tumor tissue and in some cases also blood samples being analyzed with multiple tests to provide an integrated diagnosis. Evaluation and discussion of the pathological diagnosis by a multidisciplinary board of specialists from radiology, surgery, oncology, and (neuro)pathology is crucial for translating the findings into optimal therapeutic management for individual patients.",mdz164f2,NotMatch,NotMatch
PMC6660597,Fig. 1,Cardiac ultrasound and echocardiogram. Cardiac ultrasound showing a hypoechoic mass (57 × 46 mm in the axial view) in the lower wall of the left ventricle. An unclear margin suggests tumor invasion to the ventricular muscle. The ejection fraction is within normal limits (78%).,gr1,NotMatch,NotMatch
PMC6660597,Fig. 2,"Computed tomography (CT) and brain magnetic resonance imaging (MRI). Contrast-enhanced CT shows a heterogeneously enhanced cardiac mass measuring up to 68 × 72 mm in the left ventricular wall and pericardial effusion. Moreover, there are multiple disseminated lesions in the retroperitoneum and bone of the left femur (arrow). Contrast-enhanced MRI shows a cavity after resecting the brain tumor and no local recurrence.",gr2,NotMatch,NotMatch
PMC6660597,Fig. 3,"18F-fluorodeoxyglucose positron emission tomography (FDG-PET) shows multiple accumulations including the heart, right retroperitoneum, pelvic wall, and left femoral neck (arrow).",gr3,NotMatch,NotMatch
PMC6660597,Fig. 4,"Final computed tomography (CT) before death. Two years and 6 months after onset of chest pain, noncontrast-enhanced CT shows the mass growing to 100 mm in the left ventricular wall (arrow). No pleural effusion. Chest radiograph demonstrating enlargement of the third heart shadow, but there are no symptoms of cardiac dysfunction, such as pleural effusion or increasing hilum shadow.",gr4,NotMatch,NotMatch
PMC6660597,Fig. 5,"Pathological specimens from autopsy. A protruded tumor (100-mm diameter) is observed in the left ventricular wall, infiltrating the papillary muscle. Hematoxylin-eosin staining shows spindle cell tumor of curt-wheel pattern with stag-horn vasculature. STAT6 staining was positive for nuclei.",gr5,NotMatch,NotMatch
PMC6704372,Fig. 1,A-Contrast enhanced CT in coronal view showing 12.4 × 14.0 cm heterogeneous right thoracic mass with areas of necrosis causing mass effect and leftward deviation of the mediastinum. B- Contrast enhanced CT in transverse view showing 12.4 × 12.5 cm heterogeneous right thoracic mass with areas of necrosis causing mass effect and leftward deviation of the mediastinum. C- Contrast enhanced CT showing the right thoracic mass stable size with increased areas of necrosis after serial TAE. D-Contrast enhanced CT demonstrating enhancing lesion in the liver pre embolization. E− Contrast enhanced CT demonstrating near complete remission of the liver lesion post serial TAE.,gr1,NotMatch,NotMatch
PMC6704372,Fig. 2,A-Angiography demonstrating microcatheter advancement through the left gastric artery above the diaphragm supplying feeder vessels to the thoracic mass. B-Angiographic image taken during embolization of the right internal thoracic artery as one of the extensive tumor vascular supply of the right thoracic mass.,gr2,NotMatch,NotMatch
PMC6597415,Figure 1,"Radiologic findings (A) Ultrasound showing a highly vascular, oval, circumscribed, and hypoechoic mass in the left breast at posterior depth causing mass effect on the pectoralis muscle posteriorly. (B) Mammogram shows an oval, circumscribed, and obscured mass in the left breast at posterior depth abutting the pectoralis muscle. This mass contains a single benign-appearing coarse calcification.",jbc-22-326-g001,NotMatch,NotMatch
PMC6597415,Figure 2,"Microscopic findings (A) Well demarcated tumor border; however, it is focally permeative into the surrounding adipose tissue and skeletal muscles (arrows). (B) Tumor cells are arranged haphazardly with alternating cellularity (hypocellular on left and hypercellular on right) and prominent vasculature. (C) Hypocellular area is composed of bland looking, plump spindle or oval tumor cells. (D) Hypercellular area with compact sheet-like arrangement (left side) is transited from classic tumor areas (right side). (E) Hypercellular area is composed of pleomorphic tumor cells with increased mitotic figures (hematoxylin and eosin stain; (A) ×50, (B) ×100, (C) ×400, (D) ×100, and (E) ×400).",jbc-22-326-g002,NotMatch,Match
PMC6597415,Figure 3,"Tumor cells positive for cluster of differentiation 34 (A), signal transducer and activator of transcription 6 (B), B-cell lymphoma 2 (C) negative for cytokeratin (D), S100 (E), and p63 (F) (×200).",jbc-22-326-g003,NotMatch,NotMatch
PMC6597415,Figure 4,"Immunohistochemical findings in hypercellular and pleomorphic areas cluster of differentiation 34 (A), B-cell lymphoma 2 (B), and signal transducer and activator of transcription 6 (C). Immunoreactivity shows the same staining pattern and intensity as in classic areas (×200).",jbc-22-326-g004,NotMatch,NotMatch
PMC6726169,Figure 1. ,"(a) On unenhanced phase the lesion has the same spleen’s density; (b) on arterial phase the lesion is rounded, with smooth margins, heterogeneous density, and lively rim enhancement associated to slight hyperdensity of radiating lines; a hypodense central scar is observed; (c–d) progressive filling on venous and delayed phase, with persisted hypoenhanced central scar.",bjrcr.20180036.g001,NotMatch,NotMatch
PMC6726169,Figure 2. ,"PET-CT—the lesion has low and heterogeneous FDG accumulation with a SUVmax of 4.3. FDG, fludeoxyglucose; PET, positron emission tomography; SUVmax, maximum standardized uptake value.",bjrcr.20180036.g002,NotMatch,NotMatch
PMC6726169,Figure 3. ,"MRI pre-contrast- (a, b) the lesion isn’t clearly recognized on T
1W in phase, without signal intensity drop on out of phase; (c) rounded lesion, with irregular and smooth margins, multiple radiating septa inside, with a typical “spoke wheel pattern” on T
1W, T
1 weighted; (d, e) absence of signal restriction (b-value of 800 s mm–
2).",bjrcr.20180036.g003,NotMatch,NotMatch
PMC6726169,Figure 4. ,"MRI after gadolinium administration: (a) on arterial phase peripheral and septa enhancement is recognizable; (b–d) on venous and delayed phase progressive and centripetal filling, with non-enhancing central hypointense scar is recognizable.",bjrcr.20180036.g004,NotMatch,NotMatch
PMC6726169,Figure 5. ,"Pathology (a) angiomatoid nodule upper left, fibrous stroma lower right (EE 20 ×); (b) cd8 positive splenic sinusoid in the angiomatoid nodule (CD8 20×).",bjrcr.20180036.g005,NotMatch,NotMatch
PMC6694554,Fig. 1,T1-weighted images (a) and T2-weighted coronal images (b) on MRI show a soft tissue mass with inhomogeneous densities and fine separations in the left supraclavicular fossa (arrows). Axial CT scan (c) reveals a fused multinodular mass (arrows) with local necrosis; CT-guided core needle biopsy was then performed (d),13000_2019_869_Fig1_HTML,NotMatch,NotMatch
PMC6694554,Fig. 2,Histopathological and immunohistochemical features of the core needle biopsy specimen: a Low-power view of the needle biopsy specimen. b Atypical epithelioid tumor cell nests infiltrating the hyperplastic collagen fibers mimic a metastatic carcinoma. c These tumor cells are round to polygonal with atypical mitoses (arrows) and are positive for CD23 (d),13000_2019_869_Fig2_HTML,NotMatch,NotMatch
PMC6694554,Fig. 3,Gross pathology of the resected tumor shows the fused mass is well circumscribed with an intact capsule (a) and that the cut surface is yellow-gray and tan with areas of focal hemorrhage (b),13000_2019_869_Fig3_HTML,NotMatch,NotMatch
PMC6694554,Fig. 4,"a-c: The area resembles desmoplastic infiltrative carcinoma. Atypical epithelioid tumor cells arranged in nested or pseudo-glandular structures (a) infiltrate the hyperplastic collagen fibers (b), which are positive for CD23 (c). d-f: The area resembles anaplastic large cell lymphoma. Atypical large tumor cells with a nested or patchy pattern fill the lymphatic sinuses (d). On high power, the tumor cells are round or polygonal with marked atypia (e) and are positive for CD21 (f). g-i: The area mimics hemangiopericytoma. Short spindle-shaped tumor cells are arranged radially around many fissure-like or dendritic thin-walled blood vessels (g) with only a few infiltrating lymphocytes (h), which are positive for CD23 (i)",13000_2019_869_Fig4_HTML,Match,NotMatch
PMC6694554,Fig. 5,"Mononuclear or binuclear Reed-Sternberg (R-S) cell-like large cells (arrows) are scattered in a background composed of lymphocytes and histiocytes, which resembles classical Hodgkin’s lymphoma a, b. Low- and high-power views show the typical histology of FDCS, which consists of ovoid- to spindle-shaped cells in a storiform pattern (c, d). In some regions, the transition between the areas, such as those of classical Hodgkin’s lymphoma and those with the typical morphology of FDCS, can be found (e), both of which are positive for CD21 (f)",13000_2019_869_Fig5_HTML,NotMatch,NotMatch
PMC6694554,Fig. 6,"CT shows multiple fused nodular masses in the left supraclavicular fossa with necrosis 17 months after surgery (a, arrow). Subsequently, multiple nodules in the bilateral axilla, lungs and mediastinum are found 27 months after operation (b, arrows)",13000_2019_869_Fig6_HTML,NotMatch,NotMatch
PMC6744783,Figure 1:,"(a and b) Hemangiopericytoma and solitary fibrous tumor (HPC/SFT) in a 10-day-old girl. Left: Magnetic resonance imaging (MRI) axial postcontrast T1-weighted image of HPC/SFT, Right: MRI coronal of HPC/SFT. Postcontrast T1-weighted image.",SNI-10-75-g001,Match,NotMatch
PMC6744783,Figure 2:,Postoperative computed tomography scan with obstructive hydrocephalus after subtotal resection.,SNI-10-75-g002,NotMatch,NotMatch
PMC6744783,Figure 3:,(a and b) Postoperative magnetic resonance imaging postcontrast T1-weighted image axial (left) and coronal (right) after completion of chemotherapy.,SNI-10-75-g003,NotMatch,NotMatch
PMC6744783,Figure 4:,(a) Cellular areas of short bundles of spindle cells with an eosinophilic cytoplasm and a round nucleus with fine chromatin without nucleolus and with mild-to-moderate nuclear atypia. (b) Heterogeneous cellular density with cellular heterogeneity and obvious mitoses in a cellular area of the neoplasm. (c) Immunohistochemical expression of CD34 in the neoplastic cells mainly membranous and cytoplasmic. (d) A heterogeneous expression of smooth muscle actin in bundles of spindle cells.,SNI-10-75-g004,NotMatch,NotMatch
PMC6734512,Figure 1,Fundus pictures of the right (A) and left eye (B) showing bilateral optic disc edema suggestive of papilledema,OC-09-32-g-001,NotMatch,NotMatch
PMC6734512,Figure 2,"A) Coronal T2-weighted MRI brain showing an iso-hyperintense large mass lesion in the tempo-parietal lobe (white arrows). B,C): Post contrast sagittal and axial cuts showing an intense heterogeneous enhancement of the lesion (white arrows).",OC-09-32-g-002,NotMatch,NotMatch
PMC6744537,Fig. 1,"Endoscopic ultrasonography (EUS) findings. a EUS revealed a well-demarcated cystic mass with solid components in the pancreas tail. b Color Doppler EUS revealed the tumor was hypervascular, particularly on the surface",40792_2019_699_Fig1_HTML,NotMatch,NotMatch
PMC6744537,Fig. 2,Dynamic contrast-enhanced computed tomography (CT) findings. a Plain CT scan demonstrated a 5.5-cm cystic mass with solid components inside in the pancreas tail. b Dynamic CT arterial phase scan demonstrated enhancement in the tumor rim and in the edge of the solid components with non-enhanced interior. c Solid components were gradually enhanced from the outside in the portal phase. d The tumor rim and the solid components had isodensity to the surrounding pancreatic parenchyma in the delayed phase,40792_2019_699_Fig2_HTML,NotMatch,NotMatch
PMC6744537,Fig. 3,"Magnetic resonance imaging (MRI) findings. a Solid components were hypointense to the pancreatic parenchyma on T1-weighted imaging. b On T2-weighted imaging, solid components were hyperintense. A large non-enhancing portion on the CT scan showed bright signal intensity, indicating cystic change or necrosis",40792_2019_699_Fig3_HTML,NotMatch,NotMatch
PMC6744537,Fig. 4,"Macroscopic and microscopic findings of the resected specimen of the pancreas. a The resected specimen showed a hemispheric mass protruding from the pancreas tail and measuring 5.6 × 5.4 cm in diameter. b Solid components occupied most of this cystic mass. c, d Findings of the H&E staining. Oval and spindle-shaped cells proliferated bluntly with a richly vascular stroma, resembling the structure of hemangiopericytoma. Scale bars, 50 μm. e Immunohistochemical staining was irregularly positive for CD34, a mesenchymal marker. Scale bar, 100 μm. f Nuclear expression of STAT6 was diffusely positive in the immunohistochemical staining. Scale bar, 100 μm",40792_2019_699_Fig4_HTML,Match,Match
PMC6744537,Fig. 5,"Histopathological review of the past brain tumor. a, b Findings of the H&E staining. Oval and spindle-shaped cells proliferated similarly with a richly vascular stroma. Scale bars, 50 μm. Immunohistochemical staining (c CD34, d STAT6) showed the same results as that in the pancreatic lesion. Scale bars, 100 μm",40792_2019_699_Fig5_HTML,NotMatch,Match
PMC6744806,Figure 1:,"CT head without contrast demonstrates a hyperdense left frontal mass with the erosion of the inner table of the frontal sinus, near midline.",SNI-10-148-g001,NotMatch,NotMatch
PMC6744806,Figure 2:,"MRI brain. (a) T1 noncontrast and (b) T1 postcontrast sequences demonstrate a 7.0 cm×5.0 cm×4.9 cm heterogeneously enhancing left frontal mass with T1 shortening at the posterior aspect of the lesion, suggestive of prior hemorrhage. (c) T1 postcontrast sequences also reveal a dural tail and (d) T2-weighted sequences demonstrate a partial cerebrospinal fluid cleft around the periphery of the lesion; both findings suggest that the mass is extra- axial in origin.",SNI-10-148-g002,NotMatch,NotMatch
PMC6744806,Figure 3:,CT abdomen/pelvis demonstrates a hypodense hepatic lesion (arrow) concerning for metastatic disease.,SNI-10-148-g003,NotMatch,NotMatch
PMC6744806,Figure 4:,"(a) Histologic sections of the left frontal mass demonstrate a high-grade SFT/HPC. Note the four mitotic figures in the mid-upper right (red arrows). (H & E, 200×). (b) Nuclei of the neoplastic cells express STAT6, indicating a fusion of the NAB2 and STAT6 genes (Diaminobenzidine, 100×).",SNI-10-148-g004,NotMatch,Match
PMC6744806,Figure 5:,"(a) Metastatic hemangiopericytoma in liver core biopsy (H & E, 200×). (b) Expression of STAT6 by the neoplastic cells (Diaminobenzidine, 100×).",SNI-10-148-g005,Match,Match
PMC6744806,Figure 6:,Postoperative surveillance MRI brain (T1 postcontrast) demonstrates no evidence of residual or recurrent disease.,SNI-10-148-g006,NotMatch,NotMatch
PMC7045656,Figure 1.,"(a) Unenhanced axial computed tomography showing an irregular mass in the fourth ventricle. The upper anterior part of the tumor shows slight hyperdensity, while the lower posterior part shows isodensity. (b) Contrast-enhanced axial computed tomography showing that the lower posterior part of the tumor has more pronounced enhancement than the upper anterior part. (c) Axial T1-weighted image showing an isointense mass in the fourth ventricle. (d) and (f) Axial T2-weighted image and diffusion-weighted image showing that the upper anterior part of the mass is hyperintense while the lower posterior part is hypointense, forming a black and white sign. (e) The mass is isointense on fluid-attenuated inversion recovery. (g)–(i) After gadolinium administration, the lower posterior part of the tumor has more enhancement than does the upper anterior part, forming reversed enhancement. (i) Contrast-enhanced T1-weighted sagittal image showing a flow void effect (red arrow) in the lower posterior part of the mass.",10.1177_0300060519885567-fig1,NotMatch,NotMatch
PMC7045656,Figure 2.,"Photomicrographs. (a) The tumor is composed of atypical spindle cells and a collagenized stroma, and mitotic figures can be seen (magnification = × 400, red arrow). (b) The molecular immunology borstel-1 proliferation index was 15% (magnification = × 400). (c) Neoplastic cells are strongly immunoreactive to CD34 (magnification = × 200). (d) Neoplastic cells are strongly immunoreactive to nuclear STAT6 (magnification = × 200).",10.1177_0300060519885567-fig2,NotMatch,NotMatch
PMC6882637,Figure 1,"Pictures showing when the infant was admitted and 5 years later. (A) A giant tumor located on the forehead was full of many capillaries. (B) After a 5-year follow-up period, the wound could not be found without careful examination.",medi-98-e17888-g001,NotMatch,NotMatch
PMC6882637,Figure 2,Multimodality imaging performed in this infant. (A) CTA demonstrated that the blood supply to the vascularized tumor originated mainly from the bilateral supratrochlear artery and partly from the distal part of the right superficial temporal artery. MRI showed a right extracranial mass with heterogeneous intensity on contrast-enhanced CT (B) and isointensity on T1-weighted (C) and T2-weighted images (D). There were no signs of recurrence or metastasis of the neoplasm on a CT scan (E).,medi-98-e17888-g002,NotMatch,NotMatch
PMC6882637,Figure 3,"The incision of the infantile HPC. The incision was made along the black line, which could be used for skin reconstruction.",medi-98-e17888-g003,NotMatch,NotMatch
PMC6882637,Figure 4,Histological examinations of the tumor. HE staining showing that the tumor cells had polymorphic nuclei that were round and oval-shaped and surrounded by typical staghorn-shaped blood vessels (A). Immunohistochemical staining showing that the cells were positive for CD34 (B). The rate of Ki-67 positivity was 5% (C). Original magnification × 200 (a) and × 400 (B and C).,medi-98-e17888-g004,NotMatch,NotMatch
PMC6911315,Figure 1,(A) T1-weighted magnetic resonance imaging showing an isointense mass. (B) T2-weighted imaging showing a hyperintense mass with associated spinal cord edema in the rostral region of the lesion. (C) Homogeneous enhancement after gadolinium administration. (D) Three-dimensional computed tomographic angiography reconstruction showing a high-flow hypervascular lesion.,CMAR-11-10321-g0001,NotMatch,NotMatch
PMC6911315,Figure 2,"(A) Haematoxylin and eosin staining (original magnification ×200) showing uniform spindle cells arranged in interlacing fascicles. (B) Sagittal, (C) coronal, and (D) axial contrasted T1-weighted imaging confirming a complete resection of the tumor.",CMAR-11-10321-g0002,NotMatch,NotMatch
PMC6893274,Figure 1,Follow-up CT with contrast medium one month after surgery for clear cell renal cell carcinoma showing a homogeneously enhanced mass without intralesional calcifications.,CRIOR2019-3926903.001,NotMatch,NotMatch
PMC6893274,Figure 2,"MRI findings showing an intradural-extramedullary mass with isointensity on T1-weighted images (a) and hypointensity on T2-weighted images (b), enhanced heterogeneously with gadolinium (c).",CRIOR2019-3926903.002,NotMatch,NotMatch
PMC6893274,Figure 3,"
18F-FDG-PET/CT findings showing no accumulation in the intradural-extramedullary site at the level of T9.",CRIOR2019-3926903.003,NotMatch,NotMatch
PMC6893274,Figure 4,White-yellowish hard tumor was resected in a piecemeal fashion.,CRIOR2019-3926903.004,NotMatch,NotMatch
PMC6893274,Figure 5,"The tumor consisted of spindle cells with ovoid to spindle-shaped nuclei, arranged without a pattern with stromal hyalinized collagen (HE staining) (a, b). On immunohistochemical staining, CD34 (c), bcl-2 (d), and STAT6 (e) were positive, while S-100 protein (f) and EMA (g) were negative.",CRIOR2019-3926903.005,NotMatch,NotMatch
PMC6893274,Figure 6,MRI of the thoracic spine showed no evidence of tumor recurrence three years after the surgery for intradural-extramedullary SFT/HPC.,CRIOR2019-3926903.006,NotMatch,NotMatch
PMC6776749,Fig. 1,"(a) Gadolinium-enhanced T1-weighted magnetic resonance imaging at the first GKS. The tumor located a left intracavernous tumor extending into the Meckel’s cave and posterior fossa. The tumor volume was 6.9 cm3. (b–f) Preoperative images. The tumor showed slightly high density on CT (b) and slightly high intensity on T1 (c) and T2-weighted image (d). The lesion enhanced homogenously on gadolinium-enhanced T1-weighted image (e), and no apparent feeding vessels (f). The tumor volume was 12 cm3 before the surgery. (g and h) Gadolinium-enhanced T1-weighted magnetic resonance imaging after the surgery. The tumor was resected partially, and the volume was 8.5 cm3. GKS, gamma knife surgery.",nmccrj-6-111-g001,NotMatch,NotMatch
PMC6776749,Fig. 2,Histological examination showed densely cellular neoplasm with stag-horn blood vessels (a). STAT6 was expressed in the nuclei (b).,nmccrj-6-111-g002,NotMatch,NotMatch
PMC6776749,Fig. 3,"Gadolinium-enhanced T1-weighted magnetic resonance imaging after the surgery. 8 months (a) and 23 months (b) after second gamma knife surgery (GKS), the tumor reduced in size. 29 months after second GKS, we underwent third GKS which the prescription dose for the tumor was 15 Gy (c). 18 months after third GKS, the tumor reduced in size once (d). 24 months after third GKS, we underwent fourth GKS which the prescription dose for the tumor was 16 Gy (e).",nmccrj-6-111-g003,NotMatch,NotMatch
PMC7076144,Fig. 1,"CT- Arrow show well-defined, heterogeneous, enhancing small soft tissue lesion on the left kidney, approximately 1.5 cm × 1,5 cm in size.",gr1,NotMatch,NotMatch
PMC7076144,Fig. 2,The intraoperative laparoscopic view-arrows show different anatomical structures and tumor under the renal hilum.,gr2,NotMatch,NotMatch
PMC7076144,Fig. 3,"HPC. (A) Histology shows round, well circumscribed tumor with thick fibrous capsule within and outside the renal parenchyma. It's composed of whorls and intersecting bundles of tightly packed spindle cells without atypia, mitotic figures or necrosis, with stromal hialinization and focal formation of branched vessels. (B) Immunoprofile shows strong positivity for CD34 and single cells, that are positive for bcl2, CD99 and S-100 protein, Ki-67 < 10%. Tumor cells are negative for CK AE1/AE3. The renal parenchyma around the tumor is normal.",gr3,NotMatch,NotMatch
PMC7220372,Figure 1,"(A) Axial head CT revealed a 3.0 × 2.7 cm well-defined slightly hyperdense mass without peritumoral edema in the left CPA. (B) On enhanced CT, the mass was homogeneously enhancing, extending into IAC. CPA = cerebellopontine angle, CT = computed tomography, IAC = internal auditory canal.",medi-99-e19651-g001,NotMatch,NotMatch
PMC7220372,Figure 2,"The brain MRI demonstrated a 2.4 × 2.5 × 2.6 cm ovoid mass in the left CPA. The tumor showed intermediate-slightly increased signal intensity in T1WI (A) and slightly increased signal intensity in T2WI (B). Axial (C), sagittal (D), and coronal (E) enhanced T1WI showed homogeneous and strong enhancing tumor, extending into the enlarged IAC and closely connected to the vestibulocochlear nerve. CPA = cerebellopontine angle, IAC = internal auditory canal, MRI = magnetic resonance imaging.",medi-99-e19651-g002,NotMatch,NotMatch
PMC7220372,Figure 3,"The brain MRIdemonstrated a 2.4 × 2.5 × 2.6 cm ovoid mass in the left CPA. The tumor showed intermediate-slightly increased signal intensity in T1WI (A) and slightly increased signal intensity in T2WI (B). Axial (C), sagittal (D), and coronal (E) enhanced T1WI showed homogeneous and strong enhancing tumor, extending into the enlarged IAC and closely connected to the vestibulocochlear nerve. CPA = cerebellopontine angle, IAC = internal auditory canal, MRI = magnetic resonance imaging.",medi-99-e19651-g003,NotMatch,NotMatch
PMC7113407,Fig. 1,"A 75-year-old male with previous history of renal cell carcinoma and long-standing intracranial meningioma, presented with 2-week history of vague memory loss and urinary frequency. (A) Axial CT head bone window image demonstrates the mass with peripheral and internal calcific foci “white arrow” as well as erosive/permeative changes of overlying calvarial bone, reflecting bone invasion “wide arrow.” (B) Axial T2 weighted magnetic resonance image shows heterogeneous hyperintense signal of the mass with anteromedial area of cystic changes and focal interruption of the capsule “arrow,” concerning of infiltration of the underlying left frontal lobe. Note the extensive parenchymal edema within left frontal lobe. (C) Axial and (D) sagittal MPRAGE after gadolinium administration demonstrate the cystic changes along the anteromedial margin of the mass, atypical for a meninigioma, and concerning for other alternative diagnoses such as atypical meninigioma, hemangiopericytoma, or metastasis.",gr1,Match,NotMatch
PMC7113407,Fig. 2,"A 75-year-old male with previous history of renal cell carcinoma and long-standing intracranial meningioma, presented with 2-week history of vague memory loss and urinary frequency. (A) Review of H&E stained sections demonstrates a collision of a meningioma with a metastatic carcinoma composed of clear cells. (B and C) Immunohistochemistry with progesterone receptor antibodies highlights only meningioma cells with nuclear positivity. RCC antibodies highlight the clear cells of the carcinoma. These cells were also immunoreactive for cytokeratin 7 and CD10, consistent with renal cell carcinoma.",gr2,NotMatch,Match
PMC7018895,Fig. 1,"Calvarial pseudolesions. NECT (a, c–f), T2WI (b), MR venography (g, h). Parasagittal occipital arachnoid granulation (a). Occipital encephalocele (b). Dilated vascular canals and lacunae (c). Hyperostosis frontalis interna (d). Bilateral thinning of the parietal bones (e). Enlarged parietal foramina (f). Congenital sinus pericranii (g). Iatrogenic acquired sinus pericranii from a prior ventricular drainage (h)",13244_2019_820_Fig1_HTML,NotMatch,NotMatch
PMC7018895,Fig. 2,"Fibrous dysplasia. T2WI (a), post-contrast T1WI (b), and NECT (c). Expansile lesion with distinct lytic-cystic component (arrows) and “ground-glass” fibrous tissue (arrowheads) clearly depicted on NECT, deeply T2-hypointense, which enhances heterogeneously",13244_2019_820_Fig2_HTML,NotMatch,NotMatch
PMC7018895,Fig. 3,"Epidermoid cysts (a–c and d–f) and dermoid cyst (g–i). Case 1 (a–c): Extracranial soft-tissue mass (arrows) remodeling the outer table on NECT (a), with fluid T2-signal (b), and markedly restricted diffusion (b = 1000) (c). Case 2 (d–f): Transdiploic mass (arrowheads), predominantly intracranial, T1WI (d) and T2WI (e) heterogenous and intense diffusion restriction (f). Case 3 (g–i). Frontal skull lesion (dashed arrows) disrupting the inner table on CT (g, h); content is CT-hypodense and T1-hyperintense, corresponding to fat (i)",13244_2019_820_Fig3_HTML,NotMatch,NotMatch
PMC7018895,Fig. 4,"Eosinophilic granuloma. NECT depicts inner and outer table endosteal scalloping and erosions (arrows in a) and bone sequestra (arrowhead in b). On T2WI (c), the lesion is hyperintense and bone sequestra could also be suspected (arrowhead). T1WI post-contrast (d) demonstrates intense enhancement and cranio-caudal orientation (dashed arrow)",13244_2019_820_Fig4_HTML,NotMatch,NotMatch
PMC7018895,Fig. 5,"Bone hemangiomas. Case 1 (a–c): CT (a), T1WI (b), and T2WI (c) show well-defined lytic lesion, with thickened cortical and medullar trabecular spaces (arrows in a), and internal T1 and T2 hyperintense signal corresponding to fat and vascular tissue (arrows in b and c). Case 2 (d, e): CT (d) and T1WI (e) show marked bone expansion, fat content (dashed arrows), and strikingly enlarged trabecula producing a “spoke-wheel” appearance. Case 3 (f): CT depicts interruption of outer cortical table with overcoming enlarged spiculated trabecula simulating aggressive periosteal reaction (arrowhead)",13244_2019_820_Fig5_HTML,NotMatch,NotMatch
PMC7018895,Fig. 6,"Aneurysmal bone cyst (ABC). Case 1 (a–c): Primary ABC: NECT (a), T2WI (b), and post-contrast T1WI (c) show an extremely expansile, lytic, multiloculated, septated lesion, with severe cortical thinning (arrowhead in a), fluid-fluid levels (dashed arrow in b), and lineal enhancement (arrows in c). Case 2 (d–f): Fibrous dysplasia with secondary ABC: NECT demonstrates an expansile, lytic lesion with severe cortical thinning (arrowhead in d), a characteristic fluid-fluid level (arrow in f), and associated areas of “ground-glass” matrix (dashed arrows in e)",13244_2019_820_Fig6_HTML,NotMatch,NotMatch
PMC7018895,Fig. 7,"Giant cell tumor of the bone. Axial NECT (a), T2WI (b), and T1WI post-contrast (c). Purely lytic lesion with severe expansion and cortical thinning (arrowhead in a), markedly T2 hypointense tissue content (arrow in b), and avid contrast-enhancement (dashed arrow in c)",13244_2019_820_Fig7_HTML,NotMatch,NotMatch
PMC7018895,Fig. 8,"Metastases. Lytic metastases (a–f). CT of three patients (a–c) shows: a Solitary with narrow zone of transition (arrows), b multiple with slight soft-tissue components, and (c) solitary, giant, with mixed necrotic (arrowhead) and hypervascular (dashed arrows) soft tissue. Another case (d–f) with T2WI, T1WI post-contrast, and DSC-PWI shows solitary, giant, solid-enhancing, and hypervascular soft-tissue component (arrowheads). g–i Three cases of blastic metastases. Multiple (g). Aggressive periosteal reaction (arrows in h–i)",13244_2019_820_Fig8_HTML,NotMatch,NotMatch
PMC7018895,Fig. 9,"Myeloma and plasmacytoma. Upper row. Myeloma. X-ray (a) NECT (b, c) and T1WI (d). Multiple “punched-out” lytic lesions with variable soft tissue components (a–c). Mandibular lesion suggesting myeloma instead of metastases (arrow in d). Note also the clival lesion (dashed arrow in d). Lower row. Plasmacytoma. NECT (e), T1WI post-contrast (f), and DSC-PWI (g). Single purely lytic transdiploic lesion with narrow zone of transition (arrows in e), hyperdense, hyperenhancing, and hypervascular (arrowheads respectively in e–g)",13244_2019_820_Fig9_HTML,NotMatch,NotMatch
PMC7018895,Fig. 10,Osteomas. Multiple in Gardner syndrome. NECT show mass-like proliferation of normal appearing cortical bone in the frontal (arrow) and cortical and medullary bones in the parieto-occipital (dashed arrow) lesions,13244_2019_820_Fig10_HTML,NotMatch,NotMatch
PMC7018895,Fig. 11,"Osteosarcoma. Secondary, “pagetic.” T1WI post-contrast (a and b). Aggressive, destructive, giant, and transdiploic lesion with extensive intra- and extracranial soft-tissue component containing iso to hypointense areas of probable necrosis (arrows in a and b) and deeply hypointense foci of suspected bone matrix (dashed arrows in b). Note the underlying abnormal calvarial bone with diffuse expansion, cortical thickening and heterogeneous multifocal variable signal intensity, and enhancement (arrowheads) consistent with Paget disease",13244_2019_820_Fig11_HTML,NotMatch,NotMatch
PMC7018895,Fig. 12,"Meningioma. Great polymorphism. Case 1 (a, b): Post-contrast T1WI (a) and CT (b): dural-based with dural tails (arrows) and bone lysis (dashed arrows). Case 2 (c–e): Post-contrast T1WI (c), CT (d), and DSC-PWI (e): dural-based hypervascular (arrowhead) with transdiploic growing (arrows), bone sclerosis-permeation, and aggressive-like periosteal reaction (dashed arrows). Case 3 (f, g): Post-contrast T1WI (f) and CT (g): diploic-centered plaque-like with intra- and extracranial laminar soft-tissue (arrowheads) and bone lysis-permeation (arrows). Case 4 (h): CT shows diploic-centered lesion with great spiculated hyperostosis (arrows). Case 5 (i, j) Post-contrast T1WI (i) and MR venography (j): diploic-centered with great homogeneous smooth hyperostosis (arrowhead) and intracranial soft-tissues characteristically invading the superior longitudinal venous sinus (arrows)",13244_2019_820_Fig12_HTML,NotMatch,NotMatch
PMC7018895,Fig. 13,"Hemangiopericytoma. CT (a), T2WI (b), and post-contrast T1WI (c). Dural-based “mushroom-like” mass (arrows) with brain edema (dashed-arrows), intense homogeneous enhancement, and foci of bone lysis (arrowhead)",13244_2019_820_Fig13_HTML,Match,NotMatch
PMC7018895,Fig. 14,"Lymphoma. Case 1 (a–d): NECT (a, b), post-contrast T1WI (c), and ADC map (d). Transdiploic mass with bone subtle sclerosis (arrows) and disproportionate soft-tissue components dense on CT, homogenously enhancing, and diffusion-restricting (arrowheads). Case 2 (e–g): Similar findings with bone lytic-permeation (arrows) instead",13244_2019_820_Fig14_HTML,NotMatch,NotMatch
PMC7018895,Fig. 15,"Characteristic MR spectroscopies and DSC-PWI TIC of transdiploic lesions. Green: lymphoma. Spectroscopy: high Cho + lip-lac. DSC-PWI TIC: recovers fast and ends far above the baseline. Blue: meningioma. Spectroscopy: high Cho, high Glx, Ala. DSC-PWI TIC: recovers slow and remains far under the baseline. Purple: hemangiopericytoma. Spectroscopy: high Myo. Red: metastasis. Spectroscopy: high lip. DSC-PWI TIC: recovers slowly and remains slightly under the baseline",13244_2019_820_Fig15_HTML,Match,NotMatch
PMC7018895,Fig. 16,"Miscellany. Paget disease (a, b) CT (a) and X-ray (b): Characteristic mixed bone lysis and sclerosis, cortical bone thickening, and expansion. Osteoporosis circumscripta cranii CT (c, d): large geographic radiolucent areas involving medullar and cortical bone in frontal and occipital regions (arrows). Amyloidoma (e, f) CT (e) and T2WI (f): Giant heterogeneous mass with marked T2 hypointensity and calcifications. Renal osteodystrophy CT (g): shows characteristic “salt-and-pepper pattern.” Brown tumor (h, i): unspecific well-defined, cystic appearance (arrows). Thalassemia CT (j): Diffuse diploic widening and “hair-on-end” appearance (arrow) with characteristic occipital bone preservation (arrowhead). Bone sarcoidosis (k, l) CT (k) and T2WI (l): Mixed predominantly lytic multiple lesions with lace-like internal pattern of calcification and T2 hypointensity (dashed arrows). Osteitis CT (m, n): Bone focal lysis and erosions of osteitis (arrows) contiguous to a frontal sinusitis complicated with intracranial laminar abscess (dashed arrow)",13244_2019_820_Fig16_HTML,NotMatch,NotMatch
PMC7139141,Fig. 1,"Intradural extramedullary SFT at thoracic spine in a 64-year-old man. (A) (Left) Sagittal and (right) axial MRI T1 sequence of the spine shows well circumscribed mass (1.4 × 0.7 cm) with low T1 signal intensity in posterior epidural space, lying dorsal and left lateral to the spinal cord at the level of T1-T2. (B) (Left) Sagittal and (right) axial MRI T2 sequence of the spine shows markedly dark T2 signal mass located intradural extramedullary at the level of T1-T2. Dorsal mass is compressing the spinal cord to the right side anterolaterally. (C) (Left) Sagittal and (right) axial MRI Gadolinium-enhanced sequence of the spine shows mild heterogeneous enhancement of the intradural extramedullary mass at the level of T1-T2. (D) (Left) Sagittal and (right) axial CT of the spine shows no evidence of calcification or acute hemorrhage. Mass is isodense and is difficult to delineate with adjacent structures. (E) (Left) Hematoxylin and eosin (H&E) stain, original magnification ×200, shows spindle cells embedded in a thick collagenous stroma. (Right) Immunohistochemical stain for CD34, original magnification ×200, shows strong and diffuse immunopositivity with CD34.",gr1,NotMatch,Match
PMC7318349,Figure 1,"Local control is illustrated after propensity score matching, comparing surgery (S) versus surgery plus perioperative radiotherapy (S+RT).",CNCR-126-3002-g001,NotMatch,NotMatch
PMC7318349,Figure 2,"Overall survival is illustrated after propensity score matching, comparing surgery (S) versus surgery plus perioperative radiotherapy (S+RT).",CNCR-126-3002-g002,NotMatch,NotMatch
PMC7232097,Fig. 1,Excretory phase computed tomography showed (A) a centrally necrotic pelvic mass displacing a contrast-filled urinary bladder to the right and (B) resulting in severe left hydroureteronephrosis with cortical thinning. (C) Coronal and (D) sagittal views on magnetic resonance imaging confirmed presence of a pelvic mass anterior to the rectum and displacing the urinary bladder.,gr1,NotMatch,NotMatch
PMC7232097,Fig. 2,"(A) Grossly, the 10.5 cm pelvic mass appeared well-circumscribed with a smooth surface. (B) Sectioning revealed a fleshy mass with a central necrotic lesion.",gr2,NotMatch,NotMatch
PMC7453947,Figure 1,Magnetic resonance imaging of the cervical spine showing a well-defined intense uniform enhancing T1 hypointense intradural and extramedullary mass lesion at C5-C7 level,AAM-19-144-g001,NotMatch,NotMatch
PMC7453947,Figure 2,Magnetic resonance imaging of the cervical spine revealed a well-defined intense uniform enhancing T2 hyperintense intradural and extramedullary mass lesion at C5-C7 level,AAM-19-144-g002,NotMatch,NotMatch
PMC7186106,Figure 1,"Magnetic resonance imagingIntracranial lesion from the Silvian Valley to the anterior temporal region, extension to the middle floor of the hourglass-shaped skull base, and the right extracranial temporal fossaViews. Left to right: 1 Transversal, 2 Sagital A, 3 Sagital B with gadolinium, 4 Coronal with gadoliniumRed arrows 1-4: An intracranial lesion can be observed from the Silvian Valley to the anterior temporal region, extension to the middle floor of the hourglass-shaped skull base, and right extracranial temporal fossa, with the remodeling of the posterior wall of the maxilla.3 and 4: Intimate contact with lateral wall of the orbit in its intracranial portion, showing enhancement with gadolinium.",cureus-0012-00000007447-i01,NotMatch,NotMatch
PMC7186106,Figure 2,"Cerebral angiographyRight middle meningeal artery dependent tumor from the right internal maxillary arteryRed arrow: Right external carotid arteryGreater diameters of the tumor: X1: 72.97 mm, X2: 46.66 mm",cureus-0012-00000007447-i02,NotMatch,NotMatch
PMC7186106,Figure 3,Entropy placement,cureus-0012-00000007447-i03,NotMatch,NotMatch
PMC7186106,Figure 4,Surgical site marking,cureus-0012-00000007447-i04,NotMatch,NotMatch
PMC7186106,Figure 5,"Images of the surgical procedureA: Intracranial, extradural portion of the tumor; B: Extracranial tumor portion; C: Facial reconstruction with six-hole mini plates",cureus-0012-00000007447-i05,NotMatch,NotMatch
PMC7186106,Figure 6,Final aesthetic result,cureus-0012-00000007447-i06,NotMatch,NotMatch
PMC7186106,Figure 7,CD34-positive histopathology report,cureus-0012-00000007447-i07,NotMatch,NotMatch
PMC7270616,,,asm-3-227,Empty,Empty
PMC7270616,Figure 1.,"A: Coronal computerized tomography (CT) scan (post-contrast) showing right eye proptosis and displacement of the globe laterally with well-defined highly contrast-enhancing lesion in the extraconal space in the inferior nasal part of the orbit, measuring 4×2.5 cm, causing thinning of the medial wall of the orbit with focal central fat content (white arrow). B: Spindle-shaped cells with irregular vascular channels surrounded by partially cellular and partially hyalinized tissues with classic storiform pattern in the same patient. There was no evidence of pleomorphism, mitosis or necrosis (Original magnification ×100 hematoxylin & eosin). C: The diagnosis of solitary fibrous tumor was confirmed by expression of STAT6 by the proliferating cells (Original magnification ×400 STAT6).",0256-4947.2020.227-fig1,NotMatch,Match
PMC7270616,Figure 2.,A: Sagittal CT scan of the left orbit showing a round fairly well-defined mildly enhancing soft tissue density mass lesion measuring 2.66×1.84 cm located mainly intraconally extending to the extraconal space. It was located above the left optic nerve displacing the globe inferiorly and causing thinning and slight erosion of the left superior orbital floor with no intracranial extension. B: Several dilated and staghorn-shaped blood vessels with surrounding cellular spindle cell stroma (Original magnification ×100 hematoxylin & eosin).,0256-4947.2020.227-fig2,NotMatch,Match
PMC7270616,Figure 3.,A: The clinical appearance of a slowly progressive painless medial canthal mass in the left orbit of a 53-year old male over 3 years presenting as a protruding soft mass in the subconjunctival area of the left eye supero-nasally. B & C: Coronal CT scan and axial MRI of the left orbit showing contrast-enhancing extraconal mass nasally at the medial rectus muscle insertion extending along the muscle sheath to the belly of the muscle (white arrow in the CT image). D & E: The solitary fibrous tumor in this case showing spindle-shaped cells and numerous giant cells (Original magnification ×200 in D and ×400 in E hematoxylin & eosin). F: The tumor spindle cells showed diffuse positive expression of Bcl-2 (Original magnification ×200).,0256-4947.2020.227-fig3,NotMatch,NotMatch
PMC7270616,Figure 4.,A: Axial CT scan of the right orbit with contrast showing a well-defined mildly enhanced soft tissue density mass. B: The spindle cells in the same case showing hemangiopericytoma areas with staghorn-shaped blood vessels (Original magnification ×200 hematoxylin & eosin). C: The cells diffusely express CD34 confirming the pseudoangiomatous pattern (original magnification ×200). D: The diffuse expression of CD99 by the proliferating cells (original magnification ×400).,0256-4947.2020.227-fig4,Match,NotMatch
PMC7270616,Figure 5.,Distribution of the histopathological types in 17 cases of orbital solitary fibrous tumors.,0256-4947.2020.227-fig5,NotMatch,NotMatch
PMC7313329,Figure 1.,"(A) Tumor cells in a sheet-like pattern, showing round to oval nuclei with eosinophilic cytoplasm and no obvious atypia or mitosis (hematoxylin and eosin 400×). (B) Tumor cells are strongly positive with smooth muscle actin immunostaining (400×).",10.1177_2324709620936159-fig1,NotMatch,NotMatch
PMC7313329,Figure 2.,"Lower magnification demonstrates a sheet-like pattern of monotonous round-avoid tumor cells (hematoxylin and eosin, 100×).",10.1177_2324709620936159-fig2,NotMatch,NotMatch
PMC7248296,Figure 1,"Distribution of enrolled patients. Left circle represents cases of radiologically diagnosed IHPCs; right circle represents cases of pathologically diagnosed IHPCs. Intersection (purple) of two circles represents 46 cases of enrolled IHPCs, which were correctly diagnosed by radiology; 137 cases of pathologically diagnosed meningiomas were radiologically misdiagnosed as IHPCs (blue); 109 cases of pathological diagnosed IHPCs were radiologically misdiagnosed as meningiomas (pink).",fonc-10-00534-g0001,NotMatch,NotMatch
PMC7248296,Figure 2,"ROC curves and robustness analysis results. ROC curves of the clinical model, the fusion radiomics signature, and the HMDT in the training cohort were shown in (A), and the ROC curves of the three models in the validation cohort were shown in (E). Robustness analysis for the clinical model, the fusion radiomics signature, and the HMDT in the training cohort were shown in (B–D), respectively. For the validation cohort, robustness analysis for the three models were shown in (F–H), respectively.",fonc-10-00534-g0002,NotMatch,NotMatch
PMC7248296,Figure 3,"Nomogram, calibration curve, and decision analysis curve. The nomogram that showed a linear presentation of the HMDT was shown in (A). The calibration curves in training and validation cohorts were shown in (B,C), respectively. Decision analysis curves in the training and validation cohorts were shown in (D,E). The y-axis represents the net benefit and the x-axis represents the threshold probability.",fonc-10-00534-g0003,NotMatch,NotMatch
PMC7248296,Figure 4,"Typical radiologically misdiagnosed cases. The four graphs in row were T2WI in axial view, CE-T1WI in axial and coronal view, and pathological image, respectively. Lesions in Cases (A,B) were supratentorial, posterior, and close to midline in location with internal serpentine signal voids, and absence of peritumoral edema on T2WI; irregular shape, unclear margin, and absence of the dural tail sign on CE-T1WI. Enhancement in Case (A) was heterogeneous, while in Case (B), it was homogeneous. Lesions in Cases (C,D) were supratentorial and lateral in location with extensive peritumoral edema on T2WI; homogeneous enhancement, regular shape, and clear margin on CE-T1WI. Lesion in Case (C) grew in the lateral ventricle without apparent blood supply. Lesion in Case (D) located in the frontal, presenting with internal serpentine signal voids and clear dural tail sign. Actually, Cases (A,D) were pathologically confirmed meningiomas; Cases (B,C) were pathologically confirmed IHPCs.",fonc-10-00534-g0004,NotMatch,NotMatch
PMC7595850,Fig. 1,Preoperative (A and B) and postoperative (C) CT images obtained from another hospital. Preoperative images show huge intracerebral hemorrhaging (ICH) in the right medical temporal region with intraventricular hemorrhaging in all ventricles (A and B). The postoperative image shows insertion of catheters into the region affected by ICH and the ventricle through two burr holes (C).,btrt-8-113-g001,NotMatch,NotMatch
PMC7595850,Fig. 2,Preoperative (A and B) and postoperative (C) CT images obtained from our hospital. Images show a large area of acute intracerebral hemorrhaging (ICH) in the right medial temporal lobe with intraventricular hemorrhaging (A and B) and the insertion of two catheters in to the region affected by ICH (C).,btrt-8-113-g002,NotMatch,NotMatch
PMC7595850,Fig. 3,Brain CT images obtained three days (A) and five days (B) after burr-hole drainages at our hospital. Images show slightly increased hematoma causing a severe mass effect.,btrt-8-113-g003,NotMatch,NotMatch
PMC7595850,Fig. 4,"Brain CT angiographies performed before the first burr-hole drainages (BHD) at another hospital (A) and the second BHD at our hospital (B). Images show diffused blush in the right medial temporal lobe, suggesting tumor staining. A brain CT scan from the Department of Rehabilitation Medicine (C) also shows a solid mass lesion in the right medial temporal lobe.",btrt-8-113-g004,NotMatch,NotMatch
PMC7595850,Fig. 5,"Brain MRI shows a large, 75×62×57 mm acute hemorrhagic brain tumor in the right medial temporal lobe with heterogeneous diffuse enhancement (A). Perfusion MRI shows increased relative cerebral blood volume in the right medial temporal lobe (B).",btrt-8-113-g005,NotMatch,NotMatch
PMC7595850,Fig. 6,"Microscopic examinations of the tumor show perivascular cell proliferation, hypercelluar sheets of monomorphous epithelioid cells, intratumoral staghorn vessels, pericellular reticulin staining, moderate nuclear atypia and cellularity, and extensive hemorrhaging (H&E; A: ×100, B: ×200, C: ×40, D: ×40). Immunohistochemical findings show negative for CD34, CD99, and vimentin (E: ×400, F: ×100, G: ×100) and pericellular reticulin staining (H: ×400).",btrt-8-113-g006,NotMatch,Match
PMC7402742,Figure 1,"Pre-operative non-contrast computed tomography (CT) of the patient, axial view. (A) Pre-operative cranial magnetic resonance imaging, T1-weighted gadolinium contrast. Axial (B) and coronal (C) views of the bilateral frontal lesions.",medi-99-e21605-g002,NotMatch,NotMatch
PMC7402742,Figure 2,"Computed tomography during arterial portography. (A) A hypervascular tumour with area of necrosis in both liver lobes, measuring 3.76 × 2.51 cm at the largest dimensions. (B) Pre-operative hepatic magnetic resonance imaging, T1-weighted gadolinium contrast.",medi-99-e21605-g003,NotMatch,NotMatch
PMC7402742,Figure 3,"Cells are arranged around thin-walled vascular spaces, with a staghorn appearance, [hematoxylin and eosin (H and E stain, original magnification ×200] (A and B), confirming the hypervascularity and non-epithelial origin of the neoplasms, which exhibited a mild nuclear pleomorphism, low mitotic rate (<5 mitoses/10 HPF), and few areas of necrosis. Immunohistochemical analysis was positive for CD34 (C) and vimentin (D), but negative for epithelial membrane antigen (E) and glial fibrillary acidic protein (GFAP) (F). H&E = hematoxylin and eosin.",medi-99-e21605-g004,NotMatch,Match
PMC7402742,Figure 4,"Photomicrographs of the recurrent tumour in the bilateral frontal region. (A) The tumour consisted of cells with oval nuclei arranged in a turbulent pattern surrounding slit-like ‘staghorn’ vascular channels (H and E stain, original magnification ×200.) (B) Immunohistochemical examination revealing positive staining for D34 via sporadic patterns in tumour cells. Immunohistochemical analysis was partly positive for vimentin (C) and negative for glial fibrillary acidic protein (GFAP) (D). H and E = hematoxylin and eosin.",medi-99-e21605-g005,NotMatch,NotMatch
PMC7402742,Figure 5,(A) Photomicrographs of the recurrent brain tumour in the frontal region at 6 years before. Densely packed elongated or polygonal neoplastic cells are arranged around branching staghorn-like vasculatures (H and E staining) from the brain original tumour 6 years ago. (B) Ki-67 mitotic index showing a median value of 10%. H and E = hematoxylin and eosin.,medi-99-e21605-g006,NotMatch,NotMatch
PMC7333553,Figure 1,Ultrasound examination of the occipital region shows a heterogeneously hypoechoic mass measuring up to 6 cm.,jbsr-104-1-2099-g1,NotMatch,NotMatch
PMC7333553,Figure 2,Axial CT reformat (bone window) depicts an extensive osteolysis centrally in the occipital bone with an outward bulging soft tissue mass.,jbsr-104-1-2099-g2,NotMatch,NotMatch
PMC7333553,Figure 3,Axial TSE T2-WI shows a heterogeneously iso- to hyperintense lesion centered around the occipital bone. Note the discrete vascular flow voids (arrowheads). Brain edema was absent.,jbsr-104-1-2099-g3,NotMatch,NotMatch
PMC7333553,Figure 4,Sagittal T1-WI after injection of gadolinium contrast depicts a vividly enhancing mass with sharply delineated borders.,jbsr-104-1-2099-g4,NotMatch,NotMatch
PMC7427980,Fig. 1,"Histological examination of a 75-year-old female patient with PHA. H&E-stained images demonstrate that the tumor cells are pleomorphic overlying along the blood sinuses (× 200) (a,b); immunohistochemistry demonstrates that the cells are positive for CD31 (c), CD34 (d), ERG (e), FaVIII (f) FLI-1 (g) and vimentin (h) (× 100)",40644_2020_336_Fig1_HTML,NotMatch,Match
PMC7427980,Fig. 2,"Histological examination with H&E-stained images of EHE demonstrates vascular differentiated dendritic cells and epithelioid cells of the intracellular vascular lumen (× 200) (a), MHP exhibits vascular epidermal cells radiating around the capillary outer membrane (× 200) (b), and IHE shows papillary hyperplasia in vascular endothelial cells (× 200) (c), (× 400) (d); immunohistochemistry demonstrates that the cells of MHP were positive for HMB45 (e), Melan-A (f), CD31 (g) and CD34 (h) (× 100)",40644_2020_336_Fig2_HTML,NotMatch,Match
PMC7427980,Fig. 3,"Typical cases of PHA. A 75-year-old female patient with PHA. The unenhanced CT image shows an irregular, ill-defined hypoattenuated hepatic mass (a), marginal patchy enhancement on the arterial phase (b), and progressive, gradual filling enhancement on the portal venous phase (c). A 43-year-old male patient with PHA. The MR images show hypo/hyperintense diffuse lesions on T1WI (d), hyperintense signals on T2WI (E), hypo/hyperintense signals on DWI (f) and the apparent diffusion coefficient (ADC) map (g), marginal patchy enhancement on the arterial phase (h), and progressive, gradual filling enhancement on the portal venous phase (i) and delayed phase (j)",40644_2020_336_Fig3_HTML,NotMatch,NotMatch
PMC7427980,Fig. 4,"A 52-year-old woman with EHE. The nonenhanced CT scan (a) reveals multiple ill-defined homogeneous hypoattenuated lesions. The lesions demonstrate marginal enhancement in the arterial phase (b) and heterogeneous progressive centripetal enhancement in the portal vein (c). The MRI scan (d, T1WI in-phase; e, fat-suppressed T2WI; f, DWI; g, ADC map) shows hypointensity on T1WI, hyperintensity on T2WI and high signal intensity on DWI and the ADC map. The enhancement pattern on dynamic contrast-enhanced MRI (h, arterial phase; i, portal venous phase; j, delayed phase) corresponds with that on CT. The lesion presents with the halo sign (black arrow) and lollipop sign (white arrow)",40644_2020_336_Fig4_HTML,NotMatch,NotMatch
PMC7427980,Fig. 5,"Typical cases of MHP. A 31-year-old male patient. The unenhanced CT image shows multiple hypodense hepatic lesions and spleen metastasis with ill-defined margins (a), heterogeneous marginal enhancement on the arterial phase (b), and progressive centripetal enhancement without full filling on the portal venous phase (c). A 55-year-old female patient with PHA. The MR images show hypointense lesions at the right hepatic lobe on T1WI (d), hyperintensity on T2WI (e), hyperintensity on DWI (F), hypointensity on the ADC map (g), slightly marginal enhancement on the arterial phase (H), patchy filling enhancement on the portal venous phase (i) and progressive, gradual filling enhancement on the delayed phase (j)",40644_2020_336_Fig5_HTML,NotMatch,NotMatch
PMC7427980,Fig. 6,"Typical cases of IHE. A 2-month-old female patient with IHE. The enhanced CT images display multiple hepatic lesions with markedly heterogeneous enhancement (a), gradually filling from the periphery to the center (b). A 2-month-old male patient with IHE. The enhanced CT images show a very large hepatic lesion with markedly marginal enhancement with nourishing blood vessels (c), gradually filling from the periphery to the center (d). A 7-month-old female patient with IHE. The MR images show hypointense lesions in the right hepatic lobe on T1WI (e), hyperintensity on T2WI (f), and hyperintensities on DWI (g) and the ADC map (h)",40644_2020_336_Fig6_HTML,NotMatch,NotMatch
PMC7452349,Fig 1,A 5-cm large subcutaneous nodule on the mid scalp.,gr1,NotMatch,NotMatch
PMC7452349,Fig 2,"Telangiectatic thin-walled “staghorn” blood vessels in a hypercellular patternless spindle and epithelioid blue cell tumor, Hematoxylin and eosin stain. (Original magnification: ×200.)",gr2,NotMatch,NotMatch
PMC7452349,Fig 3,"Patternless hypercellularity with variable nuclear pleomorphism and frequent mitoses including single atypical “ring” mitosis, Hematoxylin and eosin stain. (Original magnification: ×100.)",gr3,NotMatch,Match
PMC7451149,Figure 1:,"Magnetic resonance imaging brain (a) sagittal, (b) coronal demonstrating a sellar lesion with suprasellar extension exhibiting homogenous enhancement. Red arrows demonstrate a sellar lesion with suprasellar extension with homogenous enhancement.",SNI-11-238-g001,NotMatch,NotMatch
PMC7451149,Figure 2:,"On 3-month follow-up, magnetic resonance imaging (a) sagittal and (b) coronal sequences demonstrated progressive and enlarging lesion. Red arrows demonstrate the progressively enlarging lesion.",SNI-11-238-g002,NotMatch,NotMatch
PMC7451149,Figure 3:,"Magnetic resonance imaging brain imaging (a) sagittal and (b) postoperative imaging, as visualized in demonstrating gross total resection of the mass. Red arrows demonstrate removal of the previously enlarging lesion.",SNI-11-238-g003,NotMatch,NotMatch
PMC7451149,Figure 4:,"The histopathology obtained from the patient; (a-c) the hematoxylin and eosin staining demonstrating staghorn appearance with additional positivity for CD34 (d) and signal transducer and activator of transcription 6 (e), confirming solitary fibrous tumor/ hemangiopericytoma.",SNI-11-238-g004,Match,NotMatch
PMC7533099,Figure 1:,Selected computed tomography images of the spine. Axial (a) and sagittal (b) views demonstrate the left paraspinal soft-tissue mass (*) with an area of calcification that is extended from the level of T12/L1 down to the L4 level vertebra. Note the bone erosion changes in the lamina at the axial plane and the extension into the L1/L2 left neural foramina (arrows).,SNI-11-257-g001,NotMatch,NotMatch
PMC7533099,Figure 2:,Selected magnetic resonance images of the lumbosacral spine. Axial T1- and T2-weighted images at the L1/L2 level in the left neural foramina (a and b) demonstrate the left paraspinal soft- tissue mass causing erosion of the left side lamina and the spinous process of the L2 vertebra with extension through the neural foramina. No involvement of the cauda equina terminal nerve roots is noted. Axial and Sagittal T1 FS-weighted images (c and d) at the same level demonstrate soft-tissue mass enhancement.,SNI-11-257-g002,NotMatch,NotMatch
PMC7533099,Figure 3:,"Histopathological description. Malignant spindle cell proliferation, forming sheets of cells with a prominent staghorn (hemangiopericytoma) vascular pattern (a). The cells display plump spindles to ovoid monomorphic nuclei with open chromatin. Mitotic figures are noted (b). Tumor cells are diffusely positive for TLE 1 (c). CD34 and smooth muscle actin highlight the prominent vascular network (d).",SNI-11-257-g003,Match,NotMatch
PMC7481505,Fig. 1,"Noncontrast axial CT taken in June 2014 (A, B) and June 2020 (C, D) showing emergence of a hyperdense mass in the right frontal lobe (C and D, arrow).",gr1,NotMatch,NotMatch
PMC7481505,Fig. 2,"Axial T1- (A), T2- (B), and postcontrast axial (C) and coronal (D) T1- weighted MRI showing a well-demarcated, extra-axial tumor, 29 × 30 × 36 mm in dimension, appearing isointense on T1 and hyperintense on T2 (A and B, arrow). The tumor is intensely enhanced after infusion of contrast agent and protrudes superior, while lacking a dural tail sign (C and D, arrows). Inset in (D) shows erosive change in the inner table adjacent to the tumor (asterisk).",gr2,NotMatch,NotMatch
PMC7481505,Fig. 3,"(A, B) Right external carotid angiography, anteroposterior (A) and lateral (B) views, showing the tumor stain (A and B, asterisk) supplied by the middle meningeal artery (A and B, arrows). Note that a peripheral feeding vessel from the middle meningeal artery is displaced superior with the upper part of the tumor (A and B, arrowhead).",gr3,NotMatch,NotMatch
PMC7481505,Fig. 4,"(A, B) Cranial radiography after embolization, anteroposterior view (A), and magnified view of the boxed area (B) showing an embolized segment of the middle meningeal artery (B, arrowhead) and tumor vessels. Arrows in (B) indicate the upper part of the tumor protruding into the skull.",gr4,NotMatch,NotMatch
PMC7481505,Fig. 5,"(A) Intraoperative photos showing a punched-out bone erosion with round and smooth contour, 7 mm in dimension, in the inner table of the bone flap (arrows). Hyperostotic change is not noted. (B) An embolized middle meningeal artery segment (arrow) connecting to the exposed tumor (asterisk) passes through the margin of the dural defect over the upper part of the tumor. SS: sagittal suture.",gr5,NotMatch,NotMatch
PMC7481505,Fig. 6,"Microscopic appearance of the tumor comprising spindle-shaped cells accompanying branching vascular structures (arrow) and cell atypia (A). Immunohistochemical stains showing positive staining for CD34 (B) and STAT6 (C). Tumor invasion into the dura mater (arrows). (A) hematoxylin and eosin stain, × 200; B: CD34; C: STAT6, × 200; (D) hematoxylin and eosin stain, × 100.",gr6,NotMatch,NotMatch
PMC7580745,Figure 1,(a and b) Preoperative photograph showing huge elephant trunk appearance of the patient. (c and d) Postoperative photograph showing the disfigurement of the face due to repeated surgeries,CCD-11-83-g001,NotMatch,NotMatch
PMC7580745,Figure 2,(a) Alginate impression. (b) Stone cast model of the face. (c and d) Wax pattern of the prosthesis. (e) Wax pattern adapted to the defect. (f) Wax pattern retained by spectacles,CCD-11-83-g002,NotMatch,NotMatch
PMC7580745,Figure 3,Preprosthetic and postprosthetic pictures,CCD-11-83-g003,NotMatch,NotMatch
PMC7478567,Figure 1,Axial CT scan(a) pre-contrast axial image shows a large heterogeneous mass occupying the basifrontal region spanning across the midline. The mass is hyper-attenuated to the adjacent grey matter. (b) Post-contrast image shows avid enhancement of the mass with non-enhancing necrotic foci. (c) Bone window image shows erosion of the inner endplate of the left frontal bone.CT: computed tomography,cureus-0012-00000009584-i01,NotMatch,NotMatch
PMC7478567,Figure 2,"MRI(a) axial T2WI image shows the heterogeneous signal intensity of the mass, which is iso to mildly hypointense to the gray matter with cystic foci and multiple signal voids representing vessels. There is mild perilesional edema with significant mass effect and midline shift to the right. CSF cleft sign (red arrow) is seen denoting the extra-axial origin of the mass. (b) T1 post-contrast image shows an avid enhancement of the mass.MRI: magnetic resonance imaging; CSF: cerebrospinal fluid",cureus-0012-00000009584-i02,NotMatch,NotMatch
PMC7478567,Figure 3,"Hematoxylin & Eosin (H&E) stained section of hemangiopericytoma showing closely packed cells that have oval mildly pleomorphic vesicular nuclei, inconspicuous nucleoli, and eosinophilic cytoplasmNote the numerous gaping and occasionally branching blood vessels, some with a “Staghorn” appearance [x200].",cureus-0012-00000009584-i03,Match,Match
PMC7478567,Figure 4,Vimentin immunohistochemical stains are diffusely positive in tumor cells [x200],cureus-0012-00000009584-i04,NotMatch,Match
PMC7478567,Figure 5,BCL2 immunohistochemical stains are diffusely positive in tumor cells [x200],cureus-0012-00000009584-i05,NotMatch,Match
PMC7478567,Figure 6,CD34 immunohistochemical stains are focally positive in some tumor cells [x200],cureus-0012-00000009584-i06,NotMatch,Match
PMC7478567,Figure 7,CD99 immunohistochemical stains are focally positive in some tumor cells [x200],cureus-0012-00000009584-i07,NotMatch,Match
PMC7478567,Figure 8,CAM5.2 immunohistochemical stains are focally positive in some tumor cells [x200],cureus-0012-00000009584-i08,NotMatch,Match
PMC7478567,Figure 9,AE1/AE3 immunohistochemical stains are focally positive in some tumor cells [x200],cureus-0012-00000009584-i09,NotMatch,Match
PMC7478567,Figure 10,Postoperative MRI brainPost-contrast T1 fat saturation images in axial (a) and coronal (b) planes show edema at the surgical bed with no residual enhancing tumor.MRI: magnetic resonance imaging,cureus-0012-00000009584-i10,NotMatch,NotMatch
PMC7591181,Figure 1,"Clinical photograph (a) of the protuberant temporal mass distorting the left palpebral fissure. Contrast-enhanced computed tomography axial view (b) and coronal reformatted image (c) showing the large, heterogeneously enhancing calvarial mass. Postoperative appearance (d) at 6-month follow-up. Contrast-enhanced computed tomography axial view (e) and coronal reformatted image (f) showing enhancing residual extracranial component (black arrow) and postoperative cystic cavity (star) in the left temporal region and infratemporal fossa",AJNS-15-686-g001,NotMatch,NotMatch
PMC7591181,Figure 2,"(a) Microscopy showed a cellular tumor in diffuse sheet with interspersed staghorn-shaped blood vessel (H and E, ×100) (b) The individual cells showed spindle-shaped nuclei, nuclear grooving, and bland chromatin (H and E, ×400) (c) Interspersed were erythroid colonies (black arrow) and megakaryocytes (blue arrow) (H and E, ×100) (d-f) Positive immunohistochemistry for CD99 (membranocytoplasmic, ×200, d), CD34 (membranous, ×200, e), and STAT6 (nuclear, ×400, f)",AJNS-15-686-g002,NotMatch,Match
PMC7605615,Figure 1,"MRI of the patient with intracranial SFT/HPC. (A) MRI scan revealing tumors uneven enhancement, with large zones of edema around the tumors. (B and C) Postoperative residual tumor (B) with a significantly reduced signal after 2 months of radiotherapy (C).",IJGM-13-963-g0001,NotMatch,NotMatch
PMC7605615,Figure 2,"Hematoxylin and eosin staining of the SFT/HPC specimen. (A) An abundance of blood vessels was observed in tumor tissue, with an typical “staghorn” vascularization and a large number of fusiform tumor cells arranged in bundles between blood vessels. Magnification: 100×; scale bar: 100 μm. (B) Mitotic bodies were clearly visible (black arrow; ≥5 mitoses per 10 high-power fields). Magnification: 400×; scale bar: 100 μm.",IJGM-13-963-g0002,NotMatch,NotMatch
PMC7605615,Figure 3,"Immunohistochemical analysis of the SFT/HPC specimen. (A–C) with immunopositivity for CD34 (A), STAT6 (B), and BCL-2 (C). Magnification: 400×; scale bar: 100 μm.",IJGM-13-963-g0003,NotMatch,NotMatch
PMC7656086,Figure 1.,"(A) Contrast-enhanced axial computed tomography shows a heterogeneously enhancing infiltrative lumbosacral mass showing irregularly shaped borders, regions of central hypoattenuation, and lack of calcified components. The mass is filling and expanding the spinal canal extending to the retroperitoneum via the bilateral neural foramina, with encasement of the inferior mesenteric artery. (B) Encasement of the bilateral common and proximal external iliac arteries is also noted. (C) Encasement of the infrarenal abdominal aorta is better appreciated at this more cranial level. The distal ureters were also encased by the mass (not shown).",amjcaserep-21-e923176-g001,NotMatch,NotMatch
PMC7656086,Figure 2.,"(A) Sagittal T2-weighted sequence shows a heterogeneously hyperintense mass with multifocal internal hypointensities filling the entire spinal canal of the lumbar and upper sacral region. At its superior aspect, the mass abuts and superiorly displaces the conus medullaris. The cauda equina nerve roots are not identified and in view that this mass completely fills the lumbosacral spinal canal, are likely compressed or involved. There is subsequent spinal canal expansion with areas of scalloping. (B, C) Sagittal T2-weighted sequences demonstrate that the mass extends bilaterally through expanded lumbosacral neural foramina to the prevertebral/perivertebral and presacral regions with subsequent displacement of presacral vessels and bilateral psoas muscles. (D) Coronal T2-weighted sequence shows bilateral retroperitoneal involvement extending just inferior to the inferior poles of the bilateral kidneys. (E, F) Sagittal T1-weighted postcontrast fat-sat sequences also show that the mass has a heterogeneous enhancement pattern, which also involves various posterior vertebral bodies at the inferior lumbosacral region, as evidenced by contiguous vertebral body enhancement.",amjcaserep-21-e923176-g002,NotMatch,NotMatch
PMC7656086,Figure 3.,"Posterior and anterior whole-body metaiodobenzylguanidine (MIBG) scintigraphy was performed using 370 MBq of iodine-123. Multiple spot images of the entire body were collected 24 h after radionuclide administration, showing normal physiologic MIBG uptake in brown fat, nasal mucosa, and salivary glands, heart, liver, and bowel, with excretion activity in the bladder.",amjcaserep-21-e923176-g003,NotMatch,NotMatch
PMC7656086,Figure 4.,"The tumor is composed of monotonous sheets of spindle cells with abundant dilated “staghorn” vessels (hematoxylin and eosin, ×100).",amjcaserep-21-e923176-g004,NotMatch,Match
PMC7656086,Figure 5.,"Higher magnification showed monotonous spindle cells with minimal cytologic atypia and no mitosis (hematoxylin and eosin, ×400).",amjcaserep-21-e923176-g005,NotMatch,NotMatch
PMC7657444,Figure 1,"Non-contrast CT headAxial non-contrast CT head images along the superior (a), mid (b), and inferior (c) portions of the mass followed by sagittal (d) and coronal (e) reconstructions. There is a hyperdense mass, which is seen extending from the extra-axial space near the torcula along the posterior falx. There is mild surrounding vasogenic edema in the right occipital lobe. The mass exhibits a heterogeneous appearance with a relatively more dense component seen closer to its base with suspected dural venous sinus involvement (arrowhead)CT: computed tomography",cureus-0012-00000010926-i01,NotMatch,NotMatch
PMC7657444,Figure 2,"CT venogramPost-contrast CT venogram images along the middle (a) and inferior (b) portion of the mass, as well as coronal reconstruction (c). Tumoral invasion (arrowhead) is seen within the straight sinus, most posterior aspect of the superior sagittal sinus, torcula, and proximal right transverse sinus. The remaining portions of the transverse sinuses appear well opacifiedCT: computed tomography",cureus-0012-00000010926-i02,NotMatch,NotMatch
PMC7657444,Figure 3,"MRI BrainT1-weighted pre-contrast images along the superior (a) and inferior (b) aspects of the mass demonstrate mostly internal isointense signal though the main, somewhat pedunculated component exhibits a slightly T1-weighted hypointense signal relative to the base. Diffusion (c) and ADC (d) demonstrate restricted diffusion involving the main, rounded component. T1-weighted post-contrast images along the superior (e) and inferior (f) aspects of the mass demonstrate avid enhancement, though more homogenous enhancement is seen along the superior rounded component that restricts diffusion. The T2-weighted fat-saturated image demonstrates a hypointense signal along the base of the mass with a mildly hyperintense signal along the superior, rounded component. SWI sequence demonstrates areas of susceptibility artifact (arrowhead) along the base of the mass possibly related to blood productsMRI: magnetic resonance imaging; ADC: apparent diffusion coefficient; SWI: susceptibility-weighted imaging",cureus-0012-00000010926-i03,NotMatch,NotMatch
PMC7657444,Figure 4,"Postoperative MRIPostoperative T1-weighted post-contrast MP-RAGE images along the super (a), mid (b), and inferior (c) aspects of the resection cavity. The majority of the resection cavity exhibits thin peripheral post-contrast enhancement, likely post-surgical in nature. However, along the inferior aspect of the resection cavity, where the tumor was previously seen to involve the straight sinus, and torcula, there is a residual thickened enhancement (arrowhead) concerning for residual tumor, corresponding to an unresected tumor on the operative reportMRI: magnetic resonance imaging; MP-RAGE: magnetization-prepared rapid gradient-echo",cureus-0012-00000010926-i04,NotMatch,NotMatch
PMC7655240,Figure 1,"(a, b) Incidence of hemangiopericytoma (a) and hemangioendothelioma (b). Rates per 100,000 individuals are provided, and patient ages are adjusted as per the 2000 US Standard Population standard.",BMRI2020-2468320.001,Match,NotMatch
PMC7655240,Figure 2,"(a, b) Overall survival (a) and cancer-specific survival (b) of hemangiopericytoma and hemangioendothelioma patients. P values < 0.05 were considered statistically significant.",BMRI2020-2468320.002,Match,NotMatch
PMC7655240,Figure 3,"Outcomes of different treatments in hemangiopericytoma patients. OS (a–c) and CSS (d–f) of hemangiopericytoma patients treated with surgery vs. no surgery (a, d), radiotherapy vs. no radiotherapy (b, e), and chemotherapy vs. no chemotherapy (c, f). OS: overall survival; CSS: cancer-specific survival. P values < 0.05 were considered statistically significant.",BMRI2020-2468320.003,Match,NotMatch
PMC7655240,Figure 4,"Outcomes of different monotherapies and combination therapies in hemangiopericytoma patients. OS and CSS of patients treated with surgery, radiotherapy, and surgery plus radiotherapy (a, b); surgery, chemotherapy, and surgery plus chemotherapy (c, d); radiotherapy, chemotherapy, and radiotherapy plus chemotherapy (e, f). OS: overall survival; CSS: cancer-specific survival. P values < 0.05 were considered statistically significant.",BMRI2020-2468320.004,Match,NotMatch
PMC7690832,Figure 1,Diagnostic classification of rare primary malignant bone sarcoma. URCTs: undifferentiated round cells tumors; SFT: solitary fibrous tumor.,cancers-12-03092-g001,NotMatch,NotMatch
PMC7690832,Figure 2,"Histopathologic presentation of six cases of rare primary malignant bone sarcomas (A) spindle cell sarcoma of bone: tumor cells are typically organized in a fascicular or herringbone pattern; (B) angiosarcoma of bone: tumor is composed of a markedly atypical, predominantly solid epithelioid cell proliferation, featuring abundant eosinophilic cytoplasm, often harboring macronucleolated vescicular nuclei; (C–E) round cell sarcomas; (C) CIC-DUX4; (D) undifferentiated round cells sarcoma; (E) BCOR-CCNB3; (F) solitary fibrous tumor of bone with a classic hemangiopericytomatous pattern. (100× of magnification; haematoxylin and eosin staining).",cancers-12-03092-g002,Match,Match
PMC7725548,Figure 1,(a) Contrasted T1WI. (b) Contrasted T1WI image generated by ITK-SNAP software to depict the ROI of the tumor. (c) 3D ROI image of the tumor (red area) that is calculated to superimpose at all levels in the contrasted T1WI map. (d) A three-dimensional image of the tumor.,BMRI2020-5042356.001,NotMatch,NotMatch
PMC7725548,Figure 2,A total of 396 texture parameters extracted by AK software.,BMRI2020-5042356.002,NotMatch,NotMatch
PMC7725548,Figure 3,T1WI texture feature model for identification of HPC and AM performance.,BMRI2020-5042356.003,NotMatch,NotMatch
PMC7725548,Figure 4,T2WI texture feature model for identification of HPC and AM performance.,BMRI2020-5042356.004,NotMatch,NotMatch
PMC7725548,Figure 5,Contrasted T1WI texture feature model for identification of HPC and AM performance.,BMRI2020-5042356.005,NotMatch,NotMatch
PMC7725548,Figure 6,Total sequences combine the texture feature model for identification of HPC and AM performance.,BMRI2020-5042356.006,NotMatch,NotMatch
PMC8099806,Fig. 1,CT scan showing the large tumor in the left lung of patient 1,428_2020_2972_Fig1_HTML,NotMatch,NotMatch
PMC8099806,Fig. 2,"Case 1: a Overview with two nodules and diffuse dark-stained precursor lesion. H&E, bar 1 mm; b and c medium and high magnification of the proliferation in the nodules. Note the spindle cells with small clear cytoplasm and their intimate association with blood vessels. H&E, bars 0.1 mm and 50 μm. d High magnification of the diffuse lesion. The lesion is composed of spindle cells with small clear cytoplasm closely associated with small blood vessels. H&E, bar 20 μm. e Overview of the myopericytoma. The tumor cells are associated with thin-walled blood vessels and are spindle shaped. H&E, bar 0.5 mm. f High magnification of the tumor cells. There are more epithelioid clear cells, some of them positive for HMB45, some giant cells with large nuclei, and also cells with myofilaments. H&E, × 400",428_2020_2972_Fig2_HTML,NotMatch,Match
PMC8099806,Fig. 3,"Case 2: a and b show an overview of two of the multifocal lesions. H&E, × 50. In c, d, and e, higher magnification from several of these lesions is shown. Note the epithelioid cells, resembling diffuse neuroendocrine hyperplasia or also multiple nodular pneumocyte hyperplasia. In c and e, the differentiation into smooth muscle cells is suggested. H&E, × 200",428_2020_2972_Fig3_HTML,NotMatch,Match
PMC8099806,Fig. 4,"Immunohistochemistry for both cases: a and b CD31 showing the vascular network in one nodule (a) and the diffuse infiltration (b) of case 1, bar 50 μm; c CD31 expression in case 2, × 200. d Expression of vimentin in one of the lesions of case 2, × 200. Expression of VEGFR3 (e) in case 1 and VEGFR2 (f) in case 2. In VEGFR3, an antibody was used which detects the C-terminal end of the receptor; the nuclear reaction might be interpreted that the kinase domain is translocated into the nucleus, whereas the expression of VEGFR2 is membranous. Bar 50 μm and × 200. g Expression of SMA in the tumor of case 1 and in the proliferation of case 2 (h). Bar 20 μm and × 200. i Negative staining for cathepsin K and positive expression of PDGFRB (j), both in case 2. Bars 100 μm",428_2020_2972_Fig4_HTML,NotMatch,NotMatch
PMC7749949,Figure 1:,"Preoperative brain MRI of case 2. Axial T1-weighted image (a) and axial T2-weighted image (b) showing a large tumor in the right side frontotemporal region, abutting the sphenoid ridge and right cavernous sinus, extension to the right basal ganglion and right side periventricular region with relative isosignal intensity on T1WI and T2WI. Axial T1-weighted image postgadolinium enhancement (c) showing good enhancement. MRA (d) partial encasement of the right middle cerebral artery and right supraclinoid internal carotid artery (black arrows).",SNI-11-414-g001,NotMatch,NotMatch
PMC7749949,Figure 2:,"Preoperative brain MRI of case 3. Coronal axial T2-weighted image (a) and coronal T1-weighted image (b) showing a large tumor in right fronto-occipital-parietal region, abutting the posterior cerebral falx and right-sided tentorium and invading right occipital bone, isointense with cortical gray matter on T1-weighted image but hyperintense on T2-weighted image. Coronal T1-weighted image postgadolinium enhancement (c) showing heterogeneous enhancement.",SNI-11-414-g002,NotMatch,NotMatch
PMC7749949,Figure 3:,"Preoperative brain MRI of case 7. Axial T1-weighted image (a) and axial T2-weighted image (b) showing a large extra-axial well-circumscribed mass lesion in the right frontal-temporal convexity, abutting the skull bone, isointense with cortical gray matter on both T1-weighted and T2-weighted image. Axial T1-weighted image postgadolinium enhancement (c) showing good enhancement. MRA (d) showing a small aneurysm in bifurcation of the right middle cerebral artery (black arrow).",SNI-11-414-g003,NotMatch,NotMatch
PMC8183349,Figure 1.,"(A) Clinically, a nodular mass (arrow), firm in consistency is evident in the left orbital region; (B) MR imaging showing a solid mass with well circumscribed borders, exhibiting a mild hypointense T2 signal (arrow).",pathol-2020-04-195-g001,NotMatch,NotMatch
PMC8183349,Figure 2.,"Histological examination. (A) Low magnification showing an uniformly hypercellular tumor with pushing borders, circumscribed by a fibrous pseudo-capsule (H&E staining; 50x magnification). (B) Higher magnification showing moderately eosinophilic bland-looking spindle cells arranged in intersecting short fascicles with interspersed stellate-shaped, keloid-type collagen fibers (H&E staining; 100x magnification); (C,D) Neoplastic cells are positively stained with CD34 (C) and STAT-6 (D) (immunoperoxidase staining; 100x magnification).",pathol-2020-04-195-g002,NotMatch,Match
PMC7772210,Figure 1,"(A,B) The tumor presented isosignals on T1WI and T2WI. (C,E) The mass showed uniform enhancement after contrast agent injection. (D,F) Post-operative review by thoracic MRI showed that all tumors had been removed.",fsurg-07-600563-g0001,NotMatch,NotMatch
PMC7772210,Figure 2,"(A) At low magnification, the tumor tissue is rich in cells showing a rounded oval to spindle-like shape, and the intercellular stroma is rich in “antler-like” parenchyma branching vessels (HE × 100). (B) Mitotic image is not easy to be seen in high magnification (HE × 400 mm).",fsurg-07-600563-g0002,NotMatch,Match
PMC7772210,Figure 3,Both CD34 (A) and Vimentin (B) were positive by immunohistochemical staining. The Ki-67 index was ~20% (C).,fsurg-07-600563-g0003,NotMatch,NotMatch
PMC7772210,Figure 4,Kaplan-Meier survival curves showing the WHO grade (A) and tumor resection range (B) significantly affected the RFS.,fsurg-07-600563-g0004,NotMatch,NotMatch
PMC7750755,Figure 1.,Prominent staghorn blood vessels.,10.1177_2050313X20981177-fig1,NotMatch,NotMatch
PMC7750755,Figure 2.,"Tumor cells positive for (a) TTF1, (b) synaptophysin, and (c) chromogranin and (d) Ki67
proliferative index was approximately 80%.",10.1177_2050313X20981177-fig2,NotMatch,NotMatch
PMC7772862,Fig. 1,"H&E-stained histologic sections of the sinonasal tumor revealed a proliferation of fairly monomorphic round cells with lightly eosinophilic cytoplasm and ill-defined cell borders in a background of prominent branching, thin-walled blood vessels (A). By immunohistochemistry, the neoplastic cells diffusely express CD99 (B), PAX7 (C), and ERG (D). There is no expression of cytokeratin 5/6 (E). Fluorescence in situ hybridization studies using break-apart probes showed FUS gene rearrangement (F).",cro-0013-1393-g01,NotMatch,Match
PMC7772765,Figure 1.,"A) 5X Microscopic image (H&E stains): Well-circumscribed dermal lesion with scattered vessels and nerves at the periphery, B) 10X Microscopic images (H&E stains): Lesion reveals a compact whorled lobulated growth pattern with a minor capillary-sized vascular background, C and D) 40X Microscopic images (H&E stains): Tumor cells have abundant eosinophilic cytoplasm with bland-looking round, ovoid, focally spindled nuclei with focal nuclear inclusions. No mitosis or necrosis was seen.",dr-12-3-8994-g001,NotMatch,Match
PMC7772765,Figure 2.,"The tumor is diffusely positive for CD34 and h-caldesmon, faintly positive for SMA and ER, and negative for Desmin and S100; Ki67 is very low (1%); CD31 and Factor VIII highlight the vascular background.",dr-12-3-8994-g002,NotMatch,NotMatch
PMC7817527,Fig. 1,T1- and T2-weighted brain MRI scans show a voluminous extra-axial mass in the right tentorial and supratentorial spaces.,gr1,NotMatch,NotMatch
PMC7817527,Fig. 2,"Haematoxylin and eosin (H&E) staining (original magnification 20×) reveals a highly cellular tumour with a typical “staghorn” vascular channel and the proliferation of oval- to spindle-shaped cells around the vessels, revealing brisk mitotic activity (A). Neoplastic cells are immunoreactive for STAT6(original magnification 20×) (B). Neoplastic cells are diffusely immunoreactive for CD34 (original magnification 20×) (C). Neoplastic cells are diffusely immunoreactive for vimentin (original magnification 20×) (D). EMA negativity in tumour cells (E). T S-100 negativity in tumour cells (F).",gr2,NotMatch,Match
PMC7817527,Fig. 3,Postoperative PET-CT scan demonstrates gross total resection of the haemangiopericytoma in the right cerebellar hemisphere.,gr3,NotMatch,NotMatch
PMC7914433,Figure 1,Shows a solitary fibrous tumor (SFT) as a subepithelial lesion in the labial mucosa. Note that it can’t be clinically distinguished from numerous other subepithelial oral lesions.,medicina-57-00152-g001,NotMatch,NotMatch
PMC7914433,Figure 2,Shows a macroscopic view of the lesion after excision. Note the well-defined mass with a firm and rubbery consistency.,medicina-57-00152-g002,NotMatch,NotMatch
PMC7914433,Figure 3,"Low magnification showing a cellular spindle cell tumor with a “patternless pattern”. Irregular branching vessels are visible. (hematoxylin and eosin (H&E) stained, original magnification ×40).",medicina-57-00152-g003,NotMatch,Match
PMC7914433,Figure 4,"At a higher magnification the tumor cells are spindle-shaped, monomorphic, and bland-looking (H&E stained, original magnification ×200).",medicina-57-00152-g004,NotMatch,Match
PMC7914433,Figure 5,Immunohistochemical staining for CD34 shows intense and diffuse staining of most of the tumor cells.,medicina-57-00152-g005,NotMatch,NotMatch
PMC7914433,Figure 6,"CD31 stains only the endothelial cells in the vessels, but it is negative in the remaining tumor cells. The particular branching vascular pattern is demonstrated in this area.",medicina-57-00152-g006,NotMatch,NotMatch
PMC7914433,Figure 7,"STAT6 stains strongly and diffusely the nuclei of the tumor cells, a pathognomonic finding in SFT.",medicina-57-00152-g007,NotMatch,NotMatch
PMC9972268,Figure 1.,"Representative sagittal MRI findings of patient with intraspinal SFT/HPC,
schwannoma, and meningioma. SFT/HPC exhibited isointensity on both T1-
(A) and T2-weighted images (B). T1-weighted MRI after injection of
Gd-DTPA revealed an uniformizing enhancement pattern, the lack of the
dural tail sign, and irregularities in tumor margins (C). By contrast,
schwannoma showed low intensity on T1- (D), isointensity on T2-weighted
images (E), and heterogenous Gd-DTPA enhancement pattern (F). Meningioma
showed isointensity on both T1- (G) and T2-weighted images (H),
uniformizing enhancement pattern and dural tail sign (I). Edges of tumor
were well defined in both schwannoma and meningioma. Abbreviations:
SFT/HPC, solitary fibrous tumor/hemangiopericytoma; T1WI, T1-weighted
image; T2WI, T2-weighted image; Gd-DTPA, gadolinium diethylenetriamine
pentaacetic acid.",10.1177_2192568221994799-fig1,Match,NotMatch
PMC9972268,Figure 2.,"Representative histopathological findings for patients with spinal
SFT/HPC. SFT/HPC showed irregular arrangement and “patternless pattern”
of spindle-like cells on Hematoxylin-eosin staining (A). An
immunohistochemical examination exhibited that SFT/HPC was positive for
STAT6 (B) and CD34 (C). Meanwhile, S-100, which is positive in
schwannoma (D), and EMA, which is positive in 50-100% of meningioma (E),
are both negative in SFT/HPC. Abbreviations: SFT/HPC, solitary fibrous
tumor/hemangiopericytoma; EMA, epithelial membrane antigen.",10.1177_2192568221994799-fig2,Match,NotMatch
PMC7719452,Fig. 1, Case 1Fig. 1A: Magnetic resonance imaging (MRI) of brain tumor at tentorium cerebelli.Fig. 1B and 1C: Computed tomography (CT) of lung metastases.Fig. 1D and 1E: CT of pancreatic metastases.,2186-3326-82-0631-g001,NotMatch,NotMatch
PMC7719452,Fig. 2, Histopathology of Case 1.Fig. 2A: Growth of swollen spindle cells with necrosis and mitosis.Fig. 2B: Partial CD34 positivity is observed.Fig. 2C: The Ki-67 index is 20%.Fig. 2D: Strong nuclear staining with anti-STAT6 antibody can be observed.,2186-3326-82-0631-g002,NotMatch,NotMatch
PMC7719452,Fig. 3, Case 2Fig. 3A: MRI of brain tumor at the right occipital lobe.Fig. 3B: CT of metastasis at the right ilium.Fig. 3C: CT of metastasis at the seventh thoracic vertebra.,2186-3326-82-0631-g003,NotMatch,NotMatch
PMC7719452,Fig. 4, Histopathology of Case 2.Fig. 4A: Dense growth of spindle-shaped cells with a round nuclear shape.Fig. 4B: Slight CD34 positivity can be observed.Fig. 4C: The Ki-67 index is 15%.Fig. 4D: Strong nuclear staining with anti-STAT6 antibody can be observed.,2186-3326-82-0631-g004,NotMatch,NotMatch
PMC7719452,Fig. 5, Case 3Fig. 5A: Liver metastases before hepatectomy.Fig. 5B: Recurrence of brain tumor contact to the falx cerebri and the tentorium cerebelli.Fig. 5C: Recurrence of liver metastasis.Fig. 5D: Lung metastases.,2186-3326-82-0631-g005,NotMatch,NotMatch
PMC7719452,Fig. 6, Histopathology of Case 3.Fig. 6A: Growth of spindle-shaped cells with oval nuclei.Fig. 6B: CD34 positivity can be observed.Fig. 6C:The Ki-67 index is 3–4%.Fig. 6D: Strong nuclear staining with anti-STAT6 antibody can be observed.,2186-3326-82-0631-g006,NotMatch,NotMatch
PMC7719452,Fig. 7, Case 4Fig. 7A: Left intrathoracic tumor before surgery.Fig. 7B and 7C: Paratracheal lymph node metastases before (B) and after (C) TMZ+Bev.Fig. 7D: Splenic metastasis before TMZ+BevFig. 7E: Liver metastases before TMZ+BevFig. 7F: Liver metastases progressed 16 months after the initiation of TMZ+Bev.,2186-3326-82-0631-g007,NotMatch,NotMatch
PMC7719452,Fig. 8, Histopathology of Case 4.Fig. 8A: Growth of spindle-shaped cells with oval nuclei.Fig. 8B: CD34 positivity can be observed.Fig. 8C: The Ki-67 index is 3–4%.Fig. 8D: Strong nuclear staining with anti-STAT6 antibody can be observed.,2186-3326-82-0631-g008,NotMatch,NotMatch
PMC7983647,Fig. 1,Diagnostic imaging during the patient's follow-up since 2016.,cro-0014-0078-g01,NotMatch,NotMatch
PMC7983647,Fig. 2,Dose distribution of the PT courses.,cro-0014-0078-g02,NotMatch,NotMatch
PMC8756112,Fig. 1,Disease control rate related to postoperative radiotherapy (PORT). Progression-free survival (A) and local control rate (B) in all patients. Progression-free survival (C) and local control rate (D) in the patients with World Health Organization grade II after gross total resection.,crt-2021-142f1,NotMatch,NotMatch
PMC8756112,Fig. 2,"Disease control rate according to the surgical extent and RT: (A) progression-free survival and (B) local control rate. GTR, gross total resection; PORT, postoperative radiotherapy; RT, radiotherapy; STR, subtotal resection.",crt-2021-142f2,NotMatch,NotMatch
PMC8756112,Fig. 3,Local control rate according to the margin of clinical target volume in the subgroup undergoing postoperative radiotherapy.,crt-2021-142f3,NotMatch,NotMatch
PMC7962064,Figure 1,"Differentially expressed genes in icSFT/HPC and exSFT/HPC. (A) Based on global significance statistics and pathway dysregulation p-values, the greatest difference between the two groups was observed in the WNT signaling pathway. (B) Gene set enrichment analysis (GSEA) showed that WNT signaling and focal adhesion pathways of KEGG gene sets were enriched in exSFT/HPC compared to icSFT/HPC. (C) Volcano plot of differentially expressed genes according to location, a fold change in expression > 2, and p < 0.05. (D) Heatmap of representative genes showing differential expression profiles in icSFT/HPC and exSFT/HPC. (E) Linear correlation analysis of WNT5A with MMP9 expression. Circles represent groupings based on the location of SFT/HPC. (F) Box plots showing that the expression level of WNT5A was high in exSFT/HPC and that of MMP9 was high in icSFT/HPC.",cancers-13-01142-g001,NotMatch,NotMatch
PMC7962064,Figure 2,"Representative images and histofigures of icSFT/HPC and exSFT/HPC. From top to bottom, chest computed tomography (CT), brain magnetic resonance imaging, Hematoxylin and Eosin (H&E) staining, and immunohistochemical staining for STAT6, CD99, BCL2, CD34, WNT5A, and MMP9 (original magnification: 200× for H&E, STAT6, CD99, BCL2, CD34, and WNT5A; and 400× for MMP9). From left to right, benign and malignant exSFT/HPCs were followed by grade 2 and 3 icSFT/HPCs. After a review of H&E slides, SFT/HPC cases were confirmatively selected by nuclear immunoreactivity of STAT6. Compared to the similar expression of CD99 and BCL2 across grades and locations, the CD34 immunostaining intensity was weaker in icSFT/HPC than in exSFT/HPC. Expression of WNT5A was also lower in icSFT/HPC than exSFT/HPC, but expression of MMP9 in occasional tumor cells was enhanced in exSFT/HPC compared to icSFT/HPC.",cancers-13-01142-g002,NotMatch,Match
PMC7962064,Figure 3,"Analysis of IHC staining of SFT/HPC. (A) Heatmap of IHC expression of BCL2, CD99, MMP9, CD34, WNT5A, and CLDN5, displayed with grades and locations of SFT/HPCs. p-values are for the correlation between location and IHC expression. (B) Linear correlation analysis of IHC expression of MMP9 and WNT5A. Circles represent groupings according to SFT/HPC location. (C) Correlogram of IHC expression of CLDN5, CD34, WNT5A, and MMP9 according to location and grade of SFT/HPC. Red circles indicate a positive correlation between the paired variables and blue circles a negative correlation. The intracranial location was coded as a positive value, and the extracranial location as a negative value.",cancers-13-01142-g003,NotMatch,NotMatch
PMC7962064,Figure 4,"CLDN5 and CD34 expression in icSFT/HPC and exSFT/HPC. (A–F) Representative exSFT/HPC case. H&E staining showed typical microscopic features of exSFT/HPC (A). IHC staining showed moderate to strong expression of CLDN5, indicating well-preserved tight junctions of the tumor vasculature (B), and diffuse positivity for CD34 in exSFT/HPC (C). Double immunofluorescence showed strong expression of CLDN5 (D), and diffuse expression of CD34 (E). Merged image showing tumor vessels with well-preserved coexpression of CLDN5 and CD34 in exSFT/HPC (F) (D–F, scale bar, 100 μm). (G–L) Representative icSFT/HPC case. H&E staining showed typical microscopic features of icSFT/HPC (G). IHC showed some vessels with significantly decreased expression of CLDN5 (black arrowheads) (H), compared to densely labeled CD34 in tumor vessels of icSFT/HPC (I). Double immunofluorescence revealed some tumor vessels where the expression of CLDN5 was markedly decreased (J) but the expression of CD34 was maintained (gray arrows) (K). Merged image showing good contrast between vessels stained for only CD34 (gray arrows) and other vessels with coexpression of CLDN5 and CD34 (yellow arrowheads) (L) (J–L, scale bar, 100 μm).",cancers-13-01142-g004,NotMatch,Match
PMC7962064,Figure 5,"Cases of icSFT/HPC exhibiting extracranial metastasis. (A) In all six cases, WNT5A expression was markedly decreased but that of MMP9 was significantly increased by IHC. (B) The clinical progression of case four was as follows: after surgical resection and radiotherapy, the patient showed no recurrence for four-and-a-half years. On follow-up imaging at five-and-a-half years postoperatively, the patient showed distant lung metastasis and local recurrence at the intracranial location. Surgical resection of the intracranial lesion and systemic chemotherapy were performed. At eight -and-a-half years after the initial operation, the metastatic lesions became widespread despite continued chemotherapy, and the patient died six months later.",cancers-13-01142-g005,NotMatch,NotMatch
PMC7962064,Figure 6,"Hypothetical mechanism of extracranial metastasis of icSFT/HPC. Compared to exSFT/HPC, icSFT/HPC shows a decreased expression of WNT5A, which maintains vascular tightness in the central nervous system and increased expression of MMP9, which promotes tumor-cell intravasation. Decreased expression of CLDN5, a marker of vascular tight junctions, in icSFT/HPC is supportive of the hypothesis.",cancers-13-01142-g006,NotMatch,NotMatch
PMC8502657,Figure 1.,"(A, B) Magnetic resonance imaging (MRI) before surgery. Axial (A) and sagittal (B) contrast-enhanced T1-weighted images reveal a heterogeneously enhanced tumor in the left occipital lobe and cerebellum. (C, D) Follow-up MRI after surgery and radiation therapy. Axial (C) and sagittal (D) contrast-enhanced T1-weighted images showed no evidence of a residual lesion.",1349-7235-60-2973-g001,NotMatch,NotMatch
PMC8502657,Figure 2.,"Contrast-enhanced computed tomography shows multiple metastases (arrows) in the thoracic spine (A), lung (B), and liver (C).",1349-7235-60-2973-g002,NotMatch,NotMatch
PMC8502657,Figure 3.,"Serial electrocardiograms (ECGs) of the patient with SFT/HPC before and during pazopanib treatment. (A) An ECG before pazopanib treatment showing a heart rate of 50 bpm. (B) An ECG at admission during pazopanib treatment, showing sinus bradycardia of 34 bpm, a normal QRS complex, and a normal QTc of 403 ms. (C) An ECG after the short cessation of pazopanib. The patient’s heart rate returned to 50 bpm and his fatigue was improved.",1349-7235-60-2973-g003,NotMatch,NotMatch
PMC8502657,Figure 4.,Electrocardiographic monitoring at rest and during exertion. (A) An ECG at rest showing sinus bradycardia of 36 bpm. (B) The heart rate increased to 45 bpm on exertion.,1349-7235-60-2973-g004,NotMatch,NotMatch
PMC8059036,Fig. 1,"Gross appearance of SFT: a. Benign SFT appearing as a well-circumscribed, white and firm tumor. b. Malignant SFT of retroperitoneum exhibiting ill-defined borders, variegated cut surface and cystic degeneration",13000_2021_1095_Fig1_HTML,NotMatch,NotMatch
PMC8059036,Fig. 2,"a. SFT exhibiting hypo and hypercellular areas of spindle cells against collagenous background stroma along with, b. HPC-like vessels, c. stromal and perivascular fibrosis and, d. myxoid change in stroma",13000_2021_1095_Fig2_HTML,NotMatch,NotMatch
PMC8059036,Fig. 3,"a. Classic SFT exhibiting cracking artifact and, b. abundant keloid-type collagen, c&d. Cellular SFT exhibiting increased cellularity, gaping blood vessels and more darkly stained nuclei",13000_2021_1095_Fig3_HTML,NotMatch,NotMatch
PMC8059036,Fig. 4,"a. Markedly cellular tumor showing sheets of small sized cells with hyperchromasia, b. Tumor cells exhibiting round cell morphology, c. Lipomatous SFT composed of mature adipocyte intermixed with tumor cells, d. Giant cell SFT exhibiting multinucleated giant cells focally lining pseudovascular spaces",13000_2021_1095_Fig4_HTML,NotMatch,NotMatch
PMC8059036,Fig. 5,"Dedifferentiated SFT; a. Abrupt transition of conventional SFT areas with high grade sarcomatous areas with, b. marked nuclear pleomorphism and increased mitoses",13000_2021_1095_Fig5_HTML,NotMatch,NotMatch
PMC8059036,Fig. 6,"Tumor cells showing positive staining for, a. CD34, b. CD99, c. BCL2 and, d. nuclear staining for STAT6 IHC stains",13000_2021_1095_Fig6_HTML,NotMatch,NotMatch
PMC8111474,Fig. 1,"Preoperative non-enhanced computed tomography (NECT).(A) Axial NECT head image showed a solid and cystic mass, compressing the right temporal lobe, adjacent to the right cranial convexity. The solid part showed higher density than the brain parenchyma. The mass effect was marked with a midline shift from right to left.(B) Axial NECT bone image revealed hyperostosis in contact with the lesion (white arrow).",gr1,NotMatch,NotMatch
PMC8111474,Fig. 2,"Preoperative magnetic resonance imaging.(A–C) Axial images of T1WI, T2WI, and FLAIR (A, T1WI; B, T2WI; C, FLAIR) showed a heterogeneous mass with multiple cystic components adjacent to the right temporal lobe. The solid component demonstrated iso to high intense on T1WI (A) and low to slightly high intense on T2WI (B) in comparison with the cortical gray matter.(D, G, H) Contrast-enhanced T1WI (D, axial; G, coronal; H, sagittal) showed heterogeneous and good enhancement with the dural tail sign.(E) DWI showed the solid compartment with a high signal.(F) The measured minimum ADC value on ADC map was 0.79 × 10-3 mm2/s (white arrow).",gr2,NotMatch,NotMatch
PMC8111474,Fig. 3,"Histological findings(A–C) H&E stain (A, 40 ×; B, 100 ×; C, 400 ×) showed tumor cells presenting a diffuse growth pattern with abundant slit-shaped vessels in the central area. Ten high power fields (400 ×) revealed mitosis 5 or less (white arrow).(D) Silver staining (100 ×) revealed linear structures indicating collagen fibers.(E–H) Immunohistochemistry examination of vimentin (E, 100 ×), STAT6 (F, 100 ×), and CD34 (G, 100 ×) was positive. Ki-67 staining (H, 100 ×) showed a proliferative index of 15%. No other immunostainings were positive.",gr3,NotMatch,Match
PMC7812880,Figure 1,"
Imaging of the abdominal mass. A: Contrast-enhanced abdominal computed tomography (CT) scan showing a huge mass measuring 25.4 cm × 23.0 cm with mixed density and heterogeneous enhancement (arrow); B: CT 3D reconstruction showing that the feeding arteries were from the splenic artery, right colic artery, and middle colic artery (arrows). ",WJCC-9-445-g001,NotMatch,NotMatch
PMC7812880,Figure 2,"
Intraoperative external phase of the abdominal mass. A: During the operation, a tumor originating from the greater omentum was detected, which occupied most of the space in the abdominal cavity; B: The tumor was highly invasive, and several implant nodules were identified on the intestinal mesentery and greater omentum. A mesenteric implant is shown (arrow). ",WJCC-9-445-g002,NotMatch,NotMatch
PMC7812880,Figure 3,"
Pathological examination of the tumor. A: The gross morphology of the resected tumor specimen was huge (27 cm × 21 cm × 9 cm) with necrosis and hemorrhage on the surface; B: Pathological examination showed hypercellularity with spindle cells, and a high mitotic activity with a rate of 30/10 high power field (HPF); C and D: On immunohistochemistry staining, BCL-2 and DOG-1 were weakly positive; E and F: CD34 and STAT6 were negative.",WJCC-9-445-g003,NotMatch,NotMatch
PMC7812880,Figure 4,"
Gene sequencing was performed using the paraffin-embedded tumor section. A-F: Four exons of c-KIT including 9 (A), 11 (B), 13 (C), and 17 (D); and 2 exons of PDGFRA including 12 (E) and 18 (F) were sequenced using the Sanger method. The results revealed negative gene mutation in all the exons.",WJCC-9-445-g004,NotMatch,NotMatch
PMC8170013,Fig. 1,"Radiograph of the sacrum. The first sacral hiatus is asymmetrical, and is obscured on the right side. Enlargement of the first and second sacral hiatus is suspected. Osteosclerotic changes are seen at the margins (arrows). The lumbar spine and the sacroiliac joints are intact.",gr1,NotMatch,NotMatch
PMC8170013,Fig. 2,"Axial T1-weighted fast spin echo (FSE) (TR 548; TE 9.2) MR image (a) shows a lobular mass expanding the sacral spinal canal with areas of high signal intensity (arrows) identical to that of subcutaneous adipose tissue. Axial fat-suppressed T1-weighted FSE (TR 560; TE 8.7) MR image (b) shows decreased signal intensity (arrows) confirming the fatty component. Axial fat-suppressed contrast-enhanced T1-weighted FSE (TR 560; TE 8.7) MR image (c) demonstrates strong contrast enhancement of the mass, except for focal areas of fat-suppressed low signal intensity (arrows). Coronal T2-weighted FSE (TR 3200; TE 87) MR image (d) shows areas of intermediate signal intensity (arrowhead) and high signal intensity (arrow) in the mass. The former is accompanied by signal voids (curved arrow), suggesting hypervascular cellular-rich components. The latter suggests fatty components. Axial contrast-enhanced CT image obtained during the arterial phase (e) shows strong contrast enhancement of the mass and a vessel (curved arrow) corresponding to the flow voids seen in (d). The mass contains areas of hypodensity suggestive of fat (arrow).",gr2,NotMatch,NotMatch
PMC8170013,Fig. 3,"Representative hematoxylin and eosin-stained specimens of the tumor. (a) Short spindle-shaped tumor cells show patternless proliferation with various degrees of collagen fibrillation. There is an increase in the number of small blood vessels, some of which have a staghorn-like appearance. (b) Many mature adipocyte-like cells are also seen.",gr3,NotMatch,NotMatch
PMC8276951,Figure 1,"Skull base tumors in pediatric cases. Axial T1-weighted images after gadolinium showing a heterogeneous localization of the lesion as well as histology, tumors is highlighted with a white arrow. (A) Petroclival undifferentiated neuroendocrine carcinoma. (B) Cerebellopontine angle epidermoid cyst. (C) Jugular foramen meningioma. (D) Cavernous sinus Crooke’s cell adenoma. (E) Petrous temporal bone osteoblastoma. (F) Ethmoid bone ossifying fibroma. (G) Sphenoid bone fibromyxoid sarcoma. (H) Olfactory groove Ewing’s sarcoma. (I) Geniculate ganglion Schwannoma (VII nerve). (J) Bilateral cerebellopontine angle Schwannoma (VIII nerve)",JPN-16-35-g001,NotMatch,NotMatch
PMC8276951,Figure 2,Case no. 13. First surgery preoperative MR scan showing pituitary lesion extending to right cavernous sinus (white arrow). (A) Coronal T2-weighted. (B) Sagittal T1-weighted after contrast injection,JPN-16-35-g002,NotMatch,NotMatch
PMC8276951,Figure 3,Case no. 13. Second surgery preoperative MR scan showing lesion extending to right cavernous sinus and posterior fossa (white arrow). (A) Axial T1-weighted after contrast injection. (B) Coronal T1-weighted after contrast injection,JPN-16-35-g003,NotMatch,NotMatch
PMC8276951,Figure 4,Possible surgical approaches to access skull base tumors,JPN-16-35-g004,NotMatch,NotMatch
PMC8301724,Figure 1,"Magnetic resonance imaging (MRI) of the brain (T1 axial sequence with contrast) showing (A) an extra-axial, heterogeneous, highly vascularized 7.6-cm mass compressing the left parietal lobe along with a centimeter left-to-right midline shift (encircled). (B) MRI brain T1 coronal sequence with contrast demonstrating the dural tail (encircled). (C) MRI T2-fluid attenuated inversion recovery (FLAIR) sequence showing an alternating pattern of hypo-intensity and hyperintensity (""yin-yang"" sign) along with edema.",cureus-0013-00000015863-i01,NotMatch,NotMatch
PMC8301724,Figure 2,Photomicrograph (H&E stain 100×) showing a cluster of oval fibroblastic cells (encircled) intermixed with pink collagenous stroma (thick arrow) and stag-horn-shaped blood vessel (thin arrow).H&E - Hematoxylin and eosin,cureus-0013-00000015863-i02,NotMatch,Match
PMC8214353,Figure 1,Capillary blood glucose monitoring during the 72-hour fast protocol. Symptomatic hypoglycemia became evident at the sixth hour.,JAFES-36-1-090-g001,NotMatch,NotMatch
PMC8214353,Figure 2,Abdominal computerized tomography scan on axial view showing multiple hepatic (A) and right adrenal metastases (B).,JAFES-36-1-090-g002,NotMatch,NotMatch
PMC8214353,Figure 3,Chest computerized tomography scan in axial view showing bilateral sub-centimeter nodular densities in the apical segment of the right upper lobe (A) and postero-basal segment of the left lower lobe (B).,JAFES-36-1-090-g003,NotMatch,NotMatch
PMC8214353,Figure 4,"Histopathologic examination of the excised temporo-zygomatic mass. There are pericytes (black arrows) that are round to ovoid, angulated, with hyperchromatic nuclei and basophilic cytoplasm (H&E, 100x).",JAFES-36-1-090-g004,NotMatch,Match
PMC8214353,Figure 5,Comparison of 48-hour capillary blood glucose readings with and without Prednisone.,JAFES-36-1-090-g005,NotMatch,NotMatch
PMC8375015,Figure 1,"Immunohistochemical images of H&E, STAT6 and Fascin-1 staining in cases XVI and XIX. STAT6 was positive in each case and Fascin-1 was strongly positive in case XIX but negative in case XVI, of which staining was localized to the endothelium cells of the vessel. Scale bars, 50 µm. H&E, hematoxylin and eosin; STAT6, signal transducer and activator of transcription 6.",mco-15-04-02361-g00,NotMatch,Match
PMC8375015,Figure 2,Kaplan-Meier curve of patients that were or were not ‘strongly positive’ for Fascin-1. The average observation period of patients without recurrence was 127.6 months.,mco-15-04-02361-g01,NotMatch,NotMatch
PMC8359034,Fig. 1,"A diagram showing the initial patient treatments, local recurrence and salvage therapy after local recurrence. Twenty-nine (43.9%) patients had surgery followed by post-operative radiotherapy (PORT) while thirty-seven (56.1%) had surgery alone. Of the 29 patients with PORT after operation, 11 received intensity-modulated radiotherapy and 18 had stereotactic radiosurgery (SRS) (12 had gamma knife SRS and 6 had linac-based SRS). There were 12 local recurrences out of the 29 patients with surgery plus PORT, and 11 of the 37 surgery alone patients",12885_2021_8594_Fig1_HTML,NotMatch,NotMatch
PMC8359034,Fig. 2,"Figure (2-1). A, B and C: Microphotographs of the histologic images of a grade II intracranial hemangiopericytoma patient (magnification × 200). A, Hematoxylin & Eosin staining demonstrated an extensively vascularized and cellular tumor; B, Immunohistochemical staining showed a strong positivity for CD34; C, immunohistochemical staining showed a 5% positivity for Ki67; D, E and F: Microphotographs of the histologic images of a grade III intracranial hemangiopericytoma patient (magnification × 200). D, Hematoxylin & Eosin staining demonstrated an extensively vascularized and cellular tumor; E, Immunohistochemical staining showed a strong positivity for CD34; F, Immunohistochemical staining showed a 10% positivity for Ki67. Compared with grade II HPC, the grade III tumor showed a higher percentage of ki67 positivity and more prominent nuclear fission and cell morphology heterogeneity. Figure (2-2). Magnetic resonance imaging (MRI) of a grade II intracranial hemangiopericytoma patient without recurrence after gross total resection. A-C: Preoperative T1-weighted MRI scans with contrast: A axial, B coronal and C sagittal images, showing an enhanced lesion at the right temporal lobe with central necrosis. D-F Postoperative T1-weighted MRI scans with contrast: D axial, E, coronal, and F, sagittal images, showing a complete tumor removal. The patient was recurrence-free 22 months after surgery. His histologic images were shown in Fig. 2–1",12885_2021_8594_Fig2_HTML,Match,NotMatch
PMC8359034,Fig. 3,A Kaplan-Meier estimates of the local recurrence-free survival (RFS) curves in intracranial hemangiopericytoma patients. Postoperative radiotherapy (PORT) did not increase the RFS (p = 0.714). B Kaplan-Meier estimates of the local RFS curves in intracranial hemangiopericytoma patients with PORT. The RFS of the two groups with different radiotherapy techniques were similar (p = 0.960). C Kaplan-Meier estimates of the overall survival (OS) curves of intracranial hemangiopericytoma patients. There were no differences between the patients with and without PORT (p = 0.169). D Kaplan-Meier estimates of the OS curves in intracranial hemangiopericytoma patients with PORT. The OS of the two groups were similar (p = 0.256). E Kaplan-Meier estimates of the recurrence-free survival curves of propensity score-matched intracranial hemangiopericytoma patients (surgery plus radiation and surgery alone groups). Postoperative radiotherapy did not increase the RFS (p = 0.367). F Kaplan-Meier estimates of the overall survival curves of propensity score-matched intracranial hemangiopericytoma patients (surgery plus radiation and surgery alone groups). There were no differences between the patients with and without PORT (p = 0.159),12885_2021_8594_Fig3_HTML,Match,NotMatch
PMC8478505,Fig. 1,"
Gross examination of the omentum showed a nodular, circumscribed, markedly congested, dark brown tumor with dilated and congested blood vessels in the vicinity.
",10-1055-s-0041-1731942_00403_01,NotMatch,NotMatch
PMC8478505,Fig. 2,"
(
A
) Tumor cells are spindly, arranged in sheets, pattern less pattern, and vague storiform pattern (Hematoxylin and Eosin stain [H&E stain], original magnification 100X). (
B
) Cellular area with cells having spindly to plump nuclei with granular to vesicular chromatin and inconspicuous nucleoli (H&E stain, original magnification 400X).
",10-1055-s-0041-1731942_00403_02,NotMatch,Match
PMC8478505,Fig. 3,"
Tumor cells diffusely express (
A
) CD34, (
B
) Bcl2, and (
C
) STAT6 (immunohistochemistry, 3,3′-diaminobenzidine chromogen, original magnification 100X).
",10-1055-s-0041-1731942_00403_03,NotMatch,Match
PMC8572645,Figure 1,"MRI of the spinal column prior to surgical resection.Sagittal (A) and transverse (B) pre-operative MRI demonstrate a contrast-enhancing 3.1-cm T11-12 left lateral mass with intradural, extramedullary localization (yellow arrows).",cureus-0013-00000018613-i01,NotMatch,NotMatch
PMC8572645,Figure 2,Postoperative MRI of the spinal column.Sagittal (A) and transverse (B) postoperative MRI demonstrate excision of the left lateral mass (yellow arrows).,cureus-0013-00000018613-i02,NotMatch,NotMatch
PMC8572645,Figure 3,"Solitary fibrous tumor histopathology.Cellular spindle cell tumor with marked nuclear pleomorphism and high mitotic activity (hematoxylin-eosin): 40× (A), 100× (B), 200× (C), and 400× (D). Black and yellow arrows in (D) denote nuclear pleomorphism and mitotic figures, respectively.",cureus-0013-00000018613-i03,NotMatch,NotMatch
PMC8572645,Figure 4,"Immunohistochemistry validation of solitary fibrous tumor.Tumor cells express biomarkers BCL2 (A), CD34 (B), CD99 (C), and the nuclear marker STAT6 (D) indicating SFT. All images are 200× magnification.",cureus-0013-00000018613-i04,NotMatch,NotMatch
PMC8572645,Figure 5,Repeat MRI at three months follow-up.Follow-up MRI showed a stable nodular focus of enhancement at the T11-12 level extending into the proximal left neural foramen (yellow arrow). Sagittal (A) and transverse (B) images are shown.,cureus-0013-00000018613-i05,NotMatch,NotMatch
PMC8552042,Figure 1,Three surgical corridors of suboccipital paracondylar-lateral cervical approach. (1) The suboccipital retrosigmoid corridor exposes the cerebellopontine angle cistern and cerebellomedullary angle cistern; (2) The paracondylar corridor exposes the jugular foramen; (3) The lateral cervical corridor exposes the retrostyloid region of parapharyngeal space.,fonc-11-660487-g001,NotMatch,NotMatch
PMC8552042,Figure 2,"The suboccipital paracondylar-lateral cervical (SPCLC) approach. (A) Schematic diagram of the SPCLC approach, the approach accesses the dumbbell-like jugular foramen schwannomas by three compartments: the posterior fossa, jugular foramen, and retrostyloid region; (B) The head position and the incision; (C) The cutaneous muscle flap elevated to expose the suboccipital area and retrostyloid region; (D, E) The post belly of the digastric muscle (triangle) and rectus capitis lateralis (asterisk) identified; (F), The jugular process was removed. (G–I) The schematic diagram of (D–F). DM, digastric muscle; RCL, rectus capitis lateralis; TPA, transverse process of the atlas.",fonc-11-660487-g002,NotMatch,NotMatch
PMC8552042,Figure 3,"The pre- and post-operational high-resolution computed tomography (HRCT) indicated the extent of paracondylar bone removal. During the suboccipital paracondylar-lateral cervical approach, the jugular process was precisely removed while the condyle was kept intact. Red star: enlarged jugular foramen; Red arrow: the extent of removed bone mass.",fonc-11-660487-g003,NotMatch,NotMatch
PMC8552042,Figure 4,Schematic diagram of the “sandwich” skull base reconstruction method. The dural substitute was placed on the inner face of the skull base. The gelatin sponge rolls were filled up in the tumor cavity to sustain the dural substitute and one layer of gelatin sponge was cover the margin of the dural substitute to keep it in place.,fonc-11-660487-g004,NotMatch,NotMatch
PMC8552042,Figure 5,"A patient with a JFS who underwent suboccipital paracondylar-lateral cervical approach. The jugular foramen was opened posteriorly by removing the jugular process. The parapharyngeal tumor was removed first, followed by the foramen and the intracranial tumor.",fonc-11-660487-g005,NotMatch,NotMatch
PMC8552042,Figure 6,A patient with a dumbbell-like jugular foramen meningioma who underwent suboccipital paracondylar-lateral cervical approach.,fonc-11-660487-g006,NotMatch,NotMatch
PMC8552042,Figure 7,A patient with a jugular foramen paraganglioma who underwent suboccipital paracondylar-lateral cervical approach.,fonc-11-660487-g007,NotMatch,NotMatch
PMC8552042,Figure 8,"The “in situ” technique for the preservation of neurological function. The supporter stably pulls the tumor by the cup forceps to create tension between the tumor and target nerve (red arrow). Using a dissector, the chief surgeon gently divides the tumor away from the nerve along with the arachnoid interface (blue arrow).",fonc-11-660487-g008,NotMatch,NotMatch
PMC8626743,Fig. 1,"Magnetic resonance imaging of the patient. The left intervertebral foramen of C6-7, with an ill-defined margin that is 2.8 × 1.5 × 1.4 cm in size, and a slightly hyperintense T2WI signal like T1WI in the surrounding small portion, low T1WI and low T2WI signal without enhancement in the center. The spinal cord is compressed and pushed to the right. T1 weighted imaging, T1WI; T2 weighted imaging",12893_2021_1399_Fig1_HTML,NotMatch,NotMatch
PMC8626743,Fig. 2,"HE staining and IHC staining of tumor tissue. A Tumor cells were arranged in sheets and rich in blood vessels as shown in HE staining image. B–F Immunohistochemical study showing CD34 positive diffusely, β-catenin and CD31 vessels positive, SMA positive, Ki-67 15% positive. HE Hematoxylin and eosin, IHC immunohistochemical",12893_2021_1399_Fig2_HTML,NotMatch,NotMatch
PMC8626743,Fig. 3,Summary of primary endodermal hemangiopericytoma/solitary fibrous tumor in the spinal cord,12893_2021_1399_Fig3_HTML,Match,NotMatch
PMC8672547,Fig. 1,"Axial brain-parenchyma (a) and bone windows (b) of brain in non-enhanced CT demonstrating a parietal mass with subtle hyperostosis and internal calcifications. Axial T2 WI (c,d) shows a lobulated mass which is predominantly hyperintense but with some foci of low signal. Significant mass effect and subtle edema is noted. T1-WI postcontrast (e) and axial T2* MRI perfusion (f) images show a heterogeneous enhancement with honeycomb pattern and low CBV of the tumor",12883_2021_2515_Fig1_HTML,NotMatch,NotMatch
PMC8672547,Fig. 2,"Polylobulated mass with glistening nodules, focal softening, and liquefaction (a,b). Moderate cellular tumor with abundant chondroid matrix. Chondrocytes showed low-to-moderate atypia, binucleated cells, and necrosis (c)",12883_2021_2515_Fig2_HTML,NotMatch,NotMatch
PMC8627340,Figure 1,"MRI images on preoperative, 3 months postoperative, 1 year postoperative, and current period. (a, b) (08.12.2017) Preoperative MRI reveals a lesion 12 × 10 mm in diameter, hypointense in both T1-w and T2-w, heterogeneously contrast enhancing with gadolinium. (c, d) (06.03.2018) Postoperative MRI reveals a paracentral mass located in the posterior edge of the spinal canal with minimal contrast enhancement. (e, f) (19.01.2019) Control MRI reveals. (g, h) (18.02.2021): MRI at current presentation reveals a lesion which is moderately hypointense in T1-w and hypointense in T2-w with homogeneous contrast enhancement.",CRIONM2021-4559749.001,NotMatch,Match
PMC8627340,Figure 2,Pathology slides. (a) Hematoxylin and eosin staining of z200 magnification reveals spindloid nuclei and thin vascular structures. (b) Diffuse staining with CD34 at ×200 magnification. (c) 1-2% proliferation index with Ki-67 at ×200 magnification.,CRIONM2021-4559749.002,NotMatch,NotMatch
PMC8627340,Figure 3,"Plan summations and dose volume histogram (DVH) of 3DCRT, IMRT, and ARC. (a) Plan summations on axial (upper left), frontal (lower left), and sagittal (lower right) views and DVH graph (upper right) of conformal three-dimensional plan. Outer red line of plan summations represents 50% (25.2 Gy) isodose line, green line represents 42.84 Gy, and blue line represents 50.4 Gy. Red dots represent maximum point doses on each view. (b) Plan summations on axial (upper left), frontal (lower left), and sagittal (lower right) views and DVH graph (upper right) of intensity-modulated radiation therapy plan. Outer red line of plan summations represents 50% (25.2 Gy) isodose line, green line represents 42.84 Gy, and blue line represents 50.4 Gy. Red dots represent maximum point doses on each view. (c) Plan summations on axial (upper left), frontal (lower left), and sagittal (lower right) views and DVH graph (upper right) of volumetric modulated arc therapy plan. Outer red line of plan summations represents 50% (25.2 Gy) isodose line, green line represents 42.84 Gy, and blue line represents 50.4 Gy. Red dots represent maximum point doses on each view.",CRIONM2021-4559749.003,NotMatch,NotMatch
PMC8686777,Figure 1,"Coronal CT in bone window (A) demonstrates the left ethmoid mass
eroding the cribriform plate and left lateral lamella. Coronal CTA in soft
tissue window (B) shows the mass displaying arterial enhancement.
Coronal T2 MRI (C) demonstrates isointensity of the left ethmoid
mass as compared to the brain parenchyma. Coronal T1 post contrast MRI
(D) displays homogenous enhancement of the mass.",yjbm_94_4_593_g01,NotMatch,NotMatch
PMC8686777,Figure 2,"Low power (A) and high power (B) magnification
demonstrate submucosal bland spindle cells with admixed thick-wall vessels and
adipocytes, compatible with glomangiopericytoma. (C) Beta catenin
shows cytoplasmic staining. While not the typical cytoplasmic and nuclear
staining seen in glomangiopericytoma, the morphology is very classic. Orange
arrow: submucosal bland spindle cells; blue arrowhead: thick-wall vessels; green
star: adipocytes; and brown chevron: cytoplasmic beta staining.",yjbm_94_4_593_g02,NotMatch,NotMatch
PMC8683277,Figure 1,Radiologic images of case 1.(A) Coronal T1-FS imaging demonstrates a supraorbital lobular isointense mass in the right superior extraconal portion of the right orbit (red arrow). (B) Coronal T2 imaging shows an isointense mass (red arrow) with intact extraocular muscles and optic nerves bilaterally. (C) Coronal T1-FS post-gadolinium imaging shows diffuse enhancement with mild inferior depression of the right orbital globe (red arrow).FS: fat saturation,cureus-0013-00000019678-i01,NotMatch,NotMatch
PMC8683277,Figure 2,"Histologic images of case 1.Microscopic images demonstrating (A) a spindle cell neoplasm with a “patternless pattern” and “staghorn vessels,” (B) multiple mitotic figures, (C) STAT6 nuclear positivity, (D) weak CD34 positivity, (E) and elevated Ki-67 proliferation index. Panels A and C are captured at a total magnification of 100×, scale bars = 500 µm; panel B is captured at a total magnification of 400×, scale bar = 100 µm; panels D and E are captured at a total magnification of 50×, scale bars = 500 µm.STAT6: signal transducer and activator of transcription 6; CD34: cluster of differentiation 34",cureus-0013-00000019678-i02,NotMatch,NotMatch
PMC8683277,Figure 3,"Radiologic images of case 2.(A) Axial T1-FS imaging demonstrates a lobular isointense mass extending anteriorly from the orbital apex into the right orbit posteriorly with mass effect on the right optic nerve (red arrow, inset), which is displaced medially. (B) Axial T2 imaging of the isointense mass that extends medially into the sphenoid sinus and across midline anterior to the sella (blue arrow) and posteriorly into the right cavernous sinus (yellow arrow), with mass effect on the temporal lobe (green arrow). (C) Axial T1-FS and coronal (insert) post-gadolinium imaging show diffuse enhancement. Tortuous vessels (red arrow, inset) indicate hypervascularity.FS: fat saturation",cureus-0013-00000019678-i03,NotMatch,NotMatch
PMC8683277,Figure 4,"Radiologic images of case 3.(A) Coronal T1 post-gadolinium imaging demonstrates an enhancing superolateral left orbital mass causing medial displacement of the superior rectus (red arrow) and inferior displacement of the lateral rectus (blue arrow). (B) Axial T1 post-gadolinium shows the mass associated with proptosis (blue arrow), extraorbital extension through the lateral orbital wall into the left temporalis region (red arrow), intracranial extension with dural enhancement (green arrow), and medial displacement of the optic nerve (yellow arrow). (C) T1-3D-TFE post-gadolinium shows enhancing extra-axial mass along the left greater sphenoid wing with extension into the left aspect of the left orbit.3D-TFE: three-dimensional turbo field echo",cureus-0013-00000019678-i04,NotMatch,NotMatch
PMC8683277,Figure 5,"Radiologic images of case 4.Axial T1-FS post-gadolinium imaging shows a homogenously enhancing mass in the left orbit, adjacent to the lateral wall and extending into the left optic canal (green arrow), with mass effect on the optic nerve (red arrow). The mass extends to the anterior surface of the left temporal lobe and abuts the left cavernous sinus (blue arrow). Axial 3D-SPGR post-gadolinium imaging demonstrates a homogeneously enhancing extra-axial mass overlying the right frontal lobe, compatible with a second meningioma (inset).FS: fat saturation; 3D-SGPR: three-dimensional spoiled gradient echo",cureus-0013-00000019678-i05,NotMatch,NotMatch
PMC8683277,Figure 6,"Histologic images of case 4.Microscopic images demonstrate (A, B) islands of meningioma cells with adjacent muscle, (C) SSTR2A positivity, (D) PR positivity, (E) and mildly elevated Ki-67 proliferation index. Panels A, B, C, and D are captured at a total magnification of 200×, scale bars = 200 µm; panel E is captured at a total magnification of 100×, scale bar = 500 µm.SSTR2A: somatostatin receptor type 2A; PR: progesterone receptor",cureus-0013-00000019678-i06,NotMatch,NotMatch
PMC8683277,Figure 7,Radiologic images of case 5.Axial T1-FS post-gadolinium imaging demonstrates a diffusely enhancing mass surrounding the optic nerve sheath complex showing a “tram-track” appearance (red arrow). Coronal T1-FS post-gadolinium imaging: cuff of enhancing tumor (blue arrow) around a central nonenhancing dot (optic nerve) (green arrow) with a doughnut sign (inset). The mass posteriorly extends to the apex of the left orbit involving the left superior orbital fissure.FS: fat saturation,cureus-0013-00000019678-i07,NotMatch,NotMatch
PMC8763962,Figure 1,The performance of ROC curves for the predictive models the training and validation sets. (A) T1 radiomic model; (B) T2 radiomic model; (C) fusion radiomic model; (D) Clinical model; and (E) Clini-radiomic combined model.,fonc-11-792521-g001,NotMatch,NotMatch
PMC8763962,Figure 2,The six selected radiomic features had significant differences between patients with intracranial hemangiopericytoma and angiomatous meningiomas. (A) lbp-3D-k_glrlmShortRunHighGrayLevelEmphasis; (B) exponential_glcm MaximumProbability; (C) exponential_glrlm_RunVariance; (D) lbp-3D-k firstorder_10Percentile; (E) lbp-3D-k firstorder_90Percentile; and (F) gradient_gldm_Large DependenceHighGrayLevelEmphasis.,fonc-11-792521-g002,Match,NotMatch
PMC8763962,Figure 3,A violin plot showing the signature distribution of the fusion radiomic model between intracranial hemangiopericytoma and angiomatous meningioma patients.,fonc-11-792521-g003,Match,NotMatch
PMC8763962,Figure 4,"Calibration curve analysis and decision Curve Analysis for the fusion radiomic model. (A, B). Calibration curves of the fusion radiomic model in the training set (A) and validation set (B). Calibration curves depict the calibration of model in terms of the agreement between the actual observations and predictions of tumor diagnosis. The Y axis represents the actual rate. The X axis represents the predicted probability. The diagonal purple line represents perfect prediction by an ideal model. The blue (A) and green (B) lines represent the performance of the model, of which a closer fit to the diagonal purple line represents a better prediction. (C, D). Decision curve analysis for the fusion radiomic model in the training set (C) and validation set (D). The Y axis measures the net benefit. The blue (C) and green (D) line represents the fusion radiomic model. The purple line represents the assumption that all patients were diagnosed as intracranial hemangiopericytoma. The black line represents the assumption that all patients diagnosed as angiomatous meningioma.",fonc-11-792521-g004,Match,NotMatch
PMC8763962,Figure 5,Bar plots for the clini-radiomic combined model in the training (A) and validation sets (B). The blue histogram above the horizontal axis and the green histogram below the horizontal axis indicate the patients with correct diagnosis of the clini-radiomic combined model.,fonc-11-792521-g005,NotMatch,NotMatch
PMC8763962,Figure 6,"A nomogram derived from the clini-radiomic combined model. This nomogram is used based on the value of signature of radiomic model and clinical characteristics, namely, age, location 1 (supratentorial or infratentorial), location 2 (skull base or non-skull base), location 3 (paravenous sinus or non-paravenous sinus), dural tail, and peritumoral edema. Draw a vertical line from the corresponding axis of each factor until it reaches the first “Points” line. Next, summarize the points of all risk factors, and then draw a vertical line that falls vertically from the “Total Points” axis until it reaches the last axis to the diagnostic probability of intracranial hemangiopericytoma.",fonc-11-792521-g006,Match,NotMatch
PMC8763962,Figure 7,"Calibration curve analysis and decision Curve Analysis for the clini-radiomic model. (A, B). Calibration curves of the clini-radiomic model in the training set (A) and validation set (B). Calibration curves depict the calibration of model in terms of the agreement between the actual observations and predictions of tumor diagnosis. The Y axis represents the actual rate. The X axis represents the predicted probability. The diagonal purple line represents perfect prediction by an ideal model. The blue (A) and green (B) lines represent the performance of the model, of which a closer fit to the diagonal purple line represents a better prediction. (C, D). Decision curve analysis for the clini-radiomic model in the training set (C) and validation set (D). The Y axis measures the net benefit. The blue (C) and green (D) line represents the clini-radiomic model. The purple line represents the assumption that all patients were diagnosed as intracranial hemangiopericytoma. The black line represents the assumption that all patients diagnosed as angiomatous meningioma.",fonc-11-792521-g007,Match,NotMatch
PMC8769461,Fig. 1,"MRI of the lesion. (A) T1-weighted coronal image. (B) T2-weighted coronal image. (C) Gadolinium-enhanced coronal image. (D) Gadolinium-enhanced sagittal image. MRI demonstrates a mass in the sella and suprasellar regions, which has an isointense signal on T1-weighted imaging and an iso-hyperintense signal on T2-weighted imaging (A and B). The mass has heterogeneous enhancement on contrast administration (C and D), and the anterior pituitary gland is displaced to the upper right side (C, arrowheads).",nmccrj-8-697-g001,NotMatch,NotMatch
PMC8769461,Fig. 2,"Histology and immunohistochemistry. HE staining shows spindle-shaped cells arranged around the blood vessels (A) (×200). Presence of staghorn vasculature (A, arrow). CD34 staining indications were strongly positive for vascular endothelial cells and weakly positive for tumor cells (B) (×200). Clearly visible nuclear expression of STAT6 (C) (×200). TTF-1 is negative (D) (×200). HE: hematoxylin and eosin.",nmccrj-8-697-g002,NotMatch,NotMatch
PMC8769461,Fig. 3,"Coronal image of gadolinium-enhanced MRI performed 2 months after surgery (A), and 3 months (B) and 1 year and 3 months (C) after gamma knife radiosurgery. The residual tumor displayed rapid growth and the tumor’s extraction cavity was reduced (A, arrow). MRI demonstrates that the tumor in the sella shrank efficiently (B and C).",nmccrj-8-697-g003,NotMatch,NotMatch
PMC8790295,Fig. 1,Patient at presentation with inferior bulbar conjunctiva lesion.,gr1,NotMatch,NotMatch
PMC8790295,Fig. 2a,"Spindle-shaped cells arranged in sheets (hematoxylin-eosin, magnification 25x).",gr2a,NotMatch,NotMatch
PMC8790295,Fig. 2b,"Immunoperoxidase stain CD31 stains vascular channels, demonstrating a staghorn pattern (Immunoperoxidase stain CD 31, magnification x 100).",gr2b,NotMatch,Match
PMC8796561,Fig. 1,Chest radiograph showing marked kyphosis,12902_2022_934_Fig1_HTML,NotMatch,NotMatch
PMC8796561,Fig. 2,"Soft tissue mass involving the fronto-ethmoid area, abutting the left rectal medius muscle (white arrow) with possible intracranial tumor spread (black arrow) visible on a CT scan (a). MRI confirmed the intracranial invasion of the tumor (white empty arrow) (b)",12902_2022_934_Fig2_HTML,NotMatch,NotMatch
PMC8796561,Fig. 3,"View of the operation field before an endoscopically-controlled resection. Nasal septum (S), concha media (CM), polyp in the region of the maxillary sinus ostium (P), tumor (Tu)",12902_2022_934_Fig3_HTML,NotMatch,NotMatch
PMC8796561,Fig. 4,Perioperative biochemical response to the surgery performed on 20th March,12902_2022_934_Fig4_HTML,NotMatch,NotMatch
PMC8796561,Fig. 5,"Hematoxylin and eosin staining revealed glomangiopericytoma infiltrating the paranasal sinus mucosa. The tumor consisted of oval and spindle cells forming solid sheets and whorls (a). CD34 immunohistochemical staining for CD34 showed no expression and highlighted tumor branching vasculature. Stains for CKAE1/3, EMA, S-100, desmin, SMA, HMB45 were also negative (b). Immunohistochemical reaction positivity with podoplanin (c) and cyclin-D (d)",12902_2022_934_Fig5_HTML,NotMatch,NotMatch
PMC8796561,Fig. 6,Post-surgery SPECT-CT somatostatin receptor scintigraphy scans showing slightly increased radiotracer uptake in the area of the left ethmoid region,12902_2022_934_Fig6_HTML,NotMatch,NotMatch
PMC8796561,Fig. 7,"Histological sections of hematoxylin and eosin staining showing parathyroid adenoma characterized by a solid growth pattern, surrounded by a thin capsule, well demarcated from other tissues. At the periphery a rim of compressed normal parathyroid tissue admixed with fat cells is seen (a, b). Immunohistochemically, parathyroid adenoma stains intensely positive for chromogranin A (c)",12902_2022_934_Fig7_HTML,NotMatch,NotMatch
PMC8796561,Fig. 8,"Follow-up 16 months postoperatively: MRI revealed an enhancing mass at the left anterior frontal skull base and the ethmoid roof, displaying a heterogeneous signal on T1- and T2-weighted sequence suspected of residual tumor, which did not correlate with the clinical and laboratory outcomes of the patient (a). Endoscopic view of the operation field with no sign of recurrence. Nasal septum (S), nasopharynx (NP), sphenoid sinus (SS), maxillary sinus (MS), right middle turbinate (rMT), partially resected nasal septum (S’), frontal sinus ostium with a small-sized polyp (FS) (b, c)",12902_2022_934_Fig8_HTML,NotMatch,NotMatch
PMC8796561,Fig. 9,"Regulation of phosphate homeostasis by FGF-23, vitamin D and PTH",12902_2022_934_Fig9_HTML,NotMatch,NotMatch
PMC8798491,Figure 1,The timeline picture. The timeline picture presenting the related information and care of the patient.,tcr-09-02-1278-f1,NotMatch,NotMatch
PMC8798491,Figure 2,"Representative imaging and postoperative pathological results. (A) Preoperative skull 18FDG-PET-CT, showing high density lesion without FDG uptake and less tumoral viability near the left frontal lobe parafalx (red arrows); (B,C,D) abdominal FDG-PET-CT and contrast-enhanced CT revealing low density solid lesions without FDG uptake in the right posterior and left outer lobes of the liver (red arrows); (E,F) hematoxylin eosin staining indicating the spindle-like tumor cells with moderate pleomorphism, oval nuclei and a moderate amount of cytoplasm (20× magnification). FDG-PET-CT, 18FFluorodeoxyglucose positron emission tomography computed tomography.",tcr-09-02-1278-f2,NotMatch,NotMatch
PMC8798491,Figure 3,"Typical postoperative imaging photos in 2-year follow-up. (A) Skull CT demonstrating basic postoperative changes in the bilateral frontal; (B) skull MRI also revealing no special abnormality only with some changes after surgery. CT, computed tomography; MRI, magnetic resonance imaging.",tcr-09-02-1278-f3,NotMatch,NotMatch
PMC8861309,Fig. 1,"Retroperitoneal STF in the CT scan. Axial and coronal contrast-enhanced computed tomography images showing a well-defined mass (long arrows) in the left lumbar region, with vivid and homogenous enhancement in both the (A) arterial phase and the (B) venous phase. Large volumes of free intra-abdominal fluid were also observed.",gr1,NotMatch,NotMatch
PMC8861309,Fig. 2,"Chest X-ray and detection of a retroperitoneal solitary fibrous tumor via CT. (A) Anteroposterior chest X-ray showing no abnormal findings. (B) Sagittal contrast-enhanced computed tomography showing a serpiginous dilation of the right gastro-omental artery, which is the feeding artery (white arrow). Intratumoral cystic components are also present (black arrow).",gr2,NotMatch,NotMatch
PMC8861309,Fig. 3,"Pathological features of the SFT in the mesentery under a light microscope. (A and B) Hematoxylin and eosin staining at (A) x100 and (B) x400 magnification. Microscopic findings indicate hypercellular SFT with randomly organized, spindle-shaped cells, including elongated, ovoid to spindle nuclei, and scant indiscernible cytoplasm, within a predominantly collagenous stroma and thin-walled “staghorn” vessels. (C-F) Immunohistochemical staining at x400 magnification. (C) Immunohistochemical assay showing the negative reactivity of the tumor cells for SMA compared with the intense cytoplasmic immunostaining for SMA in adjacent vascular smooth muscle cells. (D) The tumor demonstrates diffuse and strong positive cytoplasmic staining for CD34. (E) The tumor cells exhibit weak and scattered cytoplasmic staining for Bcl2. (F) Ki-67-positive cells (3%). (G) Immunohistochemical assay showing the positive reactivity of the tumor cells for STAT6. SFT, solitary fibrous tumor; SMA, smooth muscle actin.",gr3,NotMatch,Match
PMC9458489,FIGURE 1,Nuclear magnetic resonance ‐ Sagittal and coronal planes evidencing an extensive tumor in the nasal cavity extending to the right rhinopharynx with important contrast enhancement,CNR2-5-e1609-g005,NotMatch,NotMatch
PMC9458489,FIGURE 2,"Cervicofacial angiotomography. Doted area: hypervascular lesion, irrigated by branches of the right maxillary artery",CNR2-5-e1609-g003,NotMatch,NotMatch
PMC9458489,FIGURE 3,(A) Pre‐embolization arteriography; (B) Post‐embolization arteriography demonstrating interruption in contrast flow,CNR2-5-e1609-g002,NotMatch,NotMatch
PMC9458489,FIGURE 4,(A) Right nasal cavity tumor; (B) Hemangiopericytoma. White arrow: Vessels with hemangiopericytoid pattern – “deer's antler”,CNR2-5-e1609-g001,Match,NotMatch
PMC8894058,Figure 1,An axial MRI image demonstrating a lobulated lesion centered within the superficial lobe parotid gland (right side).,CRIPA2022-2097634.001,NotMatch,NotMatch
PMC8894058,Figure 2,"The lesion with well-defined border and showed a thin fibrous capsule. Unremarkable salivary gland tissue noted in the periphery (H&E, ×10).",CRIPA2022-2097634.002,NotMatch,Match
PMC8894058,Figure 3,"The tumor with spindle-shaped cells without a defined architectural pattern forming short fascicles with interspersed thin collagen bundles (H&E, ×20).",CRIPA2022-2097634.003,NotMatch,Match
PMC8894058,Figure 4,"Delicate thin-walled vascular spaces, with hemangiopericytoma-like vasculature, were observed at the periphery (H&E, ×10).",CRIPA2022-2097634.004,Match,Match
PMC8894058,Figure 5,A diffuse positive immunoreactivity against CD34 (×20).,CRIPA2022-2097634.005,NotMatch,NotMatch
PMC8894058,Figure 6,"Positive immunoreactivity against STAT6, nuclear type positivity (×20).",CRIPA2022-2097634.006,NotMatch,NotMatch
PMC8956906,Figure 1,multislice computerized tomography urography and abdominal contrast showing a nodular solid lesion of size 12.3 cm x 8.9 cm x 18.1 cm at the right kidney (yellow arrow) with a suspected metastasis to the liver (green arrow),PAMJ-41-36-g001,NotMatch,NotMatch
PMC8956906,Figure 2,multislice computerized tomography angiography showing the kidney immediately adjacent to the suspected kidney cell carcinoma,PAMJ-41-36-g002,NotMatch,NotMatch
PMC8956906,Figure 3,"A) kidney tumor with intact capsule; B) tumor sliced into two parts; C) histological features of the surgical specimen with hematoxylin eosin staining, showing a tumor cell (black arrow) and a blood capillary (red arrow); D) periodic acid shift staining depicting blood capillaries of the kidney basal membrane (40x magnification)",PAMJ-41-36-g003,NotMatch,NotMatch
PMC8927090,Figure 1,Flowchart of the whole study.,fonc-12-839567-g001,NotMatch,NotMatch
PMC8927090,Figure 2,"Image preprocessing and model training. Regions of interest (ROIs) were extracted from the aligned images, and the jet colormap was applied to grayscale MRI images, followed by the use of 5 image augmentation techniques (A). After preprocessing, input image size was reshaped to 3 × 224 × 224. ResNet-50 convolutional layers were frozen, and the last classification layers were retrained for solitary fibrous tumor/hemangiopericytoma (SFT/HPC) and meningioma discrimination (B).",fonc-12-839567-g002,Match,NotMatch
PMC8927090,Figure 3,"Deep learning training and validation. We trained 300 epochs and training and validation loss reached convergence at around 100 epochs. (A, B) showed loss curve of the transfer model in the training set and validation set, respectively. (C, D) showed the accuracy curve of the transfer model in the training set and validation set, respectively.",fonc-12-839567-g003,NotMatch,NotMatch
PMC8927090,Figure 4,Model evaluation. (A) Receiver-operating characteristic (ROC) curve of the transfer model in the training set with receiver-operating characteristic curve area under the curve (AUC) of 0.92. (B) ROC curve of the radiological feature classification model in the training set with AUC of 0.74. (C) ROC curve of the transfer model in the validation set with AUC of 0.91. (D) ROC curve of the radiological feature classification model in the validation set with AUC of 0.78.,fonc-12-839567-g004,NotMatch,NotMatch
PMC8927090,Figure 5,"Visualization of feature maps. Features extracted by transfer model and visualized by t-distributed stochastic neighbor embedding (t-SNE) showed distinct clustering in the training set (A) and validation set (C), respectively. Features extracted by radiological feature classification model and visualized by t-SNE showed non-distinct clustering in the training set (B) and validation set (D), respectively.",fonc-12-839567-g005,NotMatch,NotMatch
PMC8927090,Figure 6,"Classification activation maps. (A) Distance from the model’s focal point to the tumor bulk in the ground truth group (left) and truly predicted (right) group, respectively. Wilcoxon rank test, *p < 0.05. (B) Distance from the model’s focal point (outside the tumor) to the tumor edge in the ground truth group (left) and truly predicted (right) group, respectively. Wilcoxon rank test, *p < 0.05. (C) Coarse attention maps generated using Smooth Grad-CAM++ for correctly (upper row) and incorrectly (lower row) solitary fibrous tumor/hemangiopericytoma (SFT/HPC) and meningioma classification. For each pair, the postcontrast T1-weighted scan and the Smooth Grad-CAM++ attention maps (overlaid on scan) have been shown in the cropped images. In activation maps, warmer and colder colors represent high and low contribution of pixels toward a correct prediction, respectively. ns, no significance.",fonc-12-839567-g006,Match,NotMatch
PMC8994361,Fig. 1,"Images of benign GGT located on the greater curvature of gastric antrum. A Endoscopic ultrasonography shows hypoechoic lesion with local heterogenous echo (white arrow), which originates from muscularis propria. B Upper gastrointestinal barium meal radiography shows a round filling defect with smooth boundary in the greater curvature of gastric antrum (red arrow). C Non-contrasted CT shows round soft tissue density in the lesser curvature of the gastric antrum (arrowhead), the average CT value was about 41 Hu. D Contrasted CT shows obvious enhancement in arterial phase, the average CT value was about 92 Hu. E Portal venous phase image shows central filling enhancement, the average CT value was about 140 Hu. F The contrast enhancement coronal image in the portal phase shows homogenous density of the lesion with well-defined boundary",12876_2022_2241_Fig1_HTML,NotMatch,NotMatch
PMC8994361,Fig. 2,"Images of malignant GGT of gastric antrum. A Upper gastrointestinal barium meal radiography shows a large filling defect in the lesser curvature of the stomach (red arrow). B Arterial phase image shows irregular mass of gastric antrum with deeply lobulated margin, thickening left gastric artery supplying blood can be seen (white arrow). C Portal venous phase image shows heterogeneous persistent moderate enhancement. D Coronal image of portal phase shows that the mass broke through the gastric wall and invade the liver with poorly defined boundary, cystic change and necrosis inside the tumor could be seen (arrowhead). E The round tumor cells with perivascular distribution were seen (HE,100 ×). F Prominent nucleoli and cellular atypia was seen in some areas (red arrow) (HE,100 ×). G A mitotic figure surrounded by neoplastic cells was seen (arrowhead) (HE,400 ×). H Tumor cells demonstrate the cytoplasmic staining with SMA (200 ×)",12876_2022_2241_Fig2_HTML,NotMatch,NotMatch
PMC9001026,Figure 1,"Magnetic resonance imaging of the brain with fluid-attenuated inversion recovery (A) and gadolinium-enhanced T1-weighted (B) images demonstrating an avidly contrast-enhancing, well-demarcated intraventricular tumor with associated vasogenic edema.",cureus-0014-00000023106-i01,NotMatch,NotMatch
PMC9001026,Figure 2,"Hematoxylin and eosin stains under 200× magnification demonstrating spindle cells (A) and small, thin-walled vessels (B), which are characteristic of SFT. SFT is immunoreactive for CD34 (C). There is also strong nuclear expression of STAT-6 (D).SFT: solitary fibrous tumor; STAT-6: signal transducer and activator of transcription 6",cureus-0014-00000023106-i02,NotMatch,NotMatch
PMC9001026,Figure 3,Postoperative axial (A) and coronal (B) slices of computed tomography scan of the head demonstrating expected post-surgical changes.,cureus-0014-00000023106-i03,NotMatch,NotMatch
PMC9034964,Figure 1,"CT axial view arterial phase postcontrast large 17.9 × 17.6 × 18.3 cm heterogeneous mass centered within the left hemithorax, resulting in rightward mediastinal shift. An incidental right pleural effusion is present.",CRIONM2022-8649540.001,NotMatch,NotMatch
PMC9034964,Figure 2,CT chest coronal MIP (maximum intensity projection) rightward mediastinal shift and partial right lung collapse secondary to left hemithoracic mass effect.,CRIONM2022-8649540.002,NotMatch,NotMatch
PMC9034964,Figure 3,"CT sagittal projection centered along the midline depicted anterior displacement of mediastinal structures secondary to larger left hemithoracic mass, which crosses the midline.",CRIONM2022-8649540.003,NotMatch,NotMatch
PMC9047838,Figure 1,"
Frequency of Spinal Cord 
Masses
regarding Their Location",ijcn-16-129-g001,NotMatch,NotMatch
PMC9088104,Fig. 1,"The flowchart of enrollment and follow-up. Initially, 39 patients were identified according to postoperative pathology results of SFT/HPC. Then, two patients were excluded for incomplete information and one for the extracranial lesion. Three patients lost response before the last follow-up for QoL. Moreover, eight patients had been dead before the last follow-up. Two patients did not respond to the investigation of QoL at the last follow-up",12957_2022_2619_Fig1_HTML,NotMatch,NotMatch
PMC9088104,Fig. 2,"Representative CT and MRI images before and after operation. a Preoperative CT and vascular reconstruction images exhibited the SFT/HPC lesion in the left middle cranial fossa. This irregular high-density mass showing heterogeneous enhancement had unclear boundaries and destroyed the surrounding skull. And this lesion partially enveloped the left internal carotid artery segments C3-C4. b The preoperative enhanced T1WI images were displayed. The mass was located in the left middle cranial fossa, with unclear boundaries and heterogeneous enhancement. The lesion protruded locally into the left pontine corner cistern, partially compressed the left temporal lobe and brainstem and enveloped the C3-C4 segments of the left internal carotid artery. c The enhanced T1WI images of 1-year past operation were exhibited. The area of the original lesion showed postoperative changes without significant enhancement",12957_2022_2619_Fig2_HTML,NotMatch,NotMatch
PMC9088104,Fig. 3,"Kaplan-Meier survival curves display over all-survival and progression-free survival with different EOR and WHO grade. Figures exhibited EOR (a, b) and WHO grade (c, d)-related overall-survival and progression-free survival. EOR and WHO grade in PFS were statistically significant with p-value equaling 0.024 and 0.017. GTR, gross total resection; STR, subtotal resection",12957_2022_2619_Fig3_HTML,NotMatch,NotMatch
PMC9034313,Fig. 1a,"(top left). Ultra-wide field optomap images of left fundus at initial presentation, showing a large subretinal mass in the left eye with surrounding subretinal fluid.Fig. 1b (top right). Close-up color photo of left eye subretinal mass, displaying overlying telangiectatic retinal vessels, subretinal fluid, and mottled appearance of the tumor.Fig. 1c (bottom left). Ultra-wide field fundus autofluorescence of left eye showing a hypoautofluorescent mass with surrounding subretinal fluid and high-water mark through the macula and superior retinal periphery.Fig. 1d (bottom right). Ultra-wide field image of fluorescein angiogram of left eye at 1 minute and 50 seconds, showing peripheral perivascular retinal vascular leakage and ferning, as well as patchy leakage from the mass and pooling into the subretinal space. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)",gr1,NotMatch,NotMatch
PMC9034313,Fig. 2a,"Brightness scan of left eye subretinal mass, 8.85mm × 9.23mm hypoechoic choroidal mass with hyperechoic areas on the surface and associated shadowing. The mass had low internal reflectivity on amplitude scan (not pictured).",gr2a,NotMatch,NotMatch
PMC9034313,Fig. 2b,"MRI brain without contrast, T1-weighted sagittal image showing inferior intraocular mass of left eye with extrascleral extension.",gr2b,NotMatch,NotMatch
PMC9034313,Fig. 3,"B-scan ultrasonography of the left eye at follow up, showing the choroidal mass, now with clear extrascleral extension.",gr3,NotMatch,NotMatch
PMC9034313,Fig. 4a,Gross photo of globe after removal en bloc.,gr4a,NotMatch,NotMatch
PMC9034313,Fig. 4b,"Hematoxylin & eosin (H&E) stain of tumor showing spindle cell lesion with branching vessels, 40x magnification.",gr4b,NotMatch,Match
PMC9034313,Fig. 4c,"Thin branching vessels (H&E stain), 200x magnification.",gr4c,NotMatch,Match
PMC9034313,Fig. 4d,STAT-6 immunostain positive.,gr4d,NotMatch,NotMatch
PMC9104422,Figure 1,,jbsr-106-1-2759-g1,Empty,Empty
PMC9104422,Figure 2,,jbsr-106-1-2759-g2,Empty,Empty
PMC9104422,Figure 3,,jbsr-106-1-2759-g3,Empty,Empty
PMC9128551,Figure 1,"Sankey diagram showing the relationship among location, Asari type, and surgical approach selection.",fonc-12-866225-g001,NotMatch,NotMatch
PMC9128551,Figure 2,"A 52-year-old man complained of blurred vision and unsteady gait for 2 months. The physical examination results showed left hemianopsia, and both VOS and VOD were 0.1. The MRI results revealed a falcotentorial meningioma, which had an isointense signal on T1-/T2-weighted imaging and homogeneous enhancement on contrast-enhanced MRI. The magnetic resonance venography results showed that the straight sinus was occluded (A). We implanted an Ommaya reservoir at 1 week before tumor resection and maintained the drainage at 200 ml per day. The patient then underwent tumor resection using the occipital interhemispheric approach. During the operation, the majority of the tumor base was located at the falx end and the tentorium. The tumor was removed in a piecemeal fashion. Finally, the tumor and the base were totally removed (Simpson grade I resection). The postoperative CT showed no hemorrhage or infarction (B). The pathology examination results revealed that the tumor was a hemangiopericytoma, WHO grade I.",fonc-12-866225-g002,Match,NotMatch
PMC9128551,Figure 3,"A 33-year-old man complained of headache for 2 months. The CT results revealed a mixed-density, right occipital lesion. The MRI results revealed a right occipital, mixed-signal lesion and flow voids on T1- and T2-weighted imaging. The lesion showed obvious enhancement on contrast-enhanced MRI. The magnetic resonance venography results showed an obstructed sagittal sinus (A). We performed the operation in a hybrid operating room. The cerebral digital subtraction angiography (DSA) results revealed abundant tumor blood. The feeding arteries were the right posterior cerebral artery (PCA), right external carotid artery (ECA), right meningiohypophyseal trunk, and left ECA (B). Onyx-18 was used for feeding artery embolization for the right PCA, right occipital artery, and left occipital artery. The DSA reexamination results showed that 90% of the blood supply was embolized (C). Craniotomy was then performed. The occipital interhemispheric transtentorial approach was used to reach the tumor under navigation. The tumor was tenacious, with partial calcification. Piecemeal removal was performed, and we achieved a Simpson grade II resection. The postoperative CT results showed no hemorrhage or infarction (D). The pathology examination results revealed that the tumor was a hemangiopericytoma.",fonc-12-866225-g003,Match,NotMatch
PMC9275470,Figure 1,Contrast-enhanced MRI of the brain showing the left-sided hemangiopericytoma with mass effects.,JNMA-60-250-551-g1,Match,NotMatch
PMC9275470,Figure 2,"Histopathological slide of the tumour demonstrating sheets, bundles, fascicles, nests and alveolar pattern of tumour cells with ectatic vessels traversing the tumour.",JNMA-60-250-551-g2,NotMatch,NotMatch
PMC9162938,Fig. 1,"Noncontrast axial computed tomography scans (A-C) and relevant bone-target images (D, E) showing an isodense mass in the right parietal lobe with a smooth-contoured focal erosion in the adjacent parietal bone (B-E, arrow). Neither intralesional calcification nor hyperostosis are observed in the adjacent skull. T: tumor. A (inferior)→C (superior).",gr1,NotMatch,NotMatch
PMC9162938,Fig. 2,"Axial T1- (A), T2-weighted (B), and postcontrast coronal (C) and sagittal (D) MRIs showing an intensely enhancing extra-axial mass. It appears isointense on T1- and hyperintense on T2-weighted sequences, respectively, broad-based on the convexity dura mater, and measuring 52 × 46 × 48 mm in maximal dimensions, with a portion upwardly protruding into the eroded skull.",gr2,NotMatch,NotMatch
PMC9162938,Fig. 3,"(A) Rear view of three-dimensional CT showing the ectatic left occipital artery (arrows) coursing upward, crossing the midline, entering into the right parietal foramina, and finally connecting with a dilated meningeal vessel that supplies the tumor (dashed arrows). (B) Interior view of the right parietal bone showing the occipital artery (arrows) that penetrates the parietal foramen and anastomoses with the meningeal vessel (arrowhead) adjacent to the bone erosion (asterisk) in the inner skull. RS: rhomboid suture; SS: sagittal suture.",gr3,NotMatch,NotMatch
PMC9162938,Fig. 4,Intraoperative photo showing the occipital artery penetrating into the parietal foramen that has been exposed at the reflection of the scalp flap. OA: occipital artery; PF: parietal foramen.,gr4,NotMatch,NotMatch
PMC9162938,Fig. 5,Postcontrast coronal (A) and sagittal (B) MRIs showing a total resection of the tumor.,gr5,NotMatch,NotMatch
PMC9162938,Fig. 6,"Photomicrographs of the resected specimen showing proliferation of oval- or spindle-shaped neoplastic cells arranged in storiform patterns (A). They show prominent angiogenesis occasionally presenting a staghorn appearance (B) with a MIB-1 index of 90% (C). The tumor cells are positively stained for STAT6 (D). A: hematoxylin and eosin stain, x200; B: CD34 stain, x100; C: Ki-67 stain, x200, D: STAT6 stain, x100.",gr6,NotMatch,Match
PMC9204631,Figure 1,Clinical and Treatment Timeline.,fonc-12-907324-g001,NotMatch,NotMatch
PMC9204631,Figure 2,"Brain MRI performed 44 days post-operatively and overlying radiotherapy treatment plan. (A) MRI T1 pre-contrast. (B) MRI T1 post-contrast showing peripheral nodular enhancement on the left lateral and posterior surgical bed. (C) Gamma Knife (GK) radiosurgery treatment plan overlying T1 post-contrast MRI brain. The wide post-operative area is represented by the yellow contour. The pink contours delineate the three nodular, high-risk areas.",fonc-12-907324-g002,NotMatch,NotMatch
PMC9204631,Figure 3,Brain MRI performed 34 months after completion of radiotherapy treatment. (A) T1 pre-contrast (B) T1 post-contrast showing no areas of peripheral or nodular enhancement.,fonc-12-907324-g003,NotMatch,NotMatch
PMC9219034,Figure 1.,"CT images prior to the puncture biopsy in 2017. (A) CT indicating a heterogeneously enhanced lung mass measuring up to 44×31 mm in the left upper lobe near the hilum. The arrow indicates the lung mass. (B) Preoperative CT revealed a heterogeneously enhanced round mass measuring up to 31×21 mm in the left thalamus. The arrow indicates the left thalamic mass. (C) CT (bone window) indicated a cavity after resecting the brain tumor and no local recurrence (scale bar, 20 cm). The arrow indicates the cavity after resecting the brain tumor.",ol-24-02-13375-g00,NotMatch,NotMatch
PMC9219034,Figure 2.,"Hematoxylin and eosin staining of different regions of the same solitary fibrous tumor/hemangiopericytoma specimen. (A) An abundance of blood vessels was observed in tumor tissue, with a typical ‘staghorn’ vascularization and a large number of fusiform tumor cells arranged in bundles between blood vessels (magnification, ×200). (B) HE staining indicated that sparse areas and dense areas coexisted (magnification, ×100). (C) Mitotic bodies were visible (black arrow; ≥5 mitoses per 10 high-power fields) (magnification, ×400).",ol-24-02-13375-g01,Match,Match
PMC9219034,Figure 3.,"Immunostaining of lung puncture biopsy specimen in 2017. Immunohistochemistry indicated (A) STAT6 positivity of the tumor cell nuclei, (B) Vimentin positivity in the tumor cells' cytoplasm, (C) CD34 positivity of tumor cell membrane and cytoplasm, (D) Bcl-2 positivity of tumor cell cytoplasm and membrane (magnification, ×200 for all, tumor cells with brownish-yellow staining are immunohistochemically positive).",ol-24-02-13375-g02,NotMatch,NotMatch
PMC9219034,Figure 4.,"Immunostaining of lung puncture biopsy specimen in 2017. Immunohistochemistry indicated (A) SMA negative for tumor cells and positive for vascular smooth muscle, (B) S-100 negative for tumor cells, (C) EMA negative for tumor cells, (D) PR negative for tumor cells (magnification, ×200 for all, brownish yellow indicates positive staining). SMA, smooth muscle actin; EMA, epithelial membrane antibody; PR, progesterone receptor.",ol-24-02-13375-g03,NotMatch,NotMatch
PMC9280824,Figure 1.,(a) Photomicrograph stained with hematoxylin and eosin demonstrates spindled ovoid cells arranged with no discernable architecture or histologic evidence of malignancy. Tumor cells show positive staining for (b) nuclear STAT 6 and (c) diffuse CD34 expression.,10.1177_2473974X221098709-fig1,NotMatch,NotMatch
PMC9280824,Figure 2.,(a) Photomicrograph stained with hematoxylin and eosin demonstrates hypercellular population of spindle cells with pleomorphic and vesicular nuclei. (b) High-power view shows increased mitoses (black arrows).,10.1177_2473974X221098709-fig2,NotMatch,NotMatch
PMC9280824,Figure 3.,Progression-free survival.,10.1177_2473974X221098709-fig3,NotMatch,NotMatch
PMC9327149,Fig. 1,Swimming-plot shows the treatment process for each patient,12893_2022_1718_Fig1_HTML,NotMatch,NotMatch
PMC9327149,Fig. 2,"Patient #3’s pre- and postoperative imaging of ICA balloon embolization. a, b he preoperative imaging, yellow arrow indicates the pseudoaneurysm. c The post-operative imaging",12893_2022_1718_Fig2_HTML,NotMatch,NotMatch
PMC9327149,Fig. 3,Preoperative and postoperative MRI images of the cranial base. a Patient #1. b Patient #2. c Patient #4. d Patient #6,12893_2022_1718_Fig3_HTML,NotMatch,NotMatch
PMC9327149,Fig. 4,"Exposure and protection of ICA in endoscopic endonasal surgery. a Reveal the contents of the PF. b, c Removal of the ET and preservation of the EVP. d–g Removal of lesions around ICA, free ICA. h Fill in autologous fat. i Reconstruction of cranial base with LNF. SS, sphenoid sinus; PS: pterygoid process; IA: infraorbital artery; MA: maxillary artery; PF: pterygopalatine fossa; ET: eustachian tube; EVP: evator veli palatine; IPS: inferior petrosal sinus; ICA: internal carotid artery; PD: petrous drum; LNF: lateral nasal flap",12893_2022_1718_Fig4_HTML,NotMatch,NotMatch
PMC9327149,Fig. 5,a Shows the summarization of clinical symptoms of patients with cranial base HPC/SFT from currently available publications. b Shows the HE staining picture of the typical HPCs’ patient,12893_2022_1718_Fig5_HTML,NotMatch,NotMatch
PMC9362810,Figure 1,Soft-tissue swelling in interdental papilla of 23 and 24,JISP-26-401-g001,NotMatch,NotMatch
PMC9362810,Figure 2,Radiolucency in relation to the interdental region of 23 and 24,JISP-26-401-g002,NotMatch,NotMatch
PMC9362810,Figure 3,"Postoperative photograph: Immediate (a), after 2 weeks (b) after 3 months (c)",JISP-26-401-g003,NotMatch,NotMatch
PMC9362810,Figure 4,"Photomicrograph showing parakeratinized stratified squamous surface epithelium and underlying highly cellular stroma showing numerous proliferating plump and spindle shaped tumor cells with vesicular nuclei (blue arrow) and some vascular spaces in staghorn pattern (a) H and E, ×4, (b) H and E,×20 (c) H and E,×40",JISP-26-401-g004,NotMatch,NotMatch
PMC9364051,Fig. 1,"Computed tomography (CT) scan of the brain in axial view revealing a dural-based right parietal hyperdense mass with surrounding edema, mass effect, compression of the right lateral ventricle's atrium and a right-to-left midline shift.",gr1,NotMatch,NotMatch
PMC9364051,Fig. 2,"Computed tomography (CT) scan of the brain in sagittal view revealing a dural-based right parietal hyperdense mass with surrounding edema, mass effect and compression of the right lateral ventricle's atrium.",gr2,NotMatch,NotMatch
PMC9364051,Fig. 3,"Computed tomography (CT) scan of the brain in coronal view revealing a dural-based right parietal hyperdense mass with surrounding edema, compression of the right lateral ventricle's atrium and a right-to-left midline shift.",gr3,NotMatch,NotMatch
PMC9410498,Figure 1,"A 69-year-old male patient with a second loco-regional recurrence of left supraorbital solitary fibrous tumor. (A) A brain MRI scan revealed on axial MRI T2c+ a rounded lesion on the lateral side of the left orbit, strongly suspected of disease relapse (red arrow). (B) Two weeks later, 18F-FDG PET/CT showed no radiopharmaceutical uptake in the left supraorbital region (red arrow). (C) Conversely, after seven days, 18F-FCH PET/CT showed intense uptake in the aforementioned lesion (red arrow; SUVmax 6.8).",jcm-11-04746-g001,NotMatch,NotMatch
PMC9427069,Figure 1,"T2-weighted sagittal fat-saturated (A) and axial (B) MRI images show a huge sacral and presacral, well-defined, heterogeneous, and intermediate-to-high signal intensity tumor (arrows). Dislocation of adjacent structures (rectum, uterus, and vessels) is also visible.MRI, magnetic resonance imaging",cureus-0014-00000027524-i01,NotMatch,NotMatch
PMC9427069,Figure 2,"T1-weighted fat-saturated axial (A) and contrast-enhanced axial (B) MRI images. Huge sacral and presacral heterogeneous intermediate signal intensity tumor showing an avid post-contrast enhancement (arrows). No signs of infiltration to adjacent soft tissues can be seen.MRI, magnetic resonance imaging",cureus-0014-00000027524-i02,NotMatch,NotMatch
PMC9427069,Figure 3,"A 3D reconstruction of the MR angiography of the tumor showing its hypervascularity and a large blood-supplying vessel from the internal iliac artery (arrows).3D, three-dimensional; MR, magnetic resonance",cureus-0014-00000027524-i03,NotMatch,NotMatch
PMC9427069,Figure 4,"CT of the pelvis (axial view). The arrows indicate the intrasacral tumor obturating the spinal canal and sacral foramina.CT, computed tomography",cureus-0014-00000027524-i04,NotMatch,NotMatch
PMC9427069,Figure 5,"Hematoxylin and eosin staining of tumor tissue at 200x magnification shows capillaries and spindle-shaped cells with moderately atypical nuclei arranged in large palisades (A), strong diffusely positive nuclear STAT6 (B), CD34 (C), membranous (100%) and Ki67 (D) nuclear (4%) staining, and moderate CD99 cytoplasmic and membranous (80%) staining (E).STAT6, signal transducer and activator of transcription 6; CD34, cluster of differentiation 34; CD99, cluster of differentiation 99; Ki67, marker of proliferation Ki67",cureus-0014-00000027524-i05,NotMatch,Match
PMC9462835,Figure 1,Flowchart demonstrating application of inclusion/exclusion criteria to derive analytic set of 34 patients with solitary fibrous tumor/hemangiopericytoma (SFT/HPC).,TCRM-18-901-g0001,Match,NotMatch
PMC9462835,Figure 2,Kaplan-Meier analyses with respect to various endpoints for solitary fibrous tumor/hemangiopericytoma. Shaded area indicates 95% confidence interval. (A) Local central nervous system (CNS) relapse; (B) any/global CNS relapse; (C) extraneural relapse; (D) progression-free survival; (E) overall survival.,TCRM-18-901-g0002,Match,NotMatch
PMC9497113,Figure 1,"Early sagittal contrast-enhanced T1-weighted sequence images MRI (performed at the initial diagnosis) demonstrated a spherical, extra-axial lesion in the right temporal region. The tumor presented with a characteristic peripheral enhancement that could suggest the hypothesis of hemangioperycitoma.",brainsci-12-01209-g001,NotMatch,NotMatch
PMC9497113,Figure 2,"Contrast-enhanced T1-weighted sequence images MRI (performed after surgery and radiotherapy) showed radical removal of the lesion, residual malacic area with no signs of relapsing disease, and no pathological enhancement.",brainsci-12-01209-g002,NotMatch,NotMatch
PMC9497113,Figure 3,"Contrast-enhanced T1-weighted sequence images MRI, performed after partial removal of the recurrence and Gamma Knife.",brainsci-12-01209-g003,NotMatch,NotMatch
PMC9540468,Figure 1,Computed tomography (CT) scan of the abdomen. (A). Non-Contrast CT. (B). Contrast CT.,fsurg-09-968077-g001,NotMatch,NotMatch
PMC9540468,Figure 2,Pathological findings of the surgically resected tumors. (A). Hematoxylin-eosin (HE) staining (×150). (B). Immunostaining for IGF-2 is diffuse positive (×150).,fsurg-09-968077-g002,NotMatch,NotMatch
PMC9549880,Figure 1.,Bevacizumab treatment-related adverse events.,vdac123_fig1,NotMatch,NotMatch
PMC9549880,Figure 2.,"Kaplan-Meier curves for OS (A) and PFS (B) separated by Grade. PFS, progression-free survival; OS, overall survival.",vdac123_fig2,NotMatch,NotMatch
PMC9549880,Figure 3.,"Kaplan–Meier curves for PFS (A) and OS (B) for WHO Grade I and WHO Grade II/III meningioma. WHO, World Health Organization; PFS, progression-free survival; OS, overall survival.",vdac123_fig3,NotMatch,NotMatch
PMC9554559,Figure 1,"Pathological images of intracranial SPF/HPC. (A, B). The tumor showed compact and uniform cells with a large number of small vascular cavities and compact reticular fibers with hematoxylin and eosin stain HE×100 (A) and ×200 (B). (C, D). The positive staining of CD34 was brown granular in the cytoplasm (×100) (C) and (×200) (D). (E, F). The positive staining of STAT6 was brown granular in the cytoplasm (×100) (E) and (x200) (F). (G, H). Negative staining of Ki67 in tumor cells (×100) (G) and (×200) (H).",fonc-12-994335-g001,NotMatch,Match
PMC9554559,Figure 2,Kaplan−Meier estimates of the DFS curves in intracranial SFT/HPC patients with PORT. The DFS of the two groups with different radiotherapy techniques was significantly different (p = 0.003).,fonc-12-994335-g002,NotMatch,NotMatch
PMC9554559,Figure 3,"Kaplan−Meier estimated the TTP curves of 22 intracranial SFT/HPC patients with relapse after PORT who received different treatments again (Ssurgery, surgery plus radiotherapy, others). The others included 3 patients who received radiotherapy alone and 1 patient who received symptomatic treatment. The TTP of the surgery and surgery plus radiotherapy groups was similar, but different from that of the other groups (p = 0.003).",fonc-12-994335-g003,NotMatch,NotMatch
PMC9221085,Figure 1,"Recurrence-free survival (Kaplan–Meier curve) for all patients with a spinal solitary fibrous tumor and at least 12 months of follow-up, based on our series and literature systematic review (n = 35). Each + accounts for a patient death or end of follow-up. Left: for patients with gross total resection compared to subtotal resection. Right: for patients with adjuvant radiotherapy compared to no radiotherapy. Radiotherapy significantly improved recurrence-free survival in patients with subtotal resection.",cancers-14-02839-g001,NotMatch,NotMatch
PMC9221085,Figure 2,"Graphical summary of the characteristics and clinico-radiological presentation of patients with spinal solitary fibrous tumors, including radiological types of SFT on MRI.",cancers-14-02839-g002,NotMatch,NotMatch
PMC9221085,Figure 3,"Graphical summary of the surgery, diagnosis, adjuvant treatments, and outcome of patients with spinal solitary fibrous tumors.",cancers-14-02839-g003,NotMatch,NotMatch
PMC9379674,FIG. 1.,Axial view MRI T1 with contrast. A: Preoperative image showing heterogeneously enhancing mass in the left perimesencephalic/CPA cistern. B: Postoperative image showing gross total resection of the tumor through extended retrosigmoid craniotomy.,CASE21646f1,NotMatch,NotMatch
PMC9379674,FIG. 2.,Histopathology of the resection demonstrates histological features of an SFT.,CASE21646f2,NotMatch,NotMatch
PMC9379674,FIG. 3.,Immunohistochemistry. A: Strong nuclear expression for STAT-6 (200×) confirming solitary fibrous tumor. B: Low Ki-67 of 10% positivity in hotspot (200×).,CASE21646f3,NotMatch,NotMatch
PMC9379674,FIG. 4.,"Axial view MRI T1-contrast images showing s heterogeneously enhancing mass extending from the left perimesencephalic/CPA cistern through the left hypoglossal and jugular foramen to the cervical region. Recurrence of the tumor (A), preoperative (B), postoperative (C) scan showing gross total removal of the tumor through left transotic craniectomy and cranioplasty.",CASE21646f4,NotMatch,NotMatch
PMC9379674,FIG. 5.,"Immunohistochemistry of the second resection demonstrates high-grade malignant histology with (inset) marked nuclear atypia (A), mitotic activity (B), and high Ki-67 proliferative activity (C).",CASE21646f5,NotMatch,NotMatch
PMC9592362,Figure 1.,Axial head CT revealed a 3.4 cm × 2.5 cm well-defined slightly hyperdense mass without peritumoral edema in the left cerebellar hemisphere. CT = computed tomography.,medi-101-e31355-g001,NotMatch,NotMatch
PMC9592362,Figure 2.,"The brain MRI demonstrated a 3.0 cm × 2.1 cm × 2.1 cm ovoid mass in the left occipital. The tumor showed intermediate-slightly decreased signal intensity in T1WI (A) and significantly decreased signal intensity in T2WI (B). Axial (C) DWI did not show diffusion restricted areas. Axial (D), sagittal (E), and coronal (F) enhanced T1WI showed heterogeneous and strong enhancing tumor, connecting with the adjacent meninges by a wide base and compressing the left cerebellar hemisphere. DWI = diffusion weighted imaging, MRI = magnetic resonance imaging, T1WI = T1 weighted images, T2WI = T2 weighted images.",medi-101-e31355-g002,NotMatch,NotMatch
PMC9592362,Figure 3.,"The cells were strongly positive for STAT6 (A) and Vim (B), negative for EMA, S-100, GFAP and PR, Ki-67 (<1%). EMA = epithelial membrane antigen, GFAP = glial fibrillary acidic protein, PR = progesterone receptor, STAT6 = signal transducer and activator of transcription 6, Vim = vimentin.",medi-101-e31355-g003,NotMatch,NotMatch
PMC9608010,Figure 1.,Magnetic resonance imaging of brain at initial presentation.,10.1177_23247096221132244-fig1,NotMatch,NotMatch
PMC9608010,Figure 2.,Computed tomography of the liver showing multiple liver lesions.,10.1177_23247096221132244-fig2,NotMatch,NotMatch
PMC9608010,Figure 3.,Magnetic resonance imaging of brain at recurrence post surgery.,10.1177_23247096221132244-fig3,NotMatch,NotMatch
PMC9608010,Figure 4.,Hematoxylin and eossin tain of liver biopsy.,10.1177_23247096221132244-fig4,NotMatch,NotMatch
PMC9608010,Figure 5.,Strong STAT 6 positivity on liver.,10.1177_23247096221132244-fig5,NotMatch,NotMatch
PMC9600947,Figure 1,(A): MRI imaging—T1WI Sagittal plane showed a homogeneous dark T1 signal of the mass (arrows). (B): Contrast-enhanced MRI imaging with fat saturation—axial and sagittal plane showed intense homogenous contrast enhancement of the tumor.,diagnostics-12-02473-g001,NotMatch,NotMatch
PMC9600947,Figure 2,"US showed a solid mass (arrows) located within the brachial artery wall, encasing the vessel.",diagnostics-12-02473-g002,NotMatch,NotMatch
PMC9600947,Figure 3,(A): Doppler US showed no stenosis of the brachial artery with good blood flow. (B): Doppler US showed the mass having a small nutritive artery originating in the brachial artery.,diagnostics-12-02473-g003,NotMatch,NotMatch
PMC9600947,Figure 4,Surgical specimen: Gross macroscopic appearance of the tumor with central patent arterial lumen (arrows).,diagnostics-12-02473-g004,NotMatch,NotMatch
PMC9600947,Figure 5,Histopathological findings of the surgical specimen: (a) H/E staining (b) trichrome Masson staining (c) CD 31 (d) alpha actin.,diagnostics-12-02473-g005,NotMatch,NotMatch
PMC9592151,Figure 1,"Imaging characteristics of the V3 lesion. (a) CT scan axial, sagittal and coronal views (brain and bone window) showing the lesion in the left middle fossa with enlargement of the foramen ovale (asterix). The lesion (arrow) is uniformly enhancing with a large capping cyst causing mass effect. (b) MRI scan coronal and axial views showing a mixed solid and cystic lesion (arrow) in proximity to the Meckel’s cave.",rjac445f1,NotMatch,NotMatch
PMC9592151,Figure 2,"Surgical technique. (a) Skin incision; (b) drilling of the lesser wing of the left sphenoid bone; (c) incision of the meningo-orbital band, (d) dura propria and periosteal dura at the superior orbital fissure, (e) dura propria and periosteal dura at the foramen rotundum, (f) tumor coming into view at the foramen ovale, (g) visualization of the foramen ovale from intradurally after tumor debulking.",rjac445f2,NotMatch,NotMatch
PMC9592151,Figure 3,"Electromyography of trigeminal nerve (motor). Trigger EMG of the motor branches of the trigeminal nerve with positive motor responses (mentalis muscle EMG). Nearby cranial nerves were additionally monitored including the facial nerve CN VII (orbicularis oculi, orbicularis oris and mentalis muscle) and abducens nerve CN IV (lateral rectus muscle).",rjac445f3,NotMatch,NotMatch
PMC9592151,Figure 4,"Direct nerve stimulation of the sensory V2. Direct nerve stimulation of the sensory branch V2 at the foramen ovale demonstrating cortical SSEPs recorded from scalp electrodes (montages C4’-Cz’, C4’-Fz, C4’-C3’) accordingly to the international 10–20 EEG system. Average latency: 5.4 ms, amplitude: 12.5 μV.",rjac445f4,NotMatch,NotMatch
PMC9592151,Figure 5,"Trigeminal V2 SSEP recordings. Trigeminal V2 SSEPs were continuously recorded on the scalp using the montage C4’-Fz. Average latency: 5.4 ms, amplitude: 13 μV.",rjac445f5,NotMatch,NotMatch
PMC9592151,Figure 6,Blink reflex. Blink reflex from left side stimulation of the supraorbital branch of the trigeminal nerve was observed with EMG activity from left orbicularis oculi muscle. Both early response (R1) and late reflex activity (R2) were recorded throughout the surgical procedure.,rjac445f6,NotMatch,NotMatch
PMC9610592,Figure 1:,"T2-weighted axial (a), T1-weighted sagittal (b), and T1-weighted contrast-enhanced sagittal magnetic resonance imaging (c) showing an intradural extramedullary mass at the C1 level (red arrow in (a),(b),(c)). The mass is hyperintense on T2 and isointense on T1 and is heterogeneously enhanced with gadolinium. Flow voids can be seen around the tumor (blue arrow) (a). T2-weighted sagittal MRI reveals a syringobulbia and syringomyelia (red arrow) (d). A scheme demonstrates the anatomical relationship between the tumor and the spinal cord (e). The tumor is an extramedullary mass with pial invasion or a subpial mass with extramedullary extension.",SNI-13-443-g001,NotMatch,NotMatch
PMC9610592,Figure 2:,Digital subtraction angiogram of the right vertebral artery showing dense tumor stain supplied by C1 and C2 radicular arteries (arrow).,SNI-13-443-g002,NotMatch,NotMatch
PMC9610592,Figure 3:,"Intraoperative picture showing intradural extramedullary mass with pial invasion. It was red, vascular, and richly supplied by blood vessels (a). Oozing from the tumor was controlled by hemostatic materials (*). Total gross removal was accomplished (b).",SNI-13-443-g003,NotMatch,NotMatch
PMC9610592,Figure 4:,A photograph of the surgical specimen shows large vascular spaces with the typical Staghorn appearance of the vessels.,SNI-13-443-g004,NotMatch,NotMatch
PMC9610592,Figure 5:,The postoperative T2-weighted magnetic resonance imaging 6 years after the operation shows complete tumor resection with a resolution of syringobulbia and syringomyelia.,SNI-13-443-g005,NotMatch,NotMatch
PMC9610592,Figure 6:,Anatomic location of the tumor. The tumor was most commonly located in the thoracic region followed by the cervical and lumbar levels.,SNI-13-443-g006,NotMatch,NotMatch
PMC9608766,Figure 1,"Brain MRI showed that the tumor was located in the left temporo-occipital fossa. T2WI sequence showed that the lesion was high signal (A, arrow). Diffusion-weighted imaging showed that the movement of water molecules was not restricted and showed heterogeneous low signal (B, arrow). The T1WI sequence showed that the lesion was slightly low signal (C, arrow), and the solid component of the tumor was significantly enhanced on contrast-enhanced T1WI, with multiple unenhanced cysts around it, and septum-like enhancement was seen in between (D, arrows).",fonc-12-1035800-g001,NotMatch,NotMatch
PMC9608766,Figure 2,"Hematoxylin–eosin staining showed that the tumor tissue was composed of small round cells with relatively uniform morphology, and the nuclei were deeply stained (A). Immunohistochemical staining showed that tumor cells positively expressed CD99 (B), Vimentin (C), and Bcl-2 (D).",fonc-12-1035800-g002,NotMatch,NotMatch
PMC9608766,Figure 3,"The patient’s 18F-FDG PET/CT at 5 years after operation; the maximum intensity projection figure showed multiple FDG concentration foci throughout the body (A, arrows). Axial figures showed that the right humerus (B, CT; C, PET/CT fusion), ilium (D, CT; E, PET/CT fusion), and acetabulum (F, CT; G, PET/CT fusion) can be seen with iso-density or slightly hypodense bone destruction areas with high radioactive uptake (arrows). Moreover, a hypodense mass with FDG accumulation was seen in the right iliopsoas muscle (H, CT; I, PET/CT fusion, arrows).",fonc-12-1035800-g003,NotMatch,NotMatch
PMC9608766,Figure 4,"The gender and age distribution (A) and country proportion (B) of 31 adult patients with primary intracranial EWs/PNET, and imaging features of primary intracranial EWs/PNET (C).",fonc-12-1035800-g004,NotMatch,NotMatch
PMC9608766,Figure 5,"Kaplan–Meier OS. (A) OS in all cases; (B) OS by gender; (C) OS by whether there are cranial invasion or distant metastasis. CIM, cranial invasion or distant metastasis; MST, median survival time; OS, overall survival.",fonc-12-1035800-g005,NotMatch,NotMatch
PMC9634459,Figure 1,Solitary fibrous tumor: clinical findings. Firm subcutaneous nodule (arrow) overlying the right lateral supraorbital rim. This image is published with the patient’s consent.,acr-06-22-17-f1,NotMatch,NotMatch
PMC9634459,Figure 2,"Solitary fibrous tumor: histologic findings. Dermal neoplasm consisting of spindle cells arranged in a “patternless” pattern featuring hemangiopericytoma-like vessels (arrows) dispersed throughout shown at both low (A,B) and high power (C) (hematoxylin and eosin, H&E, ×2.5, ×10, and ×20). The spindle cell population exhibits diffuse nuclear STAT6 positivity (D) (STAT6 immunohistochemistry ×20). Note that the vascular endothelial cells do not stain positive for STAT6 (D). STAT6, signal transducer and activator of transcription 6.",acr-06-22-17-f2,Match,Match
PMC9634459,Figure 3,"Proposed approach to management of superficial solitary fibrous tumor. Complete removal of tumor is advised following pathologic diagnosis if partial biopsy is obtained. SFT risk score is calculated via the model proposed by Demicco et al. (see Table 1). Serial examinations should include at a minimum: evaluation of the primary excision site, regional lymphatic examination, and review of systems. Further studies (e.g., imaging, laboratory evaluation) are guided by examination findings as well as the review of systems. If at any time metastatic or recurrent disease is suspected, prompt referral to radiation and/or medical oncology for management is recommended. STAT6, signal transducer and activator of transcription 6; PET, positron emission tomography; CT, computed tomography; SFT, solitary fibrous tumor.",acr-06-22-17-f3,NotMatch,NotMatch
PMC9699857,Figure 1:,The preferred reporting items for systematic reviews and meta-analyses protocol used for the qualitative review.,SNI-13-532-g001,NotMatch,NotMatch
PMC9699857,Figure 2:,(a) Coronal and (b) sagittal T1-weighted images demonstrating the diffusely infiltrating hyperintense tumor causing marked compression on the left and anterior spinal cord surfaces. Of notice the extraspinal extension through the left third and fourth foramina and the anterior component of the lesion located anteriorly to the third and fourth vertebral bodies. (c) Sagittal T2-weighted scan showing the inhomogeneous hypointensity of the lesion. (d) The paraspinal and the intra-extradural components of the tumor exhibited homogeneous gadolinium enhancement. (e) Postoperative T2-weighted image documented successful decompression of the spinal cord and debulking of the intraspinal component of the tumor. (f) Axial T1-weighted image after the administration of contrast showing considerable reduction of the paraspinal component of the solitary fibrous tumors/hemangiopericytomas following the four cycles of chemotherapy.,SNI-13-532-g002,Match,NotMatch
PMC9699857,Figure 3:,"Histological images showing (a) a moderately cellular tumor exhibiting ovoidal and spindle cells arranged in small fascicles and embedded in a collagenous stroma (Hematoxylin eosin). (b) Malignant cells did not show neither signs of cytologic atypia nor necrosis and present a low mitotic count (Hematoxylin eosin). (c) Immunohistochemistry shows strong and diffuse positivity for CD34, a pattern consistent with the diagnosis of solitary fibrous tumors.",SNI-13-532-g003,NotMatch,NotMatch
PMC9719821,Figure 1.,"
Changes in renal function before and 6 months after thermal ablation. The mean eGFR was 86.4 ± 27.0 mL/min/1.73 m2 (range: 34.6–128.3 mL/min/1.73 m2), and eGFR decreased significantly to 75.7 ± 25.5 mL/min/1.73 m2 (range: 15.2–101.3 mL/min/1.73 m2) at 6 months after thermal ablation.
",2432-0935-7-3-0085-g001,NotMatch,NotMatch
PMC9719821,Figure 2.,"
Kaplan–Meier curve of the local tumor control rate after thermal ablation for renal metastasis. The local tumor control rate was 93.3% (95% confidence interval [CI], 80.7%–100%) at 1, 3, and 5 years.
",2432-0935-7-3-0085-g002,NotMatch,NotMatch
PMC9719821,Figure 3.,"
Kaplan–Meier curve of progression-free survival after the initial thermal ablation for renal metastasis. The progression-free survival rate was 7.7% (95% confidence interval [CI], 0%–22.2%) at 1 and 3 years.
",2432-0935-7-3-0085-g003,NotMatch,NotMatch
PMC9719821,Figure 4.,"
Kaplan–Meier curve of overall survival after the initial thermal ablation for renal metastasis. The median survival time was 24.3 months. The overall survival rates after renal ablation were 76.9% (95% confidence interval [CI], 54.0%–99.8%) and 59.3% (95% CI, 31.3%–87.3%) at 1 and 3 years, respectively.
",2432-0935-7-3-0085-g004,NotMatch,NotMatch
PMC9830289,Fig. 1,"a Preoperative cranial MRI (T1 sequence) revealing a well-defined, isointense lesion at the right parietal bone with endo and exocranial extension. b Preoperative cranial CT scan (bone window) showing a lytic lesion at the right parietal bone with erosion of both cortical layers.",cro-0015-1021-g01,NotMatch,NotMatch
PMC9830289,Fig. 2,"Pathological and immunohistochemical analysis. a Patternless architecture with hypercellular and hypocellular areas and “stag-horn” vessels (hematoxylin and eosin; original magnification, ×50). b Bland, ovoid to spindle nuclei cells with hyaline collagen deposition (hematoxylin and eosin; original magnification, ×400). c Diffuse nuclear STAT6 expression (original magnification, ×400). d Positive immunostaining for CD34 (original magnification, ×400). e Gordon and Sweet's silver impregnation showing demonstration of reticulin fibers (original magnification, ×100). f Negative immunostaining for EMA (original magnification, ×400). g Negative immunostaining for somatostatin 2A receptors (original magnification, ×400).",cro-0015-1021-g02,NotMatch,Match
PMC9830289,Fig. 3,"Treatment volumes contoured for adjuvant RT; tumor bed is represented in green, CTV in red, and PTV in blue. Dose distribution is displayed in color wash.",cro-0015-1021-g03,NotMatch,NotMatch
PMC9689021,Figure 1,Axial (A) and coronal plane (B) of the pre-interventional CT scan of case #1 depicting a 13 cm measuring SFT/HPC in the right liver lobe (white arrows). Corresponding axial (C) and coronal plane (D) of the last follow-up CT scan 36 months after the initial diagnosis of liver metastasis and 11 months after the last SRFA session with progressively shrinking coagulation zone (white arrowheads).,curroncol-29-00687-g001,NotMatch,NotMatch
PMC9689021,Figure 2,"Axial (A) and coronal plane (B) of initial CT scans demonstrating very large SFT/HPC liver metastases in both right (white arrows) and left (white arrowheads) liver lobe. CT scan in axial (C) and coronal plane (D) after three TAE sessions revealing insufficient devascularization of the right liver lobe lesion anteriorly (white arrows). Note the beam hardening artifacts (red arrows) in the hepatic artery. Post-interventional CT scan (E) after first SRFA with laparoscopic liver packing (protection of cardio-esophageal region) showing coagulation zone (white arrowheads) with no residual vital tumor tissue visible. Contrast-enhanced MRI scan four months after first SRFA revealing a new metastasis in liver segment II (white arrows; (F)) and local recurrence in segment III following TAE (white arrowheads; (G)). MRI scan depicting three of six new liver lesions in segment IVa (white arrows; (H)) after resection of left lateral segments, all of them successfully treated with SRFA. MRI scans 15 months after the last intervention showing local recurrence at the resection margin (white arrows; (I)) and multiple new liver metastases (J).",curroncol-29-00687-g002,NotMatch,NotMatch
PMC9689021,Figure 3,"Axial (A) and coronal plane (B) of initial CT scans demonstrating multiple large SFT/HPC liver metastases affecting both right (white arrows) and left (white arrowheads) liver lobe. Axial (C) and coronal (D) plane of control CT scans following a total of six TAE sessions revealing mixed response with residual vital tumor tissue in liver segment II/III (white arrowheads; (D)). CT scans nine months after resection of left lateral segments revealing recurrent lesions in segments V, VI, VII (white arrowheads; (E,F)) and two new lesions in segments IVa and VII (white arrows; (E)). Successful treatment of recurrent lesions after a total of six SRFA and one additional TAE session as shown in the first follow-up CT scan after the last SRFA (white arrowheads; (G)). CT scan obtained following syncope 18 months after the last intervention revealing diffuse metastatic liver disease (white arrowheads; (H)), peritoneal metastases (white arrows; (H)), and ascites (red arrow; (H)) 18 months after the last intervention.",curroncol-29-00687-g003,NotMatch,NotMatch
PMC9840894,Figure 1,Preoperative magnetic resonance examination performed on the axial plane showing an extra-axial mass measuring 2x3cm localized on the left parietooccipital area.,cureus-0014-00000032607-i01,NotMatch,NotMatch
PMC9840894,Figure 2,Immunostaining with STAT6 showing diffuse strong positive staining of the neoplastic cells.,cureus-0014-00000032607-i02,NotMatch,NotMatch
PMC9840894,Figure 3,Hematoxylin and eosin showing short haphazard fascicles of spindle cells with many mitotic figures.,cureus-0014-00000032607-i03,NotMatch,NotMatch
PMC9840894,Figure 4,Positron emission tomography (PET) scan showing multiple F-fluorodeoxyglucose (FDG) avid pulmonary nodules (A) and bony lesions in the second thoracic vertebrae (B),cureus-0014-00000032607-i04,NotMatch,NotMatch
PMC9840894,Figure 5,Computed tomography (CT) showing expansile lesion in the upper third of the right humeral bone.,cureus-0014-00000032607-i05,NotMatch,NotMatch
PMC9899901,Figure 1,Flow diagram of the study.,fonc-12-977629-g001,NotMatch,NotMatch
PMC9899901,Figure 2,The distribution of the patients based on age at diagnosis.,fonc-12-977629-g002,NotMatch,NotMatch
PMC9899901,Figure 3,"Kaplan–Meier curve of overall survival. The patients were stratified by age at diagnosis (A), tumor behavior (B), tumor location (C), distant metastasis (D), and surgery (E). Picture (F) showed the Kaplan–Meier curve of the whole cohort.",fonc-12-977629-g003,NotMatch,NotMatch
PMC9913492,Figure 1,Flow chart of the study.,cancers-15-00704-g001,NotMatch,NotMatch
PMC9913492,Figure 2,"Survival analysis in newly diagnosed and recurrent iSFT patients. (A) Survival curve according to the Kaplan–Meier method showing median OS, (B) PFS, and (C) LRFS in newly diagnosed iSFTs and (D) OS2 and (E) PFS2 after the first recurrence, with their respective 95% confidence intervals (95% CI). NR: nonreached.",cancers-15-00704-g002,NotMatch,NotMatch
PMC9913492,Figure 3,"The survival curve obtained with the Kaplan–Meier method showing the difference in OS according to tumour location (A), PFS according to the WHO grade (B), LRFS according to the WHO grade (C), and LRFS according to the extent of resection with newly diagnosed iSFT (D) with their respective p value, significant if <0.05.",cancers-15-00704-g003,NotMatch,NotMatch
PMC9907904,,,medi-102-e32983-g001,Empty,Empty
PMC9913704,Figure 1,Kaplan–Meier curves representing overall survival in the NCDB (A) and overall (B) and cause-specific survival (C) in the SEER database based on risk groups.,cancers-15-00876-g001,NotMatch,NotMatch
PMC9913704,Figure 2,"Kaplan–Meier curves for overall survival in the NCDB for low-risk (A), intermediate-risk (B), and high-risk (C) groups, based on the receipt of radiotherapy (RT).",cancers-15-00876-g002,NotMatch,NotMatch
PMC9955746,Figure 1,The onset age distribution of solitary fibrous tumors (SFTs) of the lung.,curroncol-30-00138-g001,NotMatch,NotMatch
PMC9955746,Figure 2,The occurrence site distribution of solitary fibrous tumors (SFTs) of the lung.,curroncol-30-00138-g002,NotMatch,NotMatch
PMC9955746,Figure 3,"Chest CT findings of a typical solitary fibrous tumor (SFT) of the lung. (A) Lung window: Red arrow shows a well-demarcated soft tissue density shadow, which is nodular and located at the hilum, with regular morphology. (B) Plain scan of the mediastinal window: the red arrow indicates the tumor. (C) Arterial phase scan of the mediastinal window: red arrow indicates the tumor. (D) Venous phase scan of the mediastinal window: red arrow indicates the tumor.",curroncol-30-00138-g003,NotMatch,NotMatch
PMC9955746,Figure 4,"Pathological features and immunophenotypes of borderline solitary fibrous tumors (SFTs) of the lung. (A) The distribution of the tumor cells showed dense areas and sparse areas, and dilated blood vessels could be found. (B) The tumor cells were found in a whorled pattern in dense areas. (C) The tumor cells were spindle-shaped and uniform in size. Some tumor cells showed mild atypia. (D) Glass-like plastic collagen fibers were interspersed between the tumor cells. The number of spindle tumor cells and collagen fibers was almost equal. (E) Hemangiopericytoma-like conformation. (F) Numerous collagen fibers were observed in the tumor, but spindle tumor cells were relative few. (G) The tumor cells and vascular endothelial cells showed cytomembrane strong positivity for CD34. (H) The tumor cells showed nuclear strong positivity for STAT6. (I) The tumor cells showed cytoplasmic strong positivity for Vimentin. (J) The tumor cells showed both nuclear and cytoplasmic strong positivity for BCL2. (K) The tumor cells showed both nuclear and cytoplasmic strong positivity for CD99. (L) The number of Ki-67-positive cells was <5% (Ki-67 index <5%).",curroncol-30-00138-g004,Match,NotMatch
PMC9955746,Figure 5,"Pathological features and immunophenotypes of a malignant solitary fibrous tumor (SFT) of the lung. (A) The tumor cells were densely packed, and dilated vessels could be found; (B) the tumor cells were distributed around vessels; (C) the tumor cells were spindle-shaped with significant atypia; (D) frequent mitotic figures were observed (red arrows); (E) tumor necrosis was observed; (F) the tumor cells and vascular endothelial cells showed cytomembrane strong positivity for CD34; (G) the tumor cells showed both cytoplasm and cytomembrane strong positivity for BCL2; (H) the tumor cells showed both cytoplasm and cytomembrane strong positivity for CD99; (I) the number of Ki-67 positive cells was >20%(Ki-67 index >20%).",curroncol-30-00138-g005,NotMatch,NotMatch
PMC10081489,Figure 1,Bone scan of the patient showing multiple uptakes similar to metastasis.,fendo-14-1116793-g001,NotMatch,NotMatch
PMC10081489,Figure 2,"
(A, C) Maximum-intensity projection images of the patient. (B, D) Axial views of the sphenoid sinus tumor (B) and the axillary tumor (D) in 68-gallium 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid octreotate (Ga-68-DOTATATE) positron emission tomography (PET). (E, G) Axial views of the sphenoid sinus tumor (E) and the axillary tumor (G) in CT. (F, H) Fusion images.",fendo-14-1116793-g002,NotMatch,NotMatch
PMC10081489,Figure 3,"
(A, C) Maximum-intensity projection images of the patient. (B, D) Axial views of the sphenoid sinus tumor (B) and the axillary tumor (D) in 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography (18F-FDG PET). (E, G) Axial views of the sphenoid sinus tumor (E) and the axillary tumor (G) in CT. (F, H) Fusion images.",fendo-14-1116793-g003,NotMatch,NotMatch
PMC10148174,Figure 1,"Magnetic resonance imaging (MRI) T1, objectified a left temporo-parieto-occipital intraaxial",PAMJ-44-58-g001,NotMatch,NotMatch
PMC10148174,Figure 2,morphological and immunohistochimical appearance of a grade 3 malignant hemangiopericytoma of the 2016 WHO classification,PAMJ-44-58-g002,Match,NotMatch
PMC10148174,Figure 3,"MRI T1, axial section showing the disappearance of the tumor",PAMJ-44-58-g003,NotMatch,NotMatch
PMC10240854,Figure 1.,Non-contrast computed tomography and contrast-enhanced computed tomography scan of nose and PNS. Mild enhancement seen on contrast-enhanced computed tomography.,10.1177_2050313X231173787-fig1,NotMatch,NotMatch
PMC10240854,Figure 2.,Gross specimen after endoscopic surgical excision.,10.1177_2050313X231173787-fig2,NotMatch,NotMatch
PMC10240854,Figure 3.,Pathological section: respiratory epithelium with diffuse spindle cell proliferation and staghorn blood vessels in stroma.,10.1177_2050313X231173787-fig3,NotMatch,NotMatch
PMC10121372,Fig. 1,"
Axial (
a
), coronal (
b
), and sagittal (
c
) T2-weighted images centered on the cerebellopontine angle demonstrate a homogeneous extra-axial mass with internal vascularity with mass effect on the pons, middle cerebellar peduncle, and cerebellum. The mass occupies the expected location of cranial nerves V,VI,VII,VIII. (
d
). Balanced Fast Field Echo (FFE) sequence (a sequence that allows detailed visualization of the cranial nerves in the posterior fossa) demonstrates expected locations of CN VI in Dorello's canal (
white arrow
) and CN VII and CN VIII (
black arrow
). There is a large mass within the right cerebellopontine angle extending into the right internal auditory canal and occupying the prepontine cistern along the expected course of the right CN VI. Visualization of the right-sided cranial nerves is obscured by the mass. There is mass effect on the pons and middle cerebellar peduncle with partial effacement of the fourth ventricle. (
e
) Coronal T2-weighted image at the level of the internal acoustic meatus demonstrates normal left-sided CN V (
white arrow
) and CN VII and CN VIII (
black arrow
). These spaces are occupied by the mass on the right and obscure visualization of the cranial nerves.
",10-1055-a-2065-9809-i22sep0064-1,NotMatch,NotMatch
PMC10121372,Fig. 2,"
(
a
) Hematoxylin and eosin (H&E) (×20) shows a uniform, small, bland tumor cells some with plasmacytoid appearance. (
b
) H&E (×40), nuclear molding with sparse areas of background necrosis, fine granular chromatin with inconspicuous nucleoli and few mitotic figures, few apoptotic bodies and vascular infiltration. (
c
) CD56 strong diffusely positive. (
d
) Synaptophysin strong diffusely positive. (
e
) Chromogranin A strong diffusely positive. (f) Ki67 8%, which categorizes a grade 2 (3–20% Ki67 index).
",10-1055-a-2065-9809-i22sep0064-2,NotMatch,Match
PMC10121372,Fig. 3,"
(
a
) Nuclear Medicine (NM) gallium 68 PET/CT scan showing site of greater uptake in the left lower lobe (
bottom right arrow
) of the thyroid gland that corresponds to a low-density site on the CT (
b
) (
bottom right arrow
).
",10-1055-a-2065-9809-i22sep0064-3,NotMatch,NotMatch
PMC10363678,Figure 1,"MRI and Enhanced MRI images. (A) Show hyper-intense signal in the patient's lumbar MRI images. The size of the mass ~3.3 x 4.3 cm. (B–D) Show hyper-intense signal in the patient's cranium Contrast-Enhanced MR imaging. The largest signal shadow was found in the left occipital lobe, measuring ~5.3 x 4.1 cm. It was accompanied by a ruptured hemorrhage, some of which entered the left lateral ventricle. (B–D) Are axial images, with the red arrow indicating the mass.",fneur-14-1201964-g0001,NotMatch,Match
PMC10363678,Figure 2,"Enhanced CT and Pathology images. (A) Show a caudal pancreatic occlusion combined with bleeding (~6.1 x 13.5 x 8.0 cm in size). (B) Shows that the cells were also short spindle or ovoid in shape, with inconspicuous nucleoli and 3–5 nuclear fission images/10 HPF. Its features at red rectangle.",fneur-14-1201964-g0002,NotMatch,NotMatch
PMC10363678,Figure 3,"Appearance of the resected tissue and pathology images. (A) Shows the swelling was fish-like in appearance, gray in color, and slightly soft in texture. (B) Shows cranial pathology imagines.",fneur-14-1201964-g0003,NotMatch,NotMatch
PMC10363678,Figure 4,"Axial cranial CT image. (A–C) Confirmed that the left remaining occipital lobe mass (measuring 6.7 × 4.2 cm), with increased surrounding hemorrhage, and herniation formation of the left temporal lobe hook gyrus and parahippocampal gyrus.",fneur-14-1201964-g0004,NotMatch,NotMatch
PMC10363678,Figure 5,Enhanced MRI images. (A–C) Are consistent with postoperative total resection. (D–F) Show no obvious signs of recurrence of intracranial lesions in a recent review.,fneur-14-1201964-g0005,NotMatch,NotMatch
PMC10370977,Fig. 1,Right internal carotid angiogram in lateral view. Tumor stain around cavernous sinus retains until the late phase (large arrow) with a dilated feeder connecting two compartments of the tumor (arrow). (A) Arterial phase. (B) Early venous phase. (C) Late venous phase.,jnet-15-316-g001,NotMatch,NotMatch
PMC10370977,Fig. 2,Right internal carotid angiogram in lateral view. True pial feeders are seen in parasagittal lesion (arrow).,jnet-15-316-g002,NotMatch,NotMatch
PMC10370977,Fig. 3,Left vertebral angiogram in oblique view shows early venous filling of superior sagittal sinus (arrow) indicating AV shunt in the tumor. (A) Early arterial phase. (B) Late arterial phase. (C) Injection from the microcatheter advancing just proximal to the tumor. White arrowhead in (B) indicates the same site of black arrowhead in (C). AV: arteriovenous,jnet-15-316-g003,NotMatch,NotMatch
PMC10370977,Fig. 4,"(A) Gd-enhanced MRI in sagittal plane. The tumor is extending into spinal canal and pharynx (white arrows). (B) Gd-enhanced MRI in the axial plane. Dumbbell-shaped tumor is seen (white arrow). (C) Postoperative MRI. Tumor is completely removed. (D) Left vertebral angiogram in lateral view, showing tumor stain in multiple compartments. (E) NBCA is injected into the dilated connecting the feeder and the tumor. (F) The microcatheter is inserted into the dilated feeders in the spinal canal (thin arrow) from the ascending pharyngeal artery through the hypoglossal canal. (G) Tumor stain disappears completely. Gd: gadolinium; NBCA: N-butyl-2-cyanoacrylate",jnet-15-316-g004,NotMatch,NotMatch
PMC10372045,Fig. 1,"(A, B) Pretreatment Maximum Intensity Projection postcontrast venous coronal and axial CT before 2 combined treatment depicting the hypervascular hemangiopericytoma with erosion of the scapula. (C) Postcontrast coronal MRI after the 2 combined treatment focused in depicting the necrotic area in the medial portion of the lesion. (D) Postcontrast axial MRI after 2 combined treatment focused in depicting the necrotic area in the lateral portion of the lesion.",gr1,Match,NotMatch
PMC10372045,Fig. 2,First combined treatment of the medial portion of the lesion. (A) Preprocedure angiography from 6 Fr sheet from right subclavian artery demonstrates hypervascular lesion in periscapular-subclavian region with multiple feeder arising from subclavian and axillary arteries. (B) Fluoroscopic image depicts 5 cryobrobes and 2 microballoon catheters positioned in the 2 main feeders (arrows). (C) Postprocedure angiography demonstrating marked reduction of vascularization in the treated portion of the tumor. (D) Picture of the 5 cryoprobes.,gr2,NotMatch,NotMatch
PMC10372045,Fig. 3,Second combined treatment of the lateral portion of the lesion. (A). Preprocedure angiography from 6 Fr sheet from right subclavian artery demonstrates hypervascular lesion in periscapular-subclavian region with multiple feeder arising from subclavian and axillary arteries; angiography demonstrates reduction of vascularization in the previous treated portion. (B) Fluoroscopic image depicting 2 microballoon catheters positioned in the 2 main feeders (arrows). (C). Fluoroscopic image shows 5 cryoprobes positioned in the lateral portion of the lesion. (D) Postprocedure angiography demonstrating marked reduction of vascularization in the treated portion of the tumor.,gr3,NotMatch,NotMatch
PMC10447192,Figure 1.,"Magnetic resonance imaging findings.A. Before the initial surgery, a tumor arose from the left nerve root at the T4/5 level. B. Before separation surgery, magnetic resonance images showed spinal cord compression secondary to the regrowth of the recurrent tumor and progressive T4 vertebral invasion.",2432-261X-7-0402-g001,NotMatch,NotMatch
PMC10447192,Figure 2.,Intraoperative images of separation surgery.Gelfoam (1-cm thick) wrapped with Goa-Tex membrane (A) was placed between the dura mater and residual tumor as a spacer (B). Ti-alloy rods were applied medially to allow for the optimal trajectory of irradiation (C).,2432-261X-7-0402-g002,NotMatch,NotMatch
PMC10447192,Figure 3.,"Irradiation simulation of carbon ion radiotherapy (CIRT) and magnetic resonance imaging (MRI) after separation surgery and CIRT.A and B: Irradiation dose distribution on axial computed tomography images and simulation plans of the beam angle with or without rod medialization (yellow arrowheads indicate rod intervals). The area within the red outline is the gross tumor volume, and the lung volume included in the irradiated field is smaller in the simulation plan with rod medialization.C and D: MRI images after separation surgery and adjuvant CIRT are shown. The spinal cord and tumor were separated by Gelfoam wrapped with a Goa-Tex membrane after separation surgery, but a residual tumor was observed in the T4 vertebral body (C). At 1 year after adjuvant CIRT, MRI showed that the tumor size had decreased and local control was maintained (D) (C and D, red dotted lines indicate residual tumor).",2432-261X-7-0402-g003,NotMatch,NotMatch
PMC10447192,Figure 4.,"Histopathology.Hematoxylin-eosin stain: A. Yellow arrowheads indicate staghorn-like vessels (20× magnification). B. Cellular spindle cell tumor with nuclear atypia and high mitotic activity (400× magnification). According to immunohistochemistry, their intervening blood vessels expressed the biomarker CD34 (C), and tumor cells were positive for the nuclear marker STAT6 (D), indicating solitary fibrous tumor/hemangiopericytoma (200× magnification).",2432-261X-7-0402-g004,Match,NotMatch
PMC10499534,Figure 1,"Representative images of intracranial hemangiopericytoma invading the CoS, the SSS, and RTS. (a) CT scan images shows the bony invasion. (b) MRI shows heterogeneously enhancing mass inside the confluent of sinuses. (c) Brainlab® 3D reconstruction of the tumor (red) in relation with dural sinuses (blue).",CRIS2023-2349363.001,Match,NotMatch
PMC10499534,Figure 2,"
(a and b) Pre-operative carotid angiogram revealing the occlusion of the posterior third of the SSS (red arrow) by the tumor. (c) Right external carotid angiogram, moderate tumor stain feeding from the occipital artery (yellow arrow) was observed. The strait sinus directly connects to the left transverse sinus (black arrow).",CRIS2023-2349363.002,NotMatch,NotMatch
PMC10499534,Figure 3,"Illustration of the surgical steps. After exposing the CoS, bilateral TSs, and distal SSS. (a) 4 silk knots were closed at the edges of the tumor. (b) Complete removal of the dural sinuses after partial debulking of the tumor was performed.",CRIS2023-2349363.003,NotMatch,NotMatch
PMC10499534,Figure 4,"Post-operative MRI confirming the GTR of the tumor with no signs of recurrence at (a) 24 hours, (b) 3 months, (c) 6 months, and (d) 12 months. No signs of cerebral venous infarction after complete removal of the tumor.",CRIS2023-2349363.004,NotMatch,NotMatch
PMC10405728,Figure 1,Comparison of preoperative and postoperative imaging. Preoperative enhanced MRI showed heterogeneous enhancement in the bilateral frontal-parietal with a size of 5.12x9.19x6.03cm; the adjacent brain tissue and ventricle were significantly compressed and there was obvious peritumoral edema (A–C). Postoperative cranial CT and MRI demonstrated tumor was partially resected (D–F).,fonc-13-1172143-g001,NotMatch,NotMatch
PMC10405728,Figure 2,"Preoperative MRI showed slight long T2 signal shadow in the frontal-parietal lobe; after enhancement, the lesion demonstrated heterogeneous enhancement with a size of 7.1x5.0x3.7(A–D). Preoperative cerebral angiography indicated that the bilateral middle meningeal artery mainly supplied the tumor (E); after the embolization, cerebral angiography showed that the bilateral middle meningeal artery no longer supplied blood to the tumor, and the tumor staining became weak (F). Postoperative MRI indicated the tumor was near-totally resected (G, H).",fonc-13-1172143-g002,NotMatch,NotMatch
PMC10405728,Figure 3,"Preoperative enhanced MRI showed that the nodular enhancement was found in both sides of parietal cerebral falx, with the largest size of 3.4x1.8x3.6 cm (A–C). Postoperative MRI demonstrated the tumor was resected completely (D–F).",fonc-13-1172143-g003,NotMatch,Match
PMC10405728,Figure 4,"Histopathology results (A, 200×magnification and B, 400×magnification) showed the tumor cells were round and oval with visible nucleoli, mitotic figures were easy to be seen, and small focal necrosis could be seen. Thin-walled blood vessels could be observed in the stroma. Immunohistochemistry staining at 400× magnification showed that the tumor cells were positive for CD34 (C), STAT6 (D).",fonc-13-1172143-g004,NotMatch,NotMatch
PMC7936038,Fig. 1,"
Sagittal (left), coronal (middle), and axial (right) preoperative (Preop) magnetic resonance imaging (MRI) of a jugular foramen schwannoma. (Used with permission from Barrow Neurological Institute, Phoenix, Arizona.)
",10-1055-s-0040-1701680-i190060ov-1,NotMatch,NotMatch
PMC7936038,Fig. 2,"
Sagittal (left), coronal (middle), and axial (right) postoperative (Postop) magnetic resonance imaging (MRI) of a jugular foramen schwannoma. (Used with permission from Barrow Neurological Institute, Phoenix, Arizona.)
",10-1055-s-0040-1701680-i190060ov-2,NotMatch,NotMatch
